data_2klh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.79 0.329 . . . . 72.420000000000002 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.149999999999999 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.140000000000001 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.854 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.349999999999994 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.140000000000001 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HD12 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.030000000000001 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.020000000000003 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.209999999999994 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.349999999999994 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.409999999999997 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.030000000000001 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.450000000000003 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.119999999999997 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.229999999999997 110.26 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.140000000000001 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.468 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 74.349999999999994 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.467 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.040000000000006 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.510000000000005 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.450000000000003 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.140000000000001 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.149999999999999 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 74.349999999999994 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.310000000000002 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.319999999999993 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.409999999999997 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 43' ' ' THR . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 73.409999999999997 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.468 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.120000000000005 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.109999999999999 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.54 ' CE1' HG21 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.219999999999999 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.530000000000001 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 60.43 111.512 179.732 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 112.687 -0.165 . . . . 53.219999999999999 112.687 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.459 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.140000000000001 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.099999999999994 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.519999999999996 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.420000000000002 110.762 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 63.140000000000001 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.409999999999997 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.349999999999994 111.229 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 75.439999999999998 111.438 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.586 ' CD1' ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.109999999999999 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.219999999999999 111.135 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 37.299999999999997 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.310000000000002 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.585 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.430000000000007 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 103' ' ' PRO . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.530000000000001 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 73.230000000000004 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 74.099999999999994 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.040000000000006 110.834 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 73.109999999999999 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.349999999999994 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.553 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.120000000000005 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.039999999999999 111.101 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' B' ' 86' ' ' PRO . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.399999999999999 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.129999999999995 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 17' ' ' SER . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.409999999999997 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.409999999999997 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.682 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.549999999999997 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 110.942 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.684 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.409999999999997 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HD2' ' CD1' ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 63.240000000000002 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.299999999999997 111.792 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.420000000000002 111.093 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.539999999999999 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.509999999999998 111.355 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.219999999999999 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.109999999999999 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HB2' HG21 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.530000000000001 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 79' ' ' VAL . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.150000000000006 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.549999999999997 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.519999999999996 111.217 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.420000000000002 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 112' ' ' SER . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.439999999999998 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.439999999999998 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 64.25 111.327 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.019999999999996 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.140000000000001 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.129999999999995 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.386 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 74.099999999999994 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.219999999999999 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.409999999999997 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' B' ' 88' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.120000000000005 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 72.510000000000005 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.120000000000005 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.340000000000003 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.040000000000006 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.129999999999995 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.420000000000002 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.310000000000002 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.150000000000006 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.510000000000005 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 110.841 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.400000000000006 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 75.0 111.28 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 138' ' ' GLU . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.319999999999993 112.825 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.519999999999996 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.530000000000001 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.140000000000001 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.340000000000003 111.098 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 61.409999999999997 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.010000000000005 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.149999999999999 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.540000000000006 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.409999999999997 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.209999999999994 111.4 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.120000000000005 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.099999999999994 111.564 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 110.907 179.629 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.777 0.322 . . . . 71.5 110.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.530000000000001 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.874 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.421 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 75.0 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.319999999999993 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.150000000000006 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.299999999999997 112.593 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.427 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 61.420000000000002 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.443 HD12 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 73.430000000000007 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.436 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 65.439999999999998 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.409 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.140000000000001 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.310000000000002 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.450000000000003 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.019999999999996 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.439999999999998 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 73.040000000000006 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.430000000000007 110.234 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.230000000000004 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 75.109999999999999 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.474 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.319999999999993 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.329999999999998 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.430000000000007 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.435 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 72.439999999999998 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.400000000000006 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.409999999999997 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.349999999999994 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.150000000000006 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.120000000000005 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' B' ' 43' ' ' THR . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.120000000000005 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.463 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.299999999999997 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.544 ' CE1' HG21 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' B' ' 45' ' ' HIS . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.219999999999999 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.130000000000003 111.489 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.645 -0.182 . . . . 62.140000000000001 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.47 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.329999999999998 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.040000000000006 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.209999999999994 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.409999999999997 110.754 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.442 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 75.209999999999994 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.420000000000002 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.520000000000003 111.199 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.350000000000001 111.481 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.587 ' CD1' ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.049999999999997 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.200000000000003 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.421 ' HB2' ' HE2' ' B' ' 13' ' ' TYR . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.329999999999998 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.210000000000001 111.16 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.450000000000003 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.520000000000003 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.100000000000001 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 103' ' ' PRO . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 74.25 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.019999999999996 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 72.409999999999997 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 62.520000000000003 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.030000000000001 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 75.129999999999995 110.819 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.530000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.420000000000002 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.555 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.140000000000001 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.540000000000006 111.053 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 86' ' ' PRO . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.400000000000006 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.420000000000002 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' B' ' 17' ' ' SER . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.319999999999993 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.239999999999995 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.684 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.109999999999999 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.914 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 110.753 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.682 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.020000000000003 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.587 ' HD2' ' CD1' ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.030000000000001 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.119999999999997 111.835 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.329999999999998 111.103 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.430000000000007 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.240000000000002 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.310000000000002 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HB2' HG21 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.310000000000002 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.463 HD13 ' HB ' ' B' ' 79' ' ' VAL . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.439999999999998 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.230000000000004 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.349999999999994 111.242 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' B' ' 112' ' ' SER . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.230000000000004 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.310000000000002 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.120000000000005 111.384 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 75.140000000000001 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.340000000000003 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.310000000000002 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.209999999999994 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.396 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.329999999999998 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.239999999999995 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.409999999999997 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 88' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.210000000000001 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.430000000000007 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . 0.453 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.299999999999997 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.119999999999997 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 75.109999999999999 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 38.100000000000001 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.530000000000001 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.310000000000002 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.209999999999994 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.350000000000001 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 110.895 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.140000000000001 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.540000000000006 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.555 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.140000000000001 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.239999999999995 111.26 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 138' ' ' GLU . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.549999999999997 112.795 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.319999999999993 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 136' ' ' GLU . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 74.200000000000003 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.010000000000005 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.530000000000001 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 73.109999999999999 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 111.04 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.219999999999999 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.340000000000003 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.505 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.439999999999998 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.299999999999997 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.510000000000005 111.438 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.442 ' CE2' HG23 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 75.109999999999999 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.099999999999994 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.119999999999997 111.519 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.010000000000005 110.959 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.618 0.247 . . . . 75.219999999999999 111.068 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.510000000000005 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' HB2' HD21 ' A' ' 35' ' ' LEU . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.109999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.299999999999997 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.598 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 54.229999999999997 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.120000000000005 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.496 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.209999999999994 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.239999999999995 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.400000000000006 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.420000000000002 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.420000000000002 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 62.200000000000003 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.540000000000006 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.283 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.524 ' CE1' HG22 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 72.409999999999997 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.200000000000003 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.409999999999997 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.481 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 63.420000000000002 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 29' ' ' ALA . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.119999999999997 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.099999999999994 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.299999999999997 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 14' ' ' PHE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 72.120000000000005 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.219999999999999 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.549999999999997 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 73.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.140000000000001 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.030000000000001 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.239999999999995 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.119999999999997 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 74.340000000000003 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 64.510000000000005 111.39 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 63.210000000000001 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 74.129999999999995 111.498 179.296 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.624 -0.19 . . . . 37.990000000000002 112.624 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.329999999999998 111.325 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 62.109999999999999 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 73.439999999999998 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.099999999999994 110.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 74.540000000000006 111.497 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 64.219999999999999 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.400000000000006 111.252 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.299999999999997 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 111.194 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.540000000000006 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.350000000000001 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.239999999999995 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.439999999999998 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB1' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.239999999999995 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 103' ' ' PRO . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 104' ' ' ILE . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.019999999999996 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.340000000000003 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.439999999999998 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 111.129 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 112' ' ' SER . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 71.420000000000002 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.450000000000003 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.129999999999995 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.430000000000007 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.229999999999997 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.120000000000005 111.323 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.530000000000001 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.239999999999995 110.332 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.450000000000003 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 75.109999999999999 110.568 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.420000000000002 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.310000000000002 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.430000000000007 111.526 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.239999999999995 111.362 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.030000000000001 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.230000000000004 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.319999999999993 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 61.219999999999999 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.150000000000006 111.049 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.340000000000003 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' SER . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 73.310000000000002 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.436 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.229999999999997 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 73.319999999999993 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.150000000000006 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 37.990000000000002 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.239999999999995 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.129999999999995 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.420000000000002 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.510000000000005 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.439999999999998 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.040000000000006 110.742 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.150000000000006 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.230000000000004 110.934 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.109999999999999 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.209999999999994 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.020000000000003 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.109999999999999 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.596 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.239999999999995 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 72.230000000000004 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.299999999999997 110.876 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.415 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.209999999999994 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.52 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.420000000000002 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 64.319999999999993 111.521 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 138' ' ' GLU . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.310000000000002 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.239999999999995 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.52 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.439999999999998 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.040000000000006 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.521 ' HB3' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.099999999999994 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.200000000000003 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 54.119999999999997 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.428 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 73.230000000000004 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.439999999999998 110.779 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.420000000000002 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.340000000000003 111.151 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.420000000000002 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.329999999999998 111.715 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 110.862 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.642 0.258 . . . . 74.319999999999993 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.502 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.509999999999998 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.415 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 73.400000000000006 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.501 ' HB2' HD21 ' B' ' 35' ' ' LEU . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.230000000000004 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.601 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.299999999999997 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.492 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 74.340000000000003 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.492 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.510000000000005 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.415 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.439999999999998 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.129999999999995 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.420000000000002 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 71.409999999999997 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.219999999999999 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.319999999999993 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.310000000000002 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.256 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.526 ' CE1' HG22 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.299999999999997 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.422 ' O ' HG11 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.340000000000003 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.109999999999999 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.465 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.519999999999996 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.422 HG11 ' O ' ' B' ' 29' ' ' ALA . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.230000000000004 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.030000000000001 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.129999999999995 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.030000000000001 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.120000000000005 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.411 HG13 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.439999999999998 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.423 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.310000000000002 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.030000000000001 111.414 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 64.409999999999997 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.219999999999999 111.425 179.279 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 -0.188 . . . . 44.140000000000001 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.519999999999996 111.343 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.130000000000003 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.400000000000006 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.835 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 111.411 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.430000000000007 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.540000000000006 111.228 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.140000000000001 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.299999999999997 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.009999999999998 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 74.530000000000001 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.219999999999999 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.340000000000003 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.319999999999993 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.219999999999999 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' B' ' 103' ' ' PRO . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.413 ' HB ' HD12 ' B' ' 104' ' ' ILE . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.409999999999997 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.551 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.109999999999999 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.219999999999999 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.129999999999995 111.129 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.404 ' HB ' ' OG ' ' B' ' 112' ' ' SER . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 72.140000000000001 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.239999999999995 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.482 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.399999999999999 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.209999999999994 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.209999999999994 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.149999999999999 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.099999999999994 111.264 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.625 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.420000000000002 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.209999999999994 110.449 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 65.140000000000001 110.319 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.617 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.349999999999994 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.4 ' HG3' HD12 ' B' ' 70' ' ' LEU . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.119999999999997 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.420000000000002 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.200000000000003 111.4 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 111.408 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.239999999999995 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 74.109999999999999 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.200000000000003 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.413 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.049999999999997 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 75.040000000000006 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 74.319999999999993 110.954 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.450000000000003 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.554 ' HB3' ' HB2' ' B' ' 112' ' ' SER . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.319999999999993 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.432 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.019999999999996 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.409999999999997 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.230000000000004 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 38.869999999999997 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.230000000000004 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.319999999999993 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 70.329999999999998 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.310000000000002 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.010000000000005 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.100000000000001 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.350000000000001 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.099999999999994 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 72.019999999999996 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 110.922 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.520000000000003 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.89 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 74.549999999999997 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.219999999999999 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.430000000000007 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.409999999999997 111.548 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 138' ' ' GLU . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.299999999999997 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' B' ' 136' ' ' GLU . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.420000000000002 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.531 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 73.439999999999998 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.209999999999994 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.528 ' HB3' HD23 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.519999999999996 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.140000000000001 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.423 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 73.540000000000006 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.310000000000002 110.702 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.420000000000002 111.171 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.407 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.530000000000001 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.099999999999994 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.319999999999993 111.65 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.129999999999995 110.902 179.694 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.326 . . . . 64.010000000000005 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.150000000000006 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.340000000000003 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.439999999999998 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 74.530000000000001 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' HD11 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.549999999999997 110.817 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.340000000000003 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.140000000000001 112.608 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.340000000000003 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.319999999999993 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.010000000000005 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.420000000000002 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.400000000000006 110.324 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.329999999999998 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.439999999999998 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.319999999999993 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.120000000000005 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' ALA . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 73.439999999999998 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 44.039999999999999 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.129999999999995 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 111.007 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.299999999999997 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.340000000000003 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.349999999999994 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.209999999999994 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.140000000000001 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG13 HG22 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 65.349999999999994 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.099999999999994 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.404 ' CG2' ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.450000000000003 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.239999999999995 111.751 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.140000000000001 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.804 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.965 -0.353 . . . . 64.319999999999993 113.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.420000000000002 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.109999999999999 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 110.942 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.010000000000005 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.150000000000006 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.130000000000003 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.519999999999996 111.219 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.430000000000007 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 75.0 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' CD2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.420000000000002 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.030000000000001 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.040000000000006 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.240000000000002 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.120000000000005 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.019999999999996 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.030000000000001 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.230000000000004 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.229999999999997 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.331 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.340000000000003 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.219999999999999 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.408 ' HB2' HG13 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.603 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.239999999999995 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.540000000000006 112.54 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.219999999999999 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.129999999999995 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.611 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.140000000000001 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 111.0 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.319999999999993 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.400000000000006 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.430000000000007 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.239999999999995 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.430000000000007 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.200000000000003 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 75.140000000000001 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.572 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.400000000000006 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' ' CD1' ' A' ' 129' ' ' PHE . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.350000000000001 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 63.149999999999999 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.420000000000002 111.152 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.140000000000001 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.510000000000005 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.310000000000002 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.349999999999994 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.119999999999997 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.239999999999995 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 64.519999999999996 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 53.229999999999997 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 64.150000000000006 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.530000000000001 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.340000000000003 111.687 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.239999999999995 110.576 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.45 ' CD1' HD21 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.109999999999999 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.329999999999998 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.340000000000003 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.565 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.109999999999999 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.400000000000006 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.329999999999998 110.932 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.562 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.540000000000006 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.603 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.400000000000006 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.030000000000001 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.549999999999997 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.603 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.119999999999997 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.140000000000001 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.140000000000001 110.521 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.230000000000004 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.120000000000005 111.155 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.340000000000003 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.329999999999998 111.069 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.219999999999999 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.129999999999995 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.140000000000001 111.524 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.040000000000006 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 54.219999999999999 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 75.219999999999999 111.186 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.439999999999998 110.995 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.799 0.333 . . . . 74.049999999999997 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 62.340000000000003 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.55 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.299999999999997 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.44 ' CD1' HD11 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 75.329999999999998 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.430000000000007 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.519 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.109999999999999 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.109999999999999 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 72.5 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 112.589 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.399999999999999 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 74.430000000000007 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.420000000000002 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.439999999999998 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.509999999999998 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.400000000000006 110.328 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.219999999999999 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.426 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.450000000000003 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.040000000000006 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.433 HG22 HG13 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.450000000000003 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.319999999999993 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 60.43 111.003 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 64.109999999999999 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.239999999999995 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.120000000000005 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.019999999999996 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.519999999999996 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.433 HG13 HG22 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.413 ' CG2' ' HE2' ' B' ' 28' ' ' TYR . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.099999999999994 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.109999999999999 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 75.209999999999994 111.699 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 71.140000000000001 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.109999999999999 110.768 178.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.404 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.039 -0.312 . . . . 64.439999999999998 113.454 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.140000000000001 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 61' ' ' GLY . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.329999999999998 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 74.299999999999997 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.150000000000006 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.435 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.310000000000002 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.549999999999997 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.430000000000007 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.130000000000003 111.927 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 65.040000000000006 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 71.439999999999998 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.420000000000002 110.988 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.239999999999995 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.439999999999998 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.450000000000003 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.219999999999999 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 51.229999999999997 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 112.037 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.049999999999997 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.219999999999999 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.25 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.430000000000007 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.517 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' HG13 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.349999999999994 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.609 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.099999999999994 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.603 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.120000000000005 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.420000000000002 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.219999999999999 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.039999999999999 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.527 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.430000000000007 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.019999999999996 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.540000000000006 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.209999999999994 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.030000000000001 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.340000000000003 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.575 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 72.209999999999994 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.408 HD13 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.329999999999998 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.120000000000005 111.112 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.239999999999995 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.040000000000006 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.099999999999994 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.409999999999997 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.510000000000005 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.100000000000001 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.450000000000003 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.406 HD21 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.020000000000003 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 73.530000000000001 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 73.519999999999996 111.674 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 74.430000000000007 110.638 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.44 ' CD1' HD21 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 73.129999999999995 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.509999999999998 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.329999999999998 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 72.319999999999993 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.540000000000006 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.310000000000002 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.340000000000003 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.230000000000004 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.019999999999996 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.230000000000004 110.914 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.129999999999995 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.200000000000003 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.587 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 61.530000000000001 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.129999999999995 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.430000000000007 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.219999999999999 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.109999999999999 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.019999999999996 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.119999999999997 111.179 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.536 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.430000000000007 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.549999999999997 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.040000000000006 111.497 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.049999999999997 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.530000000000001 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.450000000000003 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.239999999999995 111.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.209999999999994 110.953 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.713 0.292 . . . . 75.109999999999999 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 64.049999999999997 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.130000000000003 110.787 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 74.120000000000005 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.430000000000007 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.420000000000002 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.488 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.409999999999997 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.522 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 74.409999999999997 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.51 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 74.030000000000001 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.140000000000001 112.42 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.140000000000001 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.340000000000003 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.530000000000001 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.439999999999998 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.299999999999997 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.420000000000002 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 74.010000000000005 110.737 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.569 ' CE2' HG22 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 75.219999999999999 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.539999999999999 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 32' ' ' VAL . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.55 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 75.239999999999995 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.329999999999998 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.030000000000001 111.224 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.329999999999998 110.871 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.129999999999995 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.450000000000003 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.319999999999993 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.239999999999995 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.454 HG21 HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.209999999999994 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.439999999999998 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.400000000000006 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.130000000000003 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.100000000000001 110.76 179.383 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.557 -0.217 . . . . 74.310000000000002 112.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.420000000000002 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.530000000000001 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.540000000000006 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' B' ' 118' ' ' ALA . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.420000000000002 110.792 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.349999999999994 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.430000000000007 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.439999999999998 111.117 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.209999999999994 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 70.140000000000001 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 62.420000000000002 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.010000000000005 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.040000000000006 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 103' ' ' PRO . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.230000000000004 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.349999999999994 110.577 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.450000000000003 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.450000000000003 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.120000000000005 110.71 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.539999999999999 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.549999999999997 111.525 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.540000000000006 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.340000000000003 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.119999999999997 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.52 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.120000000000005 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.439999999999998 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.520000000000003 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.120000000000005 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 73.5 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 62.229999999999997 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 38.57 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.219999999999999 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 104' ' ' ILE . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.239999999999995 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.209999999999994 111.371 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.010000000000005 111.466 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.100000000000001 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.040000000000006 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.556 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 73.109999999999999 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 98' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.219999999999999 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.129999999999995 111.075 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.403 HD12 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.150000000000006 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.310000000000002 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.611 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.310000000000002 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.450000000000003 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.140000000000001 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.540000000000006 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.219999999999999 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.310000000000002 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB3' HD12 ' B' ' 65' ' ' ILE . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.349999999999994 112.352 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.433 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.040000000000006 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 HD13 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.040000000000006 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.319999999999993 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.349999999999994 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.140000000000001 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.239999999999995 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.040000000000006 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.209999999999994 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.129999999999995 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.422 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 54.340000000000003 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.019 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.086 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.6 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.219999999999999 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.239999999999995 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.150000000000006 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.349999999999994 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.140000000000001 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 38.57 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.509999999999998 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.030000000000001 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 65.030000000000001 110.947 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.109999999999999 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.49 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.540000000000006 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.219999999999999 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.129999999999995 111.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 111.232 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.549999999999997 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 111.567 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.099999999999994 111.477 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.703 0.287 . . . . 62.030000000000001 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.230000000000004 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.310000000000002 110.75 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' B' ' 42' ' ' LEU . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 73.540000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.431 ' HA ' HG12 ' B' ' 80' ' ' VAL . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.299999999999997 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.349999999999994 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.504 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 73.400000000000006 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.52 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.150000000000006 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.515 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.329999999999998 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 36.850000000000001 112.45 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.210000000000001 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.329999999999998 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.539999999999999 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.319999999999993 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.230000000000004 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.239999999999995 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.571 ' CE2' HG22 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.25 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.109999999999999 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.310000000000002 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.53 HD12 HG22 ' B' ' 32' ' ' VAL . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.329999999999998 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.534 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.430000000000007 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.549999999999997 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.510000000000005 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.209999999999994 111.252 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.299999999999997 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.219999999999999 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.319999999999993 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 62.32 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.450000000000003 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.441 HG21 HG22 ' B' ' 46' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.230000000000004 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.130000000000003 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.427 ' NE2' HG21 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.439999999999998 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.409999999999997 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.399999999999999 110.771 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.553 -0.219 . . . . 73.510000000000005 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.329999999999998 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.530000000000001 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 118' ' ' ALA . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.099999999999994 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.457 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 71.230000000000004 111.13 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.140000000000001 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.400000000000006 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.219999999999999 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 72.239999999999995 111.541 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.400000000000006 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' B' ' 103' ' ' PRO . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 110.564 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.69 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 72.510000000000005 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 63.100000000000001 111.575 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.030000000000001 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.209999999999994 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 65.439999999999998 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.340000000000003 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.010000000000005 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.52 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.526 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 75.519999999999996 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.409999999999997 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.422 HD22 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.450000000000003 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.527 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.120000000000005 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 74.219999999999999 110.444 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' B' ' 73' ' ' LEU . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.636 HG21 HG13 ' B' ' 104' ' ' ILE . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.239999999999995 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.200000000000003 111.329 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.239999999999995 111.547 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.150000000000006 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.420000000000002 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.540000000000006 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.636 HG13 HG21 ' B' ' 98' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.049999999999997 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 75.239999999999995 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.420000000000002 111.08 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.340000000000003 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.623 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.239999999999995 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.605 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.140000000000001 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.310000000000002 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.486 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 74.230000000000004 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.109999999999999 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 75.310000000000002 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.219999999999999 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 65' ' ' ILE . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.420000000000002 112.358 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.455 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.109999999999999 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.488 HG13 HD13 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.409999999999997 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 36.850000000000001 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.230000000000004 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.100000000000001 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.129999999999995 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.329999999999998 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.099999999999994 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 73.109999999999999 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . 0.422 ' CZ ' HD22 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.230000000000004 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 73.530000000000001 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.08 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.605 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.030000000000001 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.605 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.349999999999994 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.009999999999998 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.209999999999994 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.400000000000006 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.239999999999995 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.030000000000001 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.41 ' HG2' HD12 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.219999999999999 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.310000000000002 111.028 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.200000000000003 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.491 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 74.230000000000004 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 74.120000000000005 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.349999999999994 111.271 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.439999999999998 111.236 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.219999999999999 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.040000000000006 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 111.527 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.120000000000005 111.367 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.695 0.283 . . . . 70.540000000000006 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.229999999999997 111.153 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.399999999999999 111.233 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 74.329999999999998 110.503 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 75.439999999999998 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.209999999999994 112.191 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.299999999999997 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG1' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.129999999999995 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.409999999999997 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 36.420000000000002 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.120000000000005 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.209999999999994 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.439999999999998 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.020000000000003 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.200000000000003 111.44 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 74.540000000000006 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.450000000000003 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 63.140000000000001 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.019999999999996 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.450000000000003 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.230000000000004 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.150000000000006 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.209999999999994 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.530000000000001 111.066 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.319999999999993 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.439999999999998 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.030000000000001 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.120000000000005 111.963 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 72.140000000000001 110.574 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.420000000000002 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.487 ' CE1' HG21 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 74.209999999999994 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 71.329999999999998 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.329999999999998 110.427 179.191 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 114.252 0.461 . . . . 62.32 114.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.099999999999994 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.119999999999997 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.825 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.453 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 73.109999999999999 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.200000000000003 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.109999999999999 111.773 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.319999999999993 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.510000000000005 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.299999999999997 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.519999999999996 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.409999999999997 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.149999999999999 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.409999999999997 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 36.420000000000002 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.400000000000006 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.340000000000003 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.010000000000005 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.567 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.150000000000006 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.209999999999994 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.409999999999997 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.549999999999997 111.35 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 65.109999999999999 111.627 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.349999999999994 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.119999999999997 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.439999999999998 110.541 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 HD13 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.540000000000006 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.409999999999997 112.247 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' HA3' HD21 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.409999999999997 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.409999999999997 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' B' ' 119' ' ' MET . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.340000000000003 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.310000000000002 110.765 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.530000000000001 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.030000000000001 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.430000000000007 111.818 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.049999999999997 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.540000000000006 111.466 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.400000000000006 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 74.230000000000004 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.420000000000002 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.430000000000007 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 73.150000000000006 110.913 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 74.030000000000001 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 73.299999999999997 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.540000000000006 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.584 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.140000000000001 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.399999999999999 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.329999999999998 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 36.420000000000002 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.129999999999995 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.209999999999994 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.099999999999994 110.24 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.310000000000002 111.446 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.413 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.420000000000002 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.557 HD13 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.019999999999996 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.430000000000007 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.299999999999997 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.310000000000002 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.509999999999998 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.030000000000001 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.319999999999993 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 75.140000000000001 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.439999999999998 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 73.349999999999994 110.655 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 71.230000000000004 110.975 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 65.099999999999994 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.140000000000001 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.219999999999999 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.239999999999995 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 73.040000000000006 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.120000000000005 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.439999999999998 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.340000000000003 110.867 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 72.25 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.530000000000001 111.264 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.420000000000002 111.656 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.425 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 75.400000000000006 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 73.319999999999993 111.552 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.400000000000006 110.981 179.603 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.696 0.284 . . . . 70.129999999999995 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.340000000000003 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.439999999999998 111.17 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.430000000000007 111.166 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.534 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.120000000000005 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.430000000000007 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.219999999999999 112.207 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.563 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.299999999999997 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG1' ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.209999999999994 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.210000000000001 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.420000000000002 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.519999999999996 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.510000000000005 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.310000000000002 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 37.969999999999999 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.549999999999997 111.416 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.546 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.450000000000003 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.329999999999998 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.109999999999999 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.546 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.329999999999998 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.140000000000001 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 64.109999999999999 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.209999999999994 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' B' ' 147' ' ' PHE . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.319999999999993 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.040000000000006 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 70.329999999999998 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.530000000000001 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.239999999999995 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.109999999999999 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.120000000000005 111.91 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.549999999999997 110.593 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.430000000000007 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 64.510000000000005 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.531 HG22 ' CE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.519999999999996 110.425 179.161 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 N-CA-C 114.256 0.462 . . . . 70.519999999999996 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.436 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.129999999999995 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.510000000000005 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.129999999999995 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.839 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.46 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 71.540000000000006 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.209999999999994 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.109999999999999 111.764 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.340000000000003 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.544 HD23 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.340000000000003 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.219999999999999 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.349999999999994 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.549999999999997 111.543 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 74.439999999999998 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.299999999999997 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.510000000000005 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.319999999999993 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.030000000000001 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.129999999999995 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.400000000000006 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.200000000000003 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.340000000000003 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 64.140000000000001 111.408 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.430000000000007 111.596 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . 0.48 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.299999999999997 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' B' ' 85' ' ' GLN . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.030000000000001 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.239999999999995 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.299999999999997 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.209999999999994 112.268 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' B' ' 17' ' ' SER . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 73.519999999999996 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.209999999999994 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.545 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.349999999999994 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.040000000000006 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.409999999999997 110.749 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.548 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.200000000000003 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.544 ' HG2' HD23 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.420000000000002 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.408 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.439999999999998 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.129999999999995 111.781 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.240000000000002 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.310000000000002 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.230000000000004 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.409999999999997 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.567 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 65.25 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.420000000000002 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.57 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 65.530000000000001 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.019999999999996 110.945 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.439999999999998 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.420000000000002 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.150000000000006 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.439999999999998 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.540000000000006 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.019999999999996 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 75.129999999999995 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.350000000000001 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.210000000000001 111.449 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.200000000000003 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.536 HD13 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.310000000000002 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.409999999999997 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 37.969999999999999 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 51.030000000000001 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.439999999999998 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.530000000000001 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 72.329999999999998 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.409999999999997 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.299999999999997 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.509999999999998 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.612 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 73.030000000000001 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.539999999999999 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.099999999999994 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.340000000000003 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.299999999999997 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.612 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.209999999999994 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.420000000000002 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.210000000000001 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.209999999999994 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.451 HD23 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.219999999999999 110.872 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 53.43 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 73.439999999999998 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.030000000000001 111.215 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.130000000000003 111.64 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 73.349999999999994 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.239999999999995 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.420000000000002 111.588 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.340000000000003 110.958 179.614 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.909 0.385 . . . . 72.150000000000006 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.200000000000003 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 110.732 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.039999999999999 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.329999999999998 110.953 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' HG13 ' A' ' 90' ' ' VAL . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.219999999999999 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.100000000000001 111.426 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.62 ' HB2' HG23 ' A' ' 90' ' ' VAL . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.120000000000005 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.56 HG21 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.219999999999999 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.4 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.040000000000006 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.420000000000002 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.239999999999995 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.219999999999999 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.129999999999995 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 74.540000000000006 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.439999999999998 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.530000000000001 110.644 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.100000000000001 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.039999999999999 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.471 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.439999999999998 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 31' ' ' ILE . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.209999999999994 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.400000000000006 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 43.200000000000003 111.033 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.219999999999999 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 72.25 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.109999999999999 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.439999999999998 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 110.254 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.310000000000002 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.439999999999998 110.211 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.120000000000005 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.319999999999993 111.56 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 54.340000000000003 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 60.229999999999997 110.348 178.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.621 -0.191 . . . . 74.239999999999995 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.430000000000007 111.099 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 75.420000000000002 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.420000000000002 110.659 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.040000000000006 111.117 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.299999999999997 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.099999999999994 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.299999999999997 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.120000000000005 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.409999999999997 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.519999999999996 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.219999999999999 111.435 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.420000000000002 111.177 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.319999999999993 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.524 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.239999999999995 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.400000000000006 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 104' ' ' ILE . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 74.140000000000001 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HA ' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 73.510000000000005 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.430000000000007 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.409999999999997 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 74.420000000000002 111.196 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 64.150000000000006 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 62.409999999999997 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.430000000000007 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 71.219999999999999 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.219999999999999 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.439999999999998 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' B' ' 88' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.019999999999996 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 73.5 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.019999999999996 111.08 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.5 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.049999999999997 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' HD13 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.129999999999995 111.359 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 104' ' ' ILE . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.109999999999999 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.049999999999997 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 72.209999999999994 111.862 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.439999999999998 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.030000000000001 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.219999999999999 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 98' ' ' VAL . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.329999999999998 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.340000000000003 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' HD21 ' A' ' 94' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.109999999999999 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.519 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.030000000000001 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.400000000000006 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.319999999999993 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.019999999999996 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.430000000000007 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.219999999999999 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.400000000000006 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.340000000000003 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.350000000000001 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.565 ' CE ' ' HB1' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 74.109999999999999 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.467 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.530000000000001 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.209999999999994 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.099999999999994 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HB1' ' ND1' ' B' ' 66' ' ' HIS . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 74.200000000000003 111.016 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.530000000000001 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.519999999999996 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 37.030000000000001 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.340000000000003 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.529 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.530000000000001 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.150000000000006 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.230000000000004 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.651 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 75.409999999999997 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.340000000000003 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.020000000000003 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.229999999999997 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.120000000000005 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.651 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.549999999999997 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.420000000000002 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.200000000000003 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.299999999999997 110.792 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.049999999999997 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.239999999999995 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.010000000000005 111.198 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.209999999999994 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.049999999999997 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.319999999999993 111.106 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 111.327 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.530000000000001 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.040000000000006 110.676 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.456 HG11 HG11 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.230000000000004 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 110.927 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.510000000000005 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.546 ' HB3' HG13 ' B' ' 90' ' ' VAL . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.439999999999998 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.210000000000001 111.44 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 90' ' ' VAL . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 70.400000000000006 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.551 HG21 HG12 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.219999999999999 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.403 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 74.400000000000006 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.444 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.119999999999997 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.329999999999998 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.239999999999995 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.200000000000003 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.540000000000006 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.240000000000002 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.120000000000005 110.645 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.701 ' CD2' HG22 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 63.420000000000002 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.409999999999997 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 32' ' ' VAL . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 71.120000000000005 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.475 HG21 HD11 ' B' ' 31' ' ' ILE . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.409999999999997 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.239999999999995 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.083 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.150000000000006 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.219999999999999 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.439999999999998 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 72.129999999999995 110.326 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.239999999999995 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.319999999999993 110.258 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.340000000000003 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 63.420000000000002 111.538 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.701 HG22 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.120000000000005 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.450000000000003 110.344 178.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 112.64 -0.184 . . . . 72.129999999999995 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 74.150000000000006 111.144 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.319999999999993 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 72.200000000000003 110.659 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 111.1 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.549 ' C ' ' CD2' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.299999999999997 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 75.019999999999996 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.130000000000003 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.565 ' HB1' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.239999999999995 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.421 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.209999999999994 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.458 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.420000000000002 111.496 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.150000000000006 111.132 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 51.32 111.629 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.120000000000005 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.329999999999998 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.471 ' HB ' HD13 ' B' ' 104' ' ' ILE . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.578 ' HA ' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.310000000000002 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.240000000000002 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.540000000000006 111.173 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.46 ' CG2' ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.329999999999998 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.229999999999997 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.329999999999998 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.230000000000004 110.773 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.558 HD11 ' HA3' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 64.510000000000005 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.615 HG23 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.209999999999994 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 37.729999999999997 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.420000000000002 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.086 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.506 ' CD2' ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.299999999999997 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.421 ' HD2' HD13 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.299999999999997 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.219999999999999 111.398 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.502 HG21 HG13 ' B' ' 104' ' ' ILE . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 71.409999999999997 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.219999999999999 111.896 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.310000000000002 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.563 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.400000000000006 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.502 HG13 HG21 ' B' ' 98' ' ' VAL . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.120000000000005 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' B' ' 94' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.486 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.420000000000002 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.150000000000006 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.140000000000001 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.518 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 72.200000000000003 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.420000000000002 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.483 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.329999999999998 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.329999999999998 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.465 ' HA ' ' HB3' ' B' ' 86' ' ' PRO . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 74.230000000000004 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.049999999999997 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.409999999999997 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.573 ' CE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.120000000000005 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.471 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 71.299999999999997 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.140000000000001 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . 0.462 ' HB1' ' ND1' ' A' ' 66' ' ' HIS . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.310000000000002 110.974 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.130000000000003 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.229999999999997 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.030000000000001 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.546 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.340000000000003 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 73.329999999999998 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 110.944 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.468 ' CE3' ' SD ' ' B' ' 142' ' ' MET . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.219999999999999 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.310000000000002 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.643 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.129999999999995 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.340000000000003 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.130000000000003 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 74.329999999999998 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.643 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.310000000000002 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.109999999999999 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.230000000000004 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.464 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 74.0 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 74.230000000000004 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.399999999999999 111.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.239999999999995 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.329999999999998 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.540000000000006 111.503 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.040000000000006 111.084 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.791 0.329 . . . . 62.140000000000001 111.287 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.519999999999996 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.310000000000002 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 75.209999999999994 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.430000000000007 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HD1' ' CE1' ' A' ' 28' ' ' TYR . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.219999999999999 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.409999999999997 111.952 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.329999999999998 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.561 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.200000000000003 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.450000000000003 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 37.810000000000002 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.140000000000001 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.420000000000002 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.019999999999996 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.040000000000006 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.349999999999994 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CD1' HG22 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.099999999999994 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.049999999999997 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 32' ' ' VAL . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 74.430000000000007 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 31' ' ' ILE . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.239999999999995 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.430000000000007 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.420000000000002 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.150000000000006 111.016 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.200000000000003 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.129999999999995 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.530000000000001 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.340000000000003 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' HG3' ' A' ' 44' ' ' GLU . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.430000000000007 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.439999999999998 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 61.229999999999997 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.510000000000005 110.827 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 60.030000000000001 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.149999999999999 111.864 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 120.252 -0.193 . . . . 54.240000000000002 113.329 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' HA ' HD13 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 73.329999999999998 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 64.140000000000001 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 72.209999999999994 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 62' ' ' ASP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 75.420000000000002 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.510000000000005 111.439 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.239999999999995 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.519999999999996 111.319 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.319999999999993 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 73.010000000000005 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.349999999999994 111.737 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.420000000000002 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.219999999999999 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.450000000000003 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.439999999999998 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 71.540000000000006 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.009999999999998 111.804 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.219999999999999 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.510000000000005 111.144 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 70.129999999999995 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.329999999999998 112.443 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' CD2' HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 71.510000000000005 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.350000000000001 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 17' ' ' SER . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.019999999999996 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.109999999999999 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.230000000000004 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.520000000000003 110.44 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.219999999999999 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.597 ' HD2' HD13 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.329999999999998 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.402 ' HB3' HG22 ' A' ' 79' ' ' VAL . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.229999999999997 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.46 ' CG2' HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.230000000000004 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.349999999999994 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.439999999999998 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.340000000000003 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.409999999999997 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.530000000000001 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.230000000000004 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.329999999999998 110.936 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.539999999999999 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 112' ' ' SER . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.140000000000001 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.446 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.509999999999998 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.020000000000003 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.329999999999998 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.329999999999998 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.420000000000002 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.299999999999997 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 74.5 110.725 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.526 HG12 ' HA2' ' B' ' 89' ' ' GLY . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.349999999999994 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 37.810000000000002 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.240000000000002 110.795 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 71.409999999999997 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.120000000000005 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.310000000000002 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.439999999999998 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.409999999999997 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 75.439999999999998 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 111.173 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.409999999999997 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.628 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.230000000000004 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.109999999999999 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.400000000000006 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.299999999999997 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.200000000000003 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.040000000000006 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.43 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.420000000000002 111.11 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.130000000000003 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.109999999999999 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.019999999999996 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.310000000000002 111.088 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.540000000000006 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.130000000000003 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.219999999999999 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.549999999999997 110.834 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.142 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 74.519999999999996 111.229 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.540000000000006 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.219999999999999 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.310000000000002 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.420000000000002 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HD1' ' CE1' ' B' ' 28' ' ' TYR . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.040000000000006 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.340000000000003 111.861 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.489 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.230000000000004 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.568 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.049999999999997 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.476 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 73.230000000000004 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.428 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 37.780000000000001 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.219999999999999 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.140000000000001 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.230000000000004 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.420000000000002 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.509999999999998 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.319999999999993 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.120000000000005 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.55 ' CD1' HG22 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.319999999999993 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.019999999999996 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.527 HD12 HG21 ' B' ' 32' ' ' VAL . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.519999999999996 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.527 HG21 HD12 ' B' ' 31' ' ' ILE . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.539999999999999 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.329999999999998 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.340000000000003 111.05 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.319999999999993 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.010000000000005 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.239999999999995 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.219999999999999 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.549999999999997 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' B' ' 44' ' ' GLU . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' ' 13' ' ' TYR . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.472 HG22 ' O ' ' B' ' 14' ' ' PHE . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.219999999999999 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.329999999999998 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.439999999999998 110.809 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.568 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.329999999999998 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.299999999999997 111.865 179.66 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.419 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.338 0 CA-C-O 120.21 -0.217 . . . . 65.349999999999994 113.3 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.475 ' HA ' HD13 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.140000000000001 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.319999999999993 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' B' ' 62' ' ' ASP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.519999999999996 111.421 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.209999999999994 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.230000000000004 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.299999999999997 111.259 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.605 HD13 ' HD2' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.109999999999999 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.530000000000001 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.507 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' B' ' 97' ' ' ALA . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.430000000000007 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.209999999999994 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.040000000000006 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.099999999999994 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 74.129999999999995 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.340000000000003 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.030000000000001 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.229999999999997 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.209999999999994 111.094 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.406 ' CG2' ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.340000000000003 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.140000000000001 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.409999999999997 112.384 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.430000000000007 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.416 ' CD2' HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 37.780000000000001 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' B' ' 17' ' ' SER . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.329999999999998 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.616 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 74.439999999999998 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 110.448 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.618 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.350000000000001 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.605 ' HD2' HD13 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.239999999999995 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' B' ' 79' ' ' VAL . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.140000000000001 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.019999999999996 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.319999999999993 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.349999999999994 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.230000000000004 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.099999999999994 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.129999999999995 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' B' ' 81' ' ' ALA . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.509999999999998 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.329999999999998 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.474 ' CZ ' ' HA ' ' B' ' 112' ' ' SER . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.150000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.457 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.099999999999994 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.474 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.130000000000003 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.120000000000005 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 74.409999999999997 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.140000000000001 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.239999999999995 110.616 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.109999999999999 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.099999999999994 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.329999999999998 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 89' ' ' GLY . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.340000000000003 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.209999999999994 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.229999999999997 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.239999999999995 110.753 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.350000000000001 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 63.409999999999997 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.350000000000001 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.229999999999997 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.409999999999997 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' B' ' 104' ' ' ILE . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.450000000000003 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.310000000000002 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.310000000000002 111.24 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.120000000000005 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.457 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.530000000000001 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.618 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 74.109999999999999 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.209999999999994 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.439999999999998 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.329999999999998 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.618 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.039999999999999 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.299999999999997 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.299999999999997 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.310000000000002 111.053 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.200000000000003 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.109999999999999 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.412 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.450000000000003 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 70.209999999999994 110.789 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.728 0.299 . . . . 55.450000000000003 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.240000000000002 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.400000000000006 110.995 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.209999999999994 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.540000000000006 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.409999999999997 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.530000000000001 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.340000000000003 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.120000000000005 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.509999999999998 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 75.109999999999999 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.430000000000007 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.420000000000002 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.450000000000003 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 110.079 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 46' ' ' VAL . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 74.120000000000005 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 28' ' ' TYR . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.409999999999997 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.340000000000003 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 71.409999999999997 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.140000000000001 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.439999999999998 111.255 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.329999999999998 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.329999999999998 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.409999999999997 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.409999999999997 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 HG23 HG13 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.030000000000001 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.450000000000003 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.412 HG23 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.049999999999997 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.030000000000001 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 54.4 p-80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.539999999999999 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.573 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 70.329999999999998 110.865 179.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 119.793 -0.448 . . . . 64.430000000000007 113.805 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.049999999999997 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.329999999999998 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.109999999999999 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.150000000000006 110.716 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.120000000000005 111.38 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.420000000000002 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.150000000000006 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 75.430000000000007 111.203 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.539999999999999 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.439999999999998 111.252 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.219999999999999 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 100' ' ' LEU . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.539999999999999 110.421 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.099999999999994 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.200000000000003 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.530000000000001 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 103' ' ' PRO . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 65.329999999999998 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.150000000000006 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.299999999999997 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.010000000000005 111.264 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.109999999999999 111.557 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.530000000000001 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HA ' HD13 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.329999999999998 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.109999999999999 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.140000000000001 112.532 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.400000000000006 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.299999999999997 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.654 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.140000000000001 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.519999999999996 110.274 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.649 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.409999999999997 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.129999999999995 110.761 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 79' ' ' VAL . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.119999999999997 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.5 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.129999999999995 111.301 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 74' ' ' GLN . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.519999999999996 111.328 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.399999999999999 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 73.040000000000006 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.040000000000006 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.310000000000002 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.409999999999997 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.310000000000002 110.744 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.039999999999999 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.519999999999996 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.45 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.209999999999994 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.020000000000003 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 37.700000000000003 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.420000000000002 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.209999999999994 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 HD12 ' B' ' 88' ' ' LEU . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.229999999999997 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.540000000000006 111.456 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.140000000000001 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.423 ' HE1' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.421 HG21 ' HB3' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 71.239999999999995 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.329999999999998 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.299999999999997 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 73.109999999999999 110.67 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.519999999999996 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.329999999999998 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.149999999999999 111.101 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 111.244 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.469 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.439999999999998 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.010000000000005 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.544 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 75.400000000000006 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.519999999999996 111.236 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.409999999999997 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 37.700000000000003 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.109999999999999 111.676 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.400000000000006 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.230000000000004 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.544 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.407 HD23 HG23 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.209999999999994 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.519999999999996 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.329999999999998 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.530000000000001 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.400000000000006 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 64.129999999999995 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.299999999999997 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.409999999999997 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.439999999999998 111.014 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 111.084 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.668 0.27 . . . . 72.129999999999995 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 73.019999999999996 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.425 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.219999999999999 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.439999999999998 111.007 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.219999999999999 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.44 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.240000000000002 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.522 HG22 HD11 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.439999999999998 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.414 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.430000000000007 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.109999999999999 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.120000000000005 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.530000000000001 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.299999999999997 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.010000000000005 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 72.349999999999994 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.239999999999995 110.05 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.571 ' CD1' HG22 ' B' ' 46' ' ' VAL . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.399999999999999 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.409999999999997 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.471 HD11 HG22 ' B' ' 32' ' ' VAL . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.010000000000005 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.495 HG13 HG23 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.240000000000002 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 62.130000000000003 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.310000000000002 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.218 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.420000000000002 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.450000000000003 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.439999999999998 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.420000000000002 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.340000000000003 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.495 HG23 HG13 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 73.129999999999995 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.439999999999998 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.403 HG23 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 75.219999999999999 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 72.209999999999994 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.423 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 54.4 p-80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.039999999999999 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.439999999999998 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.329999999999998 110.791 179.095 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 CA-C-O 119.865 -0.408 . . . . 41.310000000000002 113.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.428 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 74.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.340000000000003 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.430000000000007 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 110.649 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.120000000000005 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 70.140000000000001 111.172 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.200000000000003 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 111.222 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.109999999999999 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' B' ' 100' ' ' LEU . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 110.397 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.030000000000001 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 73' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.450000000000003 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' B' ' 103' ' ' PRO . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.209999999999994 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.210000000000001 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.510000000000005 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.340000000000003 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.010000000000005 111.279 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.430000000000007 111.485 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.210000000000001 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.229999999999997 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.129999999999995 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.209999999999994 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.240000000000002 112.509 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.209999999999994 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.049999999999997 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.649 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.150000000000006 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.430000000000007 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.333 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.654 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.540000000000006 110.726 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . 0.499 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.310000000000002 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.503 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.120000000000005 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.409999999999997 111.358 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' B' ' 74' ' ' GLN . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.430000000000007 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.109999999999999 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.049999999999997 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 74.439999999999998 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.450000000000003 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 110.772 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 74.120000000000005 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.340000000000003 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.209999999999994 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.430000000000007 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.430000000000007 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.424 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.140000000000001 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.010000000000005 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.49 HD23 HD12 ' A' ' 88' ' ' LEU . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.209999999999994 110.699 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.319999999999993 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.219999999999999 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.530000000000001 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.319999999999993 110.634 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.340000000000003 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.099999999999994 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.019999999999996 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.239999999999995 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.129999999999995 111.056 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.130000000000003 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 111.213 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.477 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.319999999999993 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.543 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 75.530000000000001 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.239999999999995 111.291 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.129999999999995 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.329999999999998 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.420000000000002 111.693 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.475 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.543 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 73.230000000000004 111.051 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.310000000000002 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.439999999999998 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.44 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.310000000000002 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 54.310000000000002 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 63.310000000000002 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.51 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 70.209999999999994 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 74.450000000000003 110.93 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.209999999999994 111.054 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.73 0.3 . . . . 74.150000000000006 111.276 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 73.109999999999999 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 75.200000000000003 111.319 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.404 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 75.430000000000007 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.239999999999995 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.120000000000005 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.130000000000003 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.219999999999999 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.450000000000003 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.239999999999995 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.430000000000007 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.530000000000001 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.530000000000001 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.45 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.585 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.420000000000002 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.25 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.400000000000006 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.129999999999995 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.019999999999996 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.510000000000005 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.310000000000002 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.239999999999995 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.400000000000006 112.061 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.509999999999998 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.150000000000006 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.329999999999998 109.738 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.452 ' CG2' ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.329999999999998 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.340000000000003 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 46' ' ' VAL . 51.3 p-80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.019999999999996 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.329999999999998 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.120000000000005 112.386 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 120.147 -0.252 . . . . 65.120000000000005 113.414 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 110.705 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.409999999999997 110.648 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.149999999999999 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.109999999999999 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.140000000000001 111.547 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.109999999999999 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.519999999999996 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.120000000000005 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.404 ' HB2' ' HE2' ' A' ' 13' ' ' TYR . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.200000000000003 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.129999999999995 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.463 ' HA ' HD11 ' A' ' 100' ' ' LEU . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.099999999999994 110.861 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.430000000000007 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 37.039999999999999 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 73.109999999999999 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HB ' HD13 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.099999999999994 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.450000000000003 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.210000000000001 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.299999999999997 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.574 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.310000000000002 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HA ' ' CD1' ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.409999999999997 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.030000000000001 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.329999999999998 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.414 ' CA ' ' HB3' ' B' ' 119' ' ' MET . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.329999999999998 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 75.439999999999998 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.566 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.009999999999998 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 74.219999999999999 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.230000000000004 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.656 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.420000000000002 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HD2' HD13 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.140000000000001 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.598 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.229999999999997 110.803 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.450000000000003 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 74' ' ' GLN . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.420000000000002 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.019999999999996 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.420000000000002 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.448 HD13 ' HB ' ' A' ' 79' ' ' VAL . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.319999999999993 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.340000000000003 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.530000000000001 110.593 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.420000000000002 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.310000000000002 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.140000000000001 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.540000000000006 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.540000000000006 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 37.039999999999999 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 73.510000000000005 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.319999999999993 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.510000000000005 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 61.240000000000002 111.304 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.149999999999999 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.415 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.439 HG21 HD23 ' A' ' 116' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.200000000000003 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.540000000000006 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 71.219999999999999 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.319999999999993 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.200000000000003 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 61.109999999999999 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.310000000000002 112.237 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.219999999999999 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.539999999999999 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.310000000000002 111.119 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.665 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.200000000000003 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.009999999999998 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.149999999999999 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 37.039999999999999 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.340000000000003 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.430000000000007 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 73.340000000000003 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.350000000000001 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.219999999999999 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.340000000000003 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.450000000000003 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 75.420000000000002 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.010000000000005 111.174 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.209999999999994 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.510000000000005 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.239999999999995 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.420000000000002 111.172 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 64.319999999999993 111.537 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.794 0.33 . . . . 72.510000000000005 111.229 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.509999999999998 110.846 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' B' ' 76' ' ' ALA . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.240000000000002 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.120000000000005 111.342 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.417 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 74.530000000000001 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 65.409999999999997 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.010000000000005 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.420000000000002 112.235 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.465 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.130000000000003 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.581 HG23 HG12 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.200000000000003 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.425 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.319999999999993 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.405 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.100000000000001 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.540000000000006 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.239999999999995 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.310000000000002 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 71.519999999999996 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.230000000000004 110.463 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CZ ' HG23 ' B' ' 46' ' ' VAL . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.019999999999996 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.340000000000003 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.319999999999993 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.476 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.030000000000001 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.577 ' HA ' HG23 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.099999999999994 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.510000000000005 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' B' ' 147' ' ' PHE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 75.519999999999996 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.439999999999998 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.310000000000002 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 73.120000000000005 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.329999999999998 112.034 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.450000000000003 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.319999999999993 109.683 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.45 ' CG2' ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.420000000000002 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.340000000000003 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.506 ' CE1' HG22 ' B' ' 46' ' ' VAL . 51.2 p-80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 74.230000000000004 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' B' ' 28' ' ' TYR . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 71.140000000000001 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.140000000000001 112.406 -179.777 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 120.073 -0.293 . . . . 65.109999999999999 113.358 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.530000000000001 111.077 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 110.674 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.099999999999994 110.645 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.219999999999999 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.049999999999997 111.598 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.119999999999997 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.505 HD13 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.030000000000001 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.417 ' HB2' ' HE2' ' B' ' 13' ' ' TYR . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 64.310000000000002 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . 0.448 ' HA ' HD11 ' B' ' 100' ' ' LEU . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.040000000000006 110.91 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.349999999999994 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.450000000000003 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.431 ' HB ' HD13 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 74.239999999999995 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.299999999999997 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 71.530000000000001 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.530000000000001 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.120000000000005 111.612 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.310000000000002 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.549999999999997 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.566 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.549999999999997 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.010000000000005 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.350000000000001 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.656 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 74.230000000000004 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.409999999999997 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 74.120000000000005 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.649 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.019999999999996 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.505 ' HD2' HD13 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.409999999999997 111.605 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.109999999999999 110.86 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 74.319999999999993 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' B' ' 74' ' ' GLN . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 72.400000000000006 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.530000000000001 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.230000000000004 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.109999999999999 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.431 HD13 ' HB ' ' B' ' 79' ' ' VAL . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.310000000000002 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.430000000000007 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.119999999999997 110.587 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.150000000000006 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 70.109999999999999 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' B' ' 134' ' ' TYR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.230000000000004 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 74.140000000000001 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.200000000000003 111.695 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.539999999999999 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.129999999999995 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.239999999999995 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.451 HD23 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.540000000000006 111.283 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.210000000000001 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.414 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.349999999999994 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.451 HG21 HD23 ' B' ' 116' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 71.510000000000005 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.019999999999996 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.319999999999993 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.049999999999997 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.140000000000001 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.319999999999993 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.310000000000002 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.349999999999994 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.172 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 75.430000000000007 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 73.019999999999996 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.568 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 70.329999999999998 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.430000000000007 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.240000000000002 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.420000000000002 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.568 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.409999999999997 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.310000000000002 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.430000000000007 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 74.230000000000004 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.239999999999995 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.299999999999997 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 74.409999999999997 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 35' ' ' LEU . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 72.409999999999997 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.120000000000005 111.123 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.020000000000003 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 73.530000000000001 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.040000000000006 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.129999999999995 111.19 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 74.450000000000003 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.219999999999999 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 52.439999999999998 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 HG11 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.399999999999999 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 73.340000000000003 110.488 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.150000000000006 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.605 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.109999999999999 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.501 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.299999999999997 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.539999999999999 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.109999999999999 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.130000000000003 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 72.319999999999993 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 71.340000000000003 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.140000000000001 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.420000000000002 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 HG21 ' A' ' 32' ' ' VAL . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.210000000000001 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HG13 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 63.020000000000003 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 70.400000000000006 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.200000000000003 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.439999999999998 110.984 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.349999999999994 110.857 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.109999999999999 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.439999999999998 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 HG13 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.219999999999999 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.319999999999993 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.230000000000004 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.539999999999999 110.801 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 48.8 p-80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.439999999999998 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.530000000000001 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.039999999999999 111.692 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.774 -0.131 . . . . 73.420000000000002 112.774 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 70.319999999999993 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.540000000000006 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.533 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.519999999999996 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 53.549999999999997 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.409999999999997 111.27 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.450000000000003 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 73.109999999999999 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.120000000000005 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.340000000000003 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.209999999999994 111.403 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.57 HG11 HG11 ' A' ' 12' ' ' VAL . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.439999999999998 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' HD13 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 64.329999999999998 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 73.540000000000006 112.265 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.409999999999997 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.118 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 71.239999999999995 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.120000000000005 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.219999999999999 111.512 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.439999999999998 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.605 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.109999999999999 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 37.829999999999998 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.645 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.239999999999995 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 73.200000000000003 111.111 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.637 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.210000000000001 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.510000000000005 110.617 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.08 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' CG2' HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.030000000000001 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.130000000000003 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.319999999999993 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.140000000000001 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.655 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.459 HG13 ' CG2' ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 75.0 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.310000000000002 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 132' ' ' TRP . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.010000000000005 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 62.039999999999999 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.456 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 110' ' ' PRO . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.129999999999995 111.056 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.130000000000003 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.510000000000005 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.439999999999998 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.109999999999999 110.875 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 111.165 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.555 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 63.329999999999998 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.530000000000001 111.212 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.099999999999994 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.420000000000002 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.530000000000001 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 72.230000000000004 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.209999999999994 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 43.420000000000002 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.655 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.340000000000003 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.299999999999997 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.310000000000002 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.150000000000006 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.420000000000002 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.069 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' GLU . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.239999999999995 113.252 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.219999999999999 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.109999999999999 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.239999999999995 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.400000000000006 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.340000000000003 110.964 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.519999999999996 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 63.229999999999997 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.540000000000006 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.230000000000004 111.045 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.502 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.549999999999997 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.329999999999998 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.510000000000005 111.817 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.340000000000003 110.938 179.672 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.705 0.288 . . . . 74.239999999999995 111.041 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.120000000000005 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.573 HG11 HG11 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 62.130000000000003 110.49 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 80' ' ' VAL . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.130000000000003 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.602 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.349999999999994 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 75.049999999999997 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.494 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.540000000000006 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.409999999999997 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.420000000000002 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.299999999999997 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.120000000000005 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.019999999999996 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.200000000000003 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.329999999999998 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.099999999999994 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.513 ' CD1' HG22 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 63.119999999999997 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 74.420000000000002 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.483 HD12 HG21 ' B' ' 32' ' ' VAL . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.510000000000005 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.539 HG13 HG13 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.340000000000003 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.420000000000002 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.310000000000002 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.239999999999995 110.993 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 110.874 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.400000000000006 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.140000000000001 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.539 HG13 HG13 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.329999999999998 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.340000000000003 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.431 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.510000000000005 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.040000000000006 110.802 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' HIS . . . . . 0.414 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 48.8 p-80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 70.219999999999999 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.519999999999996 111.688 179.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.726 -0.15 . . . . 54.439999999999998 112.726 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 70.230000000000004 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.239999999999995 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.040000000000006 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.558 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.120000000000005 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 72.349999999999994 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.420000000000002 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 51.539999999999999 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.109999999999999 111.246 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.409999999999997 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' TRP . . . . . 0.561 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.040000000000006 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.140000000000001 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLN . . . . . 0.494 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.340000000000003 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.150000000000006 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 111.436 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.573 HG11 HG11 ' B' ' 12' ' ' VAL . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.530000000000001 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.109999999999999 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 63.420000000000002 112.327 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.040000000000006 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.136 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 65.400000000000006 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.439999999999998 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 65.349999999999994 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.409999999999997 111.566 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 38.93 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.040000000000006 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.329999999999998 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.637 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.519999999999996 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.129999999999995 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.329999999999998 111.089 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . 0.645 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.340000000000003 110.623 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.439999999999998 111.107 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.458 ' CG2' HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.019999999999996 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 53.109999999999999 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 71.510000000000005 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.340000000000003 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.329999999999998 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.654 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.140000000000001 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.458 HG13 ' CG2' ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 64.319999999999993 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.511 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.349999999999994 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' CYS . . . . . 0.477 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 55.5 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.140000000000001 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ARG . . . . . 0.45 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.466 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.209999999999994 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 62.240000000000002 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.430000000000007 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.099999999999994 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.409999999999997 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.240000000000002 110.857 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 65.239999999999995 111.127 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.409999999999997 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.559 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.200000000000003 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.329999999999998 111.242 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.209999999999994 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.439999999999998 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 73.310000000000002 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.519999999999996 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.420000000000002 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.420000000000002 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 65.129999999999995 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 74.010000000000005 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.129999999999995 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.209999999999994 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.109999999999999 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.420000000000002 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.319999999999993 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.406 ' N ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.310000000000002 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.049999999999997 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' N ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.239999999999995 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.430000000000007 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.230000000000004 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 75.439999999999998 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.439999999999998 110.847 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.319999999999993 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.049999999999997 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 74.299999999999997 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.349999999999994 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 72.0 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.439999999999998 111.1 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.540000000000006 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.310000000000002 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 71.319999999999993 111.763 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.310000000000002 110.866 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.569 0.223 . . . . 61.140000000000001 111.403 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -123.7 124.03 41.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.371 -0.377 . . . . 72.420000000000002 110.927 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.149999999999999 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.140000000000001 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.854 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.349999999999994 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.662 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.140000000000001 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HD12 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.030000000000001 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.020000000000003 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.209999999999994 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.349999999999994 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.409999999999997 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.030000000000001 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.450000000000003 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.119999999999997 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.229999999999997 110.26 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.140000000000001 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.468 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 74.349999999999994 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.040000000000006 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.510000000000005 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.450000000000003 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.140000000000001 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.149999999999999 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 74.349999999999994 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.310000000000002 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.319999999999993 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.409999999999997 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 43' ' ' THR . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 73.409999999999997 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.120000000000005 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.109999999999999 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.54 ' CE1' HG21 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.219999999999999 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.530000000000001 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.07 49.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 60.43 111.512 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.62 111.36 11.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 75.420000000000002 111.507 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.0 59.24 0.91 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.333 0.587 . . . . 62.25 110.224 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 28.9 tt0 174.72 66.9 0.0 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.858 -1.065 . . . . 73.209999999999994 110.207 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.68 105.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 110.998 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -55.42 109.29 1.52 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.985 -0.552 . . . . 73.140000000000001 111.627 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.94 -165.38 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.244 2.63 . . . . 72.120000000000005 112.552 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.22 -0.9 . . . . 73.299999999999997 111.716 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.37 -159.58 13.8 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.889 -0.596 . . . . 62.049999999999997 112.789 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.43 130.38 46.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.704 0.287 . . . . 72.420000000000002 111.171 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.08 78.28 6.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.18 -0.464 . . . . 75.349999999999994 110.644 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.34 172.82 12.27 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.184 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.02 76.08 9.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.313 -0.403 . . . . 54.219999999999999 111.091 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.1 146.51 18.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.052 -0.594 . . . . 37.299999999999997 112.484 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.33 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.804 -0.712 . . . . 53.219999999999999 112.687 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.459 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.140000000000001 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.099999999999994 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.519999999999996 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.524 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.420000000000002 110.762 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 63.140000000000001 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.409999999999997 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.539 ' HB3' HN22 ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.349999999999994 111.229 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 75.439999999999998 111.438 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.586 ' CD1' ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.109999999999999 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.219999999999999 111.135 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 37.299999999999997 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.310000000000002 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.585 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.430000000000007 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 103' ' ' PRO . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.530000000000001 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 73.230000000000004 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 74.099999999999994 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.040000000000006 110.834 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 73.109999999999999 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.349999999999994 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.553 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.120000000000005 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.039999999999999 111.101 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' B' ' 86' ' ' PRO . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.399999999999999 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.129999999999995 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 17' ' ' SER . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.409999999999997 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.409999999999997 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.682 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.549999999999997 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 110.942 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.684 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.409999999999997 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HD2' ' CD1' ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 63.240000000000002 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.299999999999997 111.792 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.420000000000002 111.093 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.539999999999999 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.509999999999998 111.355 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.219999999999999 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.109999999999999 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HB2' HG21 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.530000000000001 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 79' ' ' VAL . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.150000000000006 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.549999999999997 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.519999999999996 111.217 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.420000000000002 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 112' ' ' SER . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.439999999999998 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.439999999999998 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 64.25 111.327 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.019999999999996 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.140000000000001 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.129999999999995 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.386 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 74.099999999999994 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.219999999999999 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.409999999999997 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' B' ' 88' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.120000000000005 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 72.510000000000005 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.120000000000005 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.340000000000003 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.040000000000006 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.129999999999995 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.420000000000002 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.310000000000002 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.150000000000006 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.510000000000005 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 110.841 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.400000000000006 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 75.0 111.28 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 138' ' ' GLU . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.319999999999993 112.825 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.519999999999996 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.530000000000001 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.140000000000001 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.340000000000003 111.098 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 61.409999999999997 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.010000000000005 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.149999999999999 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.540000000000006 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.409999999999997 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.209999999999994 111.4 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.44 ' CE2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.120000000000005 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.099999999999994 111.564 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -82.05 -32.7 30.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 110.907 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 63.35 18.29 10.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 111.696 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.8 173.15 0.58 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.69 0.281 . . . . 71.439999999999998 111.107 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.07 70.67 1.03 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.032 0.444 . . . . 74.109999999999999 110.541 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.05 -38.48 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.831 -0.622 . . . . 73.450000000000003 111.217 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -61.02 141.57 57.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.23 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.155 -0.926 . . . . 73.109999999999999 110.992 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.554 0.216 . . . . 75.120000000000005 111.357 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -123.63 124.06 41.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.373 -0.376 . . . . 71.5 110.949 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.530000000000001 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.874 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.421 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 75.0 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.319999999999993 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.150000000000006 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.667 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.299999999999997 112.593 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.427 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 61.420000000000002 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.443 HD12 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 73.430000000000007 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.436 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 65.439999999999998 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.409 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.140000000000001 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.310000000000002 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.450000000000003 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.019999999999996 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.439999999999998 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 73.040000000000006 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.430000000000007 110.234 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.230000000000004 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 75.109999999999999 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.474 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.319999999999993 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.329999999999998 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.430000000000007 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.435 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 72.439999999999998 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.400000000000006 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.409999999999997 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.349999999999994 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.150000000000006 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.120000000000005 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' B' ' 43' ' ' THR . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.120000000000005 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.463 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.299999999999997 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.544 ' CE1' HG21 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' B' ' 45' ' ' HIS . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.219999999999999 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.04 49.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.130000000000003 111.489 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.67 111.32 11.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 74.409999999999997 111.529 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -100.97 59.31 0.91 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.376 0.608 . . . . 64.150000000000006 110.22 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 28.9 tt0 174.68 66.91 0.0 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.869 -1.06 . . . . 74.430000000000007 110.236 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.73 105.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.13 -0.487 . . . . 74.239999999999995 111.001 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -55.46 109.35 1.56 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.92 -0.582 . . . . 75.120000000000005 111.561 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.0 -165.34 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.236 2.624 . . . . 70.030000000000001 112.581 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.223 -0.899 . . . . 72.219999999999999 111.726 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.39 -159.55 13.82 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 73.129999999999995 112.764 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.56 130.4 46.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.716 0.294 . . . . 73.439999999999998 111.144 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.04 78.28 6.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.134 -0.485 . . . . 73.120000000000005 110.672 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.36 172.81 12.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.894 -0.594 . . . . 61.439999999999998 111.172 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.04 76.1 9.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.102 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.06 146.48 18.16 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.076 -0.583 . . . . 72.450000000000003 112.507 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.813 -0.708 . . . . 62.140000000000001 112.645 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.47 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.329999999999998 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.040000000000006 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.209999999999994 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.522 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.409999999999997 110.754 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.442 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 75.209999999999994 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.420000000000002 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.541 ' HB3' HN22 ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.520000000000003 111.199 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.350000000000001 111.481 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.587 ' CD1' ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.049999999999997 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.200000000000003 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.421 ' HB2' ' HE2' ' B' ' 13' ' ' TYR . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.329999999999998 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.210000000000001 111.16 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.450000000000003 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.520000000000003 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.100000000000001 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 103' ' ' PRO . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 74.25 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.019999999999996 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 72.409999999999997 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 62.520000000000003 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.030000000000001 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 75.129999999999995 110.819 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.530000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.420000000000002 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.555 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.140000000000001 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.540000000000006 111.053 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 86' ' ' PRO . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.400000000000006 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.420000000000002 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' B' ' 17' ' ' SER . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.319999999999993 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.239999999999995 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.684 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.109999999999999 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.499 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.914 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 110.753 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.682 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.020000000000003 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.587 ' HD2' ' CD1' ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.030000000000001 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.119999999999997 111.835 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.329999999999998 111.103 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.430000000000007 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.240000000000002 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.310000000000002 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HB2' HG21 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.310000000000002 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.463 HD13 ' HB ' ' B' ' 79' ' ' VAL . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.439999999999998 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.230000000000004 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.349999999999994 111.242 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.465 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.597 ' HB3' ' HB2' ' B' ' 112' ' ' SER . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.230000000000004 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.310000000000002 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.120000000000005 111.384 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 75.140000000000001 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.340000000000003 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.310000000000002 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.209999999999994 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.396 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.329999999999998 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.239999999999995 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.409999999999997 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 88' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.210000000000001 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.430000000000007 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . 0.453 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.299999999999997 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.119999999999997 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 75.109999999999999 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 38.100000000000001 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.530000000000001 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.310000000000002 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.209999999999994 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.350000000000001 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 110.895 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.140000000000001 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.540000000000006 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.555 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.140000000000001 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.239999999999995 111.26 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' B' ' 138' ' ' GLU . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.549999999999997 112.795 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.319999999999993 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 136' ' ' GLU . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 74.200000000000003 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.010000000000005 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.530000000000001 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 73.109999999999999 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 111.04 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.219999999999999 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.340000000000003 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.505 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.439999999999998 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.299999999999997 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.510000000000005 111.438 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.442 ' CE2' HG23 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 75.109999999999999 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.099999999999994 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.119999999999997 111.519 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.99 -32.66 30.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.010000000000005 110.959 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 63.35 18.28 10.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 111.694 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.79 173.11 0.58 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.765 0.317 . . . . 74.120000000000005 111.087 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.08 70.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 110.503 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.04 -38.51 4.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 75.430000000000007 111.242 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -60.99 141.58 57.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.425 -0.352 . . . . 72.329999999999998 111.203 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.218 -0.896 . . . . 73.319999999999993 110.997 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.662 " H3'" ' O ' ' A' ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.667 " H3'" ' O ' ' B' ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.9 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.791 0.329 . . . . 64.219999999999999 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.41 152.93 48.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 111.068 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.510000000000005 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' HB2' HD21 ' A' ' 35' ' ' LEU . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.109999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.299999999999997 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.598 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 54.229999999999997 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.120000000000005 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.496 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.209999999999994 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.239999999999995 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.400000000000006 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.420000000000002 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.420000000000002 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 62.200000000000003 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.540000000000006 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.283 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.524 ' CE1' HG22 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 72.409999999999997 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.425 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.200000000000003 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.409999999999997 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.481 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 63.420000000000002 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 29' ' ' ALA . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.119999999999997 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.099999999999994 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.299999999999997 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 14' ' ' PHE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 72.120000000000005 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.219999999999999 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.549999999999997 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 73.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.140000000000001 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.030000000000001 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.239999999999995 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.119999999999997 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 74.340000000000003 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' NE2' ' N3 ' ' A' ' 187' ' ' 5GP . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 64.510000000000005 111.39 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 63.210000000000001 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.67 36.86 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 74.129999999999995 111.498 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.36 158.91 17.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.026 0.441 . . . . 72.420000000000002 111.418 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -139.88 49.5 1.77 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.762 0.791 . . . . 60.399999999999999 110.171 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 tt0 170.18 68.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.019 -1.446 . . . . 74.010000000000005 110.087 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 111.242 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.45 105.78 0.55 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.917 -0.583 . . . . 64.319999999999993 111.957 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.6 84.23 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.317 2.678 . . . . 73.25 112.384 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.72 151.49 45.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.432 . . . . 65.340000000000003 111.295 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.91 178.13 18.34 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.229 -0.51 . . . . 43.229999999999997 112.908 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 164.74 15.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.783 0.325 . . . . 55.130000000000003 111.213 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.4 88.78 0.66 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.039 -0.528 . . . . 72.349999999999994 110.989 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.64 55.58 0.14 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.92 -0.582 . . . . 37.990000000000002 110.83 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.89 146.3 28.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.997 -0.547 . . . . 62.350000000000001 111.237 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.44 -171.28 21.16 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.956 -0.64 . . . . 65.140000000000001 112.752 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.62 -99.53 0.89 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.188 -0.529 . . . . 37.990000000000002 112.624 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.329999999999998 111.325 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 62.109999999999999 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 73.439999999999998 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.543 HG21 ' C5 ' ' A' ' 187' ' ' 5GP . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.099999999999994 110.821 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 74.540000000000006 111.497 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 64.219999999999999 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.400000000000006 111.252 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.299999999999997 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 111.194 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.540000000000006 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.350000000000001 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.239999999999995 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.439999999999998 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB1' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.239999999999995 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 103' ' ' PRO . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 104' ' ' ILE . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.019999999999996 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.340000000000003 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.439999999999998 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 111.129 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 112' ' ' SER . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 71.420000000000002 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.450000000000003 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.129999999999995 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.430000000000007 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.229999999999997 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.120000000000005 111.323 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.530000000000001 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.239999999999995 110.332 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.450000000000003 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 75.109999999999999 110.568 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.420000000000002 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.310000000000002 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.430000000000007 111.526 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.239999999999995 111.362 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.030000000000001 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.230000000000004 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.319999999999993 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 61.219999999999999 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.150000000000006 111.049 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.340000000000003 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HB3' ' HB2' ' A' ' 112' ' ' SER . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 73.310000000000002 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.436 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.229999999999997 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 73.319999999999993 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.150000000000006 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 37.990000000000002 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.239999999999995 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.129999999999995 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.420000000000002 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.510000000000005 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.439999999999998 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.040000000000006 110.742 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.150000000000006 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.230000000000004 110.934 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.109999999999999 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.209999999999994 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.020000000000003 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.109999999999999 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.596 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.239999999999995 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 72.230000000000004 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.299999999999997 110.876 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.415 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.209999999999994 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.52 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.420000000000002 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 64.319999999999993 111.521 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 138' ' ' GLU . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.310000000000002 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.239999999999995 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.52 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.439999999999998 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.040000000000006 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.521 ' HB3' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.099999999999994 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.200000000000003 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 54.119999999999997 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.428 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 73.230000000000004 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.439999999999998 110.779 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.420000000000002 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.340000000000003 111.151 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.413 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.420000000000002 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.329999999999998 111.715 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.33 -32.64 29.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 110.862 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 60.2 27.07 16.54 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 111.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.96 -71.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.548 -0.296 . . . . 73.299999999999997 111.118 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -174.26 130.83 0.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.41 -0.359 . . . . 74.299999999999997 110.892 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.88 148.83 45.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.249 -0.432 . . . . 64.040000000000006 110.883 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.86 162.77 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.301 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.012 -0.995 . . . . 72.129999999999995 111.214 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 15.0 mtt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.778 0.323 . . . . 75.439999999999998 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.29 153.02 49.05 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.134 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.502 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.509999999999998 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.415 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 73.400000000000006 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.501 ' HB2' HD21 ' B' ' 35' ' ' LEU . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.230000000000004 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.601 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.299999999999997 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.492 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 74.340000000000003 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.492 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.510000000000005 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.415 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.439999999999998 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.129999999999995 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.420000000000002 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 71.409999999999997 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.219999999999999 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.319999999999993 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.310000000000002 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.256 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.526 ' CE1' HG22 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.299999999999997 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.422 ' O ' HG11 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.340000000000003 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.109999999999999 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.465 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.519999999999996 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.422 HG11 ' O ' ' B' ' 29' ' ' ALA . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.230000000000004 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.030000000000001 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.129999999999995 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.030000000000001 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.120000000000005 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.411 HG13 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.439999999999998 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.423 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.310000000000002 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.435 ' NE2' ' N3 ' ' B' ' 187' ' ' 5GP . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.030000000000001 111.414 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 64.409999999999997 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.68 36.91 4.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.219999999999999 111.425 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.37 158.87 17.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.979 0.419 . . . . 64.310000000000002 111.457 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -139.77 49.4 1.78 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.643 0.735 . . . . 75.439999999999998 110.223 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 4.8 tt0 170.24 68.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.009 -1.45 . . . . 75.450000000000003 110.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.28 -0.418 . . . . 72.340000000000003 111.154 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 105.79 0.55 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.95 -0.568 . . . . 73.329999999999998 111.953 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.64 84.24 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.247 2.632 . . . . 61.340000000000003 112.417 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.67 151.61 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.227 -0.442 . . . . 63.509999999999998 111.249 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.87 178.13 18.36 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.177 -0.535 . . . . 64.510000000000005 112.943 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.38 164.83 15.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.815 0.341 . . . . 73.099999999999994 111.257 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.52 88.8 0.68 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.59 55.66 0.14 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.035 -0.53 . . . . 70.099999999999994 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.92 146.34 28.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.002 -0.545 . . . . 75.349999999999994 111.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.45 -171.3 21.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.966 -0.635 . . . . 74.519999999999996 112.714 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.61 -99.44 0.89 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.057 -0.592 . . . . 44.140000000000001 112.63 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.519999999999996 111.343 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.130000000000003 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.400000000000006 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.539 HG21 ' C5 ' ' B' ' 187' ' ' 5GP . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.835 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 111.411 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.430000000000007 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.540000000000006 111.228 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.140000000000001 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.299999999999997 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.009999999999998 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 74.530000000000001 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.219999999999999 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.340000000000003 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.319999999999993 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.219999999999999 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' B' ' 103' ' ' PRO . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.413 ' HB ' HD12 ' B' ' 104' ' ' ILE . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.409999999999997 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.551 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.109999999999999 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.219999999999999 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.129999999999995 111.129 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.404 ' HB ' ' OG ' ' B' ' 112' ' ' SER . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 72.140000000000001 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.239999999999995 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.482 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.399999999999999 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.209999999999994 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.209999999999994 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.149999999999999 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.099999999999994 111.264 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.625 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.420000000000002 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.209999999999994 110.449 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 65.140000000000001 110.319 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.617 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.349999999999994 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.4 ' HG3' HD12 ' B' ' 70' ' ' LEU . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.119999999999997 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.420000000000002 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.200000000000003 111.4 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 111.408 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.239999999999995 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 74.109999999999999 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.200000000000003 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.413 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.049999999999997 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 75.040000000000006 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 74.319999999999993 110.954 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.450000000000003 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.554 ' HB3' ' HB2' ' B' ' 112' ' ' SER . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.319999999999993 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.432 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.019999999999996 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.409999999999997 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.230000000000004 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 38.869999999999997 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.230000000000004 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.319999999999993 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 70.329999999999998 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.310000000000002 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.010000000000005 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.100000000000001 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.350000000000001 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.099999999999994 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 72.019999999999996 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 110.922 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.520000000000003 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.89 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 74.549999999999997 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.219999999999999 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.430000000000007 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.409999999999997 111.548 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 138' ' ' GLU . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.299999999999997 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' B' ' 136' ' ' GLU . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.420000000000002 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.531 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 73.439999999999998 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.209999999999994 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.528 ' HB3' HD23 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.519999999999996 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.140000000000001 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.423 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 73.540000000000006 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.310000000000002 110.702 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.420000000000002 111.171 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.407 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.530000000000001 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.099999999999994 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.319999999999993 111.65 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.32 -32.59 29.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.129999999999995 110.902 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 60.17 27.12 16.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 111.252 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -71.24 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.473 -0.331 . . . . 75.230000000000004 111.104 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -174.26 130.82 0.38 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.349 . . . . 74.200000000000003 110.858 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.81 148.83 45.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.259 -0.428 . . . . 72.329999999999998 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.91 162.74 13.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.161 -0.472 . . . . 73.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.087 -0.959 . . . . 73.510000000000005 111.185 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.543 ' C5 ' HG21 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.539 ' C5 ' HG21 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.548 0.213 . . . . 75.109999999999999 111.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.33 128.44 25.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.439 -0.346 . . . . 64.010000000000005 111.137 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.150000000000006 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.340000000000003 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.439999999999998 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 74.530000000000001 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' CD1' HD11 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.549999999999997 110.817 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.340000000000003 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.140000000000001 112.608 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.340000000000003 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.319999999999993 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.010000000000005 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.420000000000002 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.400000000000006 110.324 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.329999999999998 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.439999999999998 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.319999999999993 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.120000000000005 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' ALA . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 73.439999999999998 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 44.039999999999999 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.129999999999995 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 111.007 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.299999999999997 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.340000000000003 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.349999999999994 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.209999999999994 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.140000000000001 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG13 HG22 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 65.349999999999994 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.099999999999994 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.404 ' CG2' ' HE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.450000000000003 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.467 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.239999999999995 111.751 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.140000000000001 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.68 52.3 2.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.804 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.61 147.57 23.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.983 0.42 . . . . 71.219999999999999 111.369 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.02 54.22 1.35 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.646 0.736 . . . . 62.310000000000002 110.263 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER 174.19 67.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.318 -1.31 . . . . 71.299999999999997 109.858 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.36 105.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.035 -0.53 . . . . 64.209999999999994 111.263 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -114.72 81.73 7.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 73.329999999999998 111.5 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.69 81.67 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.951 2.434 . . . . 64.439999999999998 112.326 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -99.0 130.0 45.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.321 -0.4 . . . . 71.239999999999995 111.022 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.65 -160.14 25.25 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.063 -0.589 . . . . 70.340000000000003 112.748 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.78 118.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.577 0.351 . . . . 64.540000000000006 111.29 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 53.66 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 110.905 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.49 145.18 6.63 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.937 -0.574 . . . . 65.140000000000001 111.17 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.42 8.74 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 111.041 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.94 142.44 3.46 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.066 -0.588 . . . . 74.310000000000002 112.655 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.09 -14.65 60.25 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.155 -0.545 . . . . 64.319999999999993 113.435 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.420000000000002 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.109999999999999 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.624 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 110.942 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.010000000000005 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.150000000000006 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.130000000000003 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.519999999999996 111.219 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.430000000000007 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 75.0 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' CD2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.420000000000002 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.030000000000001 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.040000000000006 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.240000000000002 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.120000000000005 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.019999999999996 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.030000000000001 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.230000000000004 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.229999999999997 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.331 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.340000000000003 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.219999999999999 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.408 ' HB2' HG13 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.603 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.239999999999995 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.540000000000006 112.54 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.219999999999999 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.129999999999995 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.611 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.140000000000001 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 111.0 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.319999999999993 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.400000000000006 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.430000000000007 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.239999999999995 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.430000000000007 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.200000000000003 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 75.140000000000001 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.572 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.400000000000006 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' ' CD1' ' A' ' 129' ' ' PHE . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.350000000000001 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 63.149999999999999 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.420000000000002 111.152 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.140000000000001 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.510000000000005 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.310000000000002 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.349999999999994 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.119999999999997 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.239999999999995 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 64.519999999999996 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 53.229999999999997 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 64.150000000000006 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.530000000000001 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.340000000000003 111.687 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.239999999999995 110.576 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.45 ' CD1' HD21 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.109999999999999 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.329999999999998 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.340000000000003 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.565 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.109999999999999 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.400000000000006 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.329999999999998 110.932 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.562 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.540000000000006 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.603 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.400000000000006 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.030000000000001 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.549999999999997 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.603 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.119999999999997 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.140000000000001 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.140000000000001 110.521 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.230000000000004 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.120000000000005 111.155 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.340000000000003 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.329999999999998 111.069 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.219999999999999 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.129999999999995 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.140000000000001 111.524 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.040000000000006 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 54.219999999999999 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 75.219999999999999 111.186 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.61 -33.23 58.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.439999999999998 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.09 17.43 10.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.367 -0.378 . . . . 74.409999999999997 111.444 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.29 175.36 1.49 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.727 0.299 . . . . 74.340000000000003 111.139 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.97 108.48 6.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.274 -0.421 . . . . 74.340000000000003 110.786 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -160.77 145.83 14.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.134 -0.485 . . . . 73.239999999999995 111.094 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.91 153.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.085 -0.507 . . . . 72.329999999999998 111.381 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.138 -0.934 . . . . 71.319999999999993 111.204 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.565 0.221 . . . . 72.299999999999997 111.407 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.31 128.46 25.76 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.423 -0.353 . . . . 74.049999999999997 111.161 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 62.340000000000003 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.55 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.299999999999997 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.44 ' CD1' HD11 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 75.329999999999998 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.430000000000007 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.519 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.109999999999999 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.109999999999999 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 72.5 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 112.589 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.399999999999999 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 74.430000000000007 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.420000000000002 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.439999999999998 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.509999999999998 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.400000000000006 110.328 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.219999999999999 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.426 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.450000000000003 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.040000000000006 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.433 HG22 HG13 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.450000000000003 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.319999999999993 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 60.43 111.003 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 64.109999999999999 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.239999999999995 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.120000000000005 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.019999999999996 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.519999999999996 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.433 HG13 HG22 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.413 ' CG2' ' HE2' ' B' ' 28' ' ' TYR . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.099999999999994 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.109999999999999 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.458 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 75.209999999999994 111.699 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 71.140000000000001 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.69 52.35 2.09 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.109999999999999 110.768 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -95.63 147.59 23.43 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.948 0.404 . . . . 62.119999999999997 111.439 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.04 54.23 1.35 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.629 0.728 . . . . 72.200000000000003 110.222 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 0.9 OUTLIER 174.11 67.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.354 -1.294 . . . . 73.400000000000006 109.927 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.24 105.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.937 -0.574 . . . . 74.299999999999997 111.308 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -114.68 81.73 7.41 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.019 -0.537 . . . . 74.310000000000002 111.499 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -86.77 81.66 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.943 2.429 . . . . 71.140000000000001 112.3 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -98.98 130.04 45.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.269 -0.423 . . . . 64.109999999999999 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.62 -160.13 25.28 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.129 -0.557 . . . . 62.210000000000001 112.664 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.8 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.836 0.35 . . . . 53.140000000000001 111.336 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.93 53.76 0.92 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 75.019999999999996 110.85 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.55 145.09 6.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.906 -0.588 . . . . 74.140000000000001 111.129 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.56 8.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.151 -0.477 . . . . 75.349999999999994 110.959 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.89 142.48 3.47 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 52.539999999999999 112.622 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.404 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -89.08 -14.85 59.98 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.242 -0.504 . . . . 64.439999999999998 113.454 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.140000000000001 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.632 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.329999999999998 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 74.299999999999997 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.150000000000006 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.435 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.310000000000002 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.549999999999997 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.430000000000007 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.130000000000003 111.927 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 65.040000000000006 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 71.439999999999998 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.420000000000002 110.988 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.239999999999995 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.439999999999998 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.450000000000003 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.575 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.219999999999999 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 51.229999999999997 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 112.037 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.049999999999997 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.219999999999999 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.25 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.430000000000007 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.517 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' HG13 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.349999999999994 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.602 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.609 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.099999999999994 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.603 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.120000000000005 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.420000000000002 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.219999999999999 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.039999999999999 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.527 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.430000000000007 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.019999999999996 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.540000000000006 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.209999999999994 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.030000000000001 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.340000000000003 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.575 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 72.209999999999994 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.408 HD13 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.488 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.329999999999998 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.120000000000005 111.112 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.239999999999995 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.040000000000006 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.565 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.099999999999994 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.409999999999997 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.510000000000005 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.100000000000001 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.450000000000003 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.406 HD21 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.020000000000003 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 73.530000000000001 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 73.519999999999996 111.674 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 74.430000000000007 110.638 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.44 ' CD1' HD21 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 73.129999999999995 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.509999999999998 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.329999999999998 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 72.319999999999993 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.540000000000006 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.310000000000002 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.340000000000003 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.230000000000004 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.019999999999996 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.230000000000004 110.914 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.129999999999995 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.200000000000003 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.587 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 61.530000000000001 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.129999999999995 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.430000000000007 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.219999999999999 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.109999999999999 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.019999999999996 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.119999999999997 111.179 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.536 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.430000000000007 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.549999999999997 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.040000000000006 111.497 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.049999999999997 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.530000000000001 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.450000000000003 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.239999999999995 111.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.67 -33.29 58.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.209999999999994 110.953 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.18 17.4 10.66 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.306 -0.406 . . . . 74.319999999999993 111.377 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.3 175.36 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.788 0.327 . . . . 72.319999999999993 111.044 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.99 108.49 6.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.231 -0.44 . . . . 70.409999999999997 110.84 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -160.74 145.96 14.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 72.299999999999997 111.039 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.8 153.48 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.049 -0.523 . . . . 72.230000000000004 111.383 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.13 -0.938 . . . . 75.530000000000001 111.215 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.624 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.632 ' C6 ' HG12 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.545 0.212 . . . . 75.310000000000002 111.462 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.07 116.67 27.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 75.109999999999999 110.897 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 64.049999999999997 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.130000000000003 110.787 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CD2' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 74.120000000000005 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.430000000000007 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.420000000000002 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.488 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.409999999999997 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.522 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 74.409999999999997 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.51 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 74.030000000000001 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.140000000000001 112.42 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.140000000000001 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.340000000000003 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.530000000000001 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.439999999999998 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.299999999999997 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.420000000000002 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 74.010000000000005 110.737 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.569 ' CE2' HG22 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 75.219999999999999 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.539999999999999 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 32' ' ' VAL . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.55 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 75.239999999999995 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.329999999999998 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.030000000000001 111.224 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.329999999999998 110.871 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.129999999999995 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.450000000000003 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.319999999999993 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.239999999999995 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.454 HG21 HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.209999999999994 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.439999999999998 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.400000000000006 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.130000000000003 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.08 60.34 1.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.100000000000001 110.76 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -108.67 131.66 54.68 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 70.219999999999999 111.757 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.89 58.33 0.85 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.366 0.603 . . . . 72.439999999999998 110.321 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.28 68.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.747 -1.115 . . . . 72.430000000000007 110.146 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.33 107.39 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.917 -0.583 . . . . 62.32 111.28 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 84.29 14.55 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.511 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.06 81.86 2.28 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.87 2.38 . . . . 73.430000000000007 112.275 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.88 140.84 39.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.138 -0.483 . . . . 64.150000000000006 111.067 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.15 -169.07 47.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.054 -0.593 . . . . 61.25 112.644 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.07 129.06 38.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.667 0.27 . . . . 75.310000000000002 111.012 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 139.57 52.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 63.329999999999998 110.965 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.14 171.04 12.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.073 -0.512 . . . . 74.540000000000006 111.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.95 94.74 2.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.186 -0.461 . . . . 64.120000000000005 111.117 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.42 -158.96 10.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.139 -0.553 . . . . 62.210000000000001 112.646 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.45 -106.34 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.907 -0.663 . . . . 74.310000000000002 112.557 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.420000000000002 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.530000000000001 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.540000000000006 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.558 HG22 ' C4 ' ' A' ' 187' ' ' 5GP . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.420000000000002 110.792 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.349999999999994 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.430000000000007 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.439999999999998 111.117 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.209999999999994 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 70.140000000000001 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 62.420000000000002 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.010000000000005 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.040000000000006 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 103' ' ' PRO . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.230000000000004 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.349999999999994 110.577 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.450000000000003 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.450000000000003 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.120000000000005 110.71 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.539999999999999 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.549999999999997 111.525 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.540000000000006 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.340000000000003 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.119999999999997 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.52 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.120000000000005 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.439999999999998 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.520000000000003 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.120000000000005 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 73.5 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 62.229999999999997 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 38.57 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.219999999999999 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 104' ' ' ILE . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.239999999999995 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.209999999999994 111.371 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.010000000000005 111.466 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.100000000000001 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.040000000000006 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.556 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 73.109999999999999 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 98' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.219999999999999 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.129999999999995 111.075 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.403 HD12 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.150000000000006 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.310000000000002 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.611 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.310000000000002 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.450000000000003 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.140000000000001 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.540000000000006 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.219999999999999 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.310000000000002 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB3' HD12 ' B' ' 65' ' ' ILE . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.349999999999994 112.352 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.433 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.040000000000006 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 HD13 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.040000000000006 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.319999999999993 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.349999999999994 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.140000000000001 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.239999999999995 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.040000000000006 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.209999999999994 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.129999999999995 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.422 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 54.340000000000003 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.019 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.086 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.6 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.219999999999999 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.239999999999995 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.150000000000006 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.349999999999994 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.140000000000001 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 38.57 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.509999999999998 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.030000000000001 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 65.030000000000001 110.947 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.109999999999999 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.49 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.540000000000006 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.219999999999999 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.129999999999995 111.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.462 ' HB1' ' CG ' ' A' ' 157' ' ' HIS . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 111.232 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.549999999999997 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 111.567 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -84.52 -21.5 30.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.099999999999994 111.477 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.13 33.22 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.883 0.473 . . . . 74.239999999999995 111.669 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.41 -67.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.264 -0.425 . . . . 72.510000000000005 111.212 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -175.08 110.57 0.12 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.296 -0.411 . . . . 72.310000000000002 110.674 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.462 ' CG ' ' HB1' ' A' ' 149' ' ' ALA . 3.6 t-80 -72.2 144.56 48.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 111.258 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.15 150.09 29.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.032 -0.531 . . . . 73.200000000000003 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -0.769 . . . . 75.310000000000002 111.005 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.482 0.182 . . . . 64.409999999999997 111.41 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.06 116.68 27.81 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.449 -0.341 . . . . 62.030000000000001 110.871 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.230000000000004 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.310000000000002 110.75 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' B' ' 42' ' ' LEU . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 73.540000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.431 ' HA ' HG12 ' B' ' 80' ' ' VAL . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.299999999999997 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.349999999999994 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.504 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 73.400000000000006 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.52 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.150000000000006 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.515 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.329999999999998 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 36.850000000000001 112.45 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.210000000000001 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.329999999999998 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.539999999999999 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.319999999999993 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.230000000000004 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.239999999999995 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.571 ' CE2' HG22 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.25 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.109999999999999 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.310000000000002 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.53 HD12 HG22 ' B' ' 32' ' ' VAL . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.329999999999998 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.534 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.430000000000007 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.549999999999997 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.510000000000005 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.209999999999994 111.252 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.299999999999997 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.219999999999999 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.319999999999993 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 62.32 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.450000000000003 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.441 HG21 HG22 ' B' ' 46' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.230000000000004 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.130000000000003 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.427 ' NE2' HG21 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.439999999999998 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.409999999999997 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.99 60.22 1.31 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.399999999999999 110.771 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -108.62 131.61 54.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.796 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.8 58.36 0.85 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.409 0.624 . . . . 64.5 110.395 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.23 68.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.8 -1.091 . . . . 72.420000000000002 110.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.25 107.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.904 -0.589 . . . . 74.519999999999996 111.287 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.45 84.37 14.61 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.433 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.08 81.97 2.25 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.909 2.406 . . . . 74.430000000000007 112.301 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.89 140.73 39.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.097 -0.501 . . . . 75.239999999999995 111.139 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.18 -169.07 47.48 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.961 -0.638 . . . . 62.32 112.692 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.03 128.98 38.52 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.688 0.28 . . . . 74.239999999999995 111.041 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.34 139.57 52.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.033 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.19 171.13 12.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.13 -0.486 . . . . 36.850000000000001 111.279 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.08 94.78 2.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.129 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.4 -158.94 10.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.1 -0.571 . . . . 75.099999999999994 112.621 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.47 -106.39 0.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.992 -0.623 . . . . 73.510000000000005 112.553 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.329999999999998 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.530000000000001 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.559 HG22 ' C4 ' ' B' ' 187' ' ' 5GP . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.099999999999994 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.457 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 71.230000000000004 111.13 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.140000000000001 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.400000000000006 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.219999999999999 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 72.239999999999995 111.541 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.400000000000006 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' B' ' 103' ' ' PRO . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 110.564 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.69 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 72.510000000000005 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 63.100000000000001 111.575 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.030000000000001 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.209999999999994 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 65.439999999999998 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.340000000000003 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.010000000000005 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.52 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.526 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 75.519999999999996 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.409999999999997 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.422 HD22 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.450000000000003 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.527 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.120000000000005 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 74.219999999999999 110.444 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' B' ' 73' ' ' LEU . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.636 HG21 HG13 ' B' ' 104' ' ' ILE . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.239999999999995 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.200000000000003 111.329 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.239999999999995 111.547 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.150000000000006 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.420000000000002 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.540000000000006 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.636 HG13 HG21 ' B' ' 98' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.049999999999997 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 75.239999999999995 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.420000000000002 111.08 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.340000000000003 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.623 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.239999999999995 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.605 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.140000000000001 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.310000000000002 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.486 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 74.230000000000004 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.109999999999999 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 75.310000000000002 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.219999999999999 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 65' ' ' ILE . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.420000000000002 112.358 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.455 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.109999999999999 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.488 HG13 HD13 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.409999999999997 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 36.850000000000001 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.230000000000004 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.100000000000001 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.129999999999995 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.329999999999998 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.099999999999994 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 73.109999999999999 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . 0.422 ' CZ ' HD22 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.230000000000004 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 73.530000000000001 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.08 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.605 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.030000000000001 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.605 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.349999999999994 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.009999999999998 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.209999999999994 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.400000000000006 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.605 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.239999999999995 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.030000000000001 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.41 ' HG2' HD12 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.219999999999999 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.310000000000002 111.028 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.200000000000003 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.491 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 74.230000000000004 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 74.120000000000005 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.349999999999994 111.271 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.466 ' HB1' ' CG ' ' B' ' 157' ' ' HIS . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.439999999999998 111.236 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.219999999999999 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.040000000000006 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 111.527 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.59 -21.53 30.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.120000000000005 111.367 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.17 33.24 0.78 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.88 0.472 . . . . 63.200000000000003 111.67 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.44 -67.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 111.143 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.1 110.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.39 . . . . 72.230000000000004 110.713 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . 0.466 ' CG ' ' HB1' ' B' ' 149' ' ' ALA . 3.7 t-80 -72.18 144.64 48.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.172 -0.467 . . . . 75.219999999999999 111.234 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.19 150.15 29.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.99 -0.55 . . . . 72.219999999999999 111.146 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.401 -0.809 . . . . 53.119999999999997 111.018 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.558 ' C4 ' HG22 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.559 ' C4 ' HG22 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.776 0.322 . . . . 54.310000000000002 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.62 133.16 22.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.403 -0.362 . . . . 70.540000000000006 111.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.229999999999997 111.153 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.399999999999999 111.233 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 74.329999999999998 110.503 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 75.439999999999998 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.209999999999994 112.191 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.299999999999997 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG1' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.129999999999995 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.409999999999997 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 36.420000000000002 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.120000000000005 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.209999999999994 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.439999999999998 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.020000000000003 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.200000000000003 111.44 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 74.540000000000006 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.450000000000003 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 63.140000000000001 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.019999999999996 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.450000000000003 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.230000000000004 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.150000000000006 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.209999999999994 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.530000000000001 111.066 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.319999999999993 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.439999999999998 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.030000000000001 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.120000000000005 111.963 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 72.140000000000001 110.574 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.420000000000002 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.487 ' CE1' HG21 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 74.209999999999994 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 71.329999999999998 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 60.03 1.54 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.329999999999998 110.427 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.44 131.68 34.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.013 -0.54 . . . . 51.229999999999997 111.688 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.86 62.53 0.63 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.838 -0.619 . . . . 61.109999999999999 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.98 53.51 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.94 -1.027 . . . . 62.340000000000003 110.97 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.9 91.13 0.54 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.914 -0.585 . . . . 73.530000000000001 110.736 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.81 70.05 50.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 111.041 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.34 -166.45 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.937 2.424 . . . . 74.340000000000003 112.594 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.35 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.362 -0.835 . . . . 72.400000000000006 111.686 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.68 140.6 8.84 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.92 -0.582 . . . . 54.109999999999999 112.54 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.03 157.46 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 111.267 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.16 163.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.914 -0.585 . . . . 72.439999999999998 111.606 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.52 98.08 2.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.984 -0.553 . . . . 74.230000000000004 111.025 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.92 166.07 28.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.996 -0.547 . . . . 72.239999999999995 110.991 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.81 12.43 65.88 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.629 -0.796 . . . . 71.519999999999996 113.879 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 -8.89 12.22 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.733 -0.733 . . . . 62.32 114.252 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.099999999999994 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.119999999999997 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.464 HG22 ' C5 ' ' A' ' 187' ' ' 5GP . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.825 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.453 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 73.109999999999999 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.200000000000003 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.505 ' HB3' HN22 ' A' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.109999999999999 111.773 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.319999999999993 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.510000000000005 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.299999999999997 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.519999999999996 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.409999999999997 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.149999999999999 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.409999999999997 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 36.420000000000002 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.400000000000006 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.340000000000003 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.010000000000005 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.567 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.150000000000006 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.209999999999994 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.409999999999997 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.549999999999997 111.35 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 65.109999999999999 111.627 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.349999999999994 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.119999999999997 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.439999999999998 110.541 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.536 HD22 HD13 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.540000000000006 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' HA3' ' O2P' ' A' ' 187' ' ' 5GP . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.409999999999997 112.247 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' HA3' HD21 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.409999999999997 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.409999999999997 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.447 ' OE2' " H4'" ' A' ' 187' ' ' 5GP . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.340000000000003 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.310000000000002 110.765 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.530000000000001 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.030000000000001 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.430000000000007 111.818 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.049999999999997 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.540000000000006 111.466 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.400000000000006 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 74.230000000000004 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.420000000000002 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.430000000000007 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 73.150000000000006 110.913 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 74.030000000000001 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 73.299999999999997 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.540000000000006 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.584 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.140000000000001 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.399999999999999 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.329999999999998 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 36.420000000000002 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.129999999999995 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.209999999999994 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.099999999999994 110.24 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.439 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.310000000000002 111.446 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.413 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.420000000000002 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.557 HD13 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.019999999999996 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.430000000000007 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.299999999999997 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.310000000000002 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.509999999999998 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.030000000000001 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.319999999999993 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 75.140000000000001 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.439999999999998 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 73.349999999999994 110.655 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 71.230000000000004 110.975 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 65.099999999999994 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.140000000000001 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.219999999999999 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.239999999999995 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 73.040000000000006 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.120000000000005 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.439999999999998 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.340000000000003 110.867 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 72.25 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.530000000000001 111.264 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.420000000000002 111.656 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.425 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 75.400000000000006 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 73.319999999999993 111.552 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.07 -33.23 44.75 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.400000000000006 110.981 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.93 18.41 11.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.242 -0.436 . . . . 71.400000000000006 111.539 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.92 0.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.629 -0.26 . . . . 72.200000000000003 110.814 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.86 113.27 9.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.397 -0.365 . . . . 73.329999999999998 110.728 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -168.68 61.78 0.06 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.976 -0.557 . . . . 75.140000000000001 110.621 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -159.19 159.47 34.34 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 111.359 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.592 -0.718 . . . . 75.230000000000004 111.4 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.768 0.318 . . . . 64.409999999999997 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.65 133.21 22.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 70.129999999999995 111.3 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.340000000000003 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.439999999999998 111.17 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.430000000000007 111.166 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.534 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.120000000000005 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.430000000000007 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.465 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.219999999999999 112.207 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.563 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.299999999999997 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG1' ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.209999999999994 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.210000000000001 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.420000000000002 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.519999999999996 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.510000000000005 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.310000000000002 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 37.969999999999999 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.549999999999997 111.416 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.546 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.450000000000003 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.329999999999998 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.109999999999999 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.546 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.329999999999998 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.140000000000001 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 64.109999999999999 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.209999999999994 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' B' ' 147' ' ' PHE . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.319999999999993 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.040000000000006 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 70.329999999999998 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.530000000000001 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.239999999999995 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.109999999999999 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.120000000000005 111.91 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.549999999999997 110.593 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.430000000000007 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 64.510000000000005 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.531 HG22 ' CE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.65 60.09 1.54 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.519999999999996 110.425 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.5 131.72 34.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.981 -0.554 . . . . 71.099999999999994 111.615 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.85 62.51 0.63 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.791 -0.64 . . . . 75.120000000000005 110.203 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.93 53.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.974 -1.012 . . . . 73.209999999999994 110.971 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 91.14 0.54 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.944 -0.571 . . . . 61.310000000000002 110.75 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.83 70.11 50.83 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.117 -0.492 . . . . 72.409999999999997 111.014 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.38 -166.51 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.956 2.438 . . . . 65.430000000000007 112.538 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.44 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.364 -0.835 . . . . 62.310000000000002 111.604 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.7 140.62 8.85 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.852 -0.613 . . . . 62.43 112.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.08 157.39 11.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.725 0.298 . . . . 72.530000000000001 111.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.27 163.04 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.901 -0.59 . . . . 72.25 111.582 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.43 98.07 2.67 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.97 -0.559 . . . . 74.239999999999995 111.04 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.04 28.88 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.055 -0.521 . . . . 71.430000000000007 111.016 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.78 12.4 65.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.617 -0.801 . . . . 40.020000000000003 113.913 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.69 -8.82 12.73 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.718 -0.741 . . . . 70.519999999999996 114.256 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.436 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.129999999999995 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.510000000000005 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.129999999999995 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.469 HG22 ' C5 ' ' B' ' 187' ' ' 5GP . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.839 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.46 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 71.540000000000006 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.209999999999994 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.503 ' HB3' HN22 ' B' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.109999999999999 111.764 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.340000000000003 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.544 HD23 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.340000000000003 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.219999999999999 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.349999999999994 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.549999999999997 111.543 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 74.439999999999998 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.299999999999997 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.510000000000005 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.319999999999993 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.030000000000001 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.129999999999995 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.400000000000006 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.200000000000003 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.340000000000003 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 64.140000000000001 111.408 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.430000000000007 111.596 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.48 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.299999999999997 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' B' ' 85' ' ' GLN . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.030000000000001 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.239999999999995 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.299999999999997 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.424 ' HA3' ' O2P' ' B' ' 187' ' ' 5GP . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.209999999999994 112.268 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' B' ' 17' ' ' SER . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 73.519999999999996 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.209999999999994 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.545 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.349999999999994 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' OE2' " H4'" ' B' ' 187' ' ' 5GP . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.040000000000006 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.409999999999997 110.749 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.548 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.200000000000003 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.544 ' HG2' HD23 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.420000000000002 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.408 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.439999999999998 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.129999999999995 111.781 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.240000000000002 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.310000000000002 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.230000000000004 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.409999999999997 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.567 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 65.25 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.420000000000002 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.57 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 65.530000000000001 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.019999999999996 110.945 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.439999999999998 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.420000000000002 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.150000000000006 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.439999999999998 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.540000000000006 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.019999999999996 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 75.129999999999995 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.350000000000001 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.445 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.210000000000001 111.449 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.443 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.200000000000003 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.536 HD13 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.310000000000002 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.409999999999997 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 37.969999999999999 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 51.030000000000001 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.439999999999998 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.530000000000001 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 72.329999999999998 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.409999999999997 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.299999999999997 110.623 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.509999999999998 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.612 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 73.030000000000001 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.539999999999999 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.099999999999994 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.340000000000003 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.299999999999997 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.612 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.209999999999994 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.420000000000002 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.210000000000001 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.209999999999994 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.451 HD23 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.219999999999999 110.872 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 53.43 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.453 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 73.439999999999998 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.030000000000001 111.215 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.130000000000003 111.64 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 73.349999999999994 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.239999999999995 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.420000000000002 111.588 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.06 -33.21 44.85 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.340000000000003 110.958 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.88 18.42 11.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.307 -0.406 . . . . 75.230000000000004 111.594 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.9 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.592 -0.276 . . . . 64.140000000000001 110.809 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.83 113.19 9.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.433 -0.348 . . . . 71.219999999999999 110.75 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -168.65 61.89 0.06 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.052 -0.522 . . . . 73.120000000000005 110.565 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -159.23 159.47 34.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.979 -0.555 . . . . 75.120000000000005 111.335 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.636 -0.697 . . . . 73.109999999999999 111.392 179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.505 HN22 ' HB3' ' A' ' 68' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.503 HN22 ' HB3' ' B' ' 68' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 53.200000000000003 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 147.69 28.15 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 111.248 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.200000000000003 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 110.732 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.039999999999999 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.329999999999998 110.953 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.53 ' HB3' HG13 ' A' ' 90' ' ' VAL . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.219999999999999 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.100000000000001 111.426 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.62 ' HB2' HG23 ' A' ' 90' ' ' VAL . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.120000000000005 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.56 HG21 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.219999999999999 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.040000000000006 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.420000000000002 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.239999999999995 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.219999999999999 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.129999999999995 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 74.540000000000006 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.439999999999998 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.530000000000001 110.644 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.702 ' CD1' HG22 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.100000000000001 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.039999999999999 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.471 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.439999999999998 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 31' ' ' ILE . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.209999999999994 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.400000000000006 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 43.200000000000003 111.033 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.219999999999999 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 72.25 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.109999999999999 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.439999999999998 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 110.254 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.310000000000002 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.486 HG21 HO2' ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.439999999999998 110.211 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.120000000000005 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.409 ' CE1' " O2'" ' A' ' 187' ' ' 5GP . 54.2 p-80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.319999999999993 111.56 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 54.340000000000003 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.9 49.37 2.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 60.229999999999997 110.348 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.42 125.97 30.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.005 -0.543 . . . . 71.329999999999998 111.634 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.0 64.66 4.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.909 -0.587 . . . . 71.030000000000001 109.498 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.58 55.9 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.96 -1.018 . . . . 74.129999999999995 110.106 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.36 159.56 30.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.666 -0.697 . . . . 74.519999999999996 111.044 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.21 129.02 0.13 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.813 -0.631 . . . . 72.109999999999999 110.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.62 -166.82 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.092 2.528 . . . . 73.439999999999998 112.636 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.97 163.9 7.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 74.510000000000005 111.212 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.03 11.29 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.252 -0.499 . . . . 37.030000000000001 113.114 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 155.82 36.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.301 . . . . 73.200000000000003 111.255 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 57.9 51.91 8.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.54 . . . . 64.129999999999995 110.898 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.17 73.48 0.33 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.656 -0.702 . . . . 63.25 110.829 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.21 171.09 20.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.989 -0.55 . . . . 64.019999999999996 111.345 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.64 172.5 20.61 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.053 -0.594 . . . . 74.129999999999995 112.648 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.84 -98.08 0.17 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.076 -0.583 . . . . 74.239999999999995 112.621 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.430000000000007 111.099 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 75.420000000000002 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.420000000000002 110.659 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.601 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.040000000000006 111.117 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.299999999999997 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.099999999999994 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.299999999999997 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HB1' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.120000000000005 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.409999999999997 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.519999999999996 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.219999999999999 111.435 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.420000000000002 111.177 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.319999999999993 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.524 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.239999999999995 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.588 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.400000000000006 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 104' ' ' ILE . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 74.140000000000001 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HA ' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 73.510000000000005 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.430000000000007 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.409999999999997 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 74.420000000000002 111.196 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 64.150000000000006 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 62.409999999999997 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.430000000000007 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 71.219999999999999 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.219999999999999 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.439999999999998 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' B' ' 88' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.019999999999996 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 73.5 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.019999999999996 111.08 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.5 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.049999999999997 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' HD13 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.129999999999995 111.359 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 104' ' ' ILE . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.109999999999999 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.049999999999997 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 72.209999999999994 111.862 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.439999999999998 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.030000000000001 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.219999999999999 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 98' ' ' VAL . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.329999999999998 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.340000000000003 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' HD21 ' A' ' 94' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.109999999999999 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.519 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.030000000000001 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.400000000000006 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.319999999999993 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.019999999999996 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.430000000000007 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.219999999999999 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.400000000000006 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.340000000000003 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.350000000000001 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.565 ' CE ' ' HB1' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 74.109999999999999 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.467 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.530000000000001 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.209999999999994 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.099999999999994 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.457 ' HB1' ' ND1' ' B' ' 66' ' ' HIS . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 74.200000000000003 111.016 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.530000000000001 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.519999999999996 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 37.030000000000001 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.340000000000003 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.529 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.530000000000001 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.150000000000006 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 75.420000000000002 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.230000000000004 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.651 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 75.409999999999997 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.340000000000003 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.020000000000003 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.229999999999997 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.120000000000005 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.651 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.549999999999997 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.420000000000002 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.200000000000003 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.299999999999997 110.792 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.049999999999997 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.239999999999995 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.010000000000005 111.198 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.209999999999994 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.049999999999997 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.32 -33.12 43.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.319999999999993 111.106 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.8 m80 61.16 19.24 9.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 111.347 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.52 176.49 1.02 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 111.311 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -153.09 111.66 3.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.09 -0.504 . . . . 70.319999999999993 110.854 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.34 154.15 22.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 111.328 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 127' ' ' SER . 59.3 t-80 -143.1 -63.25 0.41 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.173 -0.467 . . . . 62.340000000000003 110.918 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.1 -0.953 . . . . 70.209999999999994 110.988 179.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.725 0.297 . . . . 70.510000000000005 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.64 28.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.203 -0.453 . . . . 65.409999999999997 111.327 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.530000000000001 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.040000000000006 110.676 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.456 HG11 HG11 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.230000000000004 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 110.927 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.510000000000005 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.546 ' HB3' HG13 ' B' ' 90' ' ' VAL . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.439999999999998 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.6 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.210000000000001 111.44 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 90' ' ' VAL . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 70.400000000000006 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.551 HG21 HG12 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.219999999999999 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.403 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 74.400000000000006 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.444 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.119999999999997 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.329999999999998 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.239999999999995 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.200000000000003 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.540000000000006 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.240000000000002 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.120000000000005 110.645 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.701 ' CD2' HG22 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 63.420000000000002 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.409999999999997 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.475 HD11 HG21 ' B' ' 32' ' ' VAL . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 71.120000000000005 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.475 HG21 HD11 ' B' ' 31' ' ' ILE . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.409999999999997 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.239999999999995 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.083 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.150000000000006 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.219999999999999 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.439999999999998 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 72.129999999999995 110.326 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.239999999999995 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.487 HG21 HO2' ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.319999999999993 110.258 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.340000000000003 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.403 ' CE1' " O2'" ' B' ' 187' ' ' 5GP . 54.3 p-80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 63.420000000000002 111.538 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.701 HG22 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.120000000000005 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.88 49.42 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.450000000000003 110.344 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.5 125.91 29.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 111.598 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 64.58 4.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.895 -0.593 . . . . 72.439999999999998 109.472 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.57 55.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.944 -1.026 . . . . 75.409999999999997 110.081 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.29 159.64 29.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.633 -0.712 . . . . 72.109999999999999 111.085 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.19 129.03 0.13 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 115.9 -0.591 . . . . 75.129999999999995 110.953 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.67 -166.78 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.035 2.49 . . . . 75.329999999999998 112.572 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.98 163.85 7.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.278 -0.874 . . . . 72.439999999999998 111.309 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.0 11.28 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.247 -0.502 . . . . 52.210000000000001 113.086 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.26 155.77 36.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.75 0.31 . . . . 74.120000000000005 111.323 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 57.93 51.83 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.085 -0.507 . . . . 63.450000000000003 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.05 73.44 0.34 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.636 -0.711 . . . . 63.149999999999999 110.872 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.17 171.12 20.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.028 -0.533 . . . . 74.310000000000002 111.411 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.59 172.52 20.65 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.084 -0.579 . . . . 73.099999999999994 112.635 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.87 -98.14 0.17 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.077 -0.583 . . . . 72.129999999999995 112.64 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 74.150000000000006 111.144 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.319999999999993 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 72.200000000000003 110.659 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.586 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 111.1 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.549 ' C ' ' CD2' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.299999999999997 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 75.019999999999996 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.130000000000003 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.565 ' HB1' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.239999999999995 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.421 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.209999999999994 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.458 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.420000000000002 111.496 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.150000000000006 111.132 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 51.32 111.629 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.120000000000005 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.329999999999998 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.471 ' HB ' HD13 ' B' ' 104' ' ' ILE . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.578 ' HA ' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.310000000000002 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.240000000000002 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.540000000000006 111.173 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.46 ' CG2' ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.329999999999998 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.229999999999997 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.329999999999998 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.230000000000004 110.773 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.558 HD11 ' HA3' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 64.510000000000005 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.615 HG23 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.209999999999994 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 88' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 37.729999999999997 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.420000000000002 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.43 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.086 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.506 ' CD2' ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.299999999999997 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.421 ' HD2' HD13 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.299999999999997 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.219999999999999 111.398 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.502 HG21 HG13 ' B' ' 104' ' ' ILE . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 71.409999999999997 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.219999999999999 111.896 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.310000000000002 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.563 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.400000000000006 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.502 HG13 HG21 ' B' ' 98' ' ' VAL . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.120000000000005 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' B' ' 94' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.486 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.420000000000002 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.150000000000006 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.140000000000001 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.518 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 72.200000000000003 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.420000000000002 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.483 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.329999999999998 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.329999999999998 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.465 ' HA ' ' HB3' ' B' ' 86' ' ' PRO . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 74.230000000000004 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.049999999999997 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.409999999999997 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.573 ' CE ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.120000000000005 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.471 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 71.299999999999997 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.140000000000001 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . 0.462 ' HB1' ' ND1' ' A' ' 66' ' ' HIS . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.310000000000002 110.974 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.130000000000003 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.229999999999997 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' B' ' 158' ' ' HIS . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.030000000000001 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.546 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.340000000000003 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 73.329999999999998 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 110.944 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.468 ' CE3' ' SD ' ' B' ' 142' ' ' MET . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.219999999999999 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.310000000000002 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.643 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.129999999999995 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.340000000000003 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.130000000000003 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 74.329999999999998 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.643 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.310000000000002 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.109999999999999 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.230000000000004 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.464 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 74.0 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 74.230000000000004 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.399999999999999 111.244 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.239999999999995 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.329999999999998 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.540000000000006 111.503 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.31 -33.14 43.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.040000000000006 111.084 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.9 m80 61.2 19.08 9.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 53.409999999999997 111.421 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.41 176.51 1.04 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.813 0.339 . . . . 75.430000000000007 111.361 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -153.1 111.68 3.7 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 75.329999999999998 110.807 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.32 154.1 22.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.309 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.537 ' HB3' ' HA ' ' B' ' 127' ' ' SER . 59.3 t-80 -142.99 -63.35 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.13 -0.487 . . . . 73.409999999999997 110.929 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.09 -0.957 . . . . 73.239999999999995 110.98 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.601 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.6 H5'1 ' O ' ' B' ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.659 0.266 . . . . 75.340000000000003 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 147.53 27.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.266 -0.424 . . . . 62.140000000000001 111.287 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.519999999999996 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.310000000000002 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 75.209999999999994 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.430000000000007 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.484 ' HD1' ' CE1' ' A' ' 28' ' ' TYR . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.219999999999999 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.409999999999997 111.952 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.329999999999998 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.561 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.200000000000003 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.450000000000003 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 37.810000000000002 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.140000000000001 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.420000000000002 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.019999999999996 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.040000000000006 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.349999999999994 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CD1' HG22 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.099999999999994 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.049999999999997 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 32' ' ' VAL . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 74.430000000000007 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 31' ' ' ILE . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.239999999999995 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.430000000000007 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.420000000000002 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.150000000000006 111.016 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.200000000000003 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.129999999999995 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.530000000000001 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.340000000000003 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' HG3' ' A' ' 44' ' ' GLU . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.430000000000007 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.439999999999998 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 61.229999999999997 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.405 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 46.3 p-80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.510000000000005 110.827 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 60.030000000000001 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.64 44.17 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.149999999999999 111.864 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -103.85 151.16 23.42 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.02 0.438 . . . . 72.409999999999997 111.142 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.0 52.78 1.92 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.601 0.715 . . . . 51.100000000000001 110.206 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.92 70.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.282 -1.326 . . . . 74.099999999999994 110.099 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.34 99.49 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.227 -0.442 . . . . 65.230000000000004 110.923 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.89 107.77 0.86 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.718 -0.673 . . . . 64.030000000000001 111.984 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.32 -165.9 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.303 2.668 . . . . 55.32 112.504 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.74 163.3 0.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.339 -0.846 . . . . 71.329999999999998 111.59 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.24 -156.99 16.59 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.972 -0.633 . . . . 60.229999999999997 112.656 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.78 157.53 14.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.771 0.319 . . . . 72.510000000000005 111.115 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.63 52.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.969 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.11 152.26 48.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 111.233 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.63 101.97 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 110.817 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 142.44 6.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.968 -0.634 . . . . 51.030000000000001 112.359 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 65' ' ' ILE . . . -68.38 -21.8 74.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.062 -0.59 . . . . 54.240000000000002 113.329 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' HA ' HD13 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 73.329999999999998 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 64.140000000000001 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 72.209999999999994 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.609 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 75.420000000000002 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.510000000000005 111.439 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.239999999999995 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.519999999999996 111.319 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.319999999999993 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 73.010000000000005 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.349999999999994 111.737 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.420000000000002 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.219999999999999 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.450000000000003 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.439999999999998 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 71.540000000000006 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.549 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.009999999999998 111.804 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.219999999999999 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.510000000000005 111.144 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 70.129999999999995 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.329999999999998 112.443 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' CD2' HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 71.510000000000005 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.350000000000001 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 17' ' ' SER . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.019999999999996 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.109999999999999 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.230000000000004 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.520000000000003 110.44 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.219999999999999 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.597 ' HD2' HD13 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.329999999999998 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.402 ' HB3' HG22 ' A' ' 79' ' ' VAL . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.229999999999997 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.46 ' CG2' HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.230000000000004 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.349999999999994 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.439999999999998 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.340000000000003 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.409999999999997 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.46 HG13 ' CG2' ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.530000000000001 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.230000000000004 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.329999999999998 110.936 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.539999999999999 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 112' ' ' SER . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.140000000000001 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.446 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.509999999999998 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.020000000000003 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.329999999999998 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.329999999999998 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.420000000000002 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.299999999999997 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 74.5 110.725 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.526 HG12 ' HA2' ' B' ' 89' ' ' GLY . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.349999999999994 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 37.810000000000002 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.240000000000002 110.795 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 71.409999999999997 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.120000000000005 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.310000000000002 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.439999999999998 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.409999999999997 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 75.439999999999998 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 111.173 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.409999999999997 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.628 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.230000000000004 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.109999999999999 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.400000000000006 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.299999999999997 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.200000000000003 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.040000000000006 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.43 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.420000000000002 111.11 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.130000000000003 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.109999999999999 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.019999999999996 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.310000000000002 111.088 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.540000000000006 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.130000000000003 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.219999999999999 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.549999999999997 110.834 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.98 -36.93 85.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.142 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -34.81 74.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.367 -0.379 . . . . 74.530000000000001 111.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.29 -66.4 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.664 -0.244 . . . . 62.310000000000002 111.322 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.92 165.73 11.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.339 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -113.04 160.18 18.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.039 -0.528 . . . . 74.030000000000001 110.965 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.04 -75.71 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.088 -0.505 . . . . 71.420000000000002 111.314 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.039 -0.981 . . . . 72.099999999999994 111.298 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.664 0.269 . . . . 62.329999999999998 111.148 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.16 147.55 27.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.242 -0.435 . . . . 74.519999999999996 111.229 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.540000000000006 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.219999999999999 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.310000000000002 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.420000000000002 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' HD1' ' CE1' ' B' ' 28' ' ' TYR . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.040000000000006 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.563 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.340000000000003 111.861 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.489 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.230000000000004 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.568 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.049999999999997 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.476 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 73.230000000000004 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.428 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 37.780000000000001 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.219999999999999 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.140000000000001 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.230000000000004 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.420000000000002 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.509999999999998 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.319999999999993 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.120000000000005 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.55 ' CD1' HG22 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.319999999999993 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.019999999999996 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.527 HD12 HG21 ' B' ' 32' ' ' VAL . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.519999999999996 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.527 HG21 HD12 ' B' ' 31' ' ' ILE . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.539999999999999 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.329999999999998 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.340000000000003 111.05 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.319999999999993 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.010000000000005 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.239999999999995 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.219999999999999 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.549999999999997 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' B' ' 44' ' ' GLU . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' ' 13' ' ' TYR . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.472 HG22 ' O ' ' B' ' 14' ' ' PHE . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.219999999999999 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.329999999999998 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.415 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 46.1 p-80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.439999999999998 110.809 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.568 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.329999999999998 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 44.21 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.299999999999997 111.865 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -103.81 151.15 23.41 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.979 0.418 . . . . 73.329999999999998 111.169 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.02 52.83 1.92 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.514 0.673 . . . . 62.329999999999998 110.193 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.87 70.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.261 -1.336 . . . . 63.549999999999997 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.32 99.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.149 -0.478 . . . . 73.010000000000005 110.933 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -49.89 107.82 0.87 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.744 -0.662 . . . . 74.319999999999993 112.015 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.45 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.253 2.635 . . . . 72.439999999999998 112.43 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.78 163.23 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.304 -0.862 . . . . 75.230000000000004 111.584 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.29 -156.94 16.58 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.041 -0.6 . . . . 71.219999999999999 112.745 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.81 157.5 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.777 0.323 . . . . 73.219999999999999 111.136 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 136.74 52.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.18 -0.464 . . . . 72.25 110.92 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.17 152.19 48.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.066 -0.516 . . . . 75.129999999999995 111.261 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.62 101.96 1.1 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 75.349999999999994 110.829 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 142.4 6.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.984 -0.627 . . . . 63.130000000000003 112.308 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.419 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -68.31 -21.87 74.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.117 -0.564 . . . . 65.349999999999994 113.3 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.475 ' HA ' HD13 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.140000000000001 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.319999999999993 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.622 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.519999999999996 111.421 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.209999999999994 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.230000000000004 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.299999999999997 111.259 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.605 HD13 ' HD2' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.109999999999999 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.530000000000001 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.507 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' B' ' 97' ' ' ALA . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.430000000000007 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.209999999999994 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.040000000000006 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 74.340000000000003 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.099999999999994 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 74.129999999999995 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.340000000000003 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.030000000000001 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.447 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.229999999999997 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.209999999999994 111.094 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.406 ' CG2' ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.340000000000003 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.140000000000001 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.409999999999997 112.384 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.430000000000007 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.416 ' CD2' HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 37.780000000000001 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' B' ' 17' ' ' SER . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.329999999999998 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.616 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 74.439999999999998 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.5 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 110.448 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.618 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.350000000000001 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.605 ' HD2' HD13 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.239999999999995 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' B' ' 79' ' ' VAL . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.140000000000001 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.466 ' CG2' HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.019999999999996 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.319999999999993 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.349999999999994 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.230000000000004 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.099999999999994 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.129999999999995 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.406 ' HA ' ' HB2' ' B' ' 81' ' ' ALA . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.509999999999998 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.329999999999998 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.474 ' CZ ' ' HA ' ' B' ' 112' ' ' SER . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.150000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.457 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.099999999999994 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.474 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.130000000000003 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.120000000000005 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 74.409999999999997 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.140000000000001 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.239999999999995 110.616 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.109999999999999 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.099999999999994 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.329999999999998 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 89' ' ' GLY . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.340000000000003 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.209999999999994 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.229999999999997 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.239999999999995 110.753 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.350000000000001 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 63.409999999999997 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.350000000000001 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.229999999999997 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.409999999999997 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' B' ' 104' ' ' ILE . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.450000000000003 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.310000000000002 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.310000000000002 111.24 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.120000000000005 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.457 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.530000000000001 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.618 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 74.109999999999999 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.209999999999994 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.439999999999998 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.329999999999998 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.618 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.039999999999999 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.299999999999997 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.299999999999997 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.310000000000002 111.053 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.200000000000003 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.109999999999999 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.412 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.450000000000003 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 70.209999999999994 110.789 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.96 -36.89 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -34.78 74.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 74.310000000000002 111.528 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.27 -66.42 0.91 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.692 -0.231 . . . . 62.329999999999998 111.362 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.83 165.73 11.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.862 0.363 . . . . 72.129999999999995 111.431 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -113.06 160.26 18.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.091 -0.504 . . . . 73.150000000000006 110.98 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.01 -75.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.998 -0.546 . . . . 72.230000000000004 111.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.997 -1.002 . . . . 74.230000000000004 111.248 -179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.609 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.622 ' C6 ' HG12 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.031 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.87 125.2 18.94 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.998 -0.546 . . . . 55.450000000000003 111.011 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.240000000000002 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.400000000000006 110.995 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.209999999999994 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.540000000000006 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.409999999999997 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.530000000000001 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.340000000000003 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.120000000000005 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.509999999999998 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 75.109999999999999 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.430000000000007 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.420000000000002 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.450000000000003 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 110.079 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 46' ' ' VAL . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 74.120000000000005 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 28' ' ' TYR . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.409999999999997 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.340000000000003 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 71.409999999999997 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.140000000000001 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.439999999999998 111.255 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.329999999999998 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.329999999999998 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.409999999999997 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.409999999999997 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 HG23 HG13 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.030000000000001 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.450000000000003 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.412 HG23 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.049999999999997 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.030000000000001 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.511 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 54.4 p-80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.539999999999999 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.573 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.36 1.23 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 70.329999999999998 110.865 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.47 132.59 35.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.944 0.402 . . . . 74.430000000000007 111.347 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.34 58.43 1.2 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.378 0.609 . . . . 54.119999999999997 110.548 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 35.5 tt0 172.7 68.29 0.0 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.683 -1.144 . . . . 71.239999999999995 109.918 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 102.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.925 -0.58 . . . . 64.310000000000002 111.49 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.79 108.36 1.13 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.77 -0.65 . . . . 75.120000000000005 111.746 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.96 -166.17 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.332 2.688 . . . . 74.409999999999997 112.651 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.28 150.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.241 -0.89 . . . . 64.329999999999998 111.595 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.27 143.79 9.11 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.164 -0.541 . . . . 51.109999999999999 112.749 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.45 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.691 0.281 . . . . 63.32 111.145 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.03 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.071 -0.513 . . . . 72.319999999999993 111.192 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.07 87.69 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 74.219999999999999 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.12 133.05 36.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.032 -0.531 . . . . 64.140000000000001 111.332 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.44 140.67 5.56 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.099 -0.572 . . . . 65.109999999999999 112.649 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.53 -8.62 3.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.278 -0.487 . . . . 64.430000000000007 113.805 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.049999999999997 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.329999999999998 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.109999999999999 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.567 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.150000000000006 110.716 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.120000000000005 111.38 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.420000000000002 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.150000000000006 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 75.430000000000007 111.203 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.539999999999999 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.417 ' HZ3' HN21 ' A' ' 187' ' ' 5GP . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.439999999999998 111.252 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.219999999999999 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 100' ' ' LEU . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.539999999999999 110.421 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.099999999999994 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.200000000000003 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.530000000000001 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 103' ' ' PRO . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 65.329999999999998 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.150000000000006 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.299999999999997 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.010000000000005 111.264 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.109999999999999 111.557 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.530000000000001 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HA ' HD13 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.329999999999998 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.109999999999999 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.140000000000001 112.532 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.400000000000006 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.299999999999997 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.654 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.140000000000001 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.519999999999996 110.274 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.649 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.409999999999997 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.129999999999995 110.761 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 79' ' ' VAL . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.119999999999997 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.5 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.129999999999995 111.301 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 74' ' ' GLN . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.519999999999996 111.328 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.399999999999999 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 73.040000000000006 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.040000000000006 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.310000000000002 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.409999999999997 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.310000000000002 110.744 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.039999999999999 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.519999999999996 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 112' ' ' SER . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.45 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.209999999999994 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.020000000000003 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 37.700000000000003 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.420000000000002 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.209999999999994 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 HD12 ' B' ' 88' ' ' LEU . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.229999999999997 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.528 ' HB2' ' O3P' ' B' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.540000000000006 111.456 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.140000000000001 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.423 ' HE1' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.421 HG21 ' HB3' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 71.239999999999995 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.329999999999998 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.299999999999997 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 73.109999999999999 110.67 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.519999999999996 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.329999999999998 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.149999999999999 111.101 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 111.244 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.469 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.439999999999998 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.010000000000005 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.544 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 75.400000000000006 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.519999999999996 111.236 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.409999999999997 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 37.700000000000003 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.109999999999999 111.676 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.400000000000006 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.230000000000004 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.544 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.407 HD23 HG23 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.209999999999994 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.519999999999996 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.329999999999998 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.530000000000001 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.400000000000006 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 64.129999999999995 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.299999999999997 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.409999999999997 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.439999999999998 111.014 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -33.52 60.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 111.084 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.6 17.83 11.04 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.321 -0.399 . . . . 70.230000000000004 111.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.92 177.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.552 -0.294 . . . . 75.340000000000003 110.804 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.84 110.65 15.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.362 -0.381 . . . . 73.340000000000003 110.689 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.09 60.97 0.58 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 75.230000000000004 110.972 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -80.55 167.12 20.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.094 -0.503 . . . . 74.310000000000002 110.885 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.204 -0.903 . . . . 75.409999999999997 111.06 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.86 125.18 18.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.067 -0.515 . . . . 72.129999999999995 111.011 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 73.019999999999996 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.425 ' HB3' ' CD2' ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.219999999999999 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.439999999999998 111.007 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.451 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.219999999999999 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.44 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.240000000000002 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.522 HG22 HD11 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.439999999999998 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.414 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.430000000000007 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.109999999999999 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.120000000000005 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.530000000000001 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.299999999999997 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.010000000000005 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 72.349999999999994 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.239999999999995 110.05 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.571 ' CD1' HG22 ' B' ' 46' ' ' VAL . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.399999999999999 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.409999999999997 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.471 HD11 HG22 ' B' ' 32' ' ' VAL . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.010000000000005 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.495 HG13 HG23 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.240000000000002 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 62.130000000000003 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.310000000000002 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 75.319999999999993 111.218 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.420000000000002 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.450000000000003 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.439999999999998 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.420000000000002 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.340000000000003 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.495 HG23 HG13 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 73.129999999999995 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.439999999999998 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.403 HG23 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 75.219999999999999 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 72.209999999999994 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.509 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 54.4 p-80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.039999999999999 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.439999999999998 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.65 51.43 1.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.329999999999998 110.791 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.55 132.69 35.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.932 0.396 . . . . 63.539999999999999 111.367 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.37 58.42 1.21 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.353 0.597 . . . . 71.340000000000003 110.473 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 35.6 tt0 172.73 68.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.671 -1.149 . . . . 61.200000000000003 109.871 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.17 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.901 -0.591 . . . . 61.119999999999997 111.432 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.74 108.36 1.13 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.908 -0.587 . . . . 65.200000000000003 111.698 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.96 -166.19 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.338 2.692 . . . . 64.340000000000003 112.667 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.31 150.44 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.198 -0.91 . . . . 73.319999999999993 111.542 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.25 143.8 9.12 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.119 -0.563 . . . . 71.140000000000001 112.705 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.52 39.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.713 0.292 . . . . 70.200000000000003 111.113 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.01 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.021 -0.536 . . . . 73.030000000000001 111.26 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 87.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.088 -0.505 . . . . 64.310000000000002 111.213 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 133.04 36.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.98 -0.555 . . . . 54.539999999999999 111.408 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.37 140.65 5.57 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.206 -0.521 . . . . 71.430000000000007 112.698 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.43 -8.64 3.51 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.324 -0.465 . . . . 41.310000000000002 113.907 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.428 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 74.0 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.340000000000003 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.430000000000007 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.566 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 110.649 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.120000000000005 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 70.140000000000001 111.172 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.200000000000003 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.404 ' HZ3' HN21 ' B' ' 187' ' ' 5GP . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 111.222 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.109999999999999 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' B' ' 100' ' ' LEU . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 110.397 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.030000000000001 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' B' ' 73' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.450000000000003 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' B' ' 103' ' ' PRO . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.209999999999994 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.210000000000001 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.510000000000005 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.340000000000003 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.010000000000005 111.279 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.430000000000007 111.485 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.210000000000001 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.229999999999997 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.129999999999995 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.209999999999994 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.240000000000002 112.509 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.539 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.209999999999994 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.049999999999997 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.649 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.150000000000006 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.430000000000007 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.333 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.654 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.540000000000006 110.726 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . 0.499 ' HA ' ' CD2' ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.310000000000002 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.503 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.120000000000005 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.409999999999997 111.358 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' B' ' 74' ' ' GLN . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.430000000000007 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.109999999999999 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.049999999999997 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 74.439999999999998 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.450000000000003 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 110.772 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 74.120000000000005 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' B' ' 112' ' ' SER . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.340000000000003 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.209999999999994 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.430000000000007 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.430000000000007 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.424 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.140000000000001 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.010000000000005 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.49 HD23 HD12 ' A' ' 88' ' ' LEU . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.524 ' HB2' ' O3P' ' A' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.209999999999994 110.699 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.319999999999993 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.219999999999999 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.530000000000001 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.319999999999993 110.634 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.340000000000003 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.099999999999994 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.019999999999996 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.239999999999995 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.129999999999995 111.056 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.130000000000003 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 111.213 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.477 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.319999999999993 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.543 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 75.530000000000001 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.239999999999995 111.291 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.129999999999995 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.329999999999998 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.420000000000002 111.693 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.475 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.543 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 73.230000000000004 111.051 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.310000000000002 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.439999999999998 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.44 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.310000000000002 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 54.310000000000002 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 63.310000000000002 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.51 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 70.209999999999994 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 74.450000000000003 110.93 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.42 60.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.209999999999994 111.054 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.51 17.87 11.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.363 -0.38 . . . . 71.150000000000006 111.217 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.9 177.86 0.47 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.492 -0.322 . . . . 75.349999999999994 110.823 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.9 110.79 15.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.681 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -156.12 60.95 0.58 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 110.946 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.65 167.18 20.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.084 -0.507 . . . . 75.409999999999997 110.915 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.169 -0.919 . . . . 71.239999999999995 111.04 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.567 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.566 ' C6 ' HG12 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.62 0.247 . . . . 73.430000000000007 111.192 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 143.13 35.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.286 -0.416 . . . . 74.150000000000006 111.276 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 73.109999999999999 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 75.200000000000003 111.319 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.404 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 75.430000000000007 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.239999999999995 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.120000000000005 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.130000000000003 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.219999999999999 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.450000000000003 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.239999999999995 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.430000000000007 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.530000000000001 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.530000000000001 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.45 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.585 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.420000000000002 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.25 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.400000000000006 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.129999999999995 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.019999999999996 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.510000000000005 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.310000000000002 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.239999999999995 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.400000000000006 112.061 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.509999999999998 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.150000000000006 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.329999999999998 109.738 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.452 ' CG2' ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.329999999999998 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.340000000000003 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 46' ' ' VAL . 51.3 p-80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.019999999999996 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.329999999999998 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.5 46.59 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.120000000000005 112.386 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -113.78 142.34 46.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.895 0.379 . . . . 72.239999999999995 110.956 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -123.2 53.94 1.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.46 0.648 . . . . 62.210000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 37.2 tt0 167.23 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.37 -1.286 . . . . 75.239999999999995 109.834 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 104.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 110.669 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.92 83.08 14.05 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 74.150000000000006 111.831 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.17 -167.72 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.931 2.42 . . . . 62.399999999999999 112.251 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.05 149.79 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.533 -0.758 . . . . 74.420000000000002 111.417 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.77 148.54 19.54 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.006 -0.616 . . . . 74.019999999999996 112.944 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.74 115.91 14.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.637 0.256 . . . . 73.439999999999998 110.676 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.2 7.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 70.340000000000003 111.257 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.56 160.45 19.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 70.519999999999996 111.414 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 120.91 9.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 64.340000000000003 111.448 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.79 141.75 12.24 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.151 -0.547 . . . . 73.409999999999997 112.743 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.96 -7.48 84.07 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.38 -0.438 . . . . 65.120000000000005 113.414 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 110.705 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.534 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.409999999999997 110.648 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.149999999999999 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.109999999999999 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HB3' HN22 ' A' ' 187' ' ' 5GP . 1.4 mp0 -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.140000000000001 111.547 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.109999999999999 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.519999999999996 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.120000000000005 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.52 ' CZ3' ' N2 ' ' A' ' 187' ' ' 5GP . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.200000000000003 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.129999999999995 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.463 ' HA ' HD11 ' A' ' 100' ' ' LEU . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.099999999999994 110.861 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.430000000000007 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 37.039999999999999 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 103' ' ' PRO . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 73.109999999999999 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HB ' HD13 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.099999999999994 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.450000000000003 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.210000000000001 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.299999999999997 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.574 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.310000000000002 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HA ' ' CD1' ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.409999999999997 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.030000000000001 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD23 ' HA3' ' B' ' 91' ' ' GLY . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.329999999999998 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA3' ' O1P' ' A' ' 187' ' ' 5GP . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.329999999999998 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 75.439999999999998 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.566 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.009999999999998 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.649 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 74.219999999999999 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.230000000000004 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.656 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.420000000000002 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HD2' HD13 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.140000000000001 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.598 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.229999999999997 110.803 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.450000000000003 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 74' ' ' GLN . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.420000000000002 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.019999999999996 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.420000000000002 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.448 HD13 ' HB ' ' A' ' 79' ' ' VAL . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.319999999999993 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.340000000000003 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.530000000000001 110.593 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.420000000000002 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.310000000000002 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.140000000000001 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.665 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.540000000000006 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.540000000000006 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 37.039999999999999 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 73.510000000000005 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.319999999999993 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.510000000000005 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.526 ' HB2' ' O1P' ' B' ' 187' ' ' 5GP . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 61.240000000000002 111.304 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.149999999999999 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.415 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.439 HG21 HD23 ' A' ' 116' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.200000000000003 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.540000000000006 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 71.219999999999999 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.319999999999993 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.200000000000003 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 61.109999999999999 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' A' ' 156' ' ' HIS . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.310000000000002 112.237 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.219999999999999 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.539999999999999 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.310000000000002 111.119 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.665 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.200000000000003 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.009999999999998 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.149999999999999 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 37.039999999999999 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.340000000000003 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.430000000000007 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 73.340000000000003 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.350000000000001 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.219999999999999 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.340000000000003 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.450000000000003 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 75.420000000000002 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.010000000000005 111.174 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.209999999999994 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.510000000000005 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.239999999999995 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.420000000000002 111.172 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.27 -30.98 38.42 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 64.319999999999993 111.537 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.5 m80 63.94 20.16 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.541 -0.3 . . . . 75.329999999999998 111.363 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.86 -178.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.391 -0.368 . . . . 62.409999999999997 110.434 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -118.0 138.87 51.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.721 0.296 . . . . 73.019999999999996 110.804 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 168.78 19.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.124 -0.489 . . . . 71.219999999999999 111.112 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.13 148.09 37.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 73.329999999999998 111.386 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.156 -0.926 . . . . 73.230000000000004 111.049 179.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.689 0.281 . . . . 71.209999999999994 111.223 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 143.18 35.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.256 -0.429 . . . . 72.510000000000005 111.229 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.509999999999998 110.846 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' B' ' 76' ' ' ALA . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.240000000000002 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.120000000000005 111.342 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.417 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 74.530000000000001 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 65.409999999999997 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.010000000000005 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.485 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.420000000000002 112.235 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.465 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.130000000000003 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.581 HG23 HG12 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.200000000000003 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.425 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.319999999999993 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.405 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.100000000000001 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.540000000000006 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.239999999999995 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.310000000000002 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 71.519999999999996 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.230000000000004 110.463 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CZ ' HG23 ' B' ' 46' ' ' VAL . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.019999999999996 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.340000000000003 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.319999999999993 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.476 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.030000000000001 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.577 ' HA ' HG23 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.099999999999994 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.510000000000005 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' B' ' 147' ' ' PHE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 75.519999999999996 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.439999999999998 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.310000000000002 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 73.120000000000005 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.329999999999998 112.034 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.450000000000003 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.319999999999993 109.683 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.45 ' CG2' ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.420000000000002 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.340000000000003 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.506 ' CE1' HG22 ' B' ' 46' ' ' VAL . 51.2 p-80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 74.230000000000004 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' B' ' 28' ' ' TYR . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 71.140000000000001 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.41 46.58 2.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.140000000000001 112.406 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.79 142.34 46.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.882 0.372 . . . . 73.099999999999994 110.909 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -123.19 53.93 1.28 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 61.350000000000001 110.461 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 37.2 tt0 167.25 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.404 -1.271 . . . . 73.439999999999998 109.738 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.5 104.11 0.09 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.699 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.84 83.09 13.86 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.048 -0.524 . . . . 73.120000000000005 111.8 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.12 -167.74 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.97 2.447 . . . . 73.5 112.279 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.08 149.73 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 70.420000000000002 111.384 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.74 148.53 19.45 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.122 -0.561 . . . . 62.340000000000003 112.967 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.7 115.91 14.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.664 0.268 . . . . 52.520000000000003 110.635 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.23 7.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 75.25 111.216 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 160.41 19.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.985 -0.552 . . . . 74.329999999999998 111.414 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.83 120.9 9.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.113 -0.494 . . . . 73.409999999999997 111.482 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.84 141.74 12.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.124 -0.56 . . . . 75.150000000000006 112.771 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.01 -7.46 84.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.339 -0.458 . . . . 65.109999999999999 113.358 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.530000000000001 111.077 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 110.674 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.545 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.099999999999994 110.645 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.219999999999999 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.435 ' HB3' HN22 ' B' ' 187' ' ' 5GP . 1.4 mp0 -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.049999999999997 111.598 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.119999999999997 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.505 HD13 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.030000000000001 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.526 ' CZ3' ' N2 ' ' B' ' 187' ' ' 5GP . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 64.310000000000002 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . 0.448 ' HA ' HD11 ' B' ' 100' ' ' LEU . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.040000000000006 110.91 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.349999999999994 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.450000000000003 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.431 ' HB ' HD13 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 74.239999999999995 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.299999999999997 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 71.530000000000001 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.530000000000001 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.120000000000005 111.612 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.310000000000002 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.549999999999997 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.566 HD23 ' HA3' ' A' ' 91' ' ' GLY . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.549999999999997 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.51 ' HA3' ' O1P' ' B' ' 187' ' ' 5GP . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.010000000000005 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.350000000000001 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.546 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.656 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 74.230000000000004 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.409999999999997 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 74.120000000000005 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.649 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.019999999999996 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.505 ' HD2' HD13 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.409999999999997 111.605 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.109999999999999 110.86 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 74.319999999999993 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' B' ' 74' ' ' GLN . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 72.400000000000006 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.530000000000001 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.230000000000004 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.109999999999999 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.431 HD13 ' HB ' ' B' ' 79' ' ' VAL . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.310000000000002 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.430000000000007 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.119999999999997 110.587 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.150000000000006 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 70.109999999999999 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' B' ' 134' ' ' TYR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.230000000000004 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 74.140000000000001 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.200000000000003 111.695 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.539999999999999 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.129999999999995 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.239999999999995 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.451 HD23 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.531 ' HB2' ' O1P' ' A' ' 187' ' ' 5GP . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.540000000000006 111.283 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.210000000000001 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.414 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.349999999999994 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.451 HG21 HD23 ' B' ' 116' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 71.510000000000005 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.019999999999996 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.319999999999993 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.049999999999997 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.140000000000001 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.319999999999993 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' B' ' 156' ' ' HIS . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.310000000000002 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.349999999999994 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.172 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 75.430000000000007 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 73.019999999999996 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.568 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 70.329999999999998 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.430000000000007 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.240000000000002 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.420000000000002 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.568 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.409999999999997 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.310000000000002 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.430000000000007 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 74.230000000000004 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.239999999999995 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.299999999999997 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 74.409999999999997 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 35' ' ' LEU . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 72.409999999999997 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.120000000000005 111.123 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.020000000000003 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 73.530000000000001 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.040000000000006 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.129999999999995 111.19 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -30.97 38.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.85 20.28 12.14 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.618 -0.264 . . . . 74.019999999999996 111.367 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.79 -178.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.411 -0.359 . . . . 75.329999999999998 110.429 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . 0.512 ' HB3' ' HA ' ' B' ' 128' ' ' ARG . 0.2 OUTLIER -118.07 138.9 51.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 110.774 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 168.71 19.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 111.091 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.1 148.04 37.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 111.375 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.155 -0.926 . . . . 74.209999999999994 111.144 179.833 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.534 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.545 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.529 0.204 . . . . 64.340000000000003 111.423 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -129.35 134.57 47.96 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.399 -0.364 . . . . 74.450000000000003 111.037 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.219999999999999 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 52.439999999999998 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 HG11 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.399999999999999 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 73.340000000000003 110.488 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.150000000000006 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.605 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.109999999999999 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.501 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.299999999999997 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.539999999999999 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.109999999999999 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.130000000000003 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 72.319999999999993 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 71.340000000000003 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' CD1' HG22 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.140000000000001 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.420000000000002 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 HG21 ' A' ' 32' ' ' VAL . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.210000000000001 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HG13 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 63.020000000000003 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 70.400000000000006 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.200000000000003 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.439999999999998 110.984 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.349999999999994 110.857 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.109999999999999 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.439999999999998 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG13 HG13 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.219999999999999 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.319999999999993 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.230000000000004 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.539999999999999 110.801 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.5 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 48.8 p-80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.439999999999998 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.530000000000001 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.21 70.34 1.47 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.039999999999999 111.692 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.91 120.21 17.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.162 0.506 . . . . 72.530000000000001 111.194 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.68 58.76 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.344 0.592 . . . . 72.129999999999995 110.471 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 32.3 tt0 171.13 68.3 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.842 -1.072 . . . . 74.230000000000004 110.114 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.42 110.18 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 70.420000000000002 110.971 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.87 78.44 65.16 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.438 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.04 -166.61 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.952 2.435 . . . . 42.420000000000002 112.427 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.77 149.81 22.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.541 -0.754 . . . . 65.340000000000003 111.331 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.68 -172.52 27.39 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.182 -0.533 . . . . 42.520000000000003 112.747 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 118.19 6.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.822 0.344 . . . . 72.230000000000004 110.995 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.69 165.38 26.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.021 -0.536 . . . . 73.329999999999998 110.768 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.13 79.8 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.138 -0.483 . . . . 65.310000000000002 111.06 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.1 116.19 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.82 -0.627 . . . . 72.400000000000006 111.772 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.14 147.79 18.88 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.865 -0.607 . . . . 73.319999999999993 112.301 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.1 -96.54 0.1 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.853 -0.689 . . . . 73.420000000000002 112.774 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 70.319999999999993 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.540000000000006 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.573 HG22 ' C5 ' ' A' ' 187' ' ' 5GP . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.533 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.519999999999996 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 53.549999999999997 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.409999999999997 111.27 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.450000000000003 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 73.109999999999999 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.120000000000005 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.340000000000003 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.209999999999994 111.403 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.57 HG11 HG11 ' A' ' 12' ' ' VAL . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.439999999999998 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' HD13 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 64.329999999999998 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 73.540000000000006 112.265 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.409999999999997 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.118 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 71.239999999999995 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.120000000000005 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.219999999999999 111.512 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.439999999999998 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.605 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.109999999999999 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 37.829999999999998 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.645 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.239999999999995 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 73.200000000000003 111.111 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.637 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.210000000000001 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.510000000000005 110.617 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.08 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' CG2' HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.030000000000001 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.130000000000003 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.319999999999993 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.140000000000001 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.655 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.459 HG13 ' CG2' ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 75.0 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.310000000000002 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 132' ' ' TRP . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.010000000000005 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 62.039999999999999 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.456 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 110' ' ' PRO . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.129999999999995 111.056 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.130000000000003 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.510000000000005 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.439999999999998 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.109999999999999 110.875 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.441 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 75.030000000000001 111.165 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.555 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 63.329999999999998 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.530000000000001 111.212 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.099999999999994 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.420000000000002 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.530000000000001 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 72.230000000000004 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.209999999999994 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 158' ' ' HIS . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 43.420000000000002 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.655 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.340000000000003 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.299999999999997 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.310000000000002 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.150000000000006 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.420000000000002 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.069 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' GLU . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.239999999999995 113.252 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.219999999999999 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' GLU . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.109999999999999 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.239999999999995 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.400000000000006 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.340000000000003 110.964 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.519999999999996 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 63.229999999999997 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.540000000000006 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.230000000000004 111.045 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.502 ' CE2' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.549999999999997 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.329999999999998 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.510000000000005 111.817 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -80.07 -34.12 38.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.340000000000003 110.938 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.97 16.98 10.29 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.56 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 179.61 175.08 0.77 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.742 0.306 . . . . 63.420000000000002 111.088 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.02 109.77 11.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.803 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.46 -178.59 4.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 111.078 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 127' ' ' SER . 56.1 m80 -44.41 115.58 0.88 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.153 -0.476 . . . . 65.030000000000001 111.336 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.931 . . . . 74.340000000000003 111.165 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.571 0.224 . . . . 74.319999999999993 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -129.35 134.59 47.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.456 -0.338 . . . . 74.239999999999995 111.041 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.120000000000005 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.573 HG11 HG11 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 62.130000000000003 110.49 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 80' ' ' VAL . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.130000000000003 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.602 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.349999999999994 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 75.049999999999997 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.494 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.540000000000006 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.409999999999997 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.420000000000002 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.299999999999997 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.120000000000005 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.019999999999996 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.200000000000003 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.329999999999998 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.099999999999994 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.513 ' CD1' HG22 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 63.119999999999997 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 74.420000000000002 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.483 HD12 HG21 ' B' ' 32' ' ' VAL . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.510000000000005 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.539 HG13 HG13 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.340000000000003 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.420000000000002 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.310000000000002 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.239999999999995 110.993 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 110.874 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.400000000000006 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.140000000000001 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.539 HG13 HG13 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.329999999999998 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.340000000000003 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.431 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.510000000000005 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.040000000000006 110.802 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' HIS . . . . . 0.503 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 48.8 p-80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 70.219999999999999 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.22 70.44 1.47 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.519999999999996 111.688 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.94 120.21 17.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.095 0.474 . . . . 61.310000000000002 111.214 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -101.7 58.81 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.254 0.549 . . . . 72.430000000000007 110.495 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 32.3 tt0 171.03 68.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.789 -1.096 . . . . 72.219999999999999 110.067 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.51 110.24 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.925 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.88 78.36 65.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.139 -0.482 . . . . 75.409999999999997 111.478 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.11 -166.63 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.952 2.435 . . . . 54.5 112.411 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.65 149.81 22.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.596 -0.729 . . . . 70.25 111.393 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.64 -172.48 27.38 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.221 -0.514 . . . . 73.329999999999998 112.754 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.61 118.14 6.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.851 0.358 . . . . 71.319999999999993 110.972 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.68 165.4 25.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.541 . . . . 64.400000000000006 110.747 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.15 79.8 4.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.018 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . 71.13 116.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.855 -0.611 . . . . 73.349999999999994 111.762 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.09 147.84 18.88 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.965 -0.561 . . . . 71.010000000000005 112.286 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.13 -96.52 0.1 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.774 -0.727 . . . . 54.439999999999998 112.726 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 70.230000000000004 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.239999999999995 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.040000000000006 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.58 HG22 ' C5 ' ' B' ' 187' ' ' 5GP . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.558 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.120000000000005 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 72.349999999999994 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.420000000000002 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 51.539999999999999 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.109999999999999 111.246 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.409999999999997 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' TRP . . . . . 0.561 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.040000000000006 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' B' ' 76' ' ' ALA . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.140000000000001 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLN . . . . . 0.494 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.340000000000003 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.150000000000006 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 111.436 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.573 HG11 HG11 ' B' ' 12' ' ' VAL . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.530000000000001 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.109999999999999 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 63.420000000000002 112.327 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.040000000000006 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.136 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 65.400000000000006 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.439999999999998 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 65.349999999999994 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.409999999999997 111.566 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 38.93 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.040000000000006 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.329999999999998 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.637 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.519999999999996 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.129999999999995 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.329999999999998 111.089 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . 0.645 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.340000000000003 110.623 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.439999999999998 111.107 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.458 ' CG2' HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.019999999999996 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 53.109999999999999 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 71.510000000000005 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.340000000000003 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.329999999999998 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.654 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.140000000000001 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.458 HG13 ' CG2' ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 64.319999999999993 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.511 ' HB3' ' CG2' ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.349999999999994 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' CYS . . . . . 0.477 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 55.5 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.140000000000001 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ARG . . . . . 0.45 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.466 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.209999999999994 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 62.240000000000002 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.430000000000007 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.099999999999994 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.409999999999997 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.240000000000002 110.857 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' SER . . . . . 0.447 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 65.239999999999995 111.127 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.409999999999997 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.559 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.200000000000003 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.329999999999998 111.242 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.209999999999994 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.439999999999998 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 73.310000000000002 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.519999999999996 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.420000000000002 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.420000000000002 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' B' ' 158' ' ' HIS . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 65.129999999999995 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 74.010000000000005 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.129999999999995 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.209999999999994 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.109999999999999 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.420000000000002 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.319999999999993 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.406 ' N ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.310000000000002 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.049999999999997 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' N ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.239999999999995 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.430000000000007 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.230000000000004 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 75.439999999999998 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.439999999999998 110.847 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.319999999999993 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.049999999999997 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 74.299999999999997 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.349999999999994 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 72.0 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.439999999999998 111.1 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.540000000000006 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.310000000000002 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 71.319999999999993 111.763 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.91 -34.28 39.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.310000000000002 110.866 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.92 17.07 10.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.198 -0.455 . . . . 74.019999999999996 111.623 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 179.55 175.06 0.76 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.817 0.341 . . . . 74.409999999999997 111.088 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.92 109.75 11.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 110.737 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -178.55 4.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 73.209999999999994 111.174 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 127' ' ' SER . 56.3 m80 -44.43 115.61 0.88 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.465 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.167 -0.92 . . . . 70.010000000000005 111.083 -179.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' 5GP . . . . . 0.573 ' C5 ' HG22 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' 5GP . . . . . 0.58 ' C5 ' HG22 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.79 0.329 . . . . 72.42 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.15 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.14 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 78' ' ' VAL . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 55.02 110.854 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 63.4 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.35 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.482 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.14 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.738 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.03 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.02 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.21 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.35 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.41 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.03 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.45 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.12 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 31' ' ' ILE . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.23 110.26 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.14 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 62.21 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.647 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.04 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.51 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.42 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.45 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.14 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 73.23 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.31 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.32 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 72' ' ' TRP . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 62.25 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.12 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.11 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.577 ' CE1' HG22 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.22 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.53 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 52.12 111.512 179.732 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 112.687 -0.165 . . . . 53.22 112.687 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.621 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.14 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.1 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.52 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 62' ' ' ASP . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.762 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 61.32 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.41 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.35 111.229 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 72.04 111.438 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.629 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.11 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' CD1' HD12 ' A' ' 42' ' ' LEU . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.23 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.22 111.135 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 32.01 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.31 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.42 111.585 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.43 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.646 ' CG1' HG22 ' A' ' 12' ' ' VAL . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.53 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 70.03 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.12 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 35.55 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 90' ' ' VAL . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.04 110.834 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 63.43 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.35 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.12 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.04 111.101 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' B' ' 120' ' ' ILE . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.4 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.13 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 83' ' ' VAL . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.41 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.41 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.55 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.41 110.942 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.41 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.629 ' HD2' HD13 ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 54.32 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.3 111.792 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' B' ' 92' ' ' TYR . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.42 111.093 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.54 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.51 111.355 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.22 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.11 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.53 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 97' ' ' ALA . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.15 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.55 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.568 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.52 111.217 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.4 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.42 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB2' HG22 ' A' ' 84' ' ' THR . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.44 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.44 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 109' ' ' ARG . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 62.41 111.327 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.02 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.14 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.13 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.22 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 120' ' ' ILE . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.386 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 70.1 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.22 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.41 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 116' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.12 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 61.52 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.12 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.34 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.04 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.13 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.42 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.31 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.15 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.51 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 106' ' ' CYS . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.42 110.841 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.32 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.43 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.543 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.4 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 43.24 111.28 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.32 112.825 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.52 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.53 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.543 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.24 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.14 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.484 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.34 111.098 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 51.01 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.01 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.15 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.54 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.41 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.31 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.21 111.4 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.12 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 60.34 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 149' ' ' ALA . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.1 111.564 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.41 110.907 179.629 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.777 0.322 . . . . 71.5 110.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.32 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.53 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' B' ' 78' ' ' VAL . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.41 110.874 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.443 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.32 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.15 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.3 112.593 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.456 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 60.22 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.735 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 64.33 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.465 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 62.31 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.488 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.14 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.31 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.45 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.02 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.44 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 35.21 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 31' ' ' ILE . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.31 110.234 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.2 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.23 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.502 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 71.22 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.661 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.32 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.33 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.43 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 63.22 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.4 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.22 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.41 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.35 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.15 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.12 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 72' ' ' TRP . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.472 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.3 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.58 ' CE1' HG22 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.735 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.22 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.13 111.489 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.645 -0.182 . . . . 62.14 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.617 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.33 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.04 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.21 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 62' ' ' ASP . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.41 110.754 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 73.15 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.42 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.52 111.199 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.42 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.35 111.481 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.612 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.05 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.2 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.548 ' CD1' HD12 ' B' ' 42' ' ' LEU . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.33 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.21 111.16 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.45 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.52 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.24 111.572 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.1 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' B' ' 12' ' ' VAL . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 72.04 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.02 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 63.5 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 33.34 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.03 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.63 HG21 HG11 ' B' ' 90' ' ' VAL . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 63.34 110.819 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.687 HG22 ' HB2' ' B' ' 109' ' ' ARG . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.53 112.132 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' GLN . . . . . 0.415 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.42 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.14 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' B' ' 90' ' ' VAL . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.54 111.053 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' A' ' 120' ' ' ILE . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.4 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.42 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 HG21 ' B' ' 83' ' ' VAL . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.32 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.24 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.11 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.914 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.48 HD21 ' SG ' ' B' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.22 110.753 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.02 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.612 ' HD2' HD13 ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.03 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.12 111.835 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' A' ' 92' ' ' TYR . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.33 111.103 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.43 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.411 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.24 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.31 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HB2' HG23 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.11 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.531 HD12 ' HB1' ' B' ' 97' ' ' ALA . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.44 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.23 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.557 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.23 111.242 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 61.15 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.687 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.23 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.427 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.31 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' B' ' 109' ' ' ARG . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.12 111.384 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 63.32 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.34 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.31 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.21 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.968 HD22 HG21 ' B' ' 120' ' ' ILE . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.396 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.33 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.24 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.41 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.968 HG21 HD22 ' B' ' 116' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.21 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.43 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.52 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.3 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.12 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 64.31 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 22.45 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.42 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.31 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.21 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.35 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' B' ' 106' ' ' CYS . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.44 110.895 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.14 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.54 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.14 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.24 111.26 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.55 112.795 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.32 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 63.24 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.01 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.53 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 53.3 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.469 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.24 111.04 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.22 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.34 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.52 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.44 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.3 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.51 111.438 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.1 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' B' ' 149' ' ' ALA . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.12 111.519 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.01 110.959 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.618 0.247 . . . . 71.43 111.068 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.028 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.51 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 31' ' ' ILE . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.11 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.44 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.3 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.691 ' HB3' HG21 ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 33.11 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.12 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.21 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.24 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.4 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.42 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.4 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.42 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 51.4 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.14 110.283 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.845 ' CE1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 65.35 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.2 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.41 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 61.13 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 41' ' ' VAL . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.12 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.1 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.3 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.22 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.55 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 72.03 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.14 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.03 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.24 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.66 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.12 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 73.3 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 53.44 111.39 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.845 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 71.45 111.498 179.296 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.624 -0.19 . . . . 24.41 112.624 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.629 ' HA ' HD12 ' A' ' 65' ' ' ILE . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.33 111.325 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 61.31 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 71.22 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 62' ' ' ASP . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.1 110.821 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.557 ' O ' HD23 ' A' ' 70' ' ' LEU . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 70.23 111.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 62.0 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.4 111.252 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.3 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 96' ' ' ARG . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.03 111.194 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.44 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.54 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.35 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.24 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.44 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.24 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 150' ' ' TYR . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.23 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 73' ' ' LEU . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.02 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.44 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 71.55 111.129 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 109' ' ' ARG . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 54.13 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.45 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.937 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.13 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.43 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.14 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.23 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.12 111.323 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.629 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.53 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.31 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.24 110.332 179.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.64 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.45 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.664 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 72.51 110.568 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.03 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.31 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB2' ' CD ' ' B' ' 96' ' ' ARG . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.43 111.526 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.24 111.362 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.03 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.23 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.32 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.575 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 52.45 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.712 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.15 111.049 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.21 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.34 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.679 ' HB2' HG22 ' A' ' 84' ' ' THR . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 71.31 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.23 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 72.43 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.15 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 31.24 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.24 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.13 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.809 HD12 HD13 ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.42 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.51 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.44 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.04 110.742 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.15 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.23 110.934 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.11 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.21 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.02 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.11 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.24 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.624 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 71.13 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.01 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.712 HG13 ' HB3' ' A' ' 106' ' ' CYS . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.3 110.876 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.21 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.523 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.42 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 40.11 111.521 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.31 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.24 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.44 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.04 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 64.52 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.536 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.1 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.2 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 51.3 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.44 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 70.53 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.44 110.779 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.42 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.34 111.151 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.42 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.33 111.715 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.42 110.862 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.642 0.258 . . . . 74.32 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.012 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.51 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 64.4 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.556 ' CG ' HD13 ' B' ' 31' ' ' ILE . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.23 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.668 ' HB3' HG21 ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.3 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.517 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 62.23 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.51 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.44 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.13 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.31 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 52.15 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.22 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.31 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.256 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.832 ' CE1' HG21 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.3 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.487 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.34 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.11 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.556 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.52 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.909 HG23 HG21 ' B' ' 41' ' ' VAL . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.23 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.03 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 70.02 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.495 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.13 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.11 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.13 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.03 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.12 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.909 HG21 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.11 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 1.012 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.44 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.666 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.31 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.45 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.03 111.414 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.832 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 63.42 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.22 111.425 179.279 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 -0.188 . . . . 44.14 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' B' ' 65' ' ' ILE . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.52 111.343 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.13 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.4 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 62' ' ' ASP . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.835 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.549 ' O ' HD23 ' B' ' 70' ' ' LEU . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.42 111.411 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.43 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.54 111.228 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.14 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.556 HD11 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.3 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.01 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 73.23 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.22 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.34 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.537 ' HB2' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.32 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.22 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' B' ' 150' ' ' TYR . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.12 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 73' ' ' LEU . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.41 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.567 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.11 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.22 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.494 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.13 111.129 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 109' ' ' ARG . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 71.33 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.24 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.954 ' HA ' HD12 ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.4 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.21 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.21 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG21 ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.11 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.534 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.1 111.264 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.64 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.42 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.21 110.449 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 63.34 110.319 179.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.35 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.663 ' CD ' ' HB2' ' A' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.695 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.12 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.42 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ALA . . . . . 0.664 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.2 111.4 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' B' ' 100' ' ' LEU . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.35 111.408 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.24 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 61.31 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.2 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.05 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.567 ' CB ' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 71.11 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.723 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 73.01 110.954 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.21 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.45 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.673 ' HB2' HG22 ' B' ' 84' ' ' THR . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.32 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.438 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.02 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.41 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.545 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.23 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 23.42 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.14 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.23 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.32 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 63.41 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.31 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.01 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.24 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.1 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.35 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.1 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 62.42 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.62 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.13 110.922 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.52 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' B' ' 106' ' ' CYS . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.89 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 73.21 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.22 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.02 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.41 111.548 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.3 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.42 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 42.13 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.21 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.534 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.52 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.14 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.35 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 71.21 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 35' ' ' LEU . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.31 110.702 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 54.04 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.42 111.171 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.53 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.32 111.65 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.13 110.902 179.694 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.326 . . . . 64.01 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.15 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.995 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.34 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 HG12 ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.44 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 65.02 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.546 ' CG ' HD13 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.33 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.55 110.817 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.34 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.783 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.45 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.559 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.14 112.608 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.23 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.34 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.32 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.01 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.42 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' OE2' ' A' ' 82' ' ' GLU . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.4 110.324 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.33 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.44 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.32 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.12 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 41' ' ' VAL . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 71.44 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 41.03 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.13 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.007 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.3 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.34 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.35 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.21 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.14 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 62.13 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.1 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.45 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 43' ' ' THR . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.24 111.751 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.783 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.14 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.24 110.804 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.965 -0.353 . . . . 64.32 113.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.42 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.11 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.11 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CD1' ' HB1' ' B' ' 118' ' ' ALA . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.21 110.942 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.01 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.12 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.15 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.13 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.52 111.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.43 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 74.11 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.42 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.03 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.04 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.24 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.12 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.02 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.03 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.03 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 94' ' ' LEU . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.23 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' OE2' HG21 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.35 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.23 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 109' ' ' ARG . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.22 111.331 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.34 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.22 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.5 ' HB2' HG11 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.741 HD22 HD11 ' B' ' 120' ' ' ILE . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.24 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.54 112.54 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.22 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.13 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.14 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 81' ' ' ALA . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.41 111.0 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.32 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.4 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.57 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.43 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.24 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.43 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.2 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 71.55 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.4 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 79' ' ' VAL . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.35 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.782 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 55.24 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.42 111.152 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.14 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.51 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.31 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.553 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.35 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.12 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.24 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 62.24 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 51.54 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.53 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' B' ' 65' ' ' ILE . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.34 111.687 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.422 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.24 110.576 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.764 HD11 HD22 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.3 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.11 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.33 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 45.12 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.33 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.11 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.4 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 106' ' ' CYS . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.33 110.932 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 71.44 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.54 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.4 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.03 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.55 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.12 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.14 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 145' ' ' ARG . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.14 110.521 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.23 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.543 ' CD2' HG22 ' A' ' 31' ' ' ILE . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.12 111.155 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.34 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 141' ' ' THR . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.33 111.069 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.22 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.13 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' VAL . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.14 111.524 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.04 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.629 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 45.55 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.44 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 148' ' ' GLU . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 31.53 111.186 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.44 110.995 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.799 0.333 . . . . 74.05 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 60.32 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.061 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.33 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.691 HG22 HG12 ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.22 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.507 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.3 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.541 ' CG ' HD13 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 74.23 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.43 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.537 ' HB2' HG21 ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.11 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.8 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.11 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.569 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 63.22 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.468 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.42 112.589 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.4 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 73.22 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.42 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 53.22 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.35 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.51 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.442 HD21 ' OE2' ' B' ' 82' ' ' GLU . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.4 110.328 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.668 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.12 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.552 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.45 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.42 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.04 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.979 HG23 HG21 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.45 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.32 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.458 HD13 ' O ' ' B' ' 31' ' ' ILE . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 43.35 111.003 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 54.32 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.24 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.12 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.02 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.52 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.979 HG21 HG23 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 1.061 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.1 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.11 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' B' ' 43' ' ' THR . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 61.45 111.699 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 62.23 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.11 110.768 178.975 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.426 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.039 -0.312 . . . . 64.44 113.454 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.14 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.13 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.34 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.451 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.33 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.495 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 63.22 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.15 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.31 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.55 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.43 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' OE1' ' B' ' 74' ' ' GLN . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.13 111.927 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 63.41 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 65.23 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' B' ' 71' ' ' ASN . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.42 110.988 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.24 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.44 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.45 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.695 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.4 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.22 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.779 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 45.23 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 94' ' ' LEU . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.22 112.037 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.588 ' OE2' HG21 ' B' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.05 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.22 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.797 HG22 ' HB2' ' B' ' 109' ' ' ARG . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 111.25 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.43 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.442 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.33 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' SER . . . . . 0.489 ' HB2' HG11 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.35 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.33 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.34 112.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.1 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.12 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.619 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.42 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' B' ' 81' ' ' ALA . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.22 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.04 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.02 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.54 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.21 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.03 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.34 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 52.51 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.21 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.779 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.33 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.756 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.12 111.112 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.24 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.13 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.797 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.04 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.557 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.1 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.41 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.51 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.1 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.23 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.45 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.654 HD22 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.02 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 63.43 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 65' ' ' ILE . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 71.55 111.674 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.41 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 53.5 110.638 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.741 HD11 HD22 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.24 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 71.35 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.51 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.33 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 53.04 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.54 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.31 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.34 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.53 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.23 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.02 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' B' ' 106' ' ' CYS . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.23 110.914 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.13 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.2 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.59 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.31 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 34.13 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.13 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.43 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.22 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.11 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.02 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.35 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.55 ' CD2' HG22 ' B' ' 31' ' ' ILE . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.12 111.179 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.43 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.45 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.555 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.43 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.55 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.501 ' O ' HG23 ' B' ' 152' ' ' VAL . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.04 111.497 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.05 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.631 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.53 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.45 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 148' ' ' GLU . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.24 111.091 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.21 110.953 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.713 0.292 . . . . 75.11 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.753 ' HB3' HD21 ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 54.31 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 78' ' ' VAL . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.13 110.787 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 53.01 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 31' ' ' ILE . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.43 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.42 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.41 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.535 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 55.14 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 73.25 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.14 112.42 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.14 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.34 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.53 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.44 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.3 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.42 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.492 HD21 ' OE2' ' A' ' 82' ' ' GLU . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 41.12 110.737 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 72.22 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.54 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.22 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.42 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.944 HG22 HG11 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 72.22 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.33 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.11 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.835 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.03 111.224 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 41' ' ' VAL . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.33 110.871 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.23 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.34 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.13 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.45 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.32 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 11' ' ' SER . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.24 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.587 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.15 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.44 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.4 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.13 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.1 110.76 179.383 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.557 -0.217 . . . . 74.31 112.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.42 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.53 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.02 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.42 110.792 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.35 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.43 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.43 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.5 HD11 ' NE ' ' A' ' 96' ' ' ARG . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.44 111.117 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.1 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.21 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 62.42 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 60.13 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.01 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.42 111.475 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.04 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 12' ' ' VAL . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.23 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 97' ' ' ALA . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.35 110.577 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.45 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.45 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' OE2' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.12 110.71 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.54 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' ARG . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.55 111.525 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.54 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.34 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.12 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.906 HD22 HD11 ' B' ' 120' ' ' ILE . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.12 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.44 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.52 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.12 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 71.53 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.45 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 44.25 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 30.41 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.22 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.42 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.477 HG21 ' OH ' ' B' ' 92' ' ' TYR . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.24 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' B' ' 96' ' ' ARG . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.21 111.371 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 70' ' ' LEU . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.01 111.466 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.1 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.04 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 65.41 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 79' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.22 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.686 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.11 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.751 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.13 111.075 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 70.32 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.15 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HB2' HG22 ' A' ' 84' ' ' THR . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.31 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.602 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.31 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.45 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.14 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.54 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.22 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.22 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.31 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.35 112.352 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.469 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.04 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HD22 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.04 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.32 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.35 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.14 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.24 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.04 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.21 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.13 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 53.24 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 106' ' ' CYS . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.019 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.51 111.086 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.05 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.24 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.15 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.35 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.14 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.604 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 34.54 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.32 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.51 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.578 ' HG2' HD11 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.03 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 31' ' ' ILE . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 63.13 110.947 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.11 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.54 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.22 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.13 111.296 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.21 111.232 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 73.45 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.55 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 148' ' ' GLU . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.23 111.567 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.1 111.477 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.703 0.287 . . . . 62.03 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.772 ' HB3' HD21 ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.23 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 78' ' ' VAL . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.31 110.75 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.524 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 70.14 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.534 ' CB ' HD13 ' B' ' 31' ' ' ILE . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.3 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.35 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.597 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 63.42 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.15 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.33 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.42 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 24.14 112.45 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.21 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.33 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.54 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.32 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.23 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.24 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.495 HD21 ' OE2' ' B' ' 82' ' ' GLU . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.723 ' CE2' HG21 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.22 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.11 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.31 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.33 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.923 HG22 HG11 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.43 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.55 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.51 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.21 111.252 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.561 ' HG2' HG23 ' B' ' 41' ' ' VAL . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.3 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.22 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.32 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.923 HG11 HG22 ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 53.24 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' B' ' 11' ' ' SER . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.45 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.23 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.13 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.44 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.41 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.4 110.771 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.408 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.553 -0.219 . . . . 73.51 112.553 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.33 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.53 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 61' ' ' GLY . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.1 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.15 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.52 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.503 HD11 ' NE ' ' B' ' 96' ' ' ARG . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 62.01 111.13 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.14 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.4 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.22 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 61.31 111.541 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.4 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 12' ' ' VAL . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.52 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.595 HG21 ' HB1' ' B' ' 97' ' ' ALA . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.03 110.564 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 55.31 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.12 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.495 ' OE2' HD21 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.3 110.69 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 60.23 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.877 HG22 ' HB2' ' B' ' 109' ' ' ARG . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 53.32 111.575 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.03 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.761 ' HA ' HD12 ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.21 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 63.23 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.877 HD22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.34 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.01 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.543 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 64.41 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.41 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.45 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.544 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.12 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.562 ' NE ' ' HB2' ' A' ' 99' ' ' ALA . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 71.33 110.444 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.595 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.485 HG21 ' OH ' ' A' ' 92' ' ' TYR . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.24 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.2 111.329 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' B' ' 70' ' ' LEU . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.24 111.547 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.15 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.42 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.54 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' B' ' 79' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.05 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.719 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 62.12 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.763 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.42 111.08 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.34 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.877 ' HB2' HG22 ' B' ' 84' ' ' THR . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.24 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.53 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.14 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.31 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 73.32 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.11 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 74.13 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.22 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.42 112.358 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.49 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.11 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.41 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.21 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 32.51 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.23 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.1 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.13 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.33 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.1 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 72.41 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.23 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 70.21 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' B' ' 106' ' ' CYS . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.22 111.08 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.31 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.03 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.61 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.35 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.01 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.21 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.4 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.24 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.43 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.03 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.591 ' HG2' HD11 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.22 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' B' ' 31' ' ' ILE . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.31 111.028 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 61.35 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.497 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 72.42 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 71.12 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.473 ' O ' HG23 ' B' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.35 111.271 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.44 111.236 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.477 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.22 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.04 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 148' ' ' GLU . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.527 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.12 111.367 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.695 0.283 . . . . 70.54 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.51 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 42' ' ' LEU . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.23 111.153 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 78' ' ' VAL . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.4 111.233 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.574 ' HB2' HD12 ' A' ' 42' ' ' LEU . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 73.01 110.503 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.517 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.21 112.191 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.3 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.795 HG21 HG11 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.13 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.41 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 14.41 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.12 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.21 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.23 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.44 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.02 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.2 111.44 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 65.1 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.45 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 62.4 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.02 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.45 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.23 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.15 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.771 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.21 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.32 111.066 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.32 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.44 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.03 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.14 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 11' ' ' SER . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.12 111.963 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 54.51 110.574 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.42 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 61.42 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 65.03 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.33 110.427 179.191 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 114.252 0.461 . . . . 62.32 114.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.1 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.12 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD12 ' HA ' ' A' ' 62' ' ' ASP . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.825 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 71.25 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.2 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.11 111.773 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.32 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.575 HD22 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.51 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.3 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.52 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.41 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.15 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.33 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 34.2 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.4 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.34 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.01 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.944 HG23 ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.15 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.21 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.41 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 90' ' ' VAL . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.55 111.35 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 109' ' ' ARG . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 63.25 111.627 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.35 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.12 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.44 110.541 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HD11 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.54 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.41 112.247 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 83' ' ' VAL . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.41 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.41 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' B' ' 119' ' ' MET . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.34 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.31 110.765 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.53 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.03 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.43 111.818 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.05 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.54 111.466 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.4 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 52.54 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.779 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.42 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.944 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.43 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.75 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 45.5 110.913 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 54.14 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 65.34 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.54 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.14 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.4 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.59 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.33 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 13.52 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.13 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.21 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 108' ' ' PHE . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.1 110.24 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.31 111.446 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.42 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.55 HD11 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.02 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.43 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.3 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.31 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.51 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.03 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.32 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 72.44 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.44 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 54.41 110.655 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 106' ' ' CYS . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 44.32 110.975 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 52.11 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.613 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.14 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.14 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.24 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.22 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.24 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 62.11 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.12 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.44 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.34 110.867 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.03 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.469 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 71.23 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.53 111.264 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.42 111.656 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.1 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 63.15 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 52.12 111.552 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.4 110.981 179.603 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.696 0.284 . . . . 70.13 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.34 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.64 ' HB3' HD11 ' B' ' 42' ' ' LEU . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.17 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.77 HG22 HG12 ' B' ' 78' ' ' VAL . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.43 111.166 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.57 ' HB2' HD12 ' B' ' 42' ' ' LEU . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.537 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.43 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.22 112.207 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.567 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.3 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.794 HG21 HG11 ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.03 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.21 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.21 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.42 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.52 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.21 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.51 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.31 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 15.21 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.576 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.55 111.416 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.558 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.45 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.33 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.11 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.576 HG23 ' O ' ' B' ' 27' ' ' LEU . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.33 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.817 HG22 HG11 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.14 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 54.44 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.21 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.767 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.32 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.551 ' HG3' HG23 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.04 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 61.01 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.53 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.24 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.817 HG11 HG22 ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' B' ' 11' ' ' SER . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.12 111.91 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.55 110.593 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.34 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 62.15 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.794 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.44 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.52 110.425 179.161 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 N-CA-C 114.256 0.462 . . . . 70.52 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.635 ' HA ' HD12 ' B' ' 65' ' ' ILE . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.13 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.51 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.13 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' B' ' 62' ' ' ASP . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.12 110.839 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 64.31 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.21 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.11 111.764 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.34 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.34 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.22 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.35 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 73' ' ' LEU . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.31 111.543 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 62.3 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.3 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.51 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.32 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.77 HG12 HG22 ' B' ' 12' ' ' VAL . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.03 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.13 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.916 HG23 ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.4 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.2 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.34 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' B' ' 90' ' ' VAL . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 55.04 111.408 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.631 HG22 ' HB2' ' B' ' 109' ' ' ARG . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.43 111.596 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.3 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' B' ' 114' ' ' ARG . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.03 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' SER . . . . . 0.429 ' HB2' HG11 ' B' ' 83' ' ' VAL . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.24 110.611 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.3 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.21 112.268 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' B' ' 83' ' ' VAL . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 65.33 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.21 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.35 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.04 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.607 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.41 110.749 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.2 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.573 ' HG2' HD22 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.42 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.44 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 94' ' ' LEU . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.13 111.781 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.24 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.31 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.23 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.41 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.766 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 43.32 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.42 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.916 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 61.04 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.765 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.02 110.945 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.44 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.44 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.631 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.42 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.15 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.44 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.54 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.02 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.13 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 61.23 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.35 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.21 111.449 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.13 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.2 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.558 HD11 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.31 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.41 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 34.42 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 43.33 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.34 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.44 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.53 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 70.54 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.41 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.3 110.623 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.24 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' B' ' 106' ' ' CYS . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.53 111.003 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.51 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 72.14 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.54 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.1 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.34 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.3 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.616 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.21 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.42 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.21 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.21 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.47 HD21 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.23 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.22 110.872 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 44.2 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.464 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 44.45 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 64.11 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.03 111.215 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.13 111.64 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 71.22 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.24 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.42 111.588 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.34 110.958 179.614 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.909 0.385 . . . . 72.15 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.2 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.448 ' HB3' HD11 ' A' ' 42' ' ' LEU . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 64.51 110.732 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 HG12 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.04 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.33 110.953 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.22 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.1 111.426 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 90' ' ' VAL . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.12 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.22 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.539 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.04 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.42 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.24 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.22 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.13 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 63.23 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.44 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 31' ' ' ILE . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.53 110.644 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.1 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.04 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.44 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 41' ' ' VAL . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.21 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.4 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 32.41 111.033 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.22 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 72.32 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 70.54 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.11 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.44 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.909 HG11 HG22 ' A' ' 32' ' ' VAL . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.32 110.254 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 76' ' ' ALA . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.31 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.44 110.211 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.12 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.32 111.56 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 41.44 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 53.11 110.348 178.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.621 -0.191 . . . . 74.24 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.43 111.099 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 70.3 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.42 110.659 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 62' ' ' ASP . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.04 111.117 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.31 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.1 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.3 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.12 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.41 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.52 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 64.23 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 97' ' ' ALA . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.22 111.435 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HA ' HD21 ' A' ' 100' ' ' LEU . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.42 111.177 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.32 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.43 111.524 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.24 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.4 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 97' ' ' ALA . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 54.33 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 62.15 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.631 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.43 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.41 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 HG11 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 63.31 111.196 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 42.32 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 61.01 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.43 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.42 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.679 ' CD2' HD23 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 62.41 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.22 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.44 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' HD23 ' A' ' 94' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.02 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 70.3 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.02 111.08 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD23 ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.05 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD2' HD11 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' A' ' 79' ' ' VAL . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.13 111.359 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 94' ' ' LEU . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.11 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.05 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' GLN . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 62.22 111.862 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.44 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.03 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.22 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CD1' ' HB1' ' A' ' 97' ' ' ALA . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.33 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.697 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.34 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.561 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.11 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.44 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.533 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.03 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.4 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.32 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.02 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.41 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.22 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.4 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.34 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.35 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 64.51 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.53 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.21 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.1 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 71.3 111.016 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.53 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.52 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 30.43 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.34 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.53 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.15 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 64.24 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.14 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.533 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.23 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.657 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 63.23 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.34 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.02 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.23 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.12 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.55 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.03 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.42 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.2 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 31' ' ' ILE . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.3 110.792 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.11 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.05 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.24 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 152' ' ' VAL . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.01 111.198 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.21 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.695 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.05 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 148' ' ' GLU . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.32 111.106 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.822 0.344 . . . . 65.41 111.327 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.53 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.447 ' HB3' HD11 ' B' ' 42' ' ' LEU . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.04 110.676 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.616 HG22 HG12 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.23 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.13 110.927 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.51 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.44 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.21 111.44 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.514 ' HB2' HG21 ' B' ' 90' ' ' VAL . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 64.31 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.528 HG13 ' H ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.22 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.426 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 73.12 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.528 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.12 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.33 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.24 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.2 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 72.31 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.54 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.24 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 31' ' ' ILE . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.12 110.645 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.41 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 53.14 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 64.53 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.938 HG22 HG11 ' B' ' 41' ' ' VAL . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.41 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.24 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.21 111.083 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.13 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.15 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.22 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.44 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.938 HG11 HG22 ' B' ' 32' ' ' VAL . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 62.3 110.326 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' B' ' 76' ' ' ALA . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.24 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.57 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.32 110.258 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.34 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 61.13 111.538 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.12 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.45 110.344 178.911 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 112.64 -0.184 . . . . 72.13 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' B' ' 65' ' ' ILE . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 64.44 111.144 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.32 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 71.33 110.659 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' B' ' 62' ' ' ASP . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.14 111.1 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.549 ' C ' ' CD2' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.3 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 45.31 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.13 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.24 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.21 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.23 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.24 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 97' ' ' ALA . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.42 111.496 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLN . . . . . 0.431 ' HA ' HD21 ' B' ' 100' ' ' LEU . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.15 111.132 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.11 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' B' ' 42' ' ' LEU . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 44.12 111.629 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.12 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.675 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.33 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' B' ' 97' ' ' ALA . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.32 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.31 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.24 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.416 HG21 HG11 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.54 111.173 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.918 HG22 ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.33 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.23 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.33 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.23 110.773 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.666 ' CD2' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 63.41 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.43 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.21 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.576 ' HA2' HD23 ' B' ' 94' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 13.41 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.42 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.24 111.086 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.576 HD23 ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.3 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.3 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' B' ' 79' ' ' VAL . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.22 111.398 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 94' ' ' LEU . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 62.2 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.52 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 74' ' ' GLN . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.22 111.896 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.31 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.4 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HB1' ' B' ' 97' ' ' ALA . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.12 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.699 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.559 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.42 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.42 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.15 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.918 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.14 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 64.31 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.42 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.527 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.33 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.33 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.679 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 53.45 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.03 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.41 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.572 ' CE ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.12 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 63.14 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.14 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.31 110.974 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.13 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.23 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.03 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.34 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.421 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 72.11 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.34 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' B' ' 106' ' ' CYS . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.4 110.944 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.2 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.31 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.652 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.04 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.34 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.04 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.13 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 70.1 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.652 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.2 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.31 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.11 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.23 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' B' ' 31' ' ' ILE . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' B' ' 80' ' ' VAL . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 72.54 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 62.53 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.458 ' O ' HG23 ' B' ' 152' ' ' VAL . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.4 111.244 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.24 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.574 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.33 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 148' ' ' GLU . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.54 111.503 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.04 111.084 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.791 0.329 . . . . 62.14 111.287 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.52 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.983 ' HB3' HD21 ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.31 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG12 ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 63.12 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.43 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 31' ' ' ILE . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.31 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.22 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.41 111.952 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.5 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.33 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.612 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.2 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.45 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 33.23 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.14 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.42 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.02 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.04 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.35 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.1 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.05 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 143' ' ' LEU . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 72.35 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 41' ' ' VAL . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.24 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.43 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.42 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.809 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.15 111.016 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.2 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.43 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.13 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.53 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.34 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 32' ' ' VAL . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.983 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.43 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.44 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 55.51 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.51 110.827 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 55.25 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.15 111.864 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 120.252 -0.193 . . . . 54.24 113.329 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 71.42 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 55.21 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 71.44 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 62' ' ' ASP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 63.55 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.51 111.439 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.43 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.24 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.52 111.319 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.587 HD22 ' CD ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.32 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 71.03 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.49 HD12 ' NE ' ' A' ' 96' ' ' ARG . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.35 111.737 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.42 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.21 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.22 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.45 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.719 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.44 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 70.42 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' CYS . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.01 111.804 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.22 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 90' ' ' VAL . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.51 111.144 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.21 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 63.15 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' B' ' 88' ' ' LEU . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.33 112.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.4 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.737 HD23 HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 60.34 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.35 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 83' ' ' VAL . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.02 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.11 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.23 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.52 110.44 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.22 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' CD ' HD22 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.33 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.23 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.23 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 44.32 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.35 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.44 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.34 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.41 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.53 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 106' ' ' CYS . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.23 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.675 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.33 110.936 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.54 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.11 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 84' ' ' THR . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.14 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.458 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.51 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.02 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.33 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.33 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.42 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.3 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.671 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 72.04 110.725 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.2 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.44 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.52 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.728 HG13 HD23 ' B' ' 88' ' ' LEU . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.35 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.32 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 23.14 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.24 110.795 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 54.5 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.12 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.31 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.44 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.41 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 62.51 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.14 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 106' ' ' CYS . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.31 111.173 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.41 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.23 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.11 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.4 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.3 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.635 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.2 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.04 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.23 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.32 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 31' ' ' ILE . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.42 111.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.13 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.11 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.02 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.31 111.088 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.54 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.13 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.22 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.11 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.55 110.834 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.43 111.142 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 74.52 111.229 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.54 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.014 ' HB3' HD21 ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.22 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.718 HG22 HG12 ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.31 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.42 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.543 ' CG ' HD13 ' B' ' 31' ' ' ILE . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.45 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.04 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.34 111.861 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.497 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.23 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.02 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.503 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 71.45 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.514 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 35.54 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.22 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.14 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.23 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.42 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.51 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.32 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.12 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CD1' HG21 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.32 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.02 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.23 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.634 HG22 HD22 ' B' ' 143' ' ' LEU . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.1 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 41' ' ' VAL . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.02 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.33 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.34 111.05 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.32 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.01 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.24 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.22 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.55 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 32' ' ' VAL . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.51 HG23 ' CE1' ' B' ' 13' ' ' TYR . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.22 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.33 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.44 110.809 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.33 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.3 111.865 179.66 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.415 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.338 0 CA-C-O 120.21 -0.217 . . . . 65.35 113.3 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.14 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.32 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 62' ' ' ASP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.52 111.421 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.21 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.23 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.528 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.3 111.259 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.58 HD22 ' CD ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.11 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.53 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.492 HD12 ' NE ' ' B' ' 96' ' ' ARG . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.43 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.21 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.04 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 72.22 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.1 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.718 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 73.32 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.34 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.03 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.466 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.23 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.577 HG21 HG11 ' B' ' 90' ' ' VAL . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.21 111.094 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.82 HG22 ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.34 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.14 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 88' ' ' LEU . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.41 112.384 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.43 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 33.42 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.577 HG11 HG21 ' B' ' 83' ' ' VAL . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.33 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.632 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 64.3 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.514 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.1 110.448 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.35 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.58 ' CD ' HD22 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.24 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.451 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.14 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.601 HG22 HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.02 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.32 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.35 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.23 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.601 HG13 HG22 ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.1 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.681 HD13 ' N ' ' B' ' 106' ' ' CYS . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.13 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.681 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.51 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.33 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.3 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.82 ' HB2' HG22 ' B' ' 84' ' ' THR . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.15 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.468 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.1 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.488 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.13 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.12 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 70.23 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.678 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.24 110.616 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.11 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.1 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.33 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.737 HG13 HD23 ' A' ' 88' ' ' LEU . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.34 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.21 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.23 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.24 110.753 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.35 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 54.22 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.35 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.23 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.41 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.45 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.31 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 106' ' ' CYS . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.25 111.24 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.12 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.32 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.623 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.21 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.44 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.33 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.4 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.12 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.04 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.3 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.634 HD22 HG22 ' B' ' 31' ' ' ILE . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.03 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.3 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.1 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 147' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.31 111.053 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.2 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.11 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.45 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 55.22 110.789 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.728 0.299 . . . . 55.45 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.22 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' HD21 ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.02 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 78' ' ' VAL . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.4 110.995 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.21 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CG ' HD13 ' A' ' 31' ' ' ILE . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.54 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.41 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.53 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.839 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.34 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.12 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.51 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 74.12 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.31 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.43 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.42 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.45 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 31' ' ' ILE . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.42 110.079 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.756 ' HE1' HG21 ' A' ' 43' ' ' THR . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 73.21 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 HD21 ' A' ' 143' ' ' LEU . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.41 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.34 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 65.55 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.14 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' HG22 ' A' ' 41' ' ' VAL . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.44 111.255 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.33 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.33 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.41 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.41 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.03 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.45 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.756 HG21 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.05 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.03 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 54.4 p-80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.54 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.839 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.03 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 55.11 110.865 179.037 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 119.793 -0.448 . . . . 64.43 113.805 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.05 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.33 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.11 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 62' ' ' ASP . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.15 110.716 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.472 ' HA ' ' HE3' ' B' ' 119' ' ' MET . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.12 111.38 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.42 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.15 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 96' ' ' ARG . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 71.41 111.203 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.54 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.44 111.252 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.22 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.54 110.421 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.1 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.2 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.53 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 12' ' ' VAL . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.2 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HB ' HD12 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 61.11 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.15 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.3 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.01 111.264 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.846 HG22 ' HB2' ' A' ' 109' ' ' ARG . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.11 111.557 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.53 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.33 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.15 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.11 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.14 112.532 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.4 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.3 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.67 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.14 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.12 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.52 110.274 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.666 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.41 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.13 110.761 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.603 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.12 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' B' ' 96' ' ' ARG . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.13 111.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.328 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.4 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 55.01 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.04 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.31 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.41 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.678 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.31 110.744 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.04 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.52 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.846 ' HB2' HG22 ' A' ' 84' ' ' THR . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.41 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.47 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.21 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.44 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.02 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 32.34 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.42 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.21 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 120' ' ' ILE . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.23 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.54 111.456 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.14 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 41.34 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.33 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.3 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 71.45 110.67 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.52 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.33 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.15 111.101 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.44 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 106' ' ' CYS . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.03 111.244 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.44 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.01 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 73.32 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.52 111.236 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.41 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 33.32 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.11 111.676 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.4 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.23 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.58 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.32 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.616 HD21 HG22 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.21 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.52 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.33 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.53 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.4 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 54.53 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.3 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.41 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 148' ' ' GLU . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.44 111.014 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.35 111.084 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.668 0.27 . . . . 72.13 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 72.53 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.456 ' HB3' HD21 ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.22 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 78' ' ' VAL . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.44 111.007 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.22 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' B' ' 31' ' ' ILE . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.21 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.24 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.814 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.44 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.44 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.11 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.12 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.53 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.3 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.22 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.01 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 51.41 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 31' ' ' ILE . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.05 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.78 ' HE1' HG21 ' B' ' 43' ' ' THR . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 72.22 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.4 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.03 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.62 HG22 HD21 ' B' ' 143' ' ' LEU . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.01 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.789 HG22 HG11 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.24 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 41.34 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.31 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' B' ' 41' ' ' VAL . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.218 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.42 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.45 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.44 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.42 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.34 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.789 HG11 HG22 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 65.12 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.44 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.78 HG21 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 24.34 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 70.45 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.423 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 54.4 p-80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.04 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.814 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.44 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.33 110.791 179.095 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 CA-C-O 119.865 -0.408 . . . . 41.31 113.907 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 73.3 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.34 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.43 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' B' ' 62' ' ' ASP . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 62.24 110.649 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.12 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 51.52 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' B' ' 96' ' ' ARG . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 55.32 111.172 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.2 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.32 111.222 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.11 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.43 110.397 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.03 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.797 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.45 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.42 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 12' ' ' VAL . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.21 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.566 ' HB ' HD12 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.21 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.51 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.22 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.34 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.461 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.01 111.279 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.84 HG22 ' HB2' ' B' ' 109' ' ' ARG . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.12 111.485 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.21 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.785 ' HA ' HD12 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.23 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.13 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.21 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.24 112.509 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.21 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.05 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.666 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.15 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.43 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.333 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.44 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.497 ' CZ ' HD22 ' B' ' 70' ' ' LEU . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.54 110.726 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.596 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.31 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.12 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.41 111.358 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 100' ' ' LEU . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.43 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.11 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.05 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 65.2 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.45 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.691 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.31 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.691 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.12 110.772 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 63.45 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.84 ' HB2' HG22 ' B' ' 84' ' ' THR . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.34 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.467 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.21 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.41 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.43 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.43 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.44 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.14 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.01 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.592 HD22 HG21 ' B' ' 120' ' ' ILE . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.21 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 64.33 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 66' ' ' HIS . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.21 110.699 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.592 HG21 HD22 ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.32 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.22 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.53 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.24 110.634 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.34 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.1 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.02 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.24 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.13 111.056 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.13 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' B' ' 106' ' ' CYS . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.22 111.213 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.487 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.23 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.32 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.572 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 71.1 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.24 111.291 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.13 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.33 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.42 111.693 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.12 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.11 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.54 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.44 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.62 HD21 HG22 ' B' ' 31' ' ' ILE . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 53.42 111.051 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.31 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.01 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.31 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 152' ' ' VAL . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 53.51 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 43.31 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.32 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 148' ' ' GLU . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 71.11 110.93 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.21 111.054 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.73 0.3 . . . . 74.15 111.276 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.11 110.804 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.749 ' HB3' HD21 ' A' ' 42' ' ' LEU . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 78' ' ' VAL . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 72.2 111.319 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 53.12 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.24 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.12 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.495 ' N ' HG21 ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.13 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.682 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.22 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.45 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.24 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.43 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.53 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.53 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.416 HD21 ' OE1' ' A' ' 82' ' ' GLU . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.24 110.45 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 43' ' ' THR . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.12 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.42 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.23 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.4 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 HG11 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.13 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.02 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.2 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.13 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.51 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.31 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.24 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' A' ' 10' ' ' ARG . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.4 112.061 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.51 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.15 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.33 109.738 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.613 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.33 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.34 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.432 ' CE1' HG22 ' A' ' 46' ' ' VAL . 14.7 p80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.02 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.682 ' CG1' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.33 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.12 112.386 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 120.147 -0.252 . . . . 65.12 113.414 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.22 110.705 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 61.14 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD12 ' HA ' ' A' ' 62' ' ' ASP . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.648 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.15 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.11 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.14 111.547 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.11 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.52 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.12 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.422 ' HB2' ' HE2' ' A' ' 13' ' ' TYR . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.2 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.13 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.1 110.861 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.43 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 30.34 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.12 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 71.24 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HB ' HD12 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.1 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.45 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.21 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.3 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 61.31 111.574 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.31 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.816 ' HA ' HD12 ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.41 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.03 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.33 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.33 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 45.45 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.01 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.663 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 72.42 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.23 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.671 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.42 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.14 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.598 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 92' ' ' TYR . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.23 110.803 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.45 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.42 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.02 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.42 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.32 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.34 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.714 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.53 110.593 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.42 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.31 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' THR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.14 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.54 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.54 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 33.23 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 70.22 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.32 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.51 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 55.31 111.304 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.15 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.445 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.32 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD11 HD22 ' B' ' 88' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.2 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.54 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 70.31 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.32 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.2 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 45.24 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.31 112.237 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.22 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.54 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 106' ' ' CYS . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.12 111.119 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.51 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.663 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.2 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.579 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.44 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.01 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.15 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 33.12 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.34 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.43 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 63.14 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.35 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.22 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.34 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.45 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.66 ' HZ ' HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 74.44 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 152' ' ' VAL . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.01 111.174 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.21 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.51 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.24 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 148' ' ' GLU . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.42 111.172 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 60.21 111.537 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.794 0.33 . . . . 72.51 111.229 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.51 110.846 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.725 ' HB3' HD21 ' B' ' 42' ' ' LEU . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.24 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.702 HG22 HG12 ' B' ' 78' ' ' VAL . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.12 111.342 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.434 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 62.12 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.01 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.42 112.235 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.496 ' N ' HG21 ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.13 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.2 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.448 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.32 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.33 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.1 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.54 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.24 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.31 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 64.13 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.419 HD21 ' OE1' ' B' ' 82' ' ' GLU . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.23 110.463 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' B' ' 43' ' ' THR . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.02 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.34 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.32 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.547 ' O ' HD22 ' B' ' 35' ' ' LEU . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.03 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.78 HG13 HG11 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.1 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.51 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.547 HD22 ' O ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 71.24 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.44 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.31 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 72.33 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' B' ' 10' ' ' ARG . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.33 112.034 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.45 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.78 HG11 HG13 ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.32 109.683 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.614 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.42 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.34 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.436 ' CE1' HG22 ' B' ' 46' ' ' VAL . 14.8 p80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 64.41 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 43.3 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.14 112.406 -179.777 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 120.073 -0.293 . . . . 65.11 113.358 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.653 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.53 111.077 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.34 110.674 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' B' ' 62' ' ' ASP . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.1 110.645 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.22 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.05 111.598 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.12 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.14 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.03 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.434 ' HB2' ' HE2' ' B' ' 13' ' ' TYR . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 63.04 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.04 110.91 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.35 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.45 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.702 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 70.34 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.3 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 62.23 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.53 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.888 HG22 ' HB2' ' B' ' 109' ' ' ARG . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.12 111.612 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.31 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.799 ' HA ' HD12 ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.55 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' SER . . . . . 0.407 ' OG ' ' HB ' ' B' ' 90' ' ' VAL . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.55 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.01 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.496 HG21 ' N ' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.35 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.671 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 73.42 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.41 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 60.22 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.663 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.02 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.549 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.41 111.605 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.493 HG21 ' OH ' ' A' ' 92' ' ' TYR . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.11 110.86 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 71.01 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.432 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 60.44 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.53 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.23 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.648 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.11 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' B' ' 97' ' ' ALA . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.31 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.699 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.43 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.721 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.12 110.587 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.15 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 64.2 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.888 ' HB2' HG22 ' B' ' 84' ' ' THR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.23 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 70.4 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' B' ' 109' ' ' ARG . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.2 111.695 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.54 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.13 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.24 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.719 HD22 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.24 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.54 111.283 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.21 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.44 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.35 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 88' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 41.21 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.02 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.32 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.05 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.14 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.13 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' B' ' 103' ' ' PRO . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.31 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.35 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' B' ' 106' ' ' CYS . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.172 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 73.21 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 72.04 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.572 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 64.13 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.43 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.42 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.24 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.42 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.41 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.31 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.43 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.22 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 73.14 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.24 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.3 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.472 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 73.0 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' B' ' 12' ' ' VAL . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 70.34 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.476 ' O ' HG23 ' B' ' 152' ' ' VAL . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.12 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.02 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 71.32 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.04 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 148' ' ' GLU . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.13 111.19 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 74.45 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.22 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 34.21 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG13 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.4 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 61.1 110.488 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.52 ' CG ' HD13 ' A' ' 31' ' ' ILE . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.15 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.615 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.11 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.666 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.3 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.01 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.54 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.11 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.13 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.12 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 63.2 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 64.4 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.697 ' CD1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.14 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.31 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.42 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.21 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.88 HG22 HG21 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 62.11 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 62.24 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.2 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 31' ' ' ILE . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.44 110.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.35 110.857 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.2 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.03 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.11 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.44 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG21 HG22 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.22 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.32 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.57 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.23 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 41' ' ' VAL . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.54 110.801 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 48.8 p-80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.44 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.53 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.04 111.692 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.774 -0.131 . . . . 73.42 112.774 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 65.22 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.54 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.05 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 62' ' ' ASP . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 51.31 110.533 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 60.03 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.52 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.03 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 44.52 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.673 HD21 ' CZ ' ' A' ' 96' ' ' ARG . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.41 111.27 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.45 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 71.02 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.532 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.12 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.34 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.21 111.403 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 150' ' ' TYR . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.44 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.34 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 51.34 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 60.11 112.265 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.41 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 90' ' ' VAL . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.118 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 70.12 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.12 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.842 ' HG ' HD23 ' B' ' 116' ' ' LEU . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.22 111.512 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.44 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.11 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 33.23 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.664 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.24 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.02 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 81' ' ' ALA . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 64.03 111.111 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.652 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.21 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.673 ' CZ ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.51 110.617 178.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.11 111.08 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.03 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.13 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.32 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.14 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 73.11 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.726 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.12 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.534 ' H ' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.31 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 134' ' ' TYR . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.01 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.24 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 61.01 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.13 111.056 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.13 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.51 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.31 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.44 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' B' ' 88' ' ' LEU . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.11 110.875 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 70.12 111.165 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.4 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.594 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 60.23 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 116' ' ' LEU . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.53 111.212 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.1 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.42 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.53 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 62.43 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.21 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.577 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 41.15 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.662 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.34 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.3 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.14 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.31 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.15 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' HD12 ' A' ' 107' ' ' LEU . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.42 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.1 111.069 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.24 113.252 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.22 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.11 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.24 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.4 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 143' ' ' LEU . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.34 110.964 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.52 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 62.23 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.54 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.21 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.23 111.045 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.55 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.33 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 149' ' ' ALA . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.51 111.817 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.34 110.938 179.672 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.705 0.288 . . . . 74.24 111.041 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.12 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 72.51 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.531 HG13 HG13 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.53 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.496 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 54.35 110.49 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.515 ' CG ' HD13 ' B' ' 31' ' ' ILE . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.13 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.609 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.35 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.661 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 53.53 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.54 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.473 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.41 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.42 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.3 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.12 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.02 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.2 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.33 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.1 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.696 ' CD1' HG21 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 60.41 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 51.31 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.13 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.51 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.884 HG22 HG21 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.34 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.42 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.31 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 31' ' ' ILE . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.24 110.993 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' HB ' ' B' ' 41' ' ' VAL . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.35 110.874 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.24 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.4 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.14 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.884 HG21 HG22 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.33 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.34 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.573 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.51 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.46 ' HG3' HG11 ' B' ' 41' ' ' VAL . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.04 110.802 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' HIS . . . . . 0.414 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 48.8 p-80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 64.11 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.696 HG21 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.52 111.688 179.689 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.726 -0.15 . . . . 54.44 112.726 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.806 ' HA ' HD12 ' B' ' 65' ' ' ILE . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 64.24 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.24 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.04 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' B' ' 62' ' ' ASP . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.558 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.12 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 61.23 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.42 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 32.44 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.679 HD21 ' CZ ' ' B' ' 96' ' ' ARG . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.11 111.246 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.41 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.04 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 73' ' ' LEU . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.14 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLN . . . . . 0.53 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.34 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.15 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.44 111.436 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.22 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' B' ' 150' ' ' TYR . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.53 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.54 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.11 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 94' ' ' LEU . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 51.3 112.327 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.04 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' B' ' 90' ' ' VAL . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.2 111.136 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.667 HG22 ' HB2' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 62.13 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.44 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 63.35 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.21 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.41 111.566 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 22.23 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.04 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.33 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.652 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.52 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.13 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 81' ' ' ALA . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.33 111.089 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLY . . . . . 0.664 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.679 ' CZ ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.34 110.623 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.44 111.107 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.02 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 43.3 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 61.24 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.34 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.33 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.659 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.14 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.69 HG13 HG23 ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 54.13 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.721 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.35 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 106' ' ' CYS . . . . . 0.545 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 30.2 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.14 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 71.14 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ARG . . . . . 0.667 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.21 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.55 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 52.22 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.43 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.1 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.41 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.842 HD23 ' HG ' ' A' ' 88' ' ' LEU . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.24 110.857 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.402 ' O ' HG22 ' B' ' 120' ' ' ILE . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 63.13 111.127 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.41 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.593 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.2 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.532 HG12 HD22 ' B' ' 116' ' ' LEU . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.13 111.242 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.21 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.44 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 70.32 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.52 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.42 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.42 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' SER . . . . . 0.568 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 55.23 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 71.41 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 129' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.02 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.21 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.11 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.42 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' TYR . . . . . 0.584 ' HB3' HD12 ' B' ' 107' ' ' LEU . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.32 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.31 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.05 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.24 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 139' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.43 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.23 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 73.24 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 143' ' ' LEU . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.44 110.847 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.32 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.05 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.35 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 64.43 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.44 111.1 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.54 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.31 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' B' ' 149' ' ' ALA . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 60.32 111.763 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.31 110.866 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.569 0.223 . . . . 52.33 111.403 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -123.7 124.03 41.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.371 -0.377 . . . . 72.42 110.927 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.15 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.14 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 78' ' ' VAL . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 55.02 110.854 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 63.4 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.35 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.34 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.669 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.482 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.14 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.738 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.03 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.02 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.21 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.35 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.41 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.03 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.45 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.12 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 31' ' ' ILE . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.23 110.26 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.14 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 62.21 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.647 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.04 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.51 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.42 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.45 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.14 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 73.23 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.31 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.32 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 72' ' ' TRP . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 62.25 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.12 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.11 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.577 ' CE1' HG22 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.22 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.53 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.07 49.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 52.12 111.512 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.62 111.36 11.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 75.42 111.507 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.0 59.24 0.91 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.333 0.587 . . . . 62.25 110.224 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 28.9 tt0 174.72 66.9 0.0 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.858 -1.065 . . . . 73.21 110.207 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.68 105.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.168 -0.469 . . . . 74.1 110.998 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 14.0 tp10 -55.42 109.29 1.52 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.985 -0.552 . . . . 73.14 111.627 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' GLU . 73.5 Cg_endo -71.94 -165.38 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.244 2.63 . . . . 72.12 112.552 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.22 -0.9 . . . . 73.3 111.716 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.37 -159.58 13.8 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.889 -0.596 . . . . 62.05 112.789 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.43 130.38 46.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.704 0.287 . . . . 72.42 111.171 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.08 78.28 6.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.644 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.34 172.82 12.27 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.952 -0.567 . . . . 73.12 111.184 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.02 76.08 9.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.313 -0.403 . . . . 54.22 111.091 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.1 146.51 18.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.052 -0.594 . . . . 32.12 112.484 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.33 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.804 -0.712 . . . . 53.22 112.687 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.621 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.14 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.1 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.52 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.86 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.762 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 61.32 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.41 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.35 111.229 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 72.04 111.438 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.629 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.11 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' CD1' HD12 ' A' ' 42' ' ' LEU . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.23 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.22 111.135 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 32.01 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.31 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.42 111.585 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.43 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.646 ' CG1' HG22 ' A' ' 12' ' ' VAL . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.53 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 70.03 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.12 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 35.55 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 90' ' ' VAL . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.04 110.834 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 63.43 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.35 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.12 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.04 111.101 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' B' ' 120' ' ' ILE . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.4 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.13 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 83' ' ' VAL . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.41 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.41 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.55 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.41 110.942 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.41 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.629 ' HD2' HD13 ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 54.32 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.3 111.792 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' B' ' 92' ' ' TYR . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.42 111.093 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.54 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.51 111.355 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.22 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.11 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.53 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 97' ' ' ALA . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.15 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.55 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.568 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.52 111.217 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.4 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.42 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB2' HG22 ' A' ' 84' ' ' THR . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.44 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.44 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 109' ' ' ARG . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 62.41 111.327 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.02 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.14 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.13 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.22 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 120' ' ' ILE . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.386 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 70.1 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.22 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.41 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 116' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.12 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 61.52 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.12 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.34 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.04 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.13 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.42 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.31 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.15 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.51 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.12 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 106' ' ' CYS . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.42 110.841 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.32 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.43 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.543 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.4 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 43.24 111.28 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.32 112.825 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.52 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.53 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.543 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.24 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.14 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.484 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.34 111.098 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 51.01 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.01 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.15 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.54 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.41 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.31 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.21 111.4 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.12 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 60.34 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 149' ' ' ALA . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.1 111.564 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -82.05 -32.7 30.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.41 110.907 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 63.35 18.29 10.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.696 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.8 173.15 0.58 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.69 0.281 . . . . 71.44 111.107 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.07 70.67 1.03 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.032 0.444 . . . . 74.11 110.541 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.05 -38.48 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.831 -0.622 . . . . 73.45 111.217 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -61.02 141.57 57.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.433 -0.349 . . . . 74.21 111.23 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.155 -0.926 . . . . 73.11 110.992 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.554 0.216 . . . . 75.12 111.357 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -123.63 124.06 41.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.373 -0.376 . . . . 71.5 110.949 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.32 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.53 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' B' ' 78' ' ' VAL . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.41 110.874 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.443 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.32 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.15 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.68 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.3 112.593 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.456 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 60.22 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.735 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 64.33 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.465 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 62.31 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.488 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.14 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.31 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.45 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.02 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.44 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 35.21 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 31' ' ' ILE . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.31 110.234 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.2 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.23 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.33 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.502 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 71.22 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.661 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.32 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.33 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.43 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 63.22 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.4 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.22 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.41 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.35 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.15 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.12 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 72' ' ' TRP . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.472 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.3 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.58 ' CE1' HG22 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.735 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.22 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.04 49.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.13 111.489 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.67 111.32 11.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 74.41 111.529 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -100.97 59.31 0.91 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.376 0.608 . . . . 64.15 110.22 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 28.9 tt0 174.68 66.91 0.0 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.869 -1.06 . . . . 74.43 110.236 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.73 105.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.13 -0.487 . . . . 74.24 111.001 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -55.46 109.35 1.56 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.92 -0.582 . . . . 63.41 111.561 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.0 -165.34 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.236 2.624 . . . . 70.03 112.581 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.223 -0.899 . . . . 72.22 111.726 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.39 -159.55 13.82 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 73.13 112.764 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.56 130.4 46.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.716 0.294 . . . . 73.44 111.144 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.04 78.28 6.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.134 -0.485 . . . . 73.12 110.672 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.36 172.81 12.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.894 -0.594 . . . . 61.44 111.172 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.04 76.1 9.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.302 -0.408 . . . . 54.12 111.102 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.06 146.48 18.16 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.076 -0.583 . . . . 72.45 112.507 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.813 -0.708 . . . . 62.14 112.645 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.617 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.33 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.04 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.21 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.869 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.41 110.754 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 73.15 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.42 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.574 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.52 111.199 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.42 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.35 111.481 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.612 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.05 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.2 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.548 ' CD1' HD12 ' B' ' 42' ' ' LEU . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.33 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.21 111.16 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.45 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.52 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.24 111.572 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.1 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' B' ' 12' ' ' VAL . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 72.04 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.02 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 63.5 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 33.34 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.03 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.63 HG21 HG11 ' B' ' 90' ' ' VAL . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 63.34 110.819 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.687 HG22 ' HB2' ' B' ' 109' ' ' ARG . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.53 112.132 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.415 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.42 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.14 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' B' ' 90' ' ' VAL . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.54 111.053 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' A' ' 120' ' ' ILE . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.4 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.42 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 HG21 ' B' ' 83' ' ' VAL . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.32 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.24 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.11 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.475 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.914 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.48 HD21 ' SG ' ' B' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.22 110.753 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.02 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.612 ' HD2' HD13 ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.03 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.12 111.835 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' A' ' 92' ' ' TYR . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.33 111.103 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.43 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.411 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.24 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.31 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HB2' HG23 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.11 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.531 HD12 ' HB1' ' B' ' 97' ' ' ALA . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.44 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.23 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.557 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.23 111.242 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 61.15 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.687 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.23 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.427 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.31 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' B' ' 109' ' ' ARG . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.12 111.384 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 63.32 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.34 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.31 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.21 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.968 HD22 HG21 ' B' ' 120' ' ' ILE . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.396 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.33 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.24 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.41 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.968 HG21 HD22 ' B' ' 116' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.21 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.43 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.52 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.3 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.12 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 64.31 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 22.45 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.42 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.31 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.21 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.35 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' B' ' 106' ' ' CYS . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.44 110.895 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.14 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.54 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.14 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.24 111.26 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.55 112.795 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.32 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 63.24 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.01 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.53 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 53.3 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.469 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.24 111.04 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.22 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.34 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.52 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.44 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.3 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.51 111.438 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.1 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' B' ' 149' ' ' ALA . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.12 111.519 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.99 -32.66 30.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.01 110.959 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 63.35 18.28 10.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.694 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.79 173.11 0.58 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.765 0.317 . . . . 74.12 111.087 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.08 70.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.503 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.04 -38.51 4.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 75.43 111.242 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -60.99 141.58 57.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.425 -0.352 . . . . 72.33 111.203 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.218 -0.896 . . . . 73.32 110.997 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.86 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.869 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.9 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.791 0.329 . . . . 64.22 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.41 152.93 48.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.167 -0.47 . . . . 71.43 111.068 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.028 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.51 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 31' ' ' ILE . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.11 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.44 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.3 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.691 ' HB3' HG21 ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 33.11 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.12 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.21 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.24 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.4 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.42 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.4 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.42 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 51.4 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.14 110.283 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.845 ' CE1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 65.35 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.2 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.41 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 61.13 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 41' ' ' VAL . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.12 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.1 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.3 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.22 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.55 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 72.03 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.14 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.03 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.24 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.66 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.12 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 73.3 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' NE2' ' N3 ' ' A' ' 187' ' ' 5GP . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 53.44 111.39 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.845 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.67 36.86 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 71.45 111.498 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.36 158.91 17.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.026 0.441 . . . . 72.42 111.418 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -139.88 49.5 1.77 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.762 0.791 . . . . 45.02 110.171 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 tt0 170.18 68.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.019 -1.446 . . . . 74.01 110.087 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.229 -0.442 . . . . 73.11 111.242 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.45 105.78 0.55 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.917 -0.583 . . . . 64.32 111.957 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.6 84.23 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.317 2.678 . . . . 61.54 112.384 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.72 151.49 45.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.432 . . . . 65.34 111.295 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.91 178.13 18.34 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.229 -0.51 . . . . 43.23 112.908 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 164.74 15.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.783 0.325 . . . . 52.11 111.213 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.4 88.78 0.66 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.039 -0.528 . . . . 72.35 110.989 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.64 55.58 0.14 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.92 -0.582 . . . . 34.14 110.83 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.89 146.3 28.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.997 -0.547 . . . . 54.3 111.237 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.44 -171.28 21.16 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.956 -0.64 . . . . 65.14 112.752 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.62 -99.53 0.89 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.188 -0.529 . . . . 24.41 112.624 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.629 ' HA ' HD12 ' A' ' 65' ' ' ILE . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.33 111.325 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 61.31 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 71.22 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 62' ' ' ASP . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.1 110.821 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' O ' HD23 ' A' ' 70' ' ' LEU . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 70.23 111.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 62.0 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.4 111.252 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.3 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 96' ' ' ARG . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.03 111.194 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.44 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.54 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.35 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.24 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.44 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.24 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 150' ' ' TYR . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.23 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 73' ' ' LEU . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.02 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.44 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 71.55 111.129 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 109' ' ' ARG . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 54.13 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.45 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.937 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.13 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.43 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.14 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.23 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.12 111.323 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.629 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.53 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.31 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.24 110.332 179.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.64 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.45 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.664 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 72.51 110.568 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.03 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.31 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB2' ' CD ' ' B' ' 96' ' ' ARG . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.43 111.526 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.24 111.362 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.03 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.23 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.32 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.575 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 52.45 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.712 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.15 111.049 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.21 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.34 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.679 ' HB2' HG22 ' A' ' 84' ' ' THR . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 71.31 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.23 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 72.43 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.15 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 31.24 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.24 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.13 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.809 HD12 HD13 ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.42 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.51 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.44 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.04 110.742 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.15 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.11 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.23 110.934 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.11 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.21 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.02 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.11 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.24 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.624 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 71.13 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.01 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.712 HG13 ' HB3' ' A' ' 106' ' ' CYS . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.3 110.876 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.21 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.523 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.42 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 40.11 111.521 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.31 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.24 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.44 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.04 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 64.52 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.536 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.1 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.2 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 51.3 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.44 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 70.53 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.44 110.779 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.42 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.34 111.151 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.42 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.33 111.715 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.33 -32.64 29.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.42 110.862 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 60.2 27.07 16.54 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.96 -71.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.548 -0.296 . . . . 73.3 111.118 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -174.26 130.83 0.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.41 -0.359 . . . . 74.3 110.892 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.88 148.83 45.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.249 -0.432 . . . . 64.04 110.883 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.86 162.77 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.135 -0.484 . . . . 75.32 111.301 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.012 -0.995 . . . . 72.13 111.214 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 15.0 mtt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.778 0.323 . . . . 75.44 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.29 153.02 49.05 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.11 -0.496 . . . . 74.32 111.134 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.012 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.51 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 64.4 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.556 ' CG ' HD13 ' B' ' 31' ' ' ILE . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.23 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.668 ' HB3' HG21 ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.3 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.517 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 62.23 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.51 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.44 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.13 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.31 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 52.15 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.22 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.32 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.31 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.256 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.832 ' CE1' HG21 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.3 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.487 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.34 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.11 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.556 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.52 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.909 HG23 HG21 ' B' ' 41' ' ' VAL . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.23 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.03 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 70.02 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.495 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.13 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.11 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.13 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.03 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.12 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.909 HG21 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.11 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 1.012 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.44 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.666 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.31 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.45 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.435 ' NE2' ' N3 ' ' B' ' 187' ' ' 5GP . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.03 111.414 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.832 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 63.42 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.68 36.91 4.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.22 111.425 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.37 158.87 17.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.979 0.419 . . . . 64.31 111.457 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -139.77 49.4 1.78 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.643 0.735 . . . . 75.44 110.223 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 4.8 tt0 170.24 68.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.009 -1.45 . . . . 75.45 110.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.154 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 105.79 0.55 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.95 -0.568 . . . . 73.33 111.953 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.64 84.24 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.247 2.632 . . . . 61.34 112.417 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.67 151.61 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.227 -0.442 . . . . 63.51 111.249 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.87 178.13 18.36 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.177 -0.535 . . . . 64.51 112.943 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.38 164.83 15.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.815 0.341 . . . . 73.1 111.257 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.52 88.8 0.68 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.085 -0.507 . . . . 73.31 110.941 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.59 55.66 0.14 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.035 -0.53 . . . . 70.1 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.92 146.34 28.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.002 -0.545 . . . . 75.35 111.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.45 -171.3 21.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.966 -0.635 . . . . 74.52 112.714 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.61 -99.44 0.89 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.057 -0.592 . . . . 44.14 112.63 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' B' ' 65' ' ' ILE . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.52 111.343 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.13 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.4 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.623 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.835 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.549 ' O ' HD23 ' B' ' 70' ' ' LEU . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.42 111.411 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.43 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.54 111.228 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.14 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.556 HD11 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.3 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.01 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 73.23 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.22 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.34 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.537 ' HB2' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.32 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.22 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' B' ' 150' ' ' TYR . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.12 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 73' ' ' LEU . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.41 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.567 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.11 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.22 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.494 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.13 111.129 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 109' ' ' ARG . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 71.33 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.24 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.954 ' HA ' HD12 ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.4 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.21 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.21 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG21 ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.11 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.534 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.1 111.264 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.64 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.42 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.21 110.449 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 63.34 110.319 179.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.35 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.663 ' CD ' ' HB2' ' A' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.695 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.12 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.42 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.664 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.2 111.4 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' B' ' 100' ' ' LEU . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.35 111.408 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.24 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 61.31 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.2 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.05 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.567 ' CB ' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 71.11 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.723 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 73.01 110.954 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.21 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.45 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.673 ' HB2' HG22 ' B' ' 84' ' ' THR . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.32 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.438 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.02 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.41 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.545 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.23 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 23.42 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.14 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.23 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.32 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 63.41 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.31 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.01 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.24 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.1 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.35 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.1 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 62.42 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.62 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.13 110.922 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.52 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' B' ' 106' ' ' CYS . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.89 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 73.21 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.22 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.02 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.41 111.548 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.3 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.42 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 42.13 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.21 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.534 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.52 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.14 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.35 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 71.21 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 35' ' ' LEU . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.31 110.702 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 54.04 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.42 111.171 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.53 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.32 111.65 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.32 -32.59 29.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.13 110.902 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 60.17 27.12 16.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.218 -0.446 . . . . 74.44 111.252 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -71.24 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.473 -0.331 . . . . 75.23 111.104 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -174.26 130.82 0.38 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.349 . . . . 74.2 110.858 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.81 148.83 45.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.259 -0.428 . . . . 72.01 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.91 162.74 13.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.161 -0.472 . . . . 73.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.087 -0.959 . . . . 73.51 111.185 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.619 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.623 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.548 0.213 . . . . 75.11 111.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.33 128.44 25.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.439 -0.346 . . . . 64.01 111.137 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.15 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.995 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.34 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 HG12 ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.44 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 65.02 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.546 ' CG ' HD13 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.33 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.55 110.817 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.34 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.783 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.45 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.559 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.14 112.608 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.23 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.34 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.32 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.01 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.42 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' OE2' ' A' ' 82' ' ' GLU . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.4 110.324 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.33 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.44 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.32 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.12 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 41' ' ' VAL . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 71.44 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 41.03 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.13 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.007 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.3 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.34 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.35 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.21 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.14 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 62.13 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.1 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.45 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.467 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.24 111.751 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.783 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.14 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.68 52.3 2.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.24 110.804 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.61 147.57 23.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.983 0.42 . . . . 71.22 111.369 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.02 54.22 1.35 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.646 0.736 . . . . 51.42 110.263 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER 174.19 67.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.318 -1.31 . . . . 71.3 109.858 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.36 105.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.035 -0.53 . . . . 64.21 111.263 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -114.72 81.73 7.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 73.33 111.5 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.69 81.67 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.951 2.434 . . . . 64.44 112.326 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -99.0 130.0 45.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.321 -0.4 . . . . 70.32 111.022 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.65 -160.14 25.25 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.063 -0.589 . . . . 70.34 112.748 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.78 118.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.577 0.351 . . . . 64.54 111.29 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 53.66 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.905 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.49 145.18 6.63 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.937 -0.574 . . . . 65.14 111.17 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.42 8.74 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.187 -0.46 . . . . 73.43 111.041 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.94 142.44 3.46 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.066 -0.588 . . . . 74.31 112.655 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' ILE . . . -89.09 -14.65 60.25 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.155 -0.545 . . . . 64.32 113.435 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.42 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.11 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.11 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.87 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.21 110.942 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.01 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.12 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.15 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.13 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.52 111.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.43 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 74.11 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.42 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.03 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.04 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.24 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.12 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.02 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.03 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.03 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 94' ' ' LEU . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.23 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' OE2' HG21 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.35 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.23 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 109' ' ' ARG . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.22 111.331 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.34 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.22 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.5 ' HB2' HG11 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.741 HD22 HD11 ' B' ' 120' ' ' ILE . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.24 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.54 112.54 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.22 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.13 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.14 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 81' ' ' ALA . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.41 111.0 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.32 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.4 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.57 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.43 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.24 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.43 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.2 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 71.55 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.4 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 79' ' ' VAL . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.35 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.782 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 55.24 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.42 111.152 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.14 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.51 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.31 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.553 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.35 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.12 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.24 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 62.24 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 51.54 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.53 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' B' ' 65' ' ' ILE . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.34 111.687 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.422 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.24 110.576 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.764 HD11 HD22 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.3 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.11 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.33 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 45.12 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.33 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.11 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.4 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 106' ' ' CYS . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.33 110.932 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 71.44 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.54 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.4 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.03 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.55 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.12 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.14 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 145' ' ' ARG . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.14 110.521 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.23 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.543 ' CD2' HG22 ' A' ' 31' ' ' ILE . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.12 111.155 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.34 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 141' ' ' THR . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.33 111.069 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.22 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.13 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' VAL . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.14 111.524 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.04 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.629 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 45.55 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.44 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 148' ' ' GLU . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 31.53 111.186 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.61 -33.23 58.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.44 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.09 17.43 10.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.367 -0.378 . . . . 73.04 111.444 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.29 175.36 1.49 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.727 0.299 . . . . 74.2 111.139 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.97 108.48 6.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.274 -0.421 . . . . 74.34 110.786 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -160.77 145.83 14.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.134 -0.485 . . . . 73.24 111.094 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.91 153.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.085 -0.507 . . . . 64.24 111.381 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.138 -0.934 . . . . 71.32 111.204 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.565 0.221 . . . . 72.03 111.407 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.31 128.46 25.76 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.423 -0.353 . . . . 74.05 111.161 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 60.32 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.061 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.33 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.691 HG22 HG12 ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.22 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.507 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.3 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.541 ' CG ' HD13 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 74.23 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.43 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.537 ' HB2' HG21 ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.11 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.8 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.11 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.569 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 63.22 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.468 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.42 112.589 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.4 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 73.22 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.42 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 53.22 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.35 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.51 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.442 HD21 ' OE2' ' B' ' 82' ' ' GLU . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.4 110.328 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.668 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.12 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.552 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.45 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.42 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.04 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.979 HG23 HG21 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.45 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.32 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.458 HD13 ' O ' ' B' ' 31' ' ' ILE . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 43.35 111.003 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 54.32 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.24 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.12 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.02 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.52 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.979 HG21 HG23 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 1.061 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.1 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.11 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' B' ' 43' ' ' THR . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 61.45 111.699 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 62.23 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.69 52.35 2.09 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.11 110.768 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -95.63 147.59 23.43 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.948 0.404 . . . . 61.31 111.439 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.04 54.23 1.35 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.629 0.728 . . . . 72.2 110.222 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 0.9 OUTLIER 174.11 67.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.354 -1.294 . . . . 73.4 109.927 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.24 105.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.937 -0.574 . . . . 74.11 111.308 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -114.68 81.73 7.41 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.019 -0.537 . . . . 74.31 111.499 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -86.77 81.66 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.943 2.429 . . . . 63.15 112.3 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -98.98 130.04 45.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.269 -0.423 . . . . 53.22 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.62 -160.13 25.28 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.129 -0.557 . . . . 62.21 112.664 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.8 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.836 0.35 . . . . 53.14 111.336 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.93 53.76 0.92 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 75.02 110.85 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.55 145.09 6.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.906 -0.588 . . . . 74.14 111.129 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.56 8.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.151 -0.477 . . . . 75.35 110.959 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.89 142.48 3.47 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 52.54 112.622 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.426 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -89.08 -14.85 59.98 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.242 -0.504 . . . . 64.44 113.454 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.14 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.13 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.34 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.879 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.33 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.495 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 63.22 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.15 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.31 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.55 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.43 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' OE1' ' B' ' 74' ' ' GLN . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.13 111.927 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 63.41 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 65.23 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' B' ' 71' ' ' ASN . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.42 110.988 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.24 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.44 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.45 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.695 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.4 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.22 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.779 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 45.23 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 94' ' ' LEU . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.22 112.037 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.588 ' OE2' HG21 ' B' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.05 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.22 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.797 HG22 ' HB2' ' B' ' 109' ' ' ARG . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 111.25 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.43 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.442 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.33 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' SER . . . . . 0.489 ' HB2' HG11 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.35 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.33 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.34 112.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.1 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.12 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.619 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.42 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' B' ' 81' ' ' ALA . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.22 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.04 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.02 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.54 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.21 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.03 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.34 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 52.51 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.21 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.779 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.33 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.756 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.12 111.112 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.24 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.13 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.797 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.04 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.557 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.1 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.41 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.51 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.1 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.23 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.45 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.654 HD22 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.02 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 63.43 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 65' ' ' ILE . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 71.55 111.674 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.41 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 53.5 110.638 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.741 HD11 HD22 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.24 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 71.35 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.51 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.33 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 53.04 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.54 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.31 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.34 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.53 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.23 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.02 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' B' ' 106' ' ' CYS . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.23 110.914 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.13 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.2 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.59 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.31 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 34.13 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.13 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.43 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.22 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.11 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.02 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.35 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.55 ' CD2' HG22 ' B' ' 31' ' ' ILE . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.12 111.179 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.43 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.45 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.555 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.43 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.55 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.501 ' O ' HG23 ' B' ' 152' ' ' VAL . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.04 111.497 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.05 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.631 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.53 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.45 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 148' ' ' GLU . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.24 111.091 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.67 -33.29 58.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.21 110.953 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.18 17.4 10.66 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.306 -0.406 . . . . 74.32 111.377 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.3 175.36 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.788 0.327 . . . . 72.32 111.044 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.99 108.49 6.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.231 -0.44 . . . . 70.41 110.84 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -160.74 145.96 14.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 72.3 111.039 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.8 153.48 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.049 -0.523 . . . . 72.23 111.383 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.13 -0.938 . . . . 75.53 111.215 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.87 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.879 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.545 0.212 . . . . 64.41 111.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.07 116.67 27.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 75.11 110.897 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.753 ' HB3' HD21 ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 54.31 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 78' ' ' VAL . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.13 110.787 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 53.01 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 31' ' ' ILE . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.43 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.42 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.41 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.535 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 55.14 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 73.25 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.14 112.42 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.14 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.34 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.53 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.44 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.3 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.42 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.492 HD21 ' OE2' ' A' ' 82' ' ' GLU . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 41.12 110.737 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 72.22 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.54 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.22 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.42 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.944 HG22 HG11 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 72.22 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.33 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.11 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.835 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.03 111.224 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 41' ' ' VAL . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.33 110.871 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.23 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.34 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.13 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.45 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.32 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 11' ' ' SER . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.24 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.587 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.15 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.44 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.4 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.13 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.08 60.34 1.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.1 110.76 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -108.67 131.66 54.68 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 70.22 111.757 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.89 58.33 0.85 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.366 0.603 . . . . 72.44 110.321 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.28 68.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.747 -1.115 . . . . 72.43 110.146 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.33 107.39 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.917 -0.583 . . . . 62.32 111.28 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 84.29 14.55 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.511 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.06 81.86 2.28 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.87 2.38 . . . . 73.43 112.275 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.88 140.84 39.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.138 -0.483 . . . . 64.15 111.067 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.15 -169.07 47.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.054 -0.593 . . . . 61.25 112.644 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.07 129.06 38.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.667 0.27 . . . . 75.31 111.012 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 139.57 52.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 63.33 110.965 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.14 171.04 12.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.073 -0.512 . . . . 74.54 111.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.95 94.74 2.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.186 -0.461 . . . . 64.12 111.117 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.42 -158.96 10.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.139 -0.553 . . . . 62.21 112.646 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.45 -106.34 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.907 -0.663 . . . . 74.31 112.557 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.42 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.53 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.02 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.42 110.792 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.35 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.43 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.43 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.5 HD11 ' NE ' ' A' ' 96' ' ' ARG . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.44 111.117 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.1 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.21 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 62.42 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 60.13 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.01 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.42 111.475 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.04 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 12' ' ' VAL . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.23 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 97' ' ' ALA . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.35 110.577 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.45 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.45 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' OE2' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.12 110.71 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.54 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' ARG . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.55 111.525 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.54 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.34 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.12 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.906 HD22 HD11 ' B' ' 120' ' ' ILE . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.12 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.44 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.52 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.12 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 71.53 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.45 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 44.25 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 30.41 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.22 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.42 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.477 HG21 ' OH ' ' B' ' 92' ' ' TYR . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.24 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' B' ' 96' ' ' ARG . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.21 111.371 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 70' ' ' LEU . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.01 111.466 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.1 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.04 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 65.41 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 79' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.22 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.686 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.11 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.751 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.13 111.075 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 70.32 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.15 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HB2' HG22 ' A' ' 84' ' ' THR . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.31 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.602 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.31 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.45 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.14 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.54 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.22 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.22 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.31 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.35 112.352 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.469 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.04 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HD22 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.04 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.32 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.35 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.14 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.24 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.04 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.21 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.13 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 53.24 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 106' ' ' CYS . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.04 111.019 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.51 111.086 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.05 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.24 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.15 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.35 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.14 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.604 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 34.54 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.32 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.51 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.578 ' HG2' HD11 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.03 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 31' ' ' ILE . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 63.13 110.947 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.11 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.54 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.22 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.13 111.296 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 157' ' ' HIS . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.21 111.232 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 73.45 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.55 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 148' ' ' GLU . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.23 111.567 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -84.52 -21.5 30.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.1 111.477 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.13 33.22 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.883 0.473 . . . . 63.21 111.669 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.41 -67.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.264 -0.425 . . . . 72.51 111.212 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -175.08 110.57 0.12 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.296 -0.411 . . . . 72.31 110.674 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.487 ' CG ' ' HB1' ' A' ' 149' ' ' ALA . 3.6 t-80 -72.2 144.56 48.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.251 -0.431 . . . . 75.33 111.258 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.15 150.09 29.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.032 -0.531 . . . . 73.2 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -0.769 . . . . 75.31 111.005 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.482 0.182 . . . . 64.41 111.41 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.06 116.68 27.81 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.449 -0.341 . . . . 62.03 110.871 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.772 ' HB3' HD21 ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.23 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 78' ' ' VAL . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.31 110.75 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.524 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 70.14 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.534 ' CB ' HD13 ' B' ' 31' ' ' ILE . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.3 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.35 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.597 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 63.42 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.15 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.33 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.42 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 24.14 112.45 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.21 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.33 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.54 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.32 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.23 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.24 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.495 HD21 ' OE2' ' B' ' 82' ' ' GLU . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.723 ' CE2' HG21 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.22 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.11 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.31 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.33 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.923 HG22 HG11 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.43 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.55 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.51 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.21 111.252 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.561 ' HG2' HG23 ' B' ' 41' ' ' VAL . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.3 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.22 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.32 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.923 HG11 HG22 ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 53.24 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' B' ' 11' ' ' SER . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.45 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.23 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.13 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.44 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.41 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.99 60.22 1.31 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.4 110.771 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -108.62 131.61 54.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.796 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.8 58.36 0.85 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.409 0.624 . . . . 64.5 110.395 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.23 68.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.8 -1.091 . . . . 72.42 110.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.25 107.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.904 -0.589 . . . . 74.52 111.287 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.45 84.37 14.61 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.433 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.08 81.97 2.25 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.909 2.406 . . . . 74.43 112.301 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.89 140.73 39.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.097 -0.501 . . . . 75.24 111.139 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.18 -169.07 47.48 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.961 -0.638 . . . . 62.32 112.692 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.03 128.98 38.52 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.688 0.28 . . . . 74.23 111.041 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.34 139.57 52.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.188 -0.46 . . . . 75.43 111.033 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.19 171.13 12.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.13 -0.486 . . . . 34.55 111.279 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.08 94.78 2.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.191 -0.459 . . . . 63.35 111.129 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.4 -158.94 10.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.1 -0.571 . . . . 75.1 112.621 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.408 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -177.47 -106.39 0.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.992 -0.623 . . . . 73.51 112.553 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.33 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.53 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.837 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.1 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.15 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.52 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.503 HD11 ' NE ' ' B' ' 96' ' ' ARG . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 62.01 111.13 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.14 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.4 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.22 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 61.31 111.541 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.4 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 12' ' ' VAL . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.52 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.595 HG21 ' HB1' ' B' ' 97' ' ' ALA . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.03 110.564 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 55.31 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.12 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.495 ' OE2' HD21 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.3 110.69 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 60.23 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.877 HG22 ' HB2' ' B' ' 109' ' ' ARG . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 53.32 111.575 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.03 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.761 ' HA ' HD12 ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.21 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 63.23 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.877 HD22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.34 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.01 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.543 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 64.41 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.41 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.45 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.544 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.12 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.562 ' NE ' ' HB2' ' A' ' 99' ' ' ALA . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 71.33 110.444 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.595 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.485 HG21 ' OH ' ' A' ' 92' ' ' TYR . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.24 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.2 111.329 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' B' ' 70' ' ' LEU . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.24 111.547 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.15 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.42 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.54 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' B' ' 79' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.05 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.719 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 62.12 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.763 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.42 111.08 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.34 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.877 ' HB2' HG22 ' B' ' 84' ' ' THR . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.24 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.53 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.14 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.31 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 73.32 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.11 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 74.13 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.22 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.42 112.358 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.49 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.11 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.41 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.21 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 32.51 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.23 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.1 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.13 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.33 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.1 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 72.41 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.23 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 70.21 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' B' ' 106' ' ' CYS . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.22 111.08 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.31 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.03 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.61 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.35 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.01 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.21 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.4 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.24 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.43 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.03 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.591 ' HG2' HD11 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.22 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' B' ' 31' ' ' ILE . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.31 111.028 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 61.35 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.497 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 72.42 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 71.12 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.473 ' O ' HG23 ' B' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.35 111.271 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' B' ' 157' ' ' HIS . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.44 111.236 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.477 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.22 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.04 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 148' ' ' GLU . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.527 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.59 -21.53 30.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.12 111.367 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.17 33.24 0.78 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.88 0.472 . . . . 63.2 111.67 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.44 -67.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.228 -0.442 . . . . 73.12 111.143 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.1 110.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.39 . . . . 54.41 110.713 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' HIS . . . . . 0.494 ' CG ' ' HB1' ' B' ' 149' ' ' ALA . 3.7 t-80 -72.18 144.64 48.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.172 -0.467 . . . . 75.22 111.234 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.19 150.15 29.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.99 -0.55 . . . . 70.55 111.146 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.401 -0.809 . . . . 45.21 111.018 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.84 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.837 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.776 0.322 . . . . 54.31 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.62 133.16 22.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.403 -0.362 . . . . 70.54 111.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.51 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 42' ' ' LEU . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.23 111.153 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 78' ' ' VAL . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.4 111.233 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.574 ' HB2' HD12 ' A' ' 42' ' ' LEU . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 73.01 110.503 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.517 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.21 112.191 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.3 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.795 HG21 HG11 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.13 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.41 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 14.41 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.12 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.21 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.23 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.44 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.02 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.2 111.44 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 65.1 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.45 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 62.4 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.02 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.45 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.23 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.15 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.771 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.21 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.32 111.066 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.32 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.44 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.03 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.14 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 11' ' ' SER . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.12 111.963 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 54.51 110.574 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.42 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 61.42 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 65.03 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 60.03 1.54 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.33 110.427 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.44 131.68 34.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.013 -0.54 . . . . 51.23 111.688 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.86 62.53 0.63 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.838 -0.619 . . . . 61.11 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.98 53.51 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.94 -1.027 . . . . 62.34 110.97 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -164.9 91.13 0.54 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.914 -0.585 . . . . 73.53 110.736 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.81 70.05 50.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.166 -0.47 . . . . 73.12 111.041 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 51' ' ' LEU . 91.5 Cg_endo -76.34 -166.45 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.937 2.424 . . . . 74.34 112.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.35 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.362 -0.835 . . . . 72.4 111.686 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.68 140.6 8.84 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.92 -0.582 . . . . 54.11 112.54 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.03 157.46 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.732 0.301 . . . . 74.44 111.267 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.16 163.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.914 -0.585 . . . . 72.44 111.606 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.52 98.08 2.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.984 -0.553 . . . . 74.23 111.025 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.92 166.07 28.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.996 -0.547 . . . . 72.22 110.991 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.81 12.43 65.88 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.629 -0.796 . . . . 71.52 113.879 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 -8.89 12.22 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.733 -0.733 . . . . 62.32 114.252 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.1 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.12 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.817 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.825 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 71.25 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.2 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.538 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.11 111.773 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.32 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.575 HD22 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.51 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.3 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.52 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.41 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.15 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.33 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 34.2 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.4 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.34 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.01 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.944 HG23 ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.15 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.21 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.41 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 90' ' ' VAL . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.55 111.35 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 109' ' ' ARG . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 63.25 111.627 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.35 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.12 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.44 110.541 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HD11 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.54 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA3' ' O2P' ' A' ' 187' ' ' 5GP . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.41 112.247 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 83' ' ' VAL . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.41 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.41 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' B' ' 119' ' ' MET . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.34 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.31 110.765 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.53 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.03 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.43 111.818 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.05 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.54 111.466 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.4 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 52.54 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.779 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.42 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.944 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.43 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.75 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 45.5 110.913 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 54.14 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 65.34 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.54 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.14 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.4 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.59 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.33 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 13.52 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.13 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.21 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 108' ' ' PHE . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.1 110.24 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.458 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.31 111.446 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.42 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.55 HD11 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.02 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.43 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.3 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.31 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.51 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.03 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.32 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 72.44 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.44 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 54.41 110.655 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 106' ' ' CYS . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 44.32 110.975 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 52.11 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.613 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.14 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.14 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.24 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.22 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.24 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 62.11 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.12 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.44 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.34 110.867 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.03 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.469 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 71.23 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.53 111.264 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.42 111.656 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.1 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 63.15 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 52.12 111.552 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.07 -33.23 44.75 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.4 110.981 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.93 18.41 11.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.242 -0.436 . . . . 71.4 111.539 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.92 0.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.629 -0.26 . . . . 71.42 110.814 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -137.86 113.27 9.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.397 -0.365 . . . . 72.3 110.728 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -168.68 61.78 0.06 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.976 -0.557 . . . . 75.14 110.621 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -159.19 159.47 34.34 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.985 -0.552 . . . . 74.34 111.359 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.592 -0.718 . . . . 72.33 111.4 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.768 0.318 . . . . 64.41 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.65 133.21 22.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 70.13 111.3 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.34 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.64 ' HB3' HD11 ' B' ' 42' ' ' LEU . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.44 111.17 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.77 HG22 HG12 ' B' ' 78' ' ' VAL . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.43 111.166 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.57 ' HB2' HD12 ' B' ' 42' ' ' LEU . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.537 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.43 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.457 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.22 112.207 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.567 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.3 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.794 HG21 HG11 ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.03 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.21 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.21 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.42 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.52 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.21 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.51 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.31 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 15.21 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.576 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.55 111.416 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.558 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.45 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.33 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.11 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.576 HG23 ' O ' ' B' ' 27' ' ' LEU . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.33 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.817 HG22 HG11 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.14 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 54.44 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.21 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.767 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.32 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.551 ' HG3' HG23 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.04 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 61.01 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.53 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.24 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.817 HG11 HG22 ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.11 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' B' ' 11' ' ' SER . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.12 111.91 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.55 110.593 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.34 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 62.15 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.794 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.44 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.65 60.09 1.54 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.52 110.425 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.5 131.72 34.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.981 -0.554 . . . . 71.1 111.615 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.85 62.51 0.63 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.791 -0.64 . . . . 75.12 110.203 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.93 53.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.974 -1.012 . . . . 73.21 110.971 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.538 HD13 ' HD3' ' B' ' 53' ' ' PRO . 0.1 OUTLIER -164.89 91.14 0.54 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.944 -0.571 . . . . 54.24 110.75 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.83 70.11 50.83 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.117 -0.492 . . . . 72.41 111.014 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.538 ' HD3' HD13 ' B' ' 51' ' ' LEU . 91.9 Cg_endo -76.38 -166.51 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.956 2.438 . . . . 65.43 112.538 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.44 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.364 -0.835 . . . . 55.43 111.604 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.7 140.62 8.85 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.852 -0.613 . . . . 62.43 112.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.08 157.39 11.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.725 0.298 . . . . 72.53 111.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.27 163.04 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.901 -0.59 . . . . 72.25 111.582 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.43 98.07 2.67 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.97 -0.559 . . . . 74.24 111.04 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.04 28.88 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.055 -0.521 . . . . 44.34 111.016 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.78 12.4 65.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.617 -0.801 . . . . 40.02 113.913 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.69 -8.82 12.73 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.718 -0.741 . . . . 70.52 114.256 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.635 ' HA ' HD12 ' B' ' 65' ' ' ILE . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.13 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.51 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.13 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.828 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.12 110.839 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 64.31 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.21 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.535 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.11 111.764 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.34 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.34 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.22 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.35 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 73' ' ' LEU . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.31 111.543 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 62.3 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.3 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.51 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.32 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.77 HG12 HG22 ' B' ' 12' ' ' VAL . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.03 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.13 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.916 HG23 ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.4 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.2 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.34 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' B' ' 90' ' ' VAL . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 55.04 111.408 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.631 HG22 ' HB2' ' B' ' 109' ' ' ARG . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.43 111.596 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.3 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' B' ' 114' ' ' ARG . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.03 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' SER . . . . . 0.429 ' HB2' HG11 ' B' ' 83' ' ' VAL . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.24 110.611 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.3 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA3' ' O2P' ' B' ' 187' ' ' 5GP . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.21 112.268 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' B' ' 83' ' ' VAL . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 65.33 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.21 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.35 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.44 ' OE2' " H4'" ' B' ' 187' ' ' 5GP . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.04 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.607 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.41 110.749 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.2 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.573 ' HG2' HD22 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.42 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.44 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 94' ' ' LEU . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.13 111.781 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.24 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.31 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.23 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.41 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.766 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 43.32 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.42 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.916 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 61.04 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.765 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.02 110.945 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.44 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.44 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.631 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.42 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.15 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.44 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.54 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.02 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.13 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 61.23 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.35 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.462 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.21 111.449 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.13 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.2 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.558 HD11 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.31 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.41 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 34.42 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 43.33 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.34 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.44 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.53 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 70.54 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.41 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.3 110.623 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.24 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' B' ' 106' ' ' CYS . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.53 111.003 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.51 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 72.14 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.54 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.1 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.34 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.3 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.616 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.21 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.42 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.21 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.21 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.47 HD21 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.23 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.22 110.872 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 44.2 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.464 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 44.45 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 64.11 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.03 111.215 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.13 111.64 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 71.22 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.24 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.42 111.588 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.06 -33.21 44.85 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.34 110.958 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.88 18.42 11.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.307 -0.406 . . . . 75.23 111.594 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.9 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.592 -0.276 . . . . 64.14 110.809 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -137.83 113.19 9.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.433 -0.348 . . . . 71.22 110.75 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -168.65 61.89 0.06 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.052 -0.522 . . . . 55.34 110.565 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -159.23 159.47 34.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.979 -0.555 . . . . 75.12 111.335 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.636 -0.697 . . . . 73.11 111.392 179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.817 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.828 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 53.2 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 147.69 28.15 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.232 -0.44 . . . . 72.15 111.248 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.2 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.448 ' HB3' HD11 ' A' ' 42' ' ' LEU . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 64.51 110.732 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 HG12 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.04 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.33 110.953 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.22 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.593 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.1 111.426 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.535 ' HA ' " O5'" ' A' ' 187' ' ' 5GP . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.12 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.22 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.539 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.04 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.42 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.24 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.22 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.13 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 63.23 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.44 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 31' ' ' ILE . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.53 110.644 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.1 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.04 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.44 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 41' ' ' VAL . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.21 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.4 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 32.41 111.033 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.22 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 72.32 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 70.54 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.11 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.44 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.909 HG11 HG22 ' A' ' 32' ' ' VAL . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.32 110.254 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 76' ' ' ALA . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.31 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.44 110.211 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.12 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.559 ' CE1' ' N3 ' ' A' ' 187' ' ' 5GP . 26.7 p80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.32 111.56 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 41.44 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.9 49.37 2.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 53.11 110.348 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.42 125.97 30.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.005 -0.543 . . . . 71.33 111.634 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.0 64.66 4.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.909 -0.587 . . . . 71.03 109.498 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.58 55.9 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.96 -1.018 . . . . 64.43 110.106 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.36 159.56 30.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.666 -0.697 . . . . 74.3 111.044 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.21 129.02 0.13 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.813 -0.631 . . . . 72.11 110.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.62 -166.82 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.092 2.528 . . . . 73.44 112.636 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.97 163.9 7.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 74.51 111.212 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.03 11.29 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.252 -0.499 . . . . 30.2 113.114 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 155.82 36.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.301 . . . . 73.2 111.255 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 57.9 51.91 8.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.54 . . . . 64.13 110.898 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 64' ' ' PHE . . . -163.17 73.48 0.33 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.656 -0.702 . . . . 63.25 110.829 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.21 171.09 20.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.989 -0.55 . . . . 64.02 111.345 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.64 172.5 20.61 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.053 -0.594 . . . . 74.13 112.648 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.84 -98.08 0.17 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.076 -0.583 . . . . 74.24 112.621 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.43 111.099 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 70.3 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 58' ' ' ALA . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.42 110.659 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.735 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.04 111.117 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.31 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.1 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.3 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.12 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.41 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.52 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 64.23 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 97' ' ' ALA . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.22 111.435 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HA ' HD21 ' A' ' 100' ' ' LEU . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.42 111.177 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.32 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.43 111.524 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.24 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.4 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 97' ' ' ALA . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 54.33 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 62.15 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.631 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.43 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.41 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 HG11 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 63.31 111.196 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 42.32 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 61.01 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.43 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.42 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.679 ' CD2' HD23 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 62.41 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.22 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.44 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' HD23 ' A' ' 94' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.02 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 70.3 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.02 111.08 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD23 ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.05 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD2' HD11 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' A' ' 79' ' ' VAL . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.13 111.359 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 94' ' ' LEU . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.11 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.05 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' GLN . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 62.22 111.862 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.44 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.03 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.22 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CD1' ' HB1' ' A' ' 97' ' ' ALA . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.33 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.697 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.34 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.561 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.11 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.44 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.533 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.03 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.4 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.32 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.02 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.41 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.22 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.4 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.34 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.35 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 64.51 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.53 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.21 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.1 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 71.3 111.016 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.53 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.52 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 30.43 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.34 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.53 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.15 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 64.24 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.14 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.533 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.23 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.657 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 63.23 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.34 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.02 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.23 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.12 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.55 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.03 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.42 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.2 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 31' ' ' ILE . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.3 110.792 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.11 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.05 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.24 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 152' ' ' VAL . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.01 111.198 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.21 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.695 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.05 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 148' ' ' GLU . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.32 -33.12 43.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.32 111.106 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.8 m80 61.16 19.24 9.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.221 -0.445 . . . . 71.03 111.347 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.52 176.49 1.02 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.848 0.356 . . . . 75.15 111.311 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -153.09 111.66 3.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.09 -0.504 . . . . 70.32 110.854 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.34 154.15 22.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.184 -0.462 . . . . 73.4 111.328 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 127' ' ' SER . 59.3 t-80 -143.1 -63.25 0.41 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.918 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.1 -0.953 . . . . 70.21 110.988 179.907 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.725 0.297 . . . . 70.51 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.64 28.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.327 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.53 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.447 ' HB3' HD11 ' B' ' 42' ' ' LEU . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.04 110.676 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.616 HG22 HG12 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.23 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.13 110.927 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.51 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.44 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.598 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.21 111.44 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.549 ' HA ' " O5'" ' B' ' 187' ' ' 5GP . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 64.31 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.528 HG13 ' H ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.22 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.426 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 73.12 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.528 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.12 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.33 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.24 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.2 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 72.31 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.54 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.24 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 31' ' ' ILE . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.12 110.645 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.41 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 53.14 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 64.53 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.938 HG22 HG11 ' B' ' 41' ' ' VAL . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.41 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.24 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.21 111.083 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.13 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.15 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.22 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.44 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.938 HG11 HG22 ' B' ' 32' ' ' VAL . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 62.3 110.326 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' B' ' 76' ' ' ALA . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.24 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.57 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.32 110.258 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.34 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.551 ' CE1' ' N3 ' ' B' ' 187' ' ' 5GP . 26.7 p80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 61.13 111.538 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.12 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.88 49.42 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.45 110.344 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.5 125.91 29.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.047 -0.524 . . . . 73.32 111.598 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 64.58 4.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.895 -0.593 . . . . 72.44 109.472 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.57 55.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.944 -1.026 . . . . 41.35 110.081 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.29 159.64 29.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.633 -0.712 . . . . 72.11 111.085 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.19 129.03 0.13 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 115.9 -0.591 . . . . 75.13 110.953 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.67 -166.78 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.035 2.49 . . . . 75.33 112.572 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.98 163.85 7.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.278 -0.874 . . . . 72.44 111.309 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.0 11.28 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.247 -0.502 . . . . 52.21 113.086 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.26 155.77 36.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.75 0.31 . . . . 74.12 111.323 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 57.93 51.83 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.085 -0.507 . . . . 63.45 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' B' ' 64' ' ' PHE . . . -163.05 73.44 0.34 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.636 -0.711 . . . . 63.15 110.872 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.17 171.12 20.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.028 -0.533 . . . . 74.31 111.411 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.59 172.52 20.65 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.084 -0.579 . . . . 73.1 112.635 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.87 -98.14 0.17 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.077 -0.583 . . . . 72.13 112.64 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' B' ' 65' ' ' ILE . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 64.44 111.144 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.32 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.411 ' CE1' ' HB1' ' B' ' 58' ' ' ALA . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 71.33 110.659 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.72 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.14 111.1 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.549 ' C ' ' CD2' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.3 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 45.31 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.13 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.24 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.21 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.23 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.24 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 97' ' ' ALA . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.42 111.496 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLN . . . . . 0.431 ' HA ' HD21 ' B' ' 100' ' ' LEU . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.15 111.132 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.11 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' B' ' 42' ' ' LEU . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 44.12 111.629 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.12 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.675 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.33 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' B' ' 97' ' ' ALA . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.32 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.31 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.24 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.416 HG21 HG11 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.54 111.173 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.918 HG22 ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.33 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.23 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.33 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.23 110.773 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.666 ' CD2' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 63.41 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.43 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.21 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.576 ' HA2' HD23 ' B' ' 94' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 13.41 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.42 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.24 111.086 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.576 HD23 ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.3 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.3 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' B' ' 79' ' ' VAL . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.22 111.398 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 94' ' ' LEU . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 62.2 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.52 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 74' ' ' GLN . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.22 111.896 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.31 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.4 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HB1' ' B' ' 97' ' ' ALA . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.12 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.699 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.559 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.42 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.42 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.15 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.918 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.14 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 64.31 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.42 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.527 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.33 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.33 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.679 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 53.45 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.03 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.41 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.572 ' CE ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.12 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 63.14 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.14 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.31 110.974 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.13 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.23 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' B' ' 158' ' ' HIS . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.03 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.34 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.421 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 72.11 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.34 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' B' ' 106' ' ' CYS . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.4 110.944 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.2 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.31 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.652 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.04 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.34 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.04 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.13 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 70.1 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.652 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.2 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.31 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.11 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.23 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' B' ' 31' ' ' ILE . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' B' ' 80' ' ' VAL . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 72.54 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 62.53 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.458 ' O ' HG23 ' B' ' 152' ' ' VAL . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.4 111.244 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.24 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.574 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.33 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 148' ' ' GLU . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.54 111.503 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.31 -33.14 43.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.04 111.084 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.9 m80 61.2 19.08 9.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 53.41 111.421 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.41 176.51 1.04 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.813 0.339 . . . . 75.43 111.361 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -153.1 111.68 3.7 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 75.33 110.807 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.32 154.1 22.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.309 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.576 ' HB3' ' HA ' ' B' ' 127' ' ' SER . 59.3 t-80 -142.99 -63.35 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.13 -0.487 . . . . 73.41 110.929 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.09 -0.957 . . . . 73.24 110.98 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.735 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.72 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.659 0.266 . . . . 75.34 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 147.53 27.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.266 -0.424 . . . . 62.14 111.287 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.52 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.983 ' HB3' HD21 ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.31 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG12 ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 63.12 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.43 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 31' ' ' ILE . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.31 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.22 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.41 111.952 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.5 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.33 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.612 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.2 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.45 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 33.23 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.14 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.42 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.02 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.04 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.35 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.1 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.05 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 143' ' ' LEU . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 72.35 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 41' ' ' VAL . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.24 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.43 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.42 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.809 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.15 111.016 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.2 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.43 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.13 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.53 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.34 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 32' ' ' VAL . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.983 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.43 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.44 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 55.51 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.584 ' CE1' ' N3 ' ' A' ' 187' ' ' 5GP . 32.1 p80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.51 110.827 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 55.25 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.64 44.17 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.15 111.864 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -103.85 151.16 23.42 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.02 0.438 . . . . 72.41 111.142 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.0 52.78 1.92 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.601 0.715 . . . . 51.1 110.206 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.92 70.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.282 -1.326 . . . . 73.4 110.099 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.34 99.49 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.227 -0.442 . . . . 61.14 110.923 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.89 107.77 0.86 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.718 -0.673 . . . . 64.03 111.984 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.32 -165.9 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.303 2.668 . . . . 55.32 112.504 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.74 163.3 0.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.339 -0.846 . . . . 71.33 111.59 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.24 -156.99 16.59 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.972 -0.633 . . . . 60.23 112.656 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.78 157.53 14.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.771 0.319 . . . . 72.51 111.115 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.63 52.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.168 -0.469 . . . . 55.21 110.969 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.11 152.26 48.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.151 -0.477 . . . . 52.23 111.233 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.63 101.97 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.817 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 142.44 6.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.968 -0.634 . . . . 51.03 112.359 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' ILE . . . -68.38 -21.8 74.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.062 -0.59 . . . . 54.24 113.329 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 71.42 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 55.21 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 71.44 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.608 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 63.55 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.51 111.439 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.43 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.24 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.52 111.319 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.587 HD22 ' CD ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.32 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 71.03 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD12 ' NE ' ' A' ' 96' ' ' ARG . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.35 111.737 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.42 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.21 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.22 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.45 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.719 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.44 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 70.42 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' CYS . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.01 111.804 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.22 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 90' ' ' VAL . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.51 111.144 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.21 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 63.15 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' B' ' 88' ' ' LEU . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.33 112.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.4 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.737 HD23 HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 60.34 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.35 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 83' ' ' VAL . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.02 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.11 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.23 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.52 110.44 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.22 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' CD ' HD22 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.33 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.23 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.23 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 44.32 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.35 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.44 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.34 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.41 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.53 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 106' ' ' CYS . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.23 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.675 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.33 110.936 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.54 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.11 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 84' ' ' THR . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.14 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.458 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.51 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.02 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.33 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.33 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.42 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.3 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.671 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 72.04 110.725 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.2 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.44 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.52 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.728 HG13 HD23 ' B' ' 88' ' ' LEU . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.35 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.32 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 23.14 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.24 110.795 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 54.5 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.12 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.31 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.44 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.41 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 62.51 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.14 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 106' ' ' CYS . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.31 111.173 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.41 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.23 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.11 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.4 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.3 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.635 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.2 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.04 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.23 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.32 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 31' ' ' ILE . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.42 111.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.13 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.11 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.02 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.31 111.088 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.54 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.13 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.22 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.11 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' A' ' 159' ' ' HIS . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.55 110.834 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.98 -36.93 85.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.43 111.142 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -34.81 74.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.367 -0.379 . . . . 74.53 111.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.29 -66.4 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.664 -0.244 . . . . 61.11 111.322 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.92 165.73 11.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.946 0.403 . . . . 64.44 111.339 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -113.04 160.18 18.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.039 -0.528 . . . . 74.03 110.965 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.04 -75.71 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.088 -0.505 . . . . 71.42 111.314 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.49 ' CG ' HG11 ' A' ' 152' ' ' VAL . 16.6 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.039 -0.981 . . . . 72.1 111.298 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.664 0.269 . . . . 62.22 111.148 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.16 147.55 27.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.242 -0.435 . . . . 74.52 111.229 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.54 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.014 ' HB3' HD21 ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.22 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.718 HG22 HG12 ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.31 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.42 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.543 ' CG ' HD13 ' B' ' 31' ' ' ILE . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.45 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.04 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.557 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.34 111.861 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.497 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.23 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.02 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.503 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 71.45 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.514 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 35.54 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.22 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.14 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.23 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.42 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.51 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.32 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.12 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CD1' HG21 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.32 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.02 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.23 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.634 HG22 HD22 ' B' ' 143' ' ' LEU . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.1 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 41' ' ' VAL . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.02 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.33 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.34 111.05 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.32 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.01 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.24 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.22 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.55 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 32' ' ' VAL . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.51 HG23 ' CE1' ' B' ' 13' ' ' TYR . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.22 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.33 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.571 ' CE1' ' N3 ' ' B' ' 187' ' ' 5GP . 32.1 p80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.44 110.809 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.33 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 44.21 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.3 111.865 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -103.81 151.15 23.41 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.979 0.418 . . . . 73.33 111.169 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.02 52.83 1.92 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.514 0.673 . . . . 62.33 110.193 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.87 70.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.261 -1.336 . . . . 63.55 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.32 99.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.149 -0.478 . . . . 64.23 110.933 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -49.89 107.82 0.87 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.744 -0.662 . . . . 74.32 112.015 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.45 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.253 2.635 . . . . 54.32 112.43 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.78 163.23 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.304 -0.862 . . . . 75.23 111.584 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.29 -156.94 16.58 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.041 -0.6 . . . . 71.22 112.745 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.81 157.5 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.777 0.323 . . . . 73.22 111.136 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 136.74 52.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.18 -0.464 . . . . 72.25 110.92 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.17 152.19 48.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.066 -0.516 . . . . 73.22 111.261 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.62 101.96 1.1 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 75.35 110.829 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 142.4 6.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.984 -0.627 . . . . 63.13 112.308 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.415 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -68.31 -21.87 74.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.117 -0.564 . . . . 65.35 113.3 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.14 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.32 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.616 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.52 111.421 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.21 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.23 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.528 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.3 111.259 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.58 HD22 ' CD ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.11 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.53 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.492 HD12 ' NE ' ' B' ' 96' ' ' ARG . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.43 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.21 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.04 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 72.22 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.1 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.718 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 73.32 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.34 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.03 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.466 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.23 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.577 HG21 HG11 ' B' ' 90' ' ' VAL . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.21 111.094 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.82 HG22 ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.34 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.14 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 88' ' ' LEU . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.41 112.384 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.43 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 33.42 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.577 HG11 HG21 ' B' ' 83' ' ' VAL . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.33 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.632 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 64.3 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.487 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.514 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.1 110.448 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.35 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.58 ' CD ' HD22 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.24 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.451 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.14 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.601 HG22 HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.02 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.32 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.35 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.23 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.601 HG13 HG22 ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.1 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.681 HD13 ' N ' ' B' ' 106' ' ' CYS . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.13 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.681 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.51 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.33 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.3 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.82 ' HB2' HG22 ' B' ' 84' ' ' THR . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.15 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.468 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.1 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.488 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.13 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.12 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 70.23 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.678 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.24 110.616 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.11 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.1 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.33 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.737 HG13 HD23 ' A' ' 88' ' ' LEU . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.34 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.21 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.23 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.24 110.753 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.35 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 54.22 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.35 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.23 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.41 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.45 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.31 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 106' ' ' CYS . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.25 111.24 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.12 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.32 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.623 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.21 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.44 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.33 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.4 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.12 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.04 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.3 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.634 HD22 HG22 ' B' ' 31' ' ' ILE . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.03 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.3 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.1 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.31 111.053 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.2 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.11 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.45 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' B' ' 159' ' ' HIS . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 55.22 110.789 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.96 -36.89 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -34.78 74.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 74.31 111.528 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.27 -66.42 0.91 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.692 -0.231 . . . . 62.25 111.362 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.83 165.73 11.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.862 0.363 . . . . 72.13 111.431 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -113.06 160.26 18.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.091 -0.504 . . . . 44.33 110.98 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.01 -75.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.998 -0.546 . . . . 72.23 111.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' HIS . . . . . 0.49 ' CG ' HG11 ' B' ' 152' ' ' VAL . 16.7 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.997 -1.002 . . . . 74.23 111.248 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.608 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.616 ' C6 ' HG12 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.99 0.424 . . . . 74.21 111.031 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.87 125.2 18.94 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.998 -0.546 . . . . 55.45 111.011 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.22 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' HD21 ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.02 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 78' ' ' VAL . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.4 110.995 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.21 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CG ' HD13 ' A' ' 31' ' ' ILE . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.54 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.41 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.53 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.839 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.34 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.12 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.51 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 74.12 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.31 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.43 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.42 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.45 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 31' ' ' ILE . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.42 110.079 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.756 ' HE1' HG21 ' A' ' 43' ' ' THR . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 73.21 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 HD21 ' A' ' 143' ' ' LEU . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.41 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.34 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 65.55 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.14 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' HG22 ' A' ' 41' ' ' VAL . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.44 111.255 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.33 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.33 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.41 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.41 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.03 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.45 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.756 HG21 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.05 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.03 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.531 ' CE1' ' N3 ' ' A' ' 187' ' ' 5GP . 26.4 p80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.54 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.839 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.03 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.36 1.23 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 55.11 110.865 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.47 132.59 35.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.944 0.402 . . . . 74.43 111.347 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.34 58.43 1.2 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.378 0.609 . . . . 54.12 110.548 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 35.5 tt0 172.7 68.29 0.0 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.683 -1.144 . . . . 71.24 109.918 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 102.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.925 -0.58 . . . . 64.31 111.49 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.79 108.36 1.13 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.77 -0.65 . . . . 75.12 111.746 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.96 -166.17 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.332 2.688 . . . . 74.41 112.651 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.28 150.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.241 -0.89 . . . . 64.33 111.595 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.27 143.79 9.11 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.164 -0.541 . . . . 51.11 112.749 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.45 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.691 0.281 . . . . 63.32 111.145 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.03 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.071 -0.513 . . . . 72.32 111.192 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.07 87.69 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 74.22 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.12 133.05 36.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.332 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.44 140.67 5.56 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.099 -0.572 . . . . 65.11 112.649 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.53 -8.62 3.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.278 -0.487 . . . . 64.43 113.805 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.05 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.33 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.11 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.735 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.15 110.716 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.472 ' HA ' ' HE3' ' B' ' 119' ' ' MET . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.12 111.38 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.42 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.15 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 96' ' ' ARG . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 71.41 111.203 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.54 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.423 ' HZ3' HN22 ' A' ' 187' ' ' 5GP . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.44 111.252 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.22 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.54 110.421 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.1 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.2 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.53 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 12' ' ' VAL . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.2 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HB ' HD12 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 61.11 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.15 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.3 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.01 111.264 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.846 HG22 ' HB2' ' A' ' 109' ' ' ARG . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.11 111.557 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.53 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.33 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.15 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.11 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.14 112.532 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.4 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.3 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.67 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.14 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.12 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.52 110.274 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.666 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.41 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.13 110.761 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.603 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.12 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' B' ' 96' ' ' ARG . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.13 111.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.328 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.4 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 55.01 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.04 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.31 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.41 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.678 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.31 110.744 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.04 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.52 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.846 ' HB2' HG22 ' A' ' 84' ' ' THR . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.41 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.21 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.44 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.02 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 32.34 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.42 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.21 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 120' ' ' ILE . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.23 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.54 ' HB2' ' O3P' ' B' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.54 111.456 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.14 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 41.34 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.33 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.3 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 71.45 110.67 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.52 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.33 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.15 111.101 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.44 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 106' ' ' CYS . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.03 111.244 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.44 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.01 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 73.32 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.52 111.236 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.41 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 33.32 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.11 111.676 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.4 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.23 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.58 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.32 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.616 HD21 HG22 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.21 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.52 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.33 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.53 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.4 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 54.53 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.3 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.41 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 148' ' ' GLU . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.44 111.014 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -33.52 60.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.35 111.084 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.6 17.83 11.04 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.321 -0.399 . . . . 70.23 111.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.92 177.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.552 -0.294 . . . . 75.34 110.804 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.84 110.65 15.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.362 -0.381 . . . . 72.11 110.689 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.09 60.97 0.58 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 75.23 110.972 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -80.55 167.12 20.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.094 -0.503 . . . . 74.31 110.885 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.204 -0.903 . . . . 75.41 111.06 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.89 0.376 . . . . 71.12 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.86 125.18 18.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.067 -0.515 . . . . 72.13 111.011 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 72.53 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.456 ' HB3' HD21 ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.22 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 78' ' ' VAL . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.44 111.007 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.22 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' B' ' 31' ' ' ILE . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.21 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.24 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.814 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.44 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.44 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.11 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.12 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.53 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.3 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.22 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.01 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 51.41 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 31' ' ' ILE . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.05 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.78 ' HE1' HG21 ' B' ' 43' ' ' THR . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 72.22 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.4 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.03 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.62 HG22 HD21 ' B' ' 143' ' ' LEU . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.01 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.789 HG22 HG11 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.24 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 41.34 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.31 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' B' ' 41' ' ' VAL . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.218 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.42 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.45 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.44 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.42 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.34 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.789 HG11 HG22 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 65.12 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.44 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.78 HG21 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 24.34 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 70.45 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.535 ' CE1' ' N3 ' ' B' ' 187' ' ' 5GP . 26.5 p80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.04 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.814 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.44 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.65 51.43 1.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.33 110.791 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.55 132.69 35.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.932 0.396 . . . . 63.54 111.367 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.37 58.42 1.21 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.353 0.597 . . . . 71.34 110.473 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 35.6 tt0 172.73 68.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.671 -1.149 . . . . 61.2 109.871 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.17 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.901 -0.591 . . . . 60.41 111.432 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.74 108.36 1.13 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.908 -0.587 . . . . 65.2 111.698 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.96 -166.19 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.338 2.692 . . . . 64.34 112.667 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.31 150.44 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.198 -0.91 . . . . 73.32 111.542 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.25 143.8 9.12 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.119 -0.563 . . . . 71.14 112.705 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.52 39.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.713 0.292 . . . . 70.2 111.113 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.01 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.021 -0.536 . . . . 73.03 111.26 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 87.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.088 -0.505 . . . . 64.31 111.213 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 133.04 36.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.98 -0.555 . . . . 54.54 111.408 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.37 140.65 5.57 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.206 -0.521 . . . . 71.43 112.698 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.43 -8.64 3.51 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.324 -0.465 . . . . 41.31 113.907 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 73.3 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.34 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.43 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.732 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 62.24 110.649 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.12 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 51.52 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' B' ' 96' ' ' ARG . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 55.32 111.172 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.2 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.41 ' HZ3' HN22 ' B' ' 187' ' ' 5GP . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.32 111.222 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.11 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.43 110.397 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.03 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.797 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.45 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.42 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 12' ' ' VAL . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.21 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.566 ' HB ' HD12 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.21 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.51 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.22 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.34 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.461 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.01 111.279 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.84 HG22 ' HB2' ' B' ' 109' ' ' ARG . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.12 111.485 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.21 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.785 ' HA ' HD12 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.23 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.13 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.21 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.24 112.509 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.21 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.05 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.666 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.15 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.43 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.333 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.44 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.497 ' CZ ' HD22 ' B' ' 70' ' ' LEU . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.54 110.726 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.596 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.31 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.12 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.41 111.358 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 100' ' ' LEU . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.43 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.11 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.05 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 65.2 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.45 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.691 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.31 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.691 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.12 110.772 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 63.45 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.84 ' HB2' HG22 ' B' ' 84' ' ' THR . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.34 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.467 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.21 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.41 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.43 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.43 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.44 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.14 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.01 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.592 HD22 HG21 ' B' ' 120' ' ' ILE . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.21 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.538 ' HB2' ' O3P' ' A' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 64.33 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 66' ' ' HIS . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.21 110.699 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.592 HG21 HD22 ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.32 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.22 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.53 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.24 110.634 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.34 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.1 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.02 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.24 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.13 111.056 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.13 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' B' ' 106' ' ' CYS . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.22 111.213 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.487 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.23 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.32 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.572 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 71.1 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.24 111.291 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.13 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.33 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.42 111.693 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.12 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.11 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.54 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.44 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.62 HD21 HG22 ' B' ' 31' ' ' ILE . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 53.42 111.051 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.31 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.01 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.31 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 152' ' ' VAL . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 53.51 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 43.31 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.32 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 148' ' ' GLU . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 71.11 110.93 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.42 60.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.21 111.054 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.51 17.87 11.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.363 -0.38 . . . . 71.15 111.217 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.9 177.86 0.47 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.492 -0.322 . . . . 75.35 110.823 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.9 110.79 15.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.364 -0.38 . . . . 71.24 110.681 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -156.12 60.95 0.58 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.946 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.65 167.18 20.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.084 -0.507 . . . . 75.41 110.915 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.169 -0.919 . . . . 71.24 111.04 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.735 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.732 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.62 0.247 . . . . 61.22 111.192 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 143.13 35.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.286 -0.416 . . . . 74.15 111.276 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.11 110.804 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.749 ' HB3' HD21 ' A' ' 42' ' ' LEU . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 78' ' ' VAL . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 72.2 111.319 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 53.12 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.24 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.12 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.495 ' N ' HG21 ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.13 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.682 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.22 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.21 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.45 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.24 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.43 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.53 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.53 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.416 HD21 ' OE1' ' A' ' 82' ' ' GLU . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.24 110.45 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 43' ' ' THR . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.12 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.42 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.23 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.4 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 HG11 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.13 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.02 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.2 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.13 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.51 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.31 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.24 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' A' ' 10' ' ' ARG . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.4 112.061 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.51 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.15 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.33 109.738 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.613 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.33 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.34 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 46' ' ' VAL . 51.3 p-80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.02 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.682 ' CG1' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.33 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.5 46.59 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.12 112.386 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -113.78 142.34 46.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.895 0.379 . . . . 62.52 110.956 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -123.2 53.94 1.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.46 0.648 . . . . 62.21 110.446 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 37.2 tt0 167.23 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.37 -1.286 . . . . 75.24 109.834 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 104.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.455 . . . . 71.31 110.669 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.92 83.08 14.05 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 74.15 111.831 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.17 -167.72 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.931 2.42 . . . . 62.4 112.251 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.05 149.79 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.533 -0.758 . . . . 51.13 111.417 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.77 148.54 19.54 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.006 -0.616 . . . . 74.02 112.944 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.74 115.91 14.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.637 0.256 . . . . 73.44 110.676 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.2 7.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 64.34 111.257 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . . . -64.56 160.45 19.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 70.52 111.414 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 120.91 9.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 64.34 111.448 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.79 141.75 12.24 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.151 -0.547 . . . . 73.41 112.743 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.96 -7.48 84.07 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.38 -0.438 . . . . 65.12 113.414 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.22 110.705 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 61.14 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.906 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.648 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.15 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.11 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 0.5 OUTLIER -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.14 111.547 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.11 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.52 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.12 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.52 ' CZ3' ' N2 ' ' A' ' 187' ' ' 5GP . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.2 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.13 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.1 110.861 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.43 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 30.34 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.12 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 71.24 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HB ' HD12 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.1 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.45 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.21 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.3 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 61.31 111.574 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.31 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.816 ' HA ' HD12 ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.41 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.03 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.33 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA3' ' O1P' ' A' ' 187' ' ' 5GP . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.33 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 45.45 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.01 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.663 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 72.42 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.23 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.671 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.42 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.14 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.598 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 92' ' ' TYR . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.23 110.803 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.45 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' C ' HD13 ' A' ' 100' ' ' LEU . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.42 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.02 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.42 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.32 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.34 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.714 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.53 110.593 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.42 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.31 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' THR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.14 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.54 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.54 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 33.23 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 70.22 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.32 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.51 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HB2' ' O1P' ' B' ' 187' ' ' 5GP . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 55.31 111.304 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.15 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.445 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.32 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD11 HD22 ' B' ' 88' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.2 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.54 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 70.31 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.32 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.2 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 45.24 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 156' ' ' HIS . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.31 112.237 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.22 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.54 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 106' ' ' CYS . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.12 111.119 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.51 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.663 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.2 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.579 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.44 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.01 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.15 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 33.12 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.34 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.43 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 63.14 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.35 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.22 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.34 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.45 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.66 ' HZ ' HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 74.44 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 152' ' ' VAL . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.01 111.174 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.21 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.51 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.24 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 148' ' ' GLU . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.42 111.172 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.27 -30.98 38.42 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 60.21 111.537 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.5 m80 63.94 20.16 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.541 -0.3 . . . . 75.33 111.363 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.86 -178.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.391 -0.368 . . . . 55.25 110.434 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -118.0 138.87 51.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.721 0.296 . . . . 73.02 110.804 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 168.78 19.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.124 -0.489 . . . . 70.45 111.112 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.13 148.09 37.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 73.33 111.386 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.156 -0.926 . . . . 64.11 111.049 179.844 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.689 0.281 . . . . 71.21 111.223 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 143.18 35.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.256 -0.429 . . . . 72.51 111.229 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.51 110.846 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.725 ' HB3' HD21 ' B' ' 42' ' ' LEU . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.24 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.702 HG22 HG12 ' B' ' 78' ' ' VAL . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.12 111.342 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.434 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 62.12 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.01 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.473 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.42 112.235 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.496 ' N ' HG21 ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.13 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.2 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.448 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.32 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.33 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.1 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.54 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.24 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.31 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 64.13 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.419 HD21 ' OE1' ' B' ' 82' ' ' GLU . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.23 110.463 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' B' ' 43' ' ' THR . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.02 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.34 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.32 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.547 ' O ' HD22 ' B' ' 35' ' ' LEU . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.03 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.78 HG13 HG11 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.1 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.51 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.547 HD22 ' O ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 71.24 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.44 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.31 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 72.33 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' B' ' 10' ' ' ARG . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.33 112.034 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.45 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.78 HG11 HG13 ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.32 109.683 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.614 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.42 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.34 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' B' ' 46' ' ' VAL . 51.2 p-80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 64.41 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 43.3 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.41 46.58 2.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.14 112.406 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.79 142.34 46.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.882 0.372 . . . . 73.1 110.909 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -123.19 53.93 1.28 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 61.35 110.461 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 37.2 tt0 167.25 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.404 -1.271 . . . . 73.44 109.738 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.5 104.11 0.09 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 73.52 110.699 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.84 83.09 13.86 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.048 -0.524 . . . . 73.12 111.8 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.12 -167.74 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.97 2.447 . . . . 73.5 112.279 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.08 149.73 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 70.42 111.384 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.74 148.53 19.45 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.122 -0.561 . . . . 62.34 112.967 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.7 115.91 14.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.664 0.268 . . . . 52.52 110.635 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.23 7.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 75.25 111.216 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 63' ' ' GLN . . . -64.63 160.41 19.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.985 -0.552 . . . . 74.33 111.414 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.83 120.9 9.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.113 -0.494 . . . . 63.14 111.482 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.84 141.74 12.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.124 -0.56 . . . . 75.15 112.771 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.01 -7.46 84.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.339 -0.458 . . . . 65.11 113.358 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.653 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.53 111.077 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.572 ' HG2' ' HB3' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.34 110.674 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.922 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.1 110.645 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.22 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.46 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 0.5 OUTLIER -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.05 111.598 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.12 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.14 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.03 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.526 ' CZ3' ' N2 ' ' B' ' 187' ' ' 5GP . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.11 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 63.04 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.04 110.91 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.35 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.45 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.702 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 70.34 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.3 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 62.23 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.53 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.888 HG22 ' HB2' ' B' ' 109' ' ' ARG . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.12 111.612 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.31 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.799 ' HA ' HD12 ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.55 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' SER . . . . . 0.407 ' OG ' ' HB ' ' B' ' 90' ' ' VAL . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.55 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.518 ' HA3' ' O1P' ' B' ' 187' ' ' 5GP . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.01 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.496 HG21 ' N ' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.35 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.671 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 73.42 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.41 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 60.22 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.663 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.02 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.549 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.41 111.605 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.493 HG21 ' OH ' ' A' ' 92' ' ' TYR . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.11 110.86 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 71.01 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.432 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 60.44 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.53 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.23 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.648 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.11 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' B' ' 97' ' ' ALA . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.31 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.699 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.43 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.721 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.12 110.587 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.15 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 64.2 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.888 ' HB2' HG22 ' B' ' 84' ' ' THR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.23 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 70.4 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' B' ' 109' ' ' ARG . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.2 111.695 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.54 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.13 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.24 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.719 HD22 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.24 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.549 ' HB2' ' O1P' ' A' ' 187' ' ' 5GP . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.54 111.283 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.21 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.44 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.35 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 88' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 41.21 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.02 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.32 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.05 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.14 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.13 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' B' ' 156' ' ' HIS . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.31 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.35 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' B' ' 106' ' ' CYS . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.43 111.172 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 73.21 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 72.04 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.572 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 64.13 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.43 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.42 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.24 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.42 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.41 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.31 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.43 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.22 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 73.14 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.24 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.3 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.472 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 73.0 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' B' ' 12' ' ' VAL . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 70.34 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.476 ' O ' HG23 ' B' ' 152' ' ' VAL . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.12 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.02 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 71.32 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.04 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 148' ' ' GLU . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.13 111.19 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -30.97 38.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.85 20.28 12.14 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.618 -0.264 . . . . 71.44 111.367 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.79 -178.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.411 -0.359 . . . . 75.33 110.429 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' HIS . . . . . 0.537 ' HB3' ' HA ' ' B' ' 128' ' ' ARG . 0.2 OUTLIER -118.07 138.9 51.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.723 0.297 . . . . 74.22 110.774 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 168.71 19.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.141 -0.481 . . . . 74.44 111.091 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.1 148.04 37.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 72.12 111.375 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.155 -0.926 . . . . 74.21 111.144 179.833 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.906 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.922 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.529 0.204 . . . . 64.34 111.423 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -129.35 134.57 47.96 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.399 -0.364 . . . . 74.45 111.037 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.22 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 34.21 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG13 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.4 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 61.1 110.488 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.52 ' CG ' HD13 ' A' ' 31' ' ' ILE . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.15 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.615 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.11 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.666 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.3 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.01 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.54 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.11 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.13 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.12 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 63.2 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 64.4 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.697 ' CD1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.14 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.31 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.42 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.21 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.88 HG22 HG21 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 62.11 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 62.24 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.2 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 31' ' ' ILE . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.44 110.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.35 110.857 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.2 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.03 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.11 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.44 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG21 HG22 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.22 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.32 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.57 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.23 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 41' ' ' VAL . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.54 110.801 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.47 ' CE1' ' N3 ' ' A' ' 187' ' ' 5GP . 26.9 p80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.44 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.53 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.21 70.34 1.47 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.04 111.692 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.91 120.21 17.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.162 0.506 . . . . 72.53 111.194 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.68 58.76 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.344 0.592 . . . . 72.13 110.471 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 32.3 tt0 171.13 68.3 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.842 -1.072 . . . . 74.23 110.114 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.42 110.18 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.971 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.87 78.44 65.16 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.224 -0.444 . . . . 73.54 111.438 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.04 -166.61 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.952 2.435 . . . . 33.12 112.427 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.77 149.81 22.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.541 -0.754 . . . . 65.34 111.331 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.68 -172.52 27.39 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.182 -0.533 . . . . 42.52 112.747 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 118.19 6.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.822 0.344 . . . . 72.23 110.995 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.69 165.38 26.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.021 -0.536 . . . . 73.33 110.768 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -78.13 79.8 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.138 -0.483 . . . . 62.25 111.06 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 58' ' ' ALA . . . 71.1 116.19 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.82 -0.627 . . . . 72.4 111.772 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.14 147.79 18.88 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.865 -0.607 . . . . 73.32 112.301 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.1 -96.54 0.1 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.853 -0.689 . . . . 73.42 112.774 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 65.22 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.54 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.05 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 62' ' ' ASP . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 51.31 110.533 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 60.03 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.52 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.03 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 44.52 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.673 HD21 ' CZ ' ' A' ' 96' ' ' ARG . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.41 111.27 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.45 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 71.02 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.532 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.12 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.34 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.21 111.403 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 150' ' ' TYR . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.44 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.34 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 51.34 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 60.11 112.265 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.41 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 90' ' ' VAL . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.32 111.118 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 70.12 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.12 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.842 ' HG ' HD23 ' B' ' 116' ' ' LEU . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.22 111.512 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.44 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.11 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 33.23 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.664 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.24 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.02 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 81' ' ' ALA . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 64.03 111.111 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.652 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.21 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.673 ' CZ ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.51 110.617 178.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.11 111.08 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.03 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.13 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.32 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.14 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 73.11 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.726 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.12 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.534 ' H ' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.31 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 134' ' ' TYR . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.01 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.24 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 61.01 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.13 111.056 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.13 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.51 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.31 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.44 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' B' ' 88' ' ' LEU . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.11 110.875 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 70.12 111.165 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.4 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.594 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 60.23 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 116' ' ' LEU . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.53 111.212 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.1 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.42 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.53 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 62.43 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.21 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 158' ' ' HIS . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 41.15 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.662 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.34 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.3 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.14 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.31 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.15 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' HD12 ' A' ' 107' ' ' LEU . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.42 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.1 111.069 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.24 113.252 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.22 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.11 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.24 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.4 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 143' ' ' LEU . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.34 110.964 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.52 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 62.23 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.54 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.21 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.23 111.045 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.55 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.33 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 149' ' ' ALA . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.51 111.817 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -80.07 -34.12 38.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.34 110.938 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.97 16.98 10.29 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.56 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 179.61 175.08 0.77 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.742 0.306 . . . . 61.55 111.088 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.02 109.77 11.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.18 -0.464 . . . . 64.34 110.803 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.46 -178.59 4.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.102 -0.499 . . . . 74.33 111.078 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 127' ' ' SER . 56.1 m80 -44.41 115.58 0.88 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.153 -0.476 . . . . 65.03 111.336 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.931 . . . . 74.34 111.165 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.571 0.224 . . . . 74.32 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -129.35 134.59 47.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.456 -0.338 . . . . 74.24 111.041 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.12 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 72.51 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.531 HG13 HG13 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.53 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.496 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 54.35 110.49 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.515 ' CG ' HD13 ' B' ' 31' ' ' ILE . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.13 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.609 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.35 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.661 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 53.53 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.54 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.473 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.41 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.42 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.3 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.12 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.02 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.2 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.33 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.1 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.696 ' CD1' HG21 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 60.41 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 51.31 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.13 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.51 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.884 HG22 HG21 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.34 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.42 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.31 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 31' ' ' ILE . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.24 110.993 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' HB ' ' B' ' 41' ' ' VAL . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.35 110.874 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.24 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.4 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.14 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.884 HG21 HG22 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.33 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.34 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.573 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.51 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.46 ' HG3' HG11 ' B' ' 41' ' ' VAL . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.04 110.802 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' HIS . . . . . 0.462 ' CE1' ' N3 ' ' B' ' 187' ' ' 5GP . 26.9 p80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 64.11 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.696 HG21 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.22 70.44 1.47 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.52 111.688 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.94 120.21 17.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.095 0.474 . . . . 61.31 111.214 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -101.7 58.81 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.254 0.549 . . . . 72.43 110.495 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 32.3 tt0 171.03 68.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.789 -1.096 . . . . 60.13 110.067 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.51 110.24 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.177 -0.465 . . . . 61.21 110.925 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.88 78.36 65.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.139 -0.482 . . . . 75.41 111.478 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.11 -166.63 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.952 2.435 . . . . 54.5 112.411 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.65 149.81 22.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.596 -0.729 . . . . 70.25 111.393 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.64 -172.48 27.38 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.221 -0.514 . . . . 73.33 112.754 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.61 118.14 6.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.851 0.358 . . . . 71.32 110.972 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.68 165.4 25.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.541 . . . . 64.4 110.747 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' B' ' 59' ' ' ALA . . . -78.15 79.8 4.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.199 -0.455 . . . . 65.13 111.018 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 58' ' ' ALA . . . 71.13 116.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.855 -0.611 . . . . 73.35 111.762 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.09 147.84 18.88 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.965 -0.561 . . . . 71.01 112.286 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.13 -96.52 0.1 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.774 -0.727 . . . . 54.44 112.726 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.806 ' HA ' HD12 ' B' ' 65' ' ' ILE . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 64.24 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.24 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.04 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' B' ' 62' ' ' ASP . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.558 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.12 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 61.23 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.42 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 32.44 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.679 HD21 ' CZ ' ' B' ' 96' ' ' ARG . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.11 111.246 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.41 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.04 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 73' ' ' LEU . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.14 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLN . . . . . 0.53 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.34 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.15 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.44 111.436 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.22 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' B' ' 150' ' ' TYR . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.53 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.54 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.11 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 94' ' ' LEU . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 51.3 112.327 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.04 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' B' ' 90' ' ' VAL . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.2 111.136 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.667 HG22 ' HB2' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 62.13 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.44 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 63.35 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.21 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.41 111.566 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 22.23 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.04 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.33 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.652 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.52 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.13 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 81' ' ' ALA . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.33 111.089 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . 0.664 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.679 ' CZ ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.34 110.623 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.44 111.107 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.02 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 43.3 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 61.24 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.34 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.33 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.659 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.14 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.69 HG13 HG23 ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 54.13 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.721 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.35 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 106' ' ' CYS . . . . . 0.545 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 30.2 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.14 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 71.14 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ARG . . . . . 0.667 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.21 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.55 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 52.22 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.43 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.1 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.41 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.842 HD23 ' HG ' ' A' ' 88' ' ' LEU . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.24 110.857 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.455 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 63.13 111.127 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.41 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.593 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.2 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.532 HG12 HD22 ' B' ' 116' ' ' LEU . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.13 111.242 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.21 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.44 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 70.32 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.52 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.42 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.42 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 158' ' ' HIS . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 55.23 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 71.41 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.02 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.21 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.11 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.42 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' TYR . . . . . 0.584 ' HB3' HD12 ' B' ' 107' ' ' LEU . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.32 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.31 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.05 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.24 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 139' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.43 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.23 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 73.24 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 143' ' ' LEU . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.44 110.847 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.32 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.05 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.35 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 64.43 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.44 111.1 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.54 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.31 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' B' ' 149' ' ' ALA . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 60.32 111.763 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.91 -34.28 39.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.31 110.866 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.92 17.07 10.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.198 -0.455 . . . . 74.02 111.623 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 179.55 175.06 0.76 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.817 0.341 . . . . 74.41 111.088 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.92 109.75 11.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.737 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -178.55 4.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.174 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 127' ' ' SER . 56.3 m80 -44.43 115.61 0.88 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.225 -0.443 . . . . 73.22 111.465 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.167 -0.92 . . . . 70.01 111.083 -179.562 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 187' ' ' 5GP . . . . . 0.698 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' 5GP . . . . . 0.686 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.79 0.329 . . . . 72.420000000000002 110.927 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.149999999999999 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.140000000000001 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 78' ' ' VAL . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 55.020000000000003 110.854 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 63.399999999999999 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.349999999999994 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.482 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.140000000000001 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.738 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.030000000000001 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.020000000000003 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.209999999999994 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.349999999999994 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.409999999999997 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.030000000000001 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.450000000000003 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.119999999999997 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 31' ' ' ILE . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.229999999999997 110.26 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.140000000000001 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 62.210000000000001 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.647 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.040000000000006 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.510000000000005 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.450000000000003 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.140000000000001 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.149999999999999 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 73.230000000000004 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.310000000000002 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.319999999999993 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.409999999999997 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 72' ' ' TRP . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 62.25 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.120000000000005 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.109999999999999 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.577 ' CE1' HG22 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.219999999999999 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.530000000000001 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 52.119999999999997 111.512 179.732 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 112.687 -0.165 . . . . 53.219999999999999 112.687 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.621 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.140000000000001 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.099999999999994 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.519999999999996 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 62' ' ' ASP . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.420000000000002 110.762 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 61.32 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.409999999999997 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.349999999999994 111.229 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 72.040000000000006 111.438 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.629 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.109999999999999 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.547 ' CD1' HD12 ' A' ' 42' ' ' LEU . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.219999999999999 111.135 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 32.009999999999998 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.310000000000002 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.585 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.430000000000007 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.646 ' CG1' HG22 ' A' ' 12' ' ' VAL . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.530000000000001 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 70.030000000000001 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 35.549999999999997 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 90' ' ' VAL . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.040000000000006 110.834 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 63.43 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.349999999999994 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.120000000000005 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.039999999999999 111.101 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' B' ' 120' ' ' ILE . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.399999999999999 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.129999999999995 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 83' ' ' VAL . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.409999999999997 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.409999999999997 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.549999999999997 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 110.942 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.409999999999997 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.629 ' HD2' HD13 ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 54.32 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.299999999999997 111.792 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' B' ' 92' ' ' TYR . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.420000000000002 111.093 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.539999999999999 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.509999999999998 111.355 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.219999999999999 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.109999999999999 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.530000000000001 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 97' ' ' ALA . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.150000000000006 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.549999999999997 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.568 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.519999999999996 111.217 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.420000000000002 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB2' HG22 ' A' ' 84' ' ' THR . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.439999999999998 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.439999999999998 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 109' ' ' ARG . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 62.409999999999997 111.327 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.019999999999996 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.140000000000001 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.129999999999995 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 120' ' ' ILE . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.386 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 70.099999999999994 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.219999999999999 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.409999999999997 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 116' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.120000000000005 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 61.520000000000003 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.120000000000005 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.340000000000003 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.040000000000006 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.129999999999995 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.420000000000002 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.310000000000002 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.150000000000006 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.510000000000005 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 106' ' ' CYS . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 110.841 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.543 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.400000000000006 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 43.240000000000002 111.28 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.319999999999993 112.825 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.519999999999996 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.530000000000001 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.543 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.140000000000001 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.484 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.340000000000003 111.098 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 51.009999999999998 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.010000000000005 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.149999999999999 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.540000000000006 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.409999999999997 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.209999999999994 111.4 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.120000000000005 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 60.340000000000003 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 149' ' ' ALA . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.099999999999994 111.564 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 110.907 179.629 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.777 0.322 . . . . 71.5 110.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.530000000000001 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' B' ' 78' ' ' VAL . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.874 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.443 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.319999999999993 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.150000000000006 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.299999999999997 112.593 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.456 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 60.219999999999999 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.735 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 64.329999999999998 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.465 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 62.310000000000002 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.488 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.140000000000001 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.310000000000002 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.450000000000003 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.019999999999996 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.439999999999998 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 35.210000000000001 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 31' ' ' ILE . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.310000000000002 110.234 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.230000000000004 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.502 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 71.219999999999999 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.661 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.319999999999993 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.329999999999998 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.430000000000007 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 63.219999999999999 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.400000000000006 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.409999999999997 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.349999999999994 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.150000000000006 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.120000000000005 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 72' ' ' TRP . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.120000000000005 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.472 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.299999999999997 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.58 ' CE1' HG22 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.735 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.219999999999999 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.130000000000003 111.489 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.645 -0.182 . . . . 62.140000000000001 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.617 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.329999999999998 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.040000000000006 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.209999999999994 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' B' ' 62' ' ' ASP . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.409999999999997 110.754 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.420000000000002 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.520000000000003 111.199 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.42 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.350000000000001 111.481 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.612 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.049999999999997 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.200000000000003 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.548 ' CD1' HD12 ' B' ' 42' ' ' LEU . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.329999999999998 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.210000000000001 111.16 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.450000000000003 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.520000000000003 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.572 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.100000000000001 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' B' ' 12' ' ' VAL . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 72.040000000000006 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.019999999999996 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 63.5 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 33.340000000000003 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.030000000000001 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.63 HG21 HG11 ' B' ' 90' ' ' VAL . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 63.340000000000003 110.819 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.687 HG22 ' HB2' ' B' ' 109' ' ' ARG . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.530000000000001 112.132 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . 0.415 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.420000000000002 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.140000000000001 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' B' ' 90' ' ' VAL . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.540000000000006 111.053 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' A' ' 120' ' ' ILE . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.400000000000006 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.420000000000002 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 HG21 ' B' ' 83' ' ' VAL . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.319999999999993 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.239999999999995 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.109999999999999 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.914 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.48 HD21 ' SG ' ' B' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 110.753 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.020000000000003 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.612 ' HD2' HD13 ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.030000000000001 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.119999999999997 111.835 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' A' ' 92' ' ' TYR . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.329999999999998 111.103 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.430000000000007 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.411 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.240000000000002 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.310000000000002 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HB2' HG23 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.109999999999999 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.531 HD12 ' HB1' ' B' ' 97' ' ' ALA . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.439999999999998 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.230000000000004 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.557 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.230000000000004 111.242 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 61.149999999999999 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.687 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.230000000000004 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.427 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.310000000000002 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' B' ' 109' ' ' ARG . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.120000000000005 111.384 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 63.32 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.340000000000003 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.310000000000002 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.209999999999994 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.968 HD22 HG21 ' B' ' 120' ' ' ILE . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.396 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.329999999999998 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.239999999999995 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.409999999999997 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.968 HG21 HD22 ' B' ' 116' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.210000000000001 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.430000000000007 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.299999999999997 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.119999999999997 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 64.310000000000002 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 22.449999999999999 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.420000000000002 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.310000000000002 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.209999999999994 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.350000000000001 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' B' ' 106' ' ' CYS . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 110.895 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.140000000000001 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.540000000000006 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.140000000000001 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.239999999999995 111.26 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.549999999999997 112.795 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.319999999999993 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 63.240000000000002 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.010000000000005 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.530000000000001 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 53.299999999999997 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.469 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 111.04 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.219999999999999 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.340000000000003 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.52 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.439999999999998 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.299999999999997 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.510000000000005 111.438 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.099999999999994 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' B' ' 149' ' ' ALA . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.119999999999997 111.519 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.010000000000005 110.959 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.618 0.247 . . . . 71.430000000000007 111.068 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.028 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.510000000000005 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 31' ' ' ILE . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.109999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.299999999999997 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.691 ' HB3' HG21 ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 33.109999999999999 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.120000000000005 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.209999999999994 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.239999999999995 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.400000000000006 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.420000000000002 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.420000000000002 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 51.399999999999999 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.540000000000006 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.283 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.845 ' CE1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 65.349999999999994 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.200000000000003 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.409999999999997 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 61.130000000000003 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 41' ' ' VAL . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.119999999999997 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.099999999999994 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.299999999999997 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 71.109999999999999 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.219999999999999 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.549999999999997 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 72.030000000000001 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.140000000000001 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.030000000000001 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.239999999999995 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.66 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.119999999999997 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 73.299999999999997 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 53.439999999999998 111.39 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.845 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 44.130000000000003 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 71.450000000000003 111.498 179.296 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.624 -0.19 . . . . 24.41 112.624 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.629 ' HA ' HD12 ' A' ' 65' ' ' ILE . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.329999999999998 111.325 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 61.310000000000002 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 71.219999999999999 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 62' ' ' ASP . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.099999999999994 110.821 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.557 ' O ' HD23 ' A' ' 70' ' ' LEU . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 70.230000000000004 111.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 62.0 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.400000000000006 111.252 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.299999999999997 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 96' ' ' ARG . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 111.194 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.540000000000006 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.350000000000001 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.239999999999995 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.439999999999998 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.239999999999995 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 150' ' ' TYR . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 73' ' ' LEU . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.019999999999996 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.340000000000003 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.439999999999998 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 71.549999999999997 111.129 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 109' ' ' ARG . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 54.130000000000003 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.450000000000003 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.937 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.129999999999995 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.430000000000007 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.229999999999997 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.120000000000005 111.323 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.629 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.530000000000001 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.239999999999995 110.332 179.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.64 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.450000000000003 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.664 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 72.510000000000005 110.568 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.030000000000001 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.310000000000002 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB2' ' CD ' ' B' ' 96' ' ' ARG . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.430000000000007 111.526 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.239999999999995 111.362 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.030000000000001 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.230000000000004 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.319999999999993 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.575 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 52.450000000000003 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.712 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.150000000000006 111.049 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.340000000000003 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.679 ' HB2' HG22 ' A' ' 84' ' ' THR . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 71.310000000000002 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.229999999999997 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 72.430000000000007 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.150000000000006 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 31.239999999999998 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.239999999999995 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.129999999999995 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.809 HD12 HD13 ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.420000000000002 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.510000000000005 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.439999999999998 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.040000000000006 110.742 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.150000000000006 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.230000000000004 110.934 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.109999999999999 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.209999999999994 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.020000000000003 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.109999999999999 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.239999999999995 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.624 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 71.129999999999995 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.712 HG13 ' HB3' ' A' ' 106' ' ' CYS . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.299999999999997 110.876 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.209999999999994 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.523 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.420000000000002 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 40.109999999999999 111.521 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.310000000000002 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.239999999999995 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.439999999999998 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.040000000000006 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 64.519999999999996 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.536 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.099999999999994 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.200000000000003 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 51.299999999999997 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 70.530000000000001 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.439999999999998 110.779 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.420000000000002 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.340000000000003 111.151 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.420000000000002 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.329999999999998 111.715 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 110.862 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.642 0.258 . . . . 74.319999999999993 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.012 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.509999999999998 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 64.400000000000006 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.556 ' CG ' HD13 ' B' ' 31' ' ' ILE . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.230000000000004 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.668 ' HB3' HG21 ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.299999999999997 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.517 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 62.229999999999997 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.510000000000005 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.439999999999998 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.129999999999995 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.310000000000002 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 52.149999999999999 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.219999999999999 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.319999999999993 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.310000000000002 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.256 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.832 ' CE1' HG21 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.299999999999997 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.487 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.340000000000003 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.109999999999999 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.556 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.519999999999996 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.909 HG23 HG21 ' B' ' 41' ' ' VAL . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.230000000000004 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.030000000000001 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.495 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.129999999999995 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.030000000000001 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.120000000000005 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.909 HG21 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 1.012 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.439999999999998 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.666 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.310000000000002 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.030000000000001 111.414 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.832 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.219999999999999 111.425 179.279 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 -0.188 . . . . 44.140000000000001 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' B' ' 65' ' ' ILE . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.519999999999996 111.343 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.130000000000003 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.400000000000006 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 62' ' ' ASP . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.835 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.549 ' O ' HD23 ' B' ' 70' ' ' LEU . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 111.411 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.430000000000007 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.540000000000006 111.228 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.140000000000001 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.556 HD11 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.299999999999997 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.009999999999998 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 73.230000000000004 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.219999999999999 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.340000000000003 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.537 ' HB2' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.319999999999993 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.219999999999999 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' B' ' 150' ' ' TYR . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 73' ' ' LEU . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.409999999999997 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.567 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.109999999999999 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.219999999999999 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.494 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.129999999999995 111.129 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 109' ' ' ARG . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 71.329999999999998 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.239999999999995 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.954 ' HA ' HD12 ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.399999999999999 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.209999999999994 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.209999999999994 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.668 HG21 ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.109999999999999 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.534 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.099999999999994 111.264 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.64 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.420000000000002 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.209999999999994 110.449 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 63.340000000000003 110.319 179.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.349999999999994 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.663 ' CD ' ' HB2' ' A' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.695 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.119999999999997 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.420000000000002 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . 0.664 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.200000000000003 111.4 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' B' ' 100' ' ' LEU . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 111.408 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.239999999999995 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 61.310000000000002 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.200000000000003 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.049999999999997 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.567 ' CB ' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 71.109999999999999 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.723 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 73.010000000000005 110.954 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.450000000000003 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.673 ' HB2' HG22 ' B' ' 84' ' ' THR . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.319999999999993 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.438 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.019999999999996 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.409999999999997 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.545 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.230000000000004 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 23.420000000000002 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.230000000000004 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.319999999999993 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 63.409999999999997 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.310000000000002 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.010000000000005 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.100000000000001 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.350000000000001 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.099999999999994 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 62.420000000000002 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.62 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 110.922 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.520000000000003 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' B' ' 106' ' ' CYS . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.89 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 73.209999999999994 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.219999999999999 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.019999999999996 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.409999999999997 111.548 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.299999999999997 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.420000000000002 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 42.130000000000003 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.209999999999994 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.534 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.519999999999996 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.140000000000001 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 71.209999999999994 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 35' ' ' LEU . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.310000000000002 110.702 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 54.039999999999999 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.420000000000002 111.171 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.530000000000001 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.099999999999994 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.319999999999993 111.65 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.129999999999995 110.902 179.694 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.326 . . . . 64.010000000000005 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.150000000000006 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.995 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.340000000000003 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 HG12 ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.439999999999998 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 65.019999999999996 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.546 ' CG ' HD13 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.549999999999997 110.817 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.340000000000003 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.783 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.559 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.140000000000001 112.608 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.340000000000003 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.319999999999993 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.010000000000005 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.420000000000002 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' OE2' ' A' ' 82' ' ' GLU . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.400000000000006 110.324 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.329999999999998 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.439999999999998 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.319999999999993 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.120000000000005 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 41' ' ' VAL . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 71.439999999999998 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 41.030000000000001 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.129999999999995 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 111.007 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.299999999999997 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.340000000000003 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.349999999999994 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.209999999999994 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.140000000000001 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 62.130000000000003 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.099999999999994 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.450000000000003 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.46 ' CE1' HG22 ' A' ' 43' ' ' THR . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.239999999999995 111.751 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.783 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.140000000000001 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.804 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.965 -0.353 . . . . 64.319999999999993 113.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.420000000000002 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.109999999999999 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' CD1' ' HB1' ' B' ' 118' ' ' ALA . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 110.942 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.010000000000005 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.150000000000006 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.130000000000003 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.519999999999996 111.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.430000000000007 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 74.109999999999999 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.420000000000002 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.030000000000001 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.040000000000006 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.240000000000002 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.120000000000005 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.019999999999996 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.030000000000001 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 94' ' ' LEU . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.230000000000004 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' OE2' HG21 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.229999999999997 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 109' ' ' ARG . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.331 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.340000000000003 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.219999999999999 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.5 ' HB2' HG11 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.741 HD22 HD11 ' B' ' 120' ' ' ILE . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.239999999999995 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.540000000000006 112.54 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.219999999999999 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.129999999999995 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.140000000000001 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 81' ' ' ALA . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 111.0 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.319999999999993 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.400000000000006 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.57 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.430000000000007 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.239999999999995 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.430000000000007 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.200000000000003 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 71.549999999999997 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.400000000000006 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 79' ' ' VAL . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.350000000000001 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.782 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 55.240000000000002 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.420000000000002 111.152 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.140000000000001 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.510000000000005 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.310000000000002 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.553 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.349999999999994 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.119999999999997 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.239999999999995 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 62.240000000000002 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 51.539999999999999 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.530000000000001 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' B' ' 65' ' ' ILE . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.340000000000003 111.687 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.422 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.239999999999995 110.576 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.764 HD11 HD22 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.109999999999999 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.329999999999998 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 45.119999999999997 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.329999999999998 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.109999999999999 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.400000000000006 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 106' ' ' CYS . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.329999999999998 110.932 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 71.439999999999998 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.540000000000006 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.400000000000006 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.030000000000001 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.549999999999997 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.119999999999997 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.140000000000001 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 145' ' ' ARG . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.140000000000001 110.521 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.230000000000004 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.543 ' CD2' HG22 ' A' ' 31' ' ' ILE . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.120000000000005 111.155 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.340000000000003 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 141' ' ' THR . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.329999999999998 111.069 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.219999999999999 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.129999999999995 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' VAL . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.140000000000001 111.524 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.040000000000006 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.629 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 45.549999999999997 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 148' ' ' GLU . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 31.530000000000001 111.186 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.439999999999998 110.995 179.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.799 0.333 . . . . 74.049999999999997 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 60.32 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.061 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.691 HG22 HG12 ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.507 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.299999999999997 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.541 ' CG ' HD13 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 74.230000000000004 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.430000000000007 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.537 ' HB2' HG21 ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.109999999999999 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.8 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.109999999999999 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.569 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 63.219999999999999 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.468 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 112.589 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.399999999999999 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 73.219999999999999 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.420000000000002 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 53.219999999999999 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.349999999999994 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.509999999999998 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.442 HD21 ' OE2' ' B' ' 82' ' ' GLU . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.400000000000006 110.328 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.668 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.120000000000005 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.552 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.450000000000003 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.040000000000006 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.979 HG23 HG21 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.450000000000003 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.319999999999993 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.458 HD13 ' O ' ' B' ' 31' ' ' ILE . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 43.350000000000001 111.003 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 54.32 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.239999999999995 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.120000000000005 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.019999999999996 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.519999999999996 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.979 HG21 HG23 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 1.061 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.099999999999994 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.109999999999999 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' B' ' 43' ' ' THR . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 61.450000000000003 111.699 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 62.229999999999997 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.109999999999999 110.768 178.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.426 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.48 0 CA-C-O 120.039 -0.312 . . . . 64.439999999999998 113.454 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.140000000000001 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.451 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.329999999999998 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.495 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 63.219999999999999 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.150000000000006 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.310000000000002 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.549999999999997 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.430000000000007 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' OE1' ' B' ' 74' ' ' GLN . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.130000000000003 111.927 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 63.409999999999997 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 65.230000000000004 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' B' ' 71' ' ' ASN . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.420000000000002 110.988 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.239999999999995 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.439999999999998 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.450000000000003 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.695 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.219999999999999 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.779 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 45.229999999999997 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 94' ' ' LEU . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 112.037 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.588 ' OE2' HG21 ' B' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.049999999999997 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.219999999999999 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.797 HG22 ' HB2' ' B' ' 109' ' ' ARG . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.25 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.430000000000007 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.442 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . 0.489 ' HB2' HG11 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.349999999999994 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.099999999999994 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.120000000000005 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.619 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.420000000000002 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' B' ' 81' ' ' ALA . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.219999999999999 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.039999999999999 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.430000000000007 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.019999999999996 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.540000000000006 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.209999999999994 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.030000000000001 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.340000000000003 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 52.509999999999998 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.779 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.329999999999998 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.756 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.120000000000005 111.112 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.239999999999995 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.797 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.040000000000006 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.557 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.099999999999994 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.409999999999997 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.510000000000005 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.100000000000001 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.450000000000003 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.654 HD22 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.020000000000003 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 63.43 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 65' ' ' ILE . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 71.549999999999997 111.674 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.41 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 53.5 110.638 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.741 HD11 HD22 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 71.349999999999994 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.509999999999998 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.329999999999998 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 53.039999999999999 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.540000000000006 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.310000000000002 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.340000000000003 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.230000000000004 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.019999999999996 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' B' ' 106' ' ' CYS . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.230000000000004 110.914 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.129999999999995 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.200000000000003 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.59 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 34.130000000000003 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.129999999999995 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.430000000000007 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.219999999999999 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.109999999999999 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.019999999999996 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.55 ' CD2' HG22 ' B' ' 31' ' ' ILE . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.119999999999997 111.179 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.555 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.430000000000007 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.549999999999997 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.501 ' O ' HG23 ' B' ' 152' ' ' VAL . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.040000000000006 111.497 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.049999999999997 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.631 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.530000000000001 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.450000000000003 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 148' ' ' GLU . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.239999999999995 111.091 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.209999999999994 110.953 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.713 0.292 . . . . 75.109999999999999 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.753 ' HB3' HD21 ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 54.310000000000002 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 78' ' ' VAL . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.130000000000003 110.787 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 53.009999999999998 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 31' ' ' ILE . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.430000000000007 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.420000000000002 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.409999999999997 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.535 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 55.140000000000001 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 73.25 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.140000000000001 112.42 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.140000000000001 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.340000000000003 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.530000000000001 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.439999999999998 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.299999999999997 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.420000000000002 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.492 HD21 ' OE2' ' A' ' 82' ' ' GLU . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 41.119999999999997 110.737 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 72.219999999999999 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.539999999999999 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.944 HG22 HG11 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 72.219999999999999 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.329999999999998 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.835 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.030000000000001 111.224 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 41' ' ' VAL . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.329999999999998 110.871 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.129999999999995 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.450000000000003 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.319999999999993 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 11' ' ' SER . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.239999999999995 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.587 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.439999999999998 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.400000000000006 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.130000000000003 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.100000000000001 110.76 179.383 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.557 -0.217 . . . . 74.310000000000002 112.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.420000000000002 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.530000000000001 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.019999999999996 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.420000000000002 110.792 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.349999999999994 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.430000000000007 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.5 HD11 ' NE ' ' A' ' 96' ' ' ARG . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.439999999999998 111.117 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.209999999999994 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 62.420000000000002 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 60.130000000000003 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.010000000000005 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 111.475 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.040000000000006 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 12' ' ' VAL . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.230000000000004 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 97' ' ' ALA . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.349999999999994 110.577 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.450000000000003 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.450000000000003 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' OE2' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.120000000000005 110.71 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.539999999999999 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' ARG . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.549999999999997 111.525 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.540000000000006 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.340000000000003 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.119999999999997 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.906 HD22 HD11 ' B' ' 120' ' ' ILE . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.120000000000005 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.439999999999998 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.520000000000003 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.120000000000005 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 71.530000000000001 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 44.25 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 30.41 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.219999999999999 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.477 HG21 ' OH ' ' B' ' 92' ' ' TYR . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.239999999999995 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' B' ' 96' ' ' ARG . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.209999999999994 111.371 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 70' ' ' LEU . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.010000000000005 111.466 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.100000000000001 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.040000000000006 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 65.409999999999997 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 79' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.219999999999999 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.686 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.751 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.129999999999995 111.075 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.150000000000006 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HB2' HG22 ' A' ' 84' ' ' THR . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.310000000000002 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.602 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.310000000000002 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.450000000000003 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.140000000000001 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.540000000000006 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.219999999999999 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.310000000000002 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.349999999999994 112.352 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.469 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.040000000000006 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HD22 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.040000000000006 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.319999999999993 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.349999999999994 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.140000000000001 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.239999999999995 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.040000000000006 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.209999999999994 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.129999999999995 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 53.240000000000002 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 106' ' ' CYS . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.019 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.086 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.049999999999997 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.239999999999995 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.150000000000006 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.349999999999994 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.140000000000001 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.604 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 34.539999999999999 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.509999999999998 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.578 ' HG2' HD11 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.030000000000001 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 31' ' ' ILE . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 63.130000000000003 110.947 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.109999999999999 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.540000000000006 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.219999999999999 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.129999999999995 111.296 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 111.232 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.549999999999997 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 148' ' ' GLU . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 111.567 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.099999999999994 111.477 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.703 0.287 . . . . 62.030000000000001 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.772 ' HB3' HD21 ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.230000000000004 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 78' ' ' VAL . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.310000000000002 110.75 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.524 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 70.140000000000001 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.534 ' CB ' HD13 ' B' ' 31' ' ' ILE . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.299999999999997 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.349999999999994 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.597 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 63.420000000000002 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.150000000000006 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.329999999999998 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.42 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 24.140000000000001 112.45 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.210000000000001 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.329999999999998 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.539999999999999 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.319999999999993 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.230000000000004 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.239999999999995 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.495 HD21 ' OE2' ' B' ' 82' ' ' GLU . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.723 ' CE2' HG21 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.219999999999999 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.109999999999999 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.310000000000002 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.329999999999998 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.923 HG22 HG11 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.430000000000007 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.549999999999997 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.510000000000005 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.209999999999994 111.252 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.561 ' HG2' HG23 ' B' ' 41' ' ' VAL . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.299999999999997 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.219999999999999 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.319999999999993 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.923 HG11 HG22 ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 53.240000000000002 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' B' ' 11' ' ' SER . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.450000000000003 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.230000000000004 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.130000000000003 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.439999999999998 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.409999999999997 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.399999999999999 110.771 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.408 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.553 -0.219 . . . . 73.510000000000005 112.553 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.329999999999998 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.530000000000001 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 61' ' ' GLY . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.099999999999994 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.503 HD11 ' NE ' ' B' ' 96' ' ' ARG . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 62.009999999999998 111.13 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.140000000000001 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.400000000000006 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.219999999999999 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 61.310000000000002 111.541 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.400000000000006 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 12' ' ' VAL . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.595 HG21 ' HB1' ' B' ' 97' ' ' ALA . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 110.564 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 55.310000000000002 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.495 ' OE2' HD21 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.69 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 60.229999999999997 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.877 HG22 ' HB2' ' B' ' 109' ' ' ARG . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 53.32 111.575 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.030000000000001 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.761 ' HA ' HD12 ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.209999999999994 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 63.229999999999997 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.877 HD22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.340000000000003 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.010000000000005 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.543 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 64.409999999999997 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.409999999999997 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.450000000000003 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.544 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.120000000000005 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.562 ' NE ' ' HB2' ' A' ' 99' ' ' ALA . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 71.329999999999998 110.444 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.595 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.485 HG21 ' OH ' ' A' ' 92' ' ' TYR . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.239999999999995 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.200000000000003 111.329 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' B' ' 70' ' ' LEU . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.239999999999995 111.547 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.150000000000006 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.420000000000002 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.540000000000006 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' B' ' 79' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.049999999999997 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.719 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 62.119999999999997 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.763 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.420000000000002 111.08 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.340000000000003 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.877 ' HB2' HG22 ' B' ' 84' ' ' THR . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.239999999999995 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.140000000000001 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.310000000000002 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 73.319999999999993 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.109999999999999 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 74.129999999999995 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.219999999999999 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.420000000000002 112.358 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.49 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.109999999999999 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.409999999999997 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 32.509999999999998 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.230000000000004 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.100000000000001 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.129999999999995 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.329999999999998 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.099999999999994 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 72.409999999999997 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.230000000000004 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 70.209999999999994 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' B' ' 106' ' ' CYS . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.08 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.030000000000001 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.61 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.349999999999994 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.009999999999998 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.209999999999994 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.400000000000006 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.239999999999995 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.030000000000001 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.591 ' HG2' HD11 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.219999999999999 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' B' ' 31' ' ' ILE . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.310000000000002 111.028 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.200000000000003 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.497 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 72.420000000000002 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 71.120000000000005 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.473 ' O ' HG23 ' B' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.349999999999994 111.271 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.439999999999998 111.236 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.477 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.219999999999999 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.040000000000006 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 148' ' ' GLU . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 111.527 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.120000000000005 111.367 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.695 0.283 . . . . 70.540000000000006 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 42' ' ' LEU . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.229999999999997 111.153 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 78' ' ' VAL . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.399999999999999 111.233 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.574 ' HB2' HD12 ' A' ' 42' ' ' LEU . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 73.010000000000005 110.503 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.517 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 65.209999999999994 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.209999999999994 112.191 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.299999999999997 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.795 HG21 HG11 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.129999999999995 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.409999999999997 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 14.41 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.120000000000005 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.209999999999994 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.439999999999998 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.020000000000003 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.200000000000003 111.44 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 65.099999999999994 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.450000000000003 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 62.399999999999999 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.019999999999996 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.450000000000003 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.230000000000004 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.150000000000006 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.771 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.209999999999994 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.32 111.066 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.319999999999993 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.439999999999998 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.030000000000001 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 11' ' ' SER . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.120000000000005 111.963 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 54.509999999999998 110.574 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.420000000000002 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 61.420000000000002 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 65.030000000000001 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.329999999999998 110.427 179.191 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 114.252 0.461 . . . . 62.32 114.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.099999999999994 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.119999999999997 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD12 ' HA ' ' A' ' 62' ' ' ASP . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.825 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 71.25 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.200000000000003 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.109999999999999 111.773 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.319999999999993 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.575 HD22 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.510000000000005 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.299999999999997 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.519999999999996 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.409999999999997 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.149999999999999 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.329999999999998 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 34.200000000000003 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.400000000000006 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.340000000000003 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.010000000000005 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.944 HG23 ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.150000000000006 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.209999999999994 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.409999999999997 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 90' ' ' VAL . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.549999999999997 111.35 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 109' ' ' ARG . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 63.25 111.627 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.349999999999994 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.119999999999997 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.439999999999998 110.541 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HD11 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.540000000000006 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.409999999999997 112.247 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 83' ' ' VAL . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.409999999999997 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.409999999999997 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' B' ' 119' ' ' MET . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.340000000000003 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.310000000000002 110.765 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.530000000000001 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.030000000000001 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.430000000000007 111.818 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.049999999999997 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.540000000000006 111.466 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.400000000000006 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 52.539999999999999 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.779 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.420000000000002 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.944 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.430000000000007 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.75 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 45.5 110.913 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 54.140000000000001 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 65.340000000000003 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.540000000000006 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.140000000000001 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.399999999999999 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.59 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.329999999999998 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 13.52 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.129999999999995 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.209999999999994 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 108' ' ' PHE . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.099999999999994 110.24 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.310000000000002 111.446 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.420000000000002 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.55 HD11 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.019999999999996 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.430000000000007 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.299999999999997 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.310000000000002 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.509999999999998 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.030000000000001 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.319999999999993 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 72.439999999999998 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.439999999999998 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 54.409999999999997 110.655 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 106' ' ' CYS . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 44.32 110.975 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 52.109999999999999 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.613 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.140000000000001 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.219999999999999 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.239999999999995 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 62.109999999999999 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.120000000000005 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.439999999999998 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.340000000000003 110.867 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.469 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 71.230000000000004 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.530000000000001 111.264 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.420000000000002 111.656 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 63.149999999999999 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 52.119999999999997 111.552 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.400000000000006 110.981 179.603 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.696 0.284 . . . . 70.129999999999995 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.340000000000003 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.64 ' HB3' HD11 ' B' ' 42' ' ' LEU . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.439999999999998 111.17 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.77 HG22 HG12 ' B' ' 78' ' ' VAL . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.430000000000007 111.166 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.57 ' HB2' HD12 ' B' ' 42' ' ' LEU . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.537 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.120000000000005 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.430000000000007 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.219999999999999 112.207 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.567 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.299999999999997 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.794 HG21 HG11 ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.209999999999994 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.210000000000001 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.420000000000002 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.519999999999996 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.510000000000005 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.310000000000002 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 15.210000000000001 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.576 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.549999999999997 111.416 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.558 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.450000000000003 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.329999999999998 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.109999999999999 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.576 HG23 ' O ' ' B' ' 27' ' ' LEU . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.329999999999998 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.817 HG22 HG11 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.140000000000001 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 54.439999999999998 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.209999999999994 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.767 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.319999999999993 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.551 ' HG3' HG23 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.040000000000006 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 61.009999999999998 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.530000000000001 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.239999999999995 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.817 HG11 HG22 ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.109999999999999 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' B' ' 11' ' ' SER . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.120000000000005 111.91 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.549999999999997 110.593 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.340000000000003 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 62.149999999999999 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.794 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.519999999999996 110.425 179.161 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 N-CA-C 114.256 0.462 . . . . 70.519999999999996 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.635 ' HA ' HD12 ' B' ' 65' ' ' ILE . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.129999999999995 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.510000000000005 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.129999999999995 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' B' ' 62' ' ' ASP . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.839 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 64.310000000000002 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.209999999999994 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.109999999999999 111.764 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.340000000000003 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.340000000000003 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.219999999999999 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.349999999999994 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 73' ' ' LEU . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.310000000000002 111.543 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 62.299999999999997 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.299999999999997 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.510000000000005 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.319999999999993 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.77 HG12 HG22 ' B' ' 12' ' ' VAL . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.030000000000001 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.129999999999995 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.916 HG23 ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.400000000000006 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.200000000000003 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.340000000000003 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' B' ' 90' ' ' VAL . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 55.039999999999999 111.408 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.631 HG22 ' HB2' ' B' ' 109' ' ' ARG . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.430000000000007 111.596 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.299999999999997 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' B' ' 114' ' ' ARG . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.030000000000001 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . 0.429 ' HB2' HG11 ' B' ' 83' ' ' VAL . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.239999999999995 110.611 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.299999999999997 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.209999999999994 112.268 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' B' ' 83' ' ' VAL . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 65.329999999999998 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.209999999999994 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.349999999999994 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.040000000000006 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.607 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.409999999999997 110.749 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.200000000000003 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.573 ' HG2' HD22 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.420000000000002 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.439999999999998 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 94' ' ' LEU . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.129999999999995 111.781 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.240000000000002 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.310000000000002 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.230000000000004 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.409999999999997 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.766 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 43.32 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.420000000000002 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.916 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 61.039999999999999 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.765 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.019999999999996 110.945 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.439999999999998 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.631 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.420000000000002 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.150000000000006 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.439999999999998 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.540000000000006 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.019999999999996 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 61.229999999999997 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.350000000000001 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.210000000000001 111.449 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.200000000000003 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.558 HD11 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.310000000000002 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.409999999999997 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 34.420000000000002 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 43.329999999999998 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.439999999999998 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.530000000000001 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 70.540000000000006 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.409999999999997 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.299999999999997 110.623 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' B' ' 106' ' ' CYS . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.003 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.509999999999998 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.539999999999999 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.099999999999994 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.340000000000003 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.299999999999997 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.616 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.209999999999994 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.420000000000002 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.210000000000001 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.209999999999994 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.47 HD21 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.219999999999999 110.872 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 44.200000000000003 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.464 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 44.450000000000003 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 64.109999999999999 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.030000000000001 111.215 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.130000000000003 111.64 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 71.219999999999999 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.239999999999995 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.420000000000002 111.588 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.340000000000003 110.958 179.614 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.909 0.385 . . . . 72.150000000000006 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.200000000000003 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.448 ' HB3' HD11 ' A' ' 42' ' ' LEU . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.732 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 HG12 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.039999999999999 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.329999999999998 110.953 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.219999999999999 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.100000000000001 111.426 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 90' ' ' VAL . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.120000000000005 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.219999999999999 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.539 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.040000000000006 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.420000000000002 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.239999999999995 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.219999999999999 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.129999999999995 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 63.229999999999997 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.439999999999998 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 31' ' ' ILE . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.530000000000001 110.644 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 41.329999999999998 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.100000000000001 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.039999999999999 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.439999999999998 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 41' ' ' VAL . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.209999999999994 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.400000000000006 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 32.409999999999997 111.033 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.219999999999999 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 70.540000000000006 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.109999999999999 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.439999999999998 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.909 HG11 HG22 ' A' ' 32' ' ' VAL . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 110.254 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 76' ' ' ALA . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.310000000000002 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.439999999999998 110.211 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.120000000000005 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.319999999999993 111.56 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 41.439999999999998 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 53.109999999999999 110.348 178.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.621 -0.191 . . . . 74.239999999999995 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.430000000000007 111.099 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 70.299999999999997 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.420000000000002 110.659 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 62' ' ' ASP . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.040000000000006 111.117 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.099999999999994 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.299999999999997 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.120000000000005 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.409999999999997 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.519999999999996 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 97' ' ' ALA . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.219999999999999 111.435 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HA ' HD21 ' A' ' 100' ' ' LEU . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.420000000000002 111.177 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.319999999999993 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.524 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.239999999999995 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.400000000000006 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 97' ' ' ALA . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 54.329999999999998 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 62.149999999999999 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.631 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.430000000000007 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.409999999999997 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 HG11 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 63.310000000000002 111.196 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 42.32 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 61.009999999999998 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.430000000000007 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.679 ' CD2' HD23 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 62.409999999999997 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.219999999999999 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.439999999999998 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' HD23 ' A' ' 94' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.019999999999996 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 70.299999999999997 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.019999999999996 111.08 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.594 HD23 ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.049999999999997 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD2' HD11 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' A' ' 79' ' ' VAL . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.129999999999995 111.359 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 94' ' ' LEU . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.109999999999999 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.049999999999997 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' GLN . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 62.219999999999999 111.862 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.439999999999998 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.030000000000001 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.219999999999999 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CD1' ' HB1' ' A' ' 97' ' ' ALA . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.329999999999998 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.697 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.340000000000003 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.561 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.109999999999999 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.533 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.030000000000001 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.400000000000006 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.319999999999993 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.019999999999996 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.409999999999997 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.219999999999999 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.400000000000006 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.340000000000003 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.350000000000001 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 64.510000000000005 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.530000000000001 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.209999999999994 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.099999999999994 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 71.299999999999997 111.016 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.530000000000001 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.519999999999996 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 30.43 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.340000000000003 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.530000000000001 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.150000000000006 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.533 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.230000000000004 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.657 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 63.229999999999997 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.340000000000003 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.020000000000003 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.229999999999997 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.120000000000005 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.549999999999997 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.420000000000002 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.200000000000003 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 31' ' ' ILE . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.299999999999997 110.792 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.049999999999997 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.239999999999995 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 152' ' ' VAL . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.010000000000005 111.198 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.209999999999994 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.695 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.049999999999997 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 148' ' ' GLU . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.319999999999993 111.106 179.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.822 0.344 . . . . 65.409999999999997 111.327 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.530000000000001 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.447 ' HB3' HD11 ' B' ' 42' ' ' LEU . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.040000000000006 110.676 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.616 HG22 HG12 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.230000000000004 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 110.927 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.510000000000005 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.439999999999998 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.210000000000001 111.44 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.514 ' HB2' HG21 ' B' ' 90' ' ' VAL . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 64.310000000000002 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.528 HG13 ' H ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.219999999999999 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.426 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 73.120000000000005 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.528 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.119999999999997 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.329999999999998 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.239999999999995 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.200000000000003 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 72.310000000000002 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.540000000000006 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.240000000000002 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 31' ' ' ILE . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.120000000000005 110.645 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 53.140000000000001 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.409999999999997 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 64.530000000000001 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.938 HG22 HG11 ' B' ' 41' ' ' VAL . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.409999999999997 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.239999999999995 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.083 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.150000000000006 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.219999999999999 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.439999999999998 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.938 HG11 HG22 ' B' ' 32' ' ' VAL . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 62.299999999999997 110.326 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' B' ' 76' ' ' ALA . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.239999999999995 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.57 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.319999999999993 110.258 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.340000000000003 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 61.130000000000003 111.538 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.120000000000005 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.450000000000003 110.344 178.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 N-CA-C 112.64 -0.184 . . . . 72.129999999999995 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' B' ' 65' ' ' ILE . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 64.439999999999998 111.144 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.319999999999993 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 71.329999999999998 110.659 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' B' ' 62' ' ' ASP . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 111.1 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.549 ' CD2' ' C ' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.299999999999997 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 45.310000000000002 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.130000000000003 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.239999999999995 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.209999999999994 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 97' ' ' ALA . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.420000000000002 111.496 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . 0.431 ' HA ' HD21 ' B' ' 100' ' ' LEU . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.150000000000006 111.132 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' B' ' 42' ' ' LEU . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 44.119999999999997 111.629 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.120000000000005 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.675 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.329999999999998 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' B' ' 97' ' ' ALA . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.310000000000002 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.240000000000002 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.416 HG21 HG11 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.540000000000006 111.173 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.918 HG22 ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.329999999999998 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.229999999999997 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.329999999999998 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.230000000000004 110.773 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.666 ' CD2' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 63.409999999999997 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.209999999999994 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.576 ' HA2' HD23 ' B' ' 94' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 13.41 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.420000000000002 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.086 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.576 HD23 ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.299999999999997 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.299999999999997 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' B' ' 79' ' ' VAL . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.219999999999999 111.398 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 94' ' ' LEU . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 62.200000000000003 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 74' ' ' GLN . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.219999999999999 111.896 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.310000000000002 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.400000000000006 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HB1' ' B' ' 97' ' ' ALA . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.120000000000005 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.699 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.559 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.420000000000002 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.150000000000006 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.918 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.140000000000001 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 64.310000000000002 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.420000000000002 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.527 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.329999999999998 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.329999999999998 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.679 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 53.450000000000003 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.030000000000001 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.409999999999997 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.572 ' CE ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.120000000000005 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 63.140000000000001 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.140000000000001 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.310000000000002 110.974 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.130000000000003 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.229999999999997 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.030000000000001 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.340000000000003 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.421 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 72.109999999999999 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' B' ' 106' ' ' CYS . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 110.944 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.200000000000003 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.310000000000002 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.652 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.040000000000006 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.340000000000003 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.130000000000003 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 70.099999999999994 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.652 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.310000000000002 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.109999999999999 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.230000000000004 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' B' ' 31' ' ' ILE . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' B' ' 80' ' ' VAL . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 72.540000000000006 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 62.530000000000001 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.458 ' O ' HG23 ' B' ' 152' ' ' VAL . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.399999999999999 111.244 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.239999999999995 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.574 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.329999999999998 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 148' ' ' GLU . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.540000000000006 111.503 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.040000000000006 111.084 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.791 0.329 . . . . 62.140000000000001 111.287 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.519999999999996 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.983 ' HB3' HD21 ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.310000000000002 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG12 ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 63.119999999999997 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.430000000000007 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 31' ' ' ILE . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.219999999999999 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.409999999999997 111.952 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.5 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.329999999999998 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.612 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.200000000000003 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.450000000000003 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 33.229999999999997 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.140000000000001 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.420000000000002 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.019999999999996 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.040000000000006 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.349999999999994 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.099999999999994 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.049999999999997 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 143' ' ' LEU . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 72.349999999999994 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 41' ' ' VAL . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.239999999999995 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.430000000000007 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.420000000000002 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.809 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.150000000000006 111.016 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.200000000000003 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.129999999999995 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.530000000000001 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.340000000000003 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 32' ' ' VAL . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.983 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.430000000000007 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' HE1' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.439999999999998 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 55.509999999999998 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.527 ' HE1' HG22 ' A' ' 43' ' ' THR . 46.3 p-80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.510000000000005 110.827 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 55.25 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.149999999999999 111.864 179.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 120.252 -0.193 . . . . 54.240000000000002 113.329 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 71.420000000000002 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 55.210000000000001 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 71.439999999999998 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 62' ' ' ASP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 63.549999999999997 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.510000000000005 111.439 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.239999999999995 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.519999999999996 111.319 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.587 HD22 ' CD ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.319999999999993 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 71.030000000000001 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.49 HD12 ' NE ' ' A' ' 96' ' ' ARG . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.349999999999994 111.737 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.420000000000002 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.219999999999999 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.450000000000003 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.719 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.439999999999998 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 70.420000000000002 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' CYS . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.009999999999998 111.804 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.219999999999999 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 90' ' ' VAL . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.510000000000005 111.144 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 63.149999999999999 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' B' ' 88' ' ' LEU . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.329999999999998 112.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.737 HD23 HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 60.340000000000003 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.350000000000001 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 83' ' ' VAL . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.019999999999996 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.109999999999999 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.230000000000004 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.520000000000003 110.44 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.219999999999999 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' CD ' HD22 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.329999999999998 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.229999999999997 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.230000000000004 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 44.32 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.349999999999994 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.439999999999998 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.340000000000003 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.409999999999997 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.530000000000001 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 106' ' ' CYS . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.230000000000004 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.675 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.329999999999998 110.936 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.539999999999999 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 84' ' ' THR . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.140000000000001 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.458 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.509999999999998 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.020000000000003 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.329999999999998 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.329999999999998 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.420000000000002 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.299999999999997 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.671 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 72.040000000000006 110.725 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.728 HG13 HD23 ' B' ' 88' ' ' LEU . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.349999999999994 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 23.140000000000001 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.240000000000002 110.795 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 54.5 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.120000000000005 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.310000000000002 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.439999999999998 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.409999999999997 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 62.509999999999998 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 106' ' ' CYS . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 111.173 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.409999999999997 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.230000000000004 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.109999999999999 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.400000000000006 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.299999999999997 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.635 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.200000000000003 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.040000000000006 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.32 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 31' ' ' ILE . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.420000000000002 111.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.130000000000003 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.109999999999999 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.019999999999996 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.310000000000002 111.088 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.540000000000006 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.130000000000003 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.219999999999999 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.549999999999997 110.834 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.142 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.812 0.339 . . . . 74.519999999999996 111.229 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.540000000000006 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.014 ' HB3' HD21 ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.219999999999999 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.718 HG22 HG12 ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.310000000000002 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.420000000000002 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.543 ' CG ' HD13 ' B' ' 31' ' ' ILE . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.040000000000006 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.340000000000003 111.861 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.497 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.230000000000004 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.019999999999996 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.503 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 71.450000000000003 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.514 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 35.539999999999999 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.219999999999999 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.140000000000001 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.230000000000004 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.420000000000002 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.509999999999998 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.319999999999993 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.120000000000005 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CD1' HG21 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.319999999999993 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.019999999999996 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.634 HG22 HD22 ' B' ' 143' ' ' LEU . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.099999999999994 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 41' ' ' VAL . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.020000000000003 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.329999999999998 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.340000000000003 111.05 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.319999999999993 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.010000000000005 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.239999999999995 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.219999999999999 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.549999999999997 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 32' ' ' VAL . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.531 HG22 ' HE1' ' B' ' 45' ' ' HIS . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.219999999999999 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.329999999999998 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.531 ' HE1' HG22 ' B' ' 43' ' ' THR . 46.1 p-80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.439999999999998 110.809 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.329999999999998 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.299999999999997 111.865 179.66 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.415 ' O ' HG13 ' B' ' 65' ' ' ILE . . . . . . . . 0 CA--C 1.519 0.338 0 CA-C-O 120.21 -0.217 . . . . 65.349999999999994 113.3 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.140000000000001 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.319999999999993 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 62' ' ' ASP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.519999999999996 111.421 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.209999999999994 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.230000000000004 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.528 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.299999999999997 111.259 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.58 HD22 ' CD ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.109999999999999 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.530000000000001 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.492 HD12 ' NE ' ' B' ' 96' ' ' ARG . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.430000000000007 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.209999999999994 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.040000000000006 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 72.219999999999999 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.099999999999994 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.718 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.340000000000003 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.030000000000001 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.466 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.229999999999997 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.577 HG21 HG11 ' B' ' 90' ' ' VAL . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.209999999999994 111.094 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.82 HG22 ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.340000000000003 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.140000000000001 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 88' ' ' LEU . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.409999999999997 112.384 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.430000000000007 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 33.420000000000002 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.577 HG11 HG21 ' B' ' 83' ' ' VAL . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.329999999999998 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.632 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 64.299999999999997 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.514 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 110.448 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.350000000000001 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.58 ' CD ' HD22 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.239999999999995 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.451 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.140000000000001 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.601 HG22 HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.019999999999996 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.319999999999993 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.349999999999994 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.230000000000004 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.601 HG13 HG22 ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.099999999999994 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.681 HD13 ' N ' ' B' ' 106' ' ' CYS . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.129999999999995 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.681 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.509999999999998 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.329999999999998 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.82 ' HB2' HG22 ' B' ' 84' ' ' THR . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.150000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.468 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.099999999999994 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.488 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.130000000000003 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.120000000000005 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 70.230000000000004 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.140000000000001 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.678 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.239999999999995 110.616 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.109999999999999 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.099999999999994 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.329999999999998 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.737 HG13 HD23 ' A' ' 88' ' ' LEU . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.340000000000003 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.209999999999994 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.229999999999997 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.239999999999995 110.753 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.350000000000001 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 54.219999999999999 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.350000000000001 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.229999999999997 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.409999999999997 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.450000000000003 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.310000000000002 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 106' ' ' CYS . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.25 111.24 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.120000000000005 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.623 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 72.239999999999995 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.209999999999994 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.439999999999998 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.329999999999998 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.039999999999999 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.299999999999997 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.634 HD22 HG22 ' B' ' 31' ' ' ILE . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.299999999999997 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.310000000000002 111.053 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.200000000000003 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.109999999999999 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.450000000000003 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 55.219999999999999 110.789 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.728 0.299 . . . . 55.450000000000003 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.219999999999999 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' HD21 ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 78' ' ' VAL . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.400000000000006 110.995 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.209999999999994 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CG ' HD13 ' A' ' 31' ' ' ILE . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.540000000000006 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.409999999999997 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.530000000000001 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.839 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.340000000000003 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.120000000000005 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.509999999999998 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 74.120000000000005 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.430000000000007 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.420000000000002 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.450000000000003 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 31' ' ' ILE . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 110.079 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.756 ' HE1' HG21 ' A' ' 43' ' ' THR . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 73.209999999999994 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 HD21 ' A' ' 143' ' ' LEU . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.409999999999997 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.340000000000003 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 65.549999999999997 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.140000000000001 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' HG22 ' A' ' 41' ' ' VAL . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.439999999999998 111.255 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.329999999999998 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.329999999999998 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.409999999999997 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.409999999999997 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.030000000000001 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.450000000000003 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.756 HG21 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.049999999999997 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.030000000000001 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 54.4 p-80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.539999999999999 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.839 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 55.109999999999999 110.865 179.037 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 119.793 -0.448 . . . . 64.430000000000007 113.805 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.049999999999997 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.329999999999998 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.109999999999999 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 62' ' ' ASP . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.150000000000006 110.716 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.472 ' HA ' ' HE3' ' B' ' 119' ' ' MET . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.120000000000005 111.38 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.420000000000002 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.150000000000006 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 96' ' ' ARG . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 111.203 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.539999999999999 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.439999999999998 111.252 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.219999999999999 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.539999999999999 110.421 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.099999999999994 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.200000000000003 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.530000000000001 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 12' ' ' VAL . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HB ' HD12 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.150000000000006 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.299999999999997 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.010000000000005 111.264 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.846 HG22 ' HB2' ' A' ' 109' ' ' ARG . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.109999999999999 111.557 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.530000000000001 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.329999999999998 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.109999999999999 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.140000000000001 112.532 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.400000000000006 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.299999999999997 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.67 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.140000000000001 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.519999999999996 110.274 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.666 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.409999999999997 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.129999999999995 110.761 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.603 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.119999999999997 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' B' ' 96' ' ' ARG . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.129999999999995 111.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.420000000000002 111.328 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.399999999999999 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 55.009999999999998 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.040000000000006 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.310000000000002 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.409999999999997 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.678 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.310000000000002 110.744 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.039999999999999 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.519999999999996 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.846 ' HB2' HG22 ' A' ' 84' ' ' THR . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.47 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.209999999999994 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.020000000000003 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 32.340000000000003 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.420000000000002 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.209999999999994 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 120' ' ' ILE . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.229999999999997 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.540000000000006 111.456 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.140000000000001 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 41.340000000000003 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.329999999999998 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.299999999999997 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 71.450000000000003 110.67 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.519999999999996 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.329999999999998 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.149999999999999 111.101 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 106' ' ' CYS . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 111.244 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.439999999999998 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.010000000000005 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 73.319999999999993 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.519999999999996 111.236 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.409999999999997 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 33.32 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.109999999999999 111.676 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.400000000000006 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.230000000000004 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.58 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.616 HD21 HG22 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.209999999999994 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.519999999999996 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.329999999999998 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.530000000000001 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.400000000000006 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 54.530000000000001 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.299999999999997 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.409999999999997 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 148' ' ' GLU . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.439999999999998 111.014 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 111.084 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.668 0.27 . . . . 72.129999999999995 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 72.530000000000001 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.456 ' HB3' HD21 ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.219999999999999 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 78' ' ' VAL . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.439999999999998 111.007 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.219999999999999 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' B' ' 31' ' ' ILE . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.240000000000002 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.814 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.439999999999998 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.44 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.430000000000007 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.109999999999999 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.120000000000005 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.530000000000001 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.299999999999997 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.010000000000005 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 51.409999999999997 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 31' ' ' ILE . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.239999999999995 110.05 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.78 ' HE1' HG21 ' B' ' 43' ' ' THR . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 72.219999999999999 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.399999999999999 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.030000000000001 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.62 HG22 HD21 ' B' ' 143' ' ' LEU . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.010000000000005 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.789 HG22 HG11 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.240000000000002 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 41.340000000000003 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.310000000000002 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' B' ' 41' ' ' VAL . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.218 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.420000000000002 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.450000000000003 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.439999999999998 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.420000000000002 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.340000000000003 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.789 HG11 HG22 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 65.120000000000005 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.439999999999998 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.78 HG21 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 24.34 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 70.450000000000003 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.423 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 54.4 p-80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.039999999999999 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.814 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.439999999999998 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.329999999999998 110.791 179.095 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 CA-C-O 119.865 -0.408 . . . . 41.310000000000002 113.907 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 73.299999999999997 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.340000000000003 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.430000000000007 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' B' ' 62' ' ' ASP . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 62.240000000000002 110.649 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.120000000000005 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 51.520000000000003 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' B' ' 96' ' ' ARG . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 55.32 111.172 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.200000000000003 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 111.222 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.109999999999999 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 110.397 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.030000000000001 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.797 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.450000000000003 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 12' ' ' VAL . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.209999999999994 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.566 ' HB ' HD12 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.210000000000001 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.510000000000005 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.340000000000003 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.461 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.010000000000005 111.279 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.84 HG22 ' HB2' ' B' ' 109' ' ' ARG . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.120000000000005 111.485 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.210000000000001 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.785 ' HA ' HD12 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.229999999999997 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.129999999999995 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.209999999999994 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.240000000000002 112.509 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.209999999999994 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.049999999999997 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.666 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.150000000000006 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.430000000000007 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.333 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.497 ' CZ ' HD22 ' B' ' 70' ' ' LEU . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.540000000000006 110.726 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.596 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.310000000000002 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.120000000000005 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.409999999999997 111.358 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 100' ' ' LEU . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.430000000000007 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.109999999999999 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.049999999999997 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 65.200000000000003 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.450000000000003 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.691 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.691 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 110.772 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 63.450000000000003 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.84 ' HB2' HG22 ' B' ' 84' ' ' THR . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.340000000000003 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.467 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.209999999999994 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.430000000000007 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.430000000000007 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.44 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.140000000000001 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.010000000000005 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.592 HD22 HG21 ' B' ' 120' ' ' ILE . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 64.329999999999998 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 66' ' ' HIS . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.209999999999994 110.699 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.592 HG21 HD22 ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.319999999999993 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.219999999999999 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.530000000000001 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.239999999999995 110.634 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.340000000000003 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.099999999999994 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.019999999999996 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.239999999999995 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.129999999999995 111.056 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.130000000000003 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' B' ' 106' ' ' CYS . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 111.213 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.487 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.319999999999993 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.572 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 71.099999999999994 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.239999999999995 111.291 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.129999999999995 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.329999999999998 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.420000000000002 111.693 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.62 HD21 HG22 ' B' ' 31' ' ' ILE . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 53.420000000000002 111.051 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.310000000000002 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.010000000000005 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.310000000000002 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 152' ' ' VAL . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 53.509999999999998 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 43.310000000000002 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 65.209999999999994 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 148' ' ' GLU . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 71.109999999999999 110.93 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.209999999999994 111.054 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.73 0.3 . . . . 74.150000000000006 111.276 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 110.804 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.749 ' HB3' HD21 ' A' ' 42' ' ' LEU . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 72.409999999999997 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 78' ' ' VAL . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 111.319 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 53.119999999999997 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.239999999999995 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.120000000000005 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.495 ' N ' HG21 ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.130000000000003 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.682 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.219999999999999 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.450000000000003 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.239999999999995 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.430000000000007 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.530000000000001 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.530000000000001 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.416 HD21 ' OE1' ' A' ' 82' ' ' GLU . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.45 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 43' ' ' THR . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.420000000000002 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.229999999999997 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.400000000000006 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 HG11 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.129999999999995 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.019999999999996 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.510000000000005 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.310000000000002 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.239999999999995 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' A' ' 10' ' ' ARG . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.400000000000006 112.061 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.509999999999998 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.150000000000006 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.329999999999998 109.738 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.613 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.329999999999998 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.340000000000003 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 46' ' ' VAL . 51.3 p-80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.019999999999996 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.682 ' CG1' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.329999999999998 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.120000000000005 112.386 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 120.147 -0.252 . . . . 65.120000000000005 113.414 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 110.705 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 61.140000000000001 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD12 ' HA ' ' A' ' 62' ' ' ASP . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.409999999999997 110.648 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.149999999999999 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.109999999999999 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.140000000000001 111.547 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.109999999999999 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.519999999999996 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.120000000000005 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.422 ' HB2' ' HE2' ' A' ' 13' ' ' TYR . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.200000000000003 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.129999999999995 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.099999999999994 110.861 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.430000000000007 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 30.34 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 71.239999999999995 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HB ' HD12 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.099999999999994 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.450000000000003 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.210000000000001 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.299999999999997 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 61.310000000000002 111.574 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.310000000000002 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.816 ' HA ' HD12 ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.409999999999997 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.030000000000001 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.329999999999998 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.329999999999998 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 45.450000000000003 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.009999999999998 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.663 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 72.420000000000002 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.230000000000004 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.671 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.420000000000002 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.140000000000001 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.598 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 92' ' ' TYR . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.229999999999997 110.803 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.450000000000003 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.420000000000002 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.019999999999996 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.420000000000002 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.319999999999993 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.340000000000003 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.714 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.530000000000001 110.593 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.420000000000002 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.310000000000002 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' THR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.140000000000001 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.540000000000006 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.540000000000006 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 33.229999999999997 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 70.219999999999999 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.319999999999993 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.510000000000005 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 55.310000000000002 111.304 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.149999999999999 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.445 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD11 HD22 ' B' ' 88' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.200000000000003 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.540000000000006 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 70.310000000000002 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.319999999999993 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.200000000000003 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 45.240000000000002 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.310000000000002 112.237 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.219999999999999 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.539999999999999 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 106' ' ' CYS . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.120000000000005 111.119 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.663 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.200000000000003 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.579 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.009999999999998 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.149999999999999 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 33.119999999999997 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.340000000000003 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.430000000000007 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 63.140000000000001 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.350000000000001 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.219999999999999 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.340000000000003 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.450000000000003 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.66 ' HZ ' HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 74.439999999999998 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 152' ' ' VAL . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.010000000000005 111.174 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.209999999999994 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.510000000000005 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.239999999999995 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 148' ' ' GLU . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.420000000000002 111.172 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 60.210000000000001 111.537 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.794 0.33 . . . . 72.510000000000005 111.229 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.509999999999998 110.846 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.725 ' HB3' HD21 ' B' ' 42' ' ' LEU . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.240000000000002 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.702 HG22 HG12 ' B' ' 78' ' ' VAL . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.120000000000005 111.342 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.434 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 62.119999999999997 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.010000000000005 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.420000000000002 112.235 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.496 ' N ' HG21 ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.130000000000003 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.200000000000003 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.448 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.319999999999993 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.100000000000001 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.540000000000006 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.239999999999995 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.310000000000002 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 64.129999999999995 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.419 HD21 ' OE1' ' B' ' 82' ' ' GLU . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.230000000000004 110.463 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' B' ' 43' ' ' THR . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.019999999999996 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.340000000000003 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.319999999999993 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.547 ' O ' HD22 ' B' ' 35' ' ' LEU . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.030000000000001 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.78 HG13 HG11 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.099999999999994 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.510000000000005 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.547 HD22 ' O ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 71.239999999999995 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.439999999999998 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.310000000000002 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 72.329999999999998 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' B' ' 10' ' ' ARG . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.329999999999998 112.034 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.450000000000003 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.78 HG11 HG13 ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.319999999999993 109.683 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.614 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.420000000000002 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.340000000000003 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' B' ' 46' ' ' VAL . 51.2 p-80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 64.409999999999997 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 43.299999999999997 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.140000000000001 112.406 -179.777 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 120.073 -0.293 . . . . 65.109999999999999 113.358 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.653 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.530000000000001 111.077 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 110.674 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' B' ' 62' ' ' ASP . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.099999999999994 110.645 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.219999999999999 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.049999999999997 111.598 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.119999999999997 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.030000000000001 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.434 ' HB2' ' HE2' ' B' ' 13' ' ' TYR . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 63.039999999999999 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.040000000000006 110.91 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.349999999999994 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.450000000000003 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.702 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.299999999999997 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 62.229999999999997 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.530000000000001 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.888 HG22 ' HB2' ' B' ' 109' ' ' ARG . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.120000000000005 111.612 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.310000000000002 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.799 ' HA ' HD12 ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.549999999999997 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . 0.407 ' OG ' ' HB ' ' B' ' 90' ' ' VAL . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.549999999999997 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.010000000000005 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.496 HG21 ' N ' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.350000000000001 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.671 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 73.420000000000002 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.409999999999997 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 60.219999999999999 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.663 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.019999999999996 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.549 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.409999999999997 111.605 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.493 HG21 ' OH ' ' A' ' 92' ' ' TYR . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.109999999999999 110.86 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 71.010000000000005 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.432 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 60.439999999999998 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.530000000000001 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.230000000000004 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.648 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.109999999999999 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' B' ' 97' ' ' ALA . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.310000000000002 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.699 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.430000000000007 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.721 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.119999999999997 110.587 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.150000000000006 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 64.200000000000003 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.888 ' HB2' HG22 ' B' ' 84' ' ' THR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.230000000000004 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 70.400000000000006 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' B' ' 109' ' ' ARG . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.200000000000003 111.695 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.539999999999999 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.129999999999995 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.239999999999995 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.719 HD22 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.540000000000006 111.283 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.210000000000001 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.44 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.349999999999994 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 88' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 41.210000000000001 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.019999999999996 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.319999999999993 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.049999999999997 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.140000000000001 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.319999999999993 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' B' ' 103' ' ' PRO . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.310000000000002 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.349999999999994 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' B' ' 106' ' ' CYS . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.172 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 73.209999999999994 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 72.040000000000006 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.572 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 64.129999999999995 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.430000000000007 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.240000000000002 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.420000000000002 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.409999999999997 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.310000000000002 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.430000000000007 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 73.140000000000001 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.239999999999995 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.299999999999997 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.472 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 73.0 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' B' ' 12' ' ' VAL . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 70.340000000000003 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.476 ' O ' HG23 ' B' ' 152' ' ' VAL . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.120000000000005 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.020000000000003 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 71.319999999999993 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.040000000000006 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 148' ' ' GLU . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.129999999999995 111.19 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 74.450000000000003 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.219999999999999 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 34.210000000000001 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG13 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.399999999999999 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 61.100000000000001 110.488 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.52 ' CG ' HD13 ' A' ' 31' ' ' ILE . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.150000000000006 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.615 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.109999999999999 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.666 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.299999999999997 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.539999999999999 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.109999999999999 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.130000000000003 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 63.200000000000003 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 64.400000000000006 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.697 ' CD1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.140000000000001 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.420000000000002 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.210000000000001 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.88 HG22 HG21 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 62.109999999999999 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 62.240000000000002 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.200000000000003 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 31' ' ' ILE . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.439999999999998 110.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.349999999999994 110.857 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.109999999999999 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.439999999999998 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.88 HG21 HG22 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.219999999999999 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.319999999999993 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.57 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.230000000000004 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 41' ' ' VAL . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.539999999999999 110.801 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.413 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 48.8 p-80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.439999999999998 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.530000000000001 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.039999999999999 111.692 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.774 -0.131 . . . . 73.420000000000002 112.774 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 65.219999999999999 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.540000000000006 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 62' ' ' ASP . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 51.310000000000002 110.533 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 60.030000000000001 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.519999999999996 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 44.520000000000003 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.673 HD21 ' CZ ' ' A' ' 96' ' ' ARG . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.409999999999997 111.27 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.450000000000003 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 71.019999999999996 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.532 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.120000000000005 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.340000000000003 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.209999999999994 111.403 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 150' ' ' TYR . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.439999999999998 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 51.340000000000003 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 60.109999999999999 112.265 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.409999999999997 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 90' ' ' VAL . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.118 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 70.120000000000005 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.120000000000005 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.842 ' HG ' HD23 ' B' ' 116' ' ' LEU . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.219999999999999 111.512 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.439999999999998 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.109999999999999 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 33.229999999999997 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.664 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.239999999999995 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 81' ' ' ALA . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 64.030000000000001 111.111 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.652 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.210000000000001 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.673 ' CZ ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.510000000000005 110.617 178.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.08 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.030000000000001 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.130000000000003 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.319999999999993 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.140000000000001 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 73.109999999999999 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.726 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.534 ' H ' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.310000000000002 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 134' ' ' TYR . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.010000000000005 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 61.009999999999998 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.129999999999995 111.056 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.130000000000003 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.510000000000005 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.439999999999998 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' B' ' 88' ' ' LEU . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.109999999999999 110.875 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 70.120000000000005 111.165 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.594 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 60.229999999999997 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 116' ' ' LEU . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.530000000000001 111.212 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.099999999999994 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.420000000000002 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.530000000000001 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 62.43 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.209999999999994 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.577 ' HB3' ' HD2' ' A' ' 128' ' ' ARG . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 41.149999999999999 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.662 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.340000000000003 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.299999999999997 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.310000000000002 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.150000000000006 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' HD12 ' A' ' 107' ' ' LEU . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.420000000000002 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.069 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.239999999999995 113.252 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.219999999999999 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.109999999999999 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.239999999999995 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.400000000000006 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 143' ' ' LEU . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.340000000000003 110.964 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.519999999999996 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 62.229999999999997 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.540000000000006 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.230000000000004 111.045 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.549999999999997 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.329999999999998 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 149' ' ' ALA . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.510000000000005 111.817 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.340000000000003 110.938 179.672 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.705 0.288 . . . . 74.239999999999995 111.041 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.120000000000005 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 72.510000000000005 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.531 HG13 HG13 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.496 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 54.350000000000001 110.49 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.515 ' CG ' HD13 ' B' ' 31' ' ' ILE . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.130000000000003 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.609 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.349999999999994 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.661 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 53.530000000000001 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.540000000000006 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.473 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.409999999999997 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.420000000000002 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.299999999999997 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.120000000000005 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.019999999999996 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.200000000000003 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.329999999999998 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.099999999999994 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.696 ' CD1' HG21 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 60.409999999999997 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 51.310000000000002 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.510000000000005 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.884 HG22 HG21 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.340000000000003 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.420000000000002 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.310000000000002 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 31' ' ' ILE . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.239999999999995 110.993 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' HB ' ' B' ' 41' ' ' VAL . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 110.874 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.400000000000006 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.140000000000001 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.884 HG21 HG22 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.329999999999998 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.340000000000003 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.573 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.510000000000005 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.46 ' HG3' HG11 ' B' ' 41' ' ' VAL . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.040000000000006 110.802 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' HIS . . . . . 0.414 ' CG ' ' N ' ' B' ' 46' ' ' VAL . 48.8 p-80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 64.109999999999999 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.696 HG21 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.519999999999996 111.688 179.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.726 -0.15 . . . . 54.439999999999998 112.726 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.806 ' HA ' HD12 ' B' ' 65' ' ' ILE . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 64.239999999999995 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.239999999999995 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.040000000000006 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' B' ' 62' ' ' ASP . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.558 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.120000000000005 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.420000000000002 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 32.439999999999998 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.679 HD21 ' CZ ' ' B' ' 96' ' ' ARG . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.109999999999999 111.246 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.409999999999997 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.040000000000006 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 73' ' ' LEU . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.140000000000001 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLN . . . . . 0.53 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.340000000000003 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.150000000000006 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 111.436 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' B' ' 150' ' ' TYR . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.530000000000001 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.109999999999999 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 94' ' ' LEU . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 51.299999999999997 112.327 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.040000000000006 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' B' ' 90' ' ' VAL . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.136 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.667 HG22 ' HB2' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 62.130000000000003 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.439999999999998 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 63.350000000000001 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.409999999999997 111.566 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 22.23 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.040000000000006 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.329999999999998 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.652 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.519999999999996 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.129999999999995 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 81' ' ' ALA . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.329999999999998 111.089 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . 0.664 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.679 ' CZ ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.340000000000003 110.623 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.439999999999998 111.107 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.019999999999996 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 43.299999999999997 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 61.240000000000002 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.340000000000003 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.329999999999998 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.659 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.140000000000001 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.69 HG13 HG23 ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 54.130000000000003 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.721 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.349999999999994 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' CYS . . . . . 0.545 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 30.199999999999999 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.140000000000001 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ARG . . . . . 0.667 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.209999999999994 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 52.219999999999999 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.430000000000007 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.099999999999994 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.409999999999997 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.842 HD23 ' HG ' ' A' ' 88' ' ' LEU . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.240000000000002 110.857 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.402 ' O ' HG22 ' B' ' 120' ' ' ILE . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 63.130000000000003 111.127 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.409999999999997 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.593 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.200000000000003 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.532 HG12 HD22 ' B' ' 116' ' ' LEU . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.129999999999995 111.242 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.209999999999994 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.439999999999998 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 70.319999999999993 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.519999999999996 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.420000000000002 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.420000000000002 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' SER . . . . . 0.568 ' HB3' ' HD2' ' B' ' 128' ' ' ARG . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 55.229999999999997 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.019999999999996 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.209999999999994 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.109999999999999 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.420000000000002 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' TYR . . . . . 0.584 ' HB3' HD12 ' B' ' 107' ' ' LEU . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.319999999999993 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.310000000000002 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.049999999999997 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.239999999999995 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.430000000000007 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.230000000000004 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 73.239999999999995 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 71.310000000000002 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' B' ' 143' ' ' LEU . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.439999999999998 110.847 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.319999999999993 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.049999999999997 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.349999999999994 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 64.430000000000007 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.439999999999998 111.1 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.540000000000006 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.310000000000002 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' B' ' 149' ' ' ALA . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 60.32 111.763 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.310000000000002 110.866 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.569 0.223 . . . . 52.329999999999998 111.403 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -123.7 124.03 41.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.371 -0.377 . . . . 72.420000000000002 110.927 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.78 137.17 35.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.073 -0.512 . . . . 63.149999999999999 110.866 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -129.71 120.86 25.83 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.331 -0.395 . . . . 74.140000000000001 111.144 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 78' ' ' VAL . 20.2 t -108.4 124.1 64.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 55.020000000000003 110.854 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 72' ' ' TRP . 0.8 OUTLIER -101.28 124.52 47.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.196 -0.456 . . . . 63.399999999999999 110.242 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 16.0 t80 -90.33 134.53 34.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 74.349999999999994 111.064 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.81 17.43 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 111.301 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.669 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -142.59 131.74 4.79 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.148 -0.549 . . . . 72.25 112.571 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.482 ' HB2' HG21 ' A' ' 90' ' ' VAL . 7.7 t -69.7 119.37 13.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.47 0.176 . . . . 65.140000000000001 110.677 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.738 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.8 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 116.559 -0.291 . . . . 65.030000000000001 111.12 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 50.9 38.0 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.048 -0.523 . . . . 55.020000000000003 110.885 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 66.93 24.18 72.94 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.863 -0.608 . . . . 65.209999999999994 112.471 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.12 158.21 23.02 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.769 -0.729 . . . . 73.349999999999994 113.287 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -101.73 15.06 30.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.513 0.196 . . . . 60.409999999999997 111.354 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.4 -9.12 21.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.679 0.276 . . . . 64.030000000000001 111.151 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.96 -27.32 14.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.903 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -44.34 93.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.439 -0.346 . . . . 54.450000000000003 111.045 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.08 93.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.614 -0.266 . . . . 54.119999999999997 110.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 31' ' ' ILE . 9.4 tp -70.22 -37.47 75.04 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.248 -0.433 . . . . 54.229999999999997 110.26 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 14' ' ' PHE . 1.9 m-85 -65.08 -39.18 92.83 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 116.027 -0.533 . . . . 55.140000000000001 112.141 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.35 87.74 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.188 -0.205 . . . . 64.25 111.141 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.34 -34.51 61.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.451 -0.34 . . . . 74.0 111.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.5 pp -77.27 -29.87 17.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.465 0.174 . . . . 62.210000000000001 110.992 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.647 ' HA ' HG21 ' A' ' 41' ' ' VAL . 3.2 t -65.51 -41.4 90.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.503 -0.317 . . . . 72.040000000000006 110.79 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -38.91 88.94 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 120.573 0.225 . . . . 73.510000000000005 111.428 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.51 -38.0 74.22 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.48 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 6.4 mp -73.23 -36.51 66.46 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.438 -0.347 . . . . 65.450000000000003 111.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.85 -32.96 71.63 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 75.140000000000001 110.725 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -37.46 77.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 63.149999999999999 111.501 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.31 -56.99 4.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.703 -0.226 . . . . 73.230000000000004 111.091 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.25 -82.47 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.762 -0.732 . . . . 73.310000000000002 112.24 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.26 138.68 28.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.559 0.219 . . . . 74.319999999999993 110.591 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 32' ' ' VAL . 14.6 p -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.482 -0.327 . . . . 73.409999999999997 110.892 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 72' ' ' TRP . 1.9 mm? -100.47 -124.55 0.17 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.616 -0.513 . . . . 62.25 109.616 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER 24.81 52.57 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.887 0.875 . . . . 71.120000000000005 112.054 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.11 -26.24 21.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 70.109999999999999 111.205 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.577 ' CE1' HG22 ' A' ' 46' ' ' VAL . 50.9 p-80 -53.99 -33.38 56.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.294 -0.412 . . . . 64.219999999999999 111.42 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.75 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.508 -0.315 . . . . 75.530000000000001 111.202 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.07 49.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.426 -0.352 . . . . 52.119999999999997 111.512 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.62 111.36 11.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 75.420000000000002 111.507 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.0 59.24 0.91 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.333 0.587 . . . . 62.25 110.224 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 28.9 tt0 174.72 66.9 0.0 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.858 -1.065 . . . . 73.209999999999994 110.207 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.68 105.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 110.998 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 14.0 tp10 -55.42 109.29 1.52 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.985 -0.552 . . . . 73.140000000000001 111.627 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' GLU . 73.5 Cg_endo -71.94 -165.38 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.244 2.63 . . . . 72.120000000000005 112.552 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.22 -0.9 . . . . 73.299999999999997 111.716 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.37 -159.58 13.8 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.889 -0.596 . . . . 62.049999999999997 112.789 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.43 130.38 46.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.704 0.287 . . . . 72.420000000000002 111.171 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.08 78.28 6.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.18 -0.464 . . . . 75.349999999999994 110.644 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.34 172.82 12.27 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.184 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.02 76.08 9.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.313 -0.403 . . . . 54.219999999999999 111.091 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.1 146.51 18.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.052 -0.594 . . . . 32.119999999999997 112.484 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.33 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.804 -0.712 . . . . 53.219999999999999 112.687 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.621 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -60.86 -47.85 84.47 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.462 0.172 . . . . 71.140000000000001 111.117 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -58.07 -38.14 75.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.575 -0.284 . . . . 70.099999999999994 110.65 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.88 -38.05 82.56 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 116.155 -0.475 . . . . 73.519999999999996 110.389 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.86 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 5.9 mt -57.02 -44.96 83.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.954 -0.566 . . . . 73.420000000000002 110.762 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 16.5 t-80 -69.66 -36.62 76.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.945 -0.57 . . . . 61.32 111.27 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.78 -37.16 76.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.287 -0.415 . . . . 74.409999999999997 111.451 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -66.19 -39.83 89.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.709 -0.223 . . . . 75.349999999999994 111.229 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -68.23 -35.56 78.13 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.468 -0.333 . . . . 72.040000000000006 111.438 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.629 HD13 ' HD2' ' A' ' 96' ' ' ARG . 2.7 mm? -67.58 -39.8 84.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.425 -0.352 . . . . 70.5 111.424 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.05 -36.68 77.95 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.337 -0.392 . . . . 53.109999999999999 111.849 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.547 ' CD1' HD12 ' A' ' 42' ' ' LEU . 4.1 m0 -71.16 -36.9 72.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.799 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -67.79 -28.06 67.28 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.195 -0.202 . . . . 75.219999999999999 111.135 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.25 -41.91 76.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.689 0.28 . . . . 32.009999999999998 110.674 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.95 -29.27 18.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.138 -0.483 . . . . 73.310000000000002 111.375 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 73' ' ' LEU . . . -59.17 106.94 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.585 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.19 -26.63 63.04 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.804 -0.635 . . . . 74.430000000000007 110.91 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.646 ' CG1' HG22 ' A' ' 12' ' ' VAL . 9.0 p -142.98 145.91 22.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.794 0.331 . . . . 73.530000000000001 111.035 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 104' ' ' ILE . 57.7 t -117.92 136.79 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 70.030000000000001 110.68 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -130.14 131.42 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.068 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.95 147.58 46.45 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.035 0.383 . . . . 35.549999999999997 112.035 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -138.39 91.27 2.54 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.531 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 90' ' ' VAL . 1.6 t -133.62 126.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.473 . . . . 74.040000000000006 110.834 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 109' ' ' ARG . 71.6 p -79.88 -21.92 43.44 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.155 0.428 . . . . 63.43 112.155 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 156.21 78.59 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.687 0.279 . . . . 75.349999999999994 111.341 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD22 ' B' ' 88' ' ' LEU . 29.4 Cg_endo -62.65 104.09 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.85 2.367 . . . . 71.120000000000005 112.39 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 69.4 m -100.2 126.85 46.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.024 -0.535 . . . . 51.039999999999999 111.101 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.543 ' CD2' HG13 ' B' ' 120' ' ' ILE . 60.2 tp -64.21 -49.82 70.5 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.991 -0.55 . . . . 53.399999999999999 111.522 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.51 -43.0 98.77 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.998 -0.62 . . . . 73.129999999999995 112.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 83' ' ' VAL . 48.2 t -68.39 -36.87 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.499 0.149 . . . . 53.409999999999997 110.923 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.61 -39.14 96.11 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.949 -0.643 . . . . 54.409999999999997 111.58 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 9.7 t80 -61.65 -44.5 96.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.703 0.287 . . . . 64.549999999999997 110.381 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.49 91.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 110.942 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.368 -0.378 . . . . 64.0 110.751 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.702 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.61 -41.12 99.85 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.989 -0.624 . . . . 74.409999999999997 111.994 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.629 ' HD2' HD13 ' A' ' 70' ' ' LEU . 14.7 ttp-105 -68.74 -34.72 76.08 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.645 0.259 . . . . 54.32 110.539 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.62 -37.33 87.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.272 -0.422 . . . . 62.299999999999997 111.792 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' B' ' 92' ' ' TYR . 52.7 t -75.87 -34.8 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 120.571 0.224 . . . . 74.420000000000002 111.093 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.8 -35.16 57.81 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.374 -0.375 . . . . 61.539999999999999 111.288 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.0 tm? -86.67 -53.82 4.73 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.335 -0.393 . . . . 63.509999999999998 111.355 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.31 -126.19 5.07 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.944 -0.646 . . . . 74.219999999999999 112.583 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.7 -62.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 111.362 0.134 . . . . 75.109999999999999 111.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.6 Cg_endo -74.64 98.06 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.394 2.063 . . . . 63.530000000000001 112.694 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 ' HB1' ' A' ' 97' ' ' ALA . 27.8 mm -110.65 149.53 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.816 -0.629 . . . . 73.150000000000006 111.562 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -128.65 141.0 51.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.92 -0.582 . . . . 74.549999999999997 110.301 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.568 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -134.64 130.34 36.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 74.519999999999996 111.217 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -117.29 104.6 11.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.491 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 19.1 t80 -111.05 133.53 53.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.048 -0.524 . . . . 72.420000000000002 110.95 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB2' HG22 ' A' ' 84' ' ' THR . 42.9 ttt180 -76.55 115.84 51.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.559 -0.291 . . . . 63.439999999999998 110.513 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 61.1 Cg_endo -74.79 7.51 2.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.823 2.349 . . . . 75.439999999999998 113.559 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 109' ' ' ARG . 9.4 tt0 -137.32 15.73 2.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.903 -0.135 . . . . 62.409999999999997 111.327 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.599 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -76.25 -27.6 56.8 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.472 0.177 . . . . 74.019999999999996 111.12 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.05 -40.02 2.17 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.023 -0.608 . . . . 53.140000000000001 112.815 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.84 -173.12 4.44 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.231 0.539 . . . . 73.129999999999995 110.709 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.84 158.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 111.6 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 120' ' ' ILE . 35.5 mt -78.41 129.94 35.52 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.386 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.18 173.16 4.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.46 . . . . 70.099999999999994 111.919 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.51 84.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.568 -0.742 . . . . 54.219999999999999 111.935 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.64 -42.92 99.87 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.607 -0.27 . . . . 71.409999999999997 111.014 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 116' ' ' LEU . 48.6 mm -68.84 -45.62 80.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.272 -0.422 . . . . 65.120000000000005 111.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -61.29 -41.79 97.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.523 -0.308 . . . . 61.520000000000003 110.325 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -65.03 -37.25 94.01 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.961 -0.563 . . . . 75.120000000000005 112.007 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -55.52 -39.45 70.53 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.476 0.179 . . . . 72.340000000000003 110.729 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.43 76.91 3.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.061 0.458 . . . . 72.040000000000006 111.051 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.32 -19.85 60.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.765 -0.652 . . . . 74.129999999999995 111.162 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.13 -11.96 60.39 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.129 -0.558 . . . . 61.420000000000002 113.034 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.48 -75.25 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.973 0.386 . . . . 64.310000000000002 110.826 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -117.1 -9.48 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.658 -0.701 . . . . 73.150000000000006 112.02 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.21 120.28 41.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.649 0.261 . . . . 73.510000000000005 110.583 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -123.56 125.75 45.42 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 111.008 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 106' ' ' CYS . 45.3 t -112.92 102.83 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 110.841 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 47.2 m0 -97.08 148.05 23.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.21 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 7.3 p-10 -100.0 117.35 34.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 111.089 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.543 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.53 123.55 48.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.981 0.42 . . . . 75.400000000000006 111.173 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -97.16 94.03 6.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.984 -0.553 . . . . 43.240000000000002 111.28 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.92 -102.66 0.12 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.825 0.676 . . . . 74.319999999999993 112.825 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -0.97 1.26 Allowed Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.17 -0.923 . . . . 74.519999999999996 113.166 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -93.59 -0.51 56.17 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.224 0.512 . . . . 61.530000000000001 111.743 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.543 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.0 p -63.98 -35.9 75.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.978 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.12 -38.67 79.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 62.140000000000001 110.367 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.03 -41.48 97.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.648 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.484 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.74 -38.29 83.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.133 -0.485 . . . . 64.340000000000003 111.098 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.51 -37.51 71.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.434 -0.348 . . . . 51.009999999999998 111.021 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -38.51 73.13 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.307 -0.406 . . . . 75.010000000000005 110.665 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -73.3 -34.05 65.52 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.262 -0.426 . . . . 61.149999999999999 110.886 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 25.2 t80 -69.63 -40.02 76.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.398 . . . . 72.540000000000006 111.055 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.25 -33.66 49.56 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.669 -0.241 . . . . 74.409999999999997 110.667 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.17 66.46 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 110.696 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -73.52 -25.67 60.53 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.41 -0.359 . . . . 75.209999999999994 111.4 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -76.18 -39.5 54.65 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.475 -0.33 . . . . 75.120000000000005 110.837 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.5 -35.84 68.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.188 -0.46 . . . . 60.340000000000003 111.263 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 149' ' ' ALA . 7.1 p -74.07 -35.58 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.508 -0.314 . . . . 73.099999999999994 111.564 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -82.05 -32.7 30.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.545 -0.298 . . . . 73.409999999999997 110.907 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 63.35 18.29 10.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.696 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.8 173.15 0.58 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.69 0.281 . . . . 71.439999999999998 111.107 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.07 70.67 1.03 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.032 0.444 . . . . 74.109999999999999 110.541 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.05 -38.48 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.831 -0.622 . . . . 73.450000000000003 111.217 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -61.02 141.57 57.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.23 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.155 -0.926 . . . . 73.109999999999999 110.992 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.554 0.216 . . . . 75.120000000000005 111.357 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -123.63 124.06 41.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.373 -0.376 . . . . 71.5 110.949 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -95.82 137.21 35.21 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.826 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -129.67 120.78 25.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.299 -0.41 . . . . 74.530000000000001 111.185 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' B' ' 78' ' ' VAL . 20.1 t -108.37 124.06 64.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.233 -0.439 . . . . 64.409999999999997 110.874 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.443 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.8 OUTLIER -101.18 124.5 46.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.283 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 15.9 t80 -90.29 134.48 34.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.388 -0.369 . . . . 64.319999999999993 111.143 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -117.07 109.84 17.47 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.309 -0.405 . . . . 75.150000000000006 111.301 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.68 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -142.6 131.71 4.78 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.149 -0.548 . . . . 64.299999999999997 112.593 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.456 ' HB2' HG21 ' B' ' 90' ' ' VAL . 7.7 t -69.66 119.35 13.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.506 0.194 . . . . 60.219999999999999 110.658 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.735 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -103.88 -41.77 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 116.587 -0.278 . . . . 64.329999999999998 111.128 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.465 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 50.82 38.07 18.75 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.059 -0.519 . . . . 62.310000000000002 110.912 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.488 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 66.95 24.11 72.95 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.761 -0.654 . . . . 60.140000000000001 112.496 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.04 158.19 23.06 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.87 -0.681 . . . . 61.32 113.302 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -101.82 15.11 30.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.501 0.191 . . . . 73.310000000000002 111.285 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -101.41 -9.06 21.45 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.58 0.229 . . . . 55.450000000000003 111.156 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.97 -27.38 14.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.019999999999996 110.856 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -44.38 93.23 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.445 -0.343 . . . . 63.439999999999998 111.054 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.13 93.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.587 -0.279 . . . . 35.210000000000001 110.779 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 31' ' ' ILE . 9.3 tp -70.1 -37.59 75.42 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.255 -0.43 . . . . 75.310000000000002 110.234 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' B' ' 14' ' ' PHE . 1.9 m-85 -65.05 -39.21 92.96 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.007 -0.542 . . . . 75.200000000000003 112.111 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.24 87.65 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.164 -0.214 . . . . 71.230000000000004 111.174 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -75.47 -34.45 60.9 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.476 -0.329 . . . . 73.329999999999998 111.801 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.502 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.5 pp -77.35 -29.79 16.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.49 0.186 . . . . 71.219999999999999 111.003 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.661 ' HA ' HG21 ' B' ' 41' ' ' VAL . 3.2 t -65.47 -41.47 91.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.538 -0.301 . . . . 70.319999999999993 110.784 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -39.0 89.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.595 0.236 . . . . 73.329999999999998 111.418 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -70.49 -38.09 74.31 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.353 -0.385 . . . . 75.430000000000007 111.441 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' B' ' 41' ' ' VAL . 6.4 mp -73.13 -36.53 66.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.426 -0.352 . . . . 63.219999999999999 111.274 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -69.82 -33.0 71.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.365 -0.38 . . . . 71.400000000000006 110.767 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -37.37 77.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.522 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -56.98 4.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.665 -0.243 . . . . 71.409999999999997 111.052 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.3 -82.46 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.751 -0.737 . . . . 73.349999999999994 112.234 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -144.31 138.75 28.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.621 0.248 . . . . 71.150000000000006 110.54 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' B' ' 32' ' ' VAL . 14.5 p -118.59 140.47 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.444 -0.344 . . . . 64.120000000000005 110.918 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 72' ' ' TRP . 1.9 mm? -100.5 -124.59 0.17 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.579 -0.526 . . . . 72.120000000000005 109.579 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.472 ' CG2' ' HE1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER 24.8 52.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.911 0.885 . . . . 71.299999999999997 112.063 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.13 -26.26 21.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.196 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.58 ' CE1' HG22 ' B' ' 46' ' ' VAL . 50.8 p-80 -53.99 -33.32 56.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 111.424 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.735 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -84.82 39.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.788 0.328 . . . . 53.219999999999999 111.198 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -178.04 49.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.425 -0.352 . . . . 54.130000000000003 111.489 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -131.67 111.32 11.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 74.409999999999997 111.529 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -100.97 59.31 0.91 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.376 0.608 . . . . 64.150000000000006 110.22 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 28.9 tt0 174.68 66.91 0.0 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.869 -1.06 . . . . 74.430000000000007 110.236 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.73 105.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.13 -0.487 . . . . 74.239999999999995 111.001 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -55.46 109.35 1.56 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.92 -0.582 . . . . 63.409999999999997 111.561 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.0 -165.34 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.236 2.624 . . . . 70.030000000000001 112.581 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.59 166.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.223 -0.899 . . . . 72.219999999999999 111.726 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.39 -159.55 13.82 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 73.129999999999995 112.764 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.56 130.4 46.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.716 0.294 . . . . 73.439999999999998 111.144 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.04 78.28 6.71 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.134 -0.485 . . . . 73.120000000000005 110.672 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.36 172.81 12.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.894 -0.594 . . . . 61.439999999999998 111.172 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.04 76.1 9.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.102 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.06 146.48 18.16 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.076 -0.583 . . . . 72.450000000000003 112.507 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.53 -94.37 0.09 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.813 -0.708 . . . . 62.140000000000001 112.645 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.617 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -60.79 -47.92 84.14 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.507 0.194 . . . . 71.329999999999998 111.114 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -57.97 -38.19 75.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.558 -0.292 . . . . 71.040000000000006 110.678 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.9 -37.99 82.43 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.075 -0.511 . . . . 65.209999999999994 110.402 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.869 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 5.9 mt -57.11 -44.95 84.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.012 -0.54 . . . . 75.409999999999997 110.754 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 16.5 t-80 -69.67 -36.6 76.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.298 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.75 -37.12 76.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.32 -0.4 . . . . 64.420000000000002 111.52 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.574 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -66.23 -39.88 89.87 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.723 -0.217 . . . . 54.520000000000003 111.199 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.42 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -68.16 -35.58 78.29 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.467 -0.333 . . . . 55.350000000000001 111.481 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.612 HD13 ' HD2' ' B' ' 96' ' ' ARG . 2.7 mm? -67.61 -39.76 84.74 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.426 -0.352 . . . . 73.049999999999997 111.403 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.11 -36.57 77.67 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.417 -0.356 . . . . 75.200000000000003 111.878 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.548 ' CD1' HD12 ' B' ' 42' ' ' LEU . 4.0 m0 -71.22 -36.93 72.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.81 0.3 . . . . 71.329999999999998 111.81 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -67.77 -28.07 67.3 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 121.188 -0.205 . . . . 52.210000000000001 111.16 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -56.21 -41.93 76.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.548 -0.296 . . . . 75.450000000000003 110.658 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -89.9 -29.36 18.59 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.191 -0.459 . . . . 62.520000000000003 111.358 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' B' ' 73' ' ' LEU . . . -59.11 106.93 0.48 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.572 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.25 -26.59 62.96 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.801 -0.636 . . . . 54.100000000000001 110.84 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' B' ' 12' ' ' VAL . 9.1 p -143.03 145.96 22.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.82 0.343 . . . . 72.040000000000006 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' B' ' 104' ' ' ILE . 58.0 t -117.91 136.86 53.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.085 -0.507 . . . . 70.019999999999996 110.716 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -130.2 131.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 63.5 110.005 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.62 46.43 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.0 0.37 . . . . 33.340000000000003 112.0 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -138.42 91.26 2.53 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.777 -0.647 . . . . 73.030000000000001 110.537 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.63 HG21 HG11 ' B' ' 90' ' ' VAL . 1.6 t -133.61 126.7 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.108 -0.497 . . . . 63.340000000000003 110.819 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.687 HG22 ' HB2' ' B' ' 109' ' ' ARG . 72.0 p -79.91 -21.88 43.42 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.132 0.419 . . . . 71.530000000000001 112.132 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.415 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -129.1 156.24 78.52 Favored Pre-proline 0 N--CA 1.463 0.189 0 CA-C-O 120.711 0.291 . . . . 72.420000000000002 111.395 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.518 ' HA ' HD22 ' A' ' 88' ' ' LEU . 29.3 Cg_endo -62.72 104.11 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.829 2.353 . . . . 75.140000000000001 112.329 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' B' ' 90' ' ' VAL . 69.4 m -100.17 126.8 46.49 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.031 -0.531 . . . . 72.540000000000006 111.053 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' A' ' 120' ' ' ILE . 60.0 tp -64.17 -49.76 70.81 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.957 -0.565 . . . . 74.400000000000006 111.576 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.98 98.72 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.001 -0.619 . . . . 60.420000000000002 112.577 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 HG21 ' B' ' 83' ' ' VAL . 48.3 t -68.42 -36.86 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.418 0.152 . . . . 64.319999999999993 110.94 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.63 -39.11 96.09 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.942 -0.647 . . . . 74.239999999999995 111.589 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.702 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 9.6 t80 -61.69 -44.45 96.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.653 0.263 . . . . 71.109999999999999 110.407 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.475 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 46.8 mt-10 -60.42 -40.51 91.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.914 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.48 HD21 ' SG ' ' B' ' 106' ' ' CYS . 4.9 mp -62.54 -40.73 97.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.361 -0.381 . . . . 73.219999999999999 110.753 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.6 -41.2 99.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.006 -0.616 . . . . 53.020000000000003 111.94 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.612 ' HD2' HD13 ' B' ' 70' ' ' LEU . 14.7 ttp-105 -68.71 -34.75 76.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 72.030000000000001 110.53 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.531 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.62 -37.23 86.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.276 -0.42 . . . . 50.119999999999997 111.835 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.422 HG21 ' OH ' ' A' ' 92' ' ' TYR . 52.6 t -75.95 -34.72 27.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.596 0.236 . . . . 72.329999999999998 111.103 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.11 57.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.345 -0.389 . . . . 72.430000000000007 111.309 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.411 ' C ' HD13 ' B' ' 100' ' ' LEU . 3.0 tm? -86.62 -53.86 4.72 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.333 -0.394 . . . . 74.25 111.396 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.22 -126.21 5.05 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.013 -0.613 . . . . 52.240000000000002 112.559 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -167.74 -62.42 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.398 0.147 . . . . 72.310000000000002 111.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HB2' HG23 ' B' ' 78' ' ' VAL . 73.4 Cg_endo -74.7 98.1 1.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.398 2.065 . . . . 74.109999999999999 112.65 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.531 HD12 ' HB1' ' B' ' 97' ' ' ALA . 27.8 mm -110.72 149.58 13.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.794 -0.639 . . . . 72.439999999999998 111.557 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.2 OUTLIER -128.71 141.0 51.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.838 -0.619 . . . . 74.230000000000004 110.265 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.557 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.6 OUTLIER -134.61 130.35 36.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.307 -0.406 . . . . 71.230000000000004 111.242 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -117.34 104.63 11.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.245 -0.434 . . . . 61.149999999999999 110.433 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 19.2 t80 -111.1 133.51 53.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.044 -0.526 . . . . 73.25 110.922 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.687 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.0 ttt180 -76.54 115.89 51.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.512 -0.313 . . . . 74.230000000000004 110.513 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.427 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 61.2 Cg_endo -74.79 7.4 2.8 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.873 2.382 . . . . 71.310000000000002 113.545 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' B' ' 109' ' ' ARG . 9.4 tt0 -137.21 15.72 3.01 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.079 0.152 . . . . 71.120000000000005 111.384 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.8 OUTLIER -76.21 -27.58 56.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.466 0.174 . . . . 63.32 111.127 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.06 -40.05 2.17 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.963 -0.636 . . . . 74.340000000000003 112.77 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -173.13 4.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.282 0.563 . . . . 64.310000000000002 110.737 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.8 158.19 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 71.209999999999994 111.643 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.968 HD22 HG21 ' B' ' 120' ' ' ILE . 35.6 mt -78.42 129.86 35.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.396 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p -67.08 173.16 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.056 0.455 . . . . 64.329999999999998 111.945 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.6 85.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.577 -0.738 . . . . 74.239999999999995 111.86 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 7.8 tpt -62.63 -42.98 99.9 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.618 -0.264 . . . . 73.409999999999997 110.987 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.968 HG21 HD22 ' B' ' 116' ' ' LEU . 48.6 mm -68.71 -45.61 80.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.273 -0.421 . . . . 62.210000000000001 111.28 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -61.37 -41.8 97.67 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 74.430000000000007 110.235 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -65.01 -37.27 94.05 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 112.039 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -55.47 -39.51 70.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.498 0.19 . . . . 73.299999999999997 110.701 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.4 76.92 3.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 54.119999999999997 111.042 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -19.83 60.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.773 -0.648 . . . . 64.310000000000002 111.117 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.11 -11.92 60.42 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.183 -0.532 . . . . 22.449999999999999 113.078 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.3 m -67.42 -75.27 0.1 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.864 0.364 . . . . 62.420000000000002 110.862 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.44 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -117.08 -9.5 11.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 72.310000000000002 112.049 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -105.2 120.28 41.14 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.613 0.244 . . . . 72.209999999999994 110.553 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -123.54 125.75 45.44 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.273 -0.421 . . . . 61.350000000000001 111.088 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' B' ' 106' ' ' CYS . 45.3 t -112.95 102.79 14.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 110.895 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 47.4 m0 -96.97 148.02 23.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.079 -0.51 . . . . 75.140000000000001 111.262 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 7.3 p-10 -99.96 117.36 34.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.734 -0.666 . . . . 74.540000000000006 111.067 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.2 p90 -115.54 123.58 48.85 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.974 0.416 . . . . 60.140000000000001 111.212 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -97.2 94.02 6.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 73.239999999999995 111.26 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.89 -102.65 0.12 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.795 0.665 . . . . 55.549999999999997 112.795 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.03 -0.95 1.25 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 115.152 -0.931 . . . . 73.319999999999993 113.169 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -93.61 -0.5 56.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.243 0.522 . . . . 63.240000000000002 111.788 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 8.9 p -63.91 -35.95 75.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 120.832 0.349 . . . . 73.010000000000005 111.033 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.99 -38.76 79.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.823 -0.626 . . . . 73.530000000000001 110.341 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 10.2 m -64.04 -41.39 97.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.247 -0.433 . . . . 53.299999999999997 110.662 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.469 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -67.82 -38.3 83.05 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 111.04 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.49 -37.53 71.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.478 -0.328 . . . . 75.219999999999999 111.044 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.79 -38.49 73.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.733 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -73.35 -34.03 65.4 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.235 -0.438 . . . . 71.340000000000003 110.893 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.52 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.9 t80 -69.65 -39.98 76.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.353 -0.385 . . . . 71.25 111.033 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.3 -33.66 49.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.626 -0.261 . . . . 75.439999999999998 110.652 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.94 -39.25 66.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.298 -0.41 . . . . 75.299999999999997 110.649 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -73.4 -25.72 60.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 75.510000000000005 111.438 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.476 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -76.16 -39.5 54.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.835 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 20.3 tp -72.52 -35.85 68.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.122 -0.49 . . . . 71.099999999999994 111.254 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' B' ' 149' ' ' ALA . 7.1 p -74.03 -35.73 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.529 -0.305 . . . . 52.119999999999997 111.519 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.99 -32.66 30.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.513 -0.312 . . . . 74.010000000000005 110.959 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 63.35 18.28 10.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 111.694 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 177.79 173.11 0.58 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.765 0.317 . . . . 74.120000000000005 111.087 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -123.08 70.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.237 -0.438 . . . . 71.030000000000001 110.503 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -112.04 -38.51 4.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 75.430000000000007 111.242 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -60.99 141.58 57.22 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.425 -0.352 . . . . 72.329999999999998 111.203 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.218 -0.896 . . . . 73.319999999999993 110.997 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.86 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.869 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 14.9 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.791 0.329 . . . . 64.219999999999999 111.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.41 152.93 48.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 111.068 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -89.94 124.76 35.0 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.297 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.028 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.4 m -134.81 130.71 36.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.432 -0.349 . . . . 63.32 111.61 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' HG ' ' A' ' 35' ' ' LEU . 2.7 p -128.08 116.55 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.995 -0.548 . . . . 72.510000000000005 110.914 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 2.0 t80 -93.6 131.7 38.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.796 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 31' ' ' ILE . 27.8 t80 -112.59 120.7 42.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 71.109999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 1.8 m -119.33 130.35 55.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 110.677 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.94 31.4 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.282 -0.961 . . . . 53.299999999999997 113.821 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.691 ' HB3' HG21 ' A' ' 90' ' ' VAL . 84.3 p 50.59 102.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.082 0.441 . . . . 33.109999999999999 111.858 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -92.05 -42.47 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 120.66 0.267 . . . . 73.120000000000005 110.467 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 51.37 38.95 23.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.846 -0.615 . . . . 73.209999999999994 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 58.79 27.9 62.38 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.251 -0.886 . . . . 72.239999999999995 111.962 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.2 157.23 24.78 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 120.73 -0.748 . . . . 70.400000000000006 113.458 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -104.18 16.28 26.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.628 0.252 . . . . 74.420000000000002 110.858 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -101.74 -25.2 13.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 110.989 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.52 -26.33 24.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.022 -0.535 . . . . 70.420000000000002 110.808 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.38 -40.89 71.9 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.536 -0.302 . . . . 51.399999999999999 110.786 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.68 97.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 74.540000000000006 110.585 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.5 tp -71.57 -37.19 71.08 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.283 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.845 ' CE1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.75 -33.33 74.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.802 -0.635 . . . . 65.349999999999994 111.371 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -70.75 -38.12 73.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.7 0.286 . . . . 65.200000000000003 111.341 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.01 -34.3 57.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.458 -0.337 . . . . 74.409999999999997 111.306 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -78.4 -32.67 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 116.758 -0.201 . . . . 61.130000000000003 111.177 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.932 HG23 HG21 ' A' ' 41' ' ' VAL . 9.5 p -67.26 -33.58 63.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.762 -0.199 . . . . 62.119999999999997 111.216 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.33 -41.19 77.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.674 0.273 . . . . 73.099999999999994 110.625 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.75 -36.61 67.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 75.299999999999997 110.771 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.8 mp -67.41 -40.09 85.56 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.14 -0.482 . . . . 71.109999999999999 110.875 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.46 -33.51 75.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.303 -0.408 . . . . 74.219999999999999 110.645 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.42 70.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.148 -0.478 . . . . 64.549999999999997 111.365 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.91 -56.27 4.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.678 -0.237 . . . . 72.030000000000001 110.618 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.03 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.981 -0.628 . . . . 71.25 112.29 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -149.7 129.54 13.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 72.140000000000001 111.197 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 32' ' ' VAL . 8.2 p -84.56 143.85 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 75.030000000000001 110.728 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.4 mm? -107.21 3.9 26.11 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.827 0.306 . . . . 75.239999999999995 111.827 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.66 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.85 59.05 1.68 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.451 0.643 . . . . 62.119999999999997 110.433 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -26.41 20.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.418 -0.81 . . . . 73.299999999999997 110.509 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' NE2' ' N3 ' ' A' ' 187' ' ' 5GP . 45.9 p-80 -60.25 -31.8 70.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.9 -0.591 . . . . 53.439999999999998 111.39 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.845 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -57.31 -17.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 44.130000000000003 111.546 -179.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.67 36.86 4.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.498 0.185 . . . . 71.450000000000003 111.498 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.36 158.91 17.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.026 0.441 . . . . 72.420000000000002 111.418 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -139.88 49.5 1.77 Allowed 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.762 0.791 . . . . 45.020000000000003 110.171 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 tt0 170.18 68.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.019 -1.446 . . . . 74.010000000000005 110.087 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 111.242 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.45 105.78 0.55 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.917 -0.583 . . . . 64.319999999999993 111.957 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.6 84.23 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.317 2.678 . . . . 61.539999999999999 112.384 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.72 151.49 45.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.251 -0.432 . . . . 65.340000000000003 111.295 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.91 178.13 18.34 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.229 -0.51 . . . . 43.229999999999997 112.908 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 164.74 15.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.783 0.325 . . . . 52.109999999999999 111.213 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.4 88.78 0.66 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.039 -0.528 . . . . 72.349999999999994 110.989 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.64 55.58 0.14 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.92 -0.582 . . . . 34.140000000000001 110.83 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.89 146.3 28.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.997 -0.547 . . . . 54.299999999999997 111.237 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.44 -171.28 21.16 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.956 -0.64 . . . . 65.140000000000001 112.752 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.62 -99.53 0.89 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.188 -0.529 . . . . 24.41 112.624 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.629 ' HA ' HD12 ' A' ' 65' ' ' ILE . 2.3 p30 -67.16 -40.31 86.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.126 0.171 . . . . 63.329999999999998 111.325 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.44 -38.64 74.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.65 -0.25 . . . . 61.310000000000002 111.1 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -62.97 -37.09 85.72 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.428 -0.351 . . . . 71.219999999999999 110.567 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 62' ' ' ASP . 48.7 mt -61.9 -43.63 97.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.216 -0.447 . . . . 65.099999999999994 110.821 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' O ' HD23 ' A' ' 70' ' ' LEU . 14.4 t-80 -63.97 -40.23 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.679 . . . . 70.230000000000004 111.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.84 -36.63 72.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 62.0 111.357 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.3 -38.99 71.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 71.400000000000006 111.252 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.69 82.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.449 -0.341 . . . . 73.299999999999997 111.28 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 96' ' ' ARG . 4.1 mm? -71.69 -36.84 70.72 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 111.194 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.41 -37.91 74.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.348 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 7.8 m0 -66.29 -39.91 89.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.463 -0.335 . . . . 73.540000000000006 111.109 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -65.82 -30.44 71.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 61.350000000000001 111.246 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -40.57 65.05 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.654 0.264 . . . . 64.239999999999995 110.769 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.76 -31.55 17.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.168 -0.469 . . . . 70.439999999999998 111.102 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -56.15 105.25 0.18 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.971 0.415 . . . . 72.239999999999995 111.591 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.48 -29.18 69.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.689 -0.687 . . . . 75.5 110.568 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG21 ' CE2' ' A' ' 150' ' ' TYR . 11.8 p -141.63 143.15 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 110.825 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 73' ' ' LEU . 61.0 t -118.88 126.08 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.096 -0.502 . . . . 71.019999999999996 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -114.04 140.8 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.164 -0.471 . . . . 55.340000000000003 110.097 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -127.77 143.5 51.13 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.782 0.289 . . . . 64.439999999999998 111.782 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 2.7 tt0 -140.2 95.23 2.85 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.078 -0.51 . . . . 74.530000000000001 110.622 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -137.91 137.59 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.151 -0.477 . . . . 71.549999999999997 111.129 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 109' ' ' ARG . 18.4 p -101.14 22.96 11.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.36 -0.382 . . . . 54.130000000000003 111.514 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.32 151.14 5.32 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-O 120.574 0.226 . . . . 75.450000000000003 111.103 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.937 ' HA ' HD12 ' B' ' 88' ' ' LEU . 24.1 Cg_endo -60.76 99.03 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 75.129999999999995 112.589 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.35 125.77 46.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.884 -0.598 . . . . 74.430000000000007 110.721 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.954 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -67.9 -46.98 70.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 111.498 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.05 -44.46 97.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.006 -0.616 . . . . 42.229999999999997 112.549 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 17' ' ' SER . 72.0 t -67.56 -38.3 80.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.566 0.222 . . . . 74.25 110.411 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -61.35 -39.43 97.24 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.323 -0.711 . . . . 74.120000000000005 111.323 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.629 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.9 t80 -62.58 -45.85 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.971 -0.381 . . . . 71.530000000000001 109.971 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -37.25 76.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 110.292 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -65.14 -40.35 94.28 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.31 -0.404 . . . . 74.239999999999995 110.332 179.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.64 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -61.59 -42.45 99.76 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.984 -0.627 . . . . 43.450000000000003 111.825 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.664 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.81 68.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.603 0.24 . . . . 72.510000000000005 110.568 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -65.92 -37.39 85.96 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.189 -0.46 . . . . 52.030000000000001 111.432 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.33 -34.91 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.628 -0.26 . . . . 72.310000000000002 110.953 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.663 ' HB2' ' CD ' ' B' ' 96' ' ' ARG . . . -72.22 -37.98 69.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.397 -0.365 . . . . 64.430000000000007 111.526 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -87.1 -54.11 4.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 73.239999999999995 111.362 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.41 6.54 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.0 -0.619 . . . . 61.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.24 -60.71 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 111.406 0.15 . . . . 71.030000000000001 111.406 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 128' ' ' ARG . 59.9 Cg_endo -71.13 98.53 0.82 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.318 2.012 . . . . 74.230000000000004 112.354 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 79' ' ' VAL . 37.3 mm -110.82 149.77 13.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.857 -0.611 . . . . 75.319999999999993 111.39 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.575 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.67 141.72 51.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.776 -0.647 . . . . 52.450000000000003 110.024 179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.712 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -134.69 132.43 38.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.52 -0.309 . . . . 71.150000000000006 111.049 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.598 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.29 99.22 6.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.891 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 17.2 t80 -114.36 127.28 55.77 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.939 -0.573 . . . . 73.340000000000003 111.076 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.679 ' HB2' HG22 ' A' ' 84' ' ' THR . 31.1 ttt180 -63.11 120.14 58.74 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.571 -0.286 . . . . 71.310000000000002 110.385 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' CG ' ' HB2' ' A' ' 133' ' ' ASP . 58.5 Cg_endo -72.51 9.47 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.034 2.489 . . . . 61.229999999999997 114.071 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 22.59 0.8 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.533 0.206 . . . . 72.430000000000007 111.202 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -73.35 -28.97 62.34 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.543 0.211 . . . . 74.150000000000006 111.173 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.89 -39.68 2.48 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.966 -0.635 . . . . 31.239999999999998 112.655 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -87.96 -173.23 4.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.33 0.586 . . . . 73.239999999999995 110.749 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.41 163.21 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.232 -0.895 . . . . 72.129999999999995 111.157 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.809 HD12 HD13 ' B' ' 88' ' ' LEU . 1.3 mm? -75.95 -101.36 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.307 -0.406 . . . . 73.420000000000002 110.489 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.55 168.28 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.464 0.306 . . . . 71.510000000000005 110.462 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.02 -31.83 71.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.396 . . . . 65.439999999999998 111.238 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -67.58 -47.78 68.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.551 -0.295 . . . . 73.040000000000006 110.742 179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 29.8 mm -65.37 -47.06 88.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.253 -0.43 . . . . 73.150000000000006 110.757 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.46 -39.9 89.22 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 74.109999999999999 110.52 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.55 -40.22 98.48 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.107 -0.497 . . . . 63.32 112.191 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.83 -40.63 80.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.626 0.251 . . . . 72.230000000000004 110.934 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.28 85.08 3.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 52.109999999999999 111.287 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.1 -19.26 34.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.947 -0.57 . . . . 74.209999999999994 111.164 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.97 -10.66 44.53 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.145 -0.55 . . . . 63.020000000000003 113.609 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -73.62 0.15 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.215 0.507 . . . . 45.109999999999999 110.877 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 8.2 mpt_? -114.78 -13.91 12.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 71.239999999999995 111.985 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.624 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 2.6 t80 -105.07 122.54 46.09 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.704 0.288 . . . . 71.129999999999995 110.897 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.87 126.8 40.52 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 111.044 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.712 HG13 ' HB3' ' A' ' 106' ' ' CYS . 44.1 t -108.94 95.05 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.162 -0.472 . . . . 62.299999999999997 110.876 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.1 m0 -87.03 147.8 25.55 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.145 -0.48 . . . . 75.319999999999993 111.057 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 p-10 -104.98 113.0 26.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.705 . . . . 64.209999999999994 111.287 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.523 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -109.75 122.34 47.27 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.243 -0.435 . . . . 70.420000000000002 111.008 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -98.94 94.5 6.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.12 -0.491 . . . . 40.109999999999999 111.521 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.9 -102.65 0.12 Allowed 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.989 0.737 . . . . 72.0 112.989 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.93 -2.53 1.27 Allowed Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.398 -0.819 . . . . 54.310000000000002 113.064 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -95.82 3.78 53.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 117.398 0.599 . . . . 65.239999999999995 111.59 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 12.7 p -67.34 -37.02 78.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-O 120.765 0.317 . . . . 75.439999999999998 111.108 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.7 -38.44 70.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.595 . . . . 65.040000000000006 110.485 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.6 m -66.27 -41.05 90.4 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.203 -0.453 . . . . 64.519999999999996 110.543 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.536 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.42 -36.74 71.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.021 -0.536 . . . . 64.099999999999994 111.17 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.02 -39.12 76.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.372 -0.376 . . . . 72.200000000000003 110.811 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.81 -37.93 73.29 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.245 -0.434 . . . . 51.299999999999997 110.62 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -68.97 -33.99 74.59 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 111.192 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 27.8 t80 -68.4 -40.91 81.16 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.575 -0.284 . . . . 70.530000000000001 110.841 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -76.29 -34.44 59.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 70.439999999999998 110.779 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.17 -38.15 66.3 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.256 -0.429 . . . . 75.420000000000002 110.829 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -72.49 -26.88 61.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.276 -0.42 . . . . 64.340000000000003 111.151 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -75.66 -39.41 57.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.378 -0.374 . . . . 75.420000000000002 110.789 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -36.23 69.78 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.259 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.9 p -72.38 -32.97 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.512 -0.313 . . . . 74.329999999999998 111.715 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.33 -32.64 29.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.543 0.211 . . . . 74.420000000000002 110.862 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 60.2 27.07 16.54 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 111.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.96 -71.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.548 -0.296 . . . . 73.299999999999997 111.118 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -174.26 130.83 0.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.41 -0.359 . . . . 74.299999999999997 110.892 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.88 148.83 45.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.249 -0.432 . . . . 64.040000000000006 110.883 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.86 162.77 13.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.301 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.012 -0.995 . . . . 72.129999999999995 111.214 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 15.0 mtt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.778 0.323 . . . . 75.439999999999998 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -138.29 153.02 49.05 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.11 -0.496 . . . . 74.319999999999993 111.134 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -90.02 124.74 35.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.22 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.012 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.2 m -134.84 130.73 36.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.863 0.363 . . . . 61.509999999999998 111.537 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' HG ' ' B' ' 35' ' ' LEU . 2.7 p -128.02 116.51 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.991 -0.549 . . . . 64.400000000000006 111.056 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 2.0 t80 -93.66 131.72 38.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.703 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.556 ' CG ' HD13 ' B' ' 31' ' ' ILE . 28.2 t80 -112.65 120.78 42.74 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.364 -0.38 . . . . 72.230000000000004 111.078 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 1.8 m -119.36 130.33 55.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.621 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 31.4 1.09 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.26 -0.972 . . . . 54.43 113.82 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.668 ' HB3' HG21 ' B' ' 90' ' ' VAL . 84.6 p 50.71 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.785 0.434 . . . . 53.299999999999997 111.829 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.517 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -91.95 -42.56 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 120.617 0.246 . . . . 62.229999999999997 110.495 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 51.29 38.98 22.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.831 -0.622 . . . . 75.510000000000005 110.079 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 58.82 27.98 62.57 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.323 -0.853 . . . . 65.439999999999998 111.959 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.21 157.22 24.77 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.693 -0.765 . . . . 64.129999999999995 113.377 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -104.11 16.1 26.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.63 0.252 . . . . 72.310000000000002 110.785 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -101.67 -25.27 13.92 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.492 -0.322 . . . . 52.149999999999999 110.993 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -86.51 -26.33 24.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.0 -0.545 . . . . 74.219999999999999 110.796 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -40.89 71.94 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.515 -0.311 . . . . 73.319999999999993 110.775 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.71 97.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.383 -0.371 . . . . 72.310000000000002 110.568 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.5 tp -71.54 -37.24 71.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.256 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.832 ' CE1' HG21 ' B' ' 46' ' ' VAL . 2.5 m-85 -67.73 -33.28 74.56 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.802 -0.635 . . . . 71.299999999999997 111.4 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.487 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -70.79 -38.13 73.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.648 0.261 . . . . 54.340000000000003 111.337 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.97 -34.22 57.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.487 -0.324 . . . . 72.109999999999999 111.347 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.556 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -78.52 -32.57 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.762 -0.199 . . . . 75.519999999999996 111.187 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.909 HG23 HG21 ' B' ' 41' ' ' VAL . 9.6 p -67.35 -33.63 63.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.721 -0.218 . . . . 74.230000000000004 111.198 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -69.2 -41.22 77.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.678 0.275 . . . . 72.030000000000001 110.681 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -72.76 -36.53 67.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.849 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.495 HD21 ' HB2' ' B' ' 14' ' ' PHE . 5.8 mp -67.47 -40.1 85.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.783 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -67.48 -33.5 75.24 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.554 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.33 70.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.377 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.99 -56.37 4.44 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.64 -0.255 . . . . 75.129999999999995 110.568 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.94 -86.75 0.06 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.909 -0.662 . . . . 42.030000000000001 112.339 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -149.77 129.53 13.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.646 0.26 . . . . 73.120000000000005 111.244 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.909 HG21 HG23 ' B' ' 32' ' ' VAL . 8.2 p -84.47 143.9 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 110.721 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 1.012 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.4 mm? -107.3 4.0 26.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.791 0.293 . . . . 75.439999999999998 111.791 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.666 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.8 59.01 1.68 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.513 0.673 . . . . 61.310000000000002 110.541 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -26.35 20.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.427 -0.806 . . . . 72.450000000000003 110.464 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.435 ' NE2' ' N3 ' ' B' ' 187' ' ' 5GP . 45.6 p-80 -60.22 -31.87 70.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.924 -0.58 . . . . 75.030000000000001 111.414 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.832 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.6 OUTLIER -57.29 -17.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 111.616 -179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.68 36.91 4.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.501 0.191 . . . . 75.219999999999999 111.425 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -108.37 158.87 17.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.979 0.419 . . . . 64.310000000000002 111.457 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -139.77 49.4 1.78 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.643 0.735 . . . . 75.439999999999998 110.223 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 4.8 tt0 170.24 68.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.009 -1.45 . . . . 75.450000000000003 110.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.27 100.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.28 -0.418 . . . . 72.340000000000003 111.154 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.5 105.79 0.55 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.95 -0.568 . . . . 73.329999999999998 111.953 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.64 84.24 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.247 2.632 . . . . 61.340000000000003 112.417 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.67 151.61 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.227 -0.442 . . . . 63.509999999999998 111.249 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.87 178.13 18.36 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.177 -0.535 . . . . 64.510000000000005 112.943 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.38 164.83 15.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.815 0.341 . . . . 73.099999999999994 111.257 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -70.52 88.8 0.68 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.941 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -164.59 55.66 0.14 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.035 -0.53 . . . . 70.099999999999994 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.92 146.34 28.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.002 -0.545 . . . . 75.349999999999994 111.25 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.45 -171.3 21.19 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.966 -0.635 . . . . 74.519999999999996 112.714 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.61 -99.44 0.89 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.057 -0.592 . . . . 44.140000000000001 112.63 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' B' ' 65' ' ' ILE . 2.3 p30 -67.22 -40.35 86.38 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.452 0.167 . . . . 74.519999999999996 111.343 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -57.33 -38.63 74.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.591 -0.277 . . . . 51.130000000000003 111.103 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -63.04 -37.03 85.56 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.465 -0.334 . . . . 74.400000000000006 110.514 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.623 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 48.5 mt -62.03 -43.51 97.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.835 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.549 ' O ' HD23 ' B' ' 70' ' ' LEU . 14.5 t-80 -64.08 -40.17 95.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 73.420000000000002 111.411 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -70.88 -36.54 72.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 70.430000000000007 111.406 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.36 -38.96 71.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.44 -0.345 . . . . 65.540000000000006 111.228 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.63 82.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.524 -0.307 . . . . 45.140000000000001 111.278 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.556 HD11 ' HG3' ' B' ' 96' ' ' ARG . 4.1 mm? -71.77 -36.86 70.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.225 -0.443 . . . . 73.299999999999997 111.09 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.43 -37.81 74.44 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.337 -0.392 . . . . 51.009999999999998 111.349 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 7.7 m0 -66.45 -39.82 89.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.529 -0.305 . . . . 73.230000000000004 111.042 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -65.91 -30.47 71.06 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.436 -0.347 . . . . 70.219999999999999 111.244 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -40.65 64.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.576 -0.284 . . . . 73.340000000000003 110.795 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -89.73 -31.58 17.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.018 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.537 ' HB2' ' HG ' ' B' ' 42' ' ' LEU . . . -56.22 105.22 0.18 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.006 0.431 . . . . 65.319999999999993 111.542 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.45 -29.13 69.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.657 -0.701 . . . . 70.219999999999999 110.506 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' B' ' 150' ' ' TYR . 11.8 p -141.66 143.11 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 72.120000000000005 110.796 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.452 HG21 HD21 ' B' ' 73' ' ' LEU . 61.0 t -118.86 126.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 71.409999999999997 110.845 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.567 HG23 ' CB ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -114.01 140.75 33.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.121 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -127.74 143.56 51.13 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.753 0.279 . . . . 73.109999999999999 111.753 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 2.7 tt0 -140.29 95.27 2.85 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.078 -0.51 . . . . 70.219999999999999 110.59 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.494 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -137.85 137.61 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.089 -0.505 . . . . 74.129999999999995 111.129 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 109' ' ' ARG . 18.5 p -101.12 23.04 11.39 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.338 -0.392 . . . . 71.329999999999998 111.594 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.35 151.1 5.28 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-O 120.536 0.208 . . . . 73.239999999999995 111.118 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.954 ' HA ' HD12 ' A' ' 88' ' ' LEU . 24.0 Cg_endo -60.79 99.11 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.914 2.409 . . . . 43.399999999999999 112.563 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -100.33 125.78 46.59 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.957 -0.565 . . . . 74.209999999999994 110.701 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -67.92 -47.07 69.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.47 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -44.36 97.47 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.077 -0.582 . . . . 71.209999999999994 112.567 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.668 HG21 ' HB3' ' B' ' 17' ' ' SER . 73.9 t -67.64 -38.36 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 110.35 -0.241 . . . . 61.109999999999999 110.35 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.534 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -61.33 -39.44 97.24 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.264 -0.735 . . . . 65.099999999999994 111.264 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.64 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.8 t80 -62.65 -45.83 91.0 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.925 -0.398 . . . . 73.420000000000002 109.925 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 119' ' ' MET . 0.9 OUTLIER -58.88 -37.15 75.92 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.08 -0.509 . . . . 74.209999999999994 110.449 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.4 OUTLIER -65.26 -40.29 93.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.321 -0.399 . . . . 63.340000000000003 110.319 179.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -61.67 -42.38 99.75 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.942 -0.647 . . . . 74.349999999999994 111.892 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.663 ' CD ' ' HB2' ' A' ' 99' ' ' ALA . 5.4 mmm-85 -70.57 -31.9 69.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.676 0.274 . . . . 63.32 110.609 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.695 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -65.72 -37.41 86.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.187 -0.461 . . . . 40.119999999999997 111.459 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.44 -34.85 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.641 -0.254 . . . . 75.420000000000002 110.889 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.664 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -72.29 -37.99 68.88 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 55.200000000000003 111.4 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' B' ' 100' ' ' LEU . 0.3 OUTLIER -87.06 -54.17 4.47 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 111.408 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.43 -131.6 6.62 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.101 -0.571 . . . . 73.239999999999995 112.73 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.08 -60.83 0.01 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 111.369 0.137 . . . . 61.310000000000002 111.369 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' B' ' 128' ' ' ARG . 60.0 Cg_endo -70.98 98.43 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.411 2.074 . . . . 65.200000000000003 112.386 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' B' ' 79' ' ' VAL . 37.2 mm -110.72 149.73 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.909 -0.587 . . . . 63.049999999999997 111.437 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.567 ' CB ' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -128.64 141.79 51.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.625 . . . . 71.109999999999999 110.058 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.723 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -134.74 132.41 38.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.558 -0.292 . . . . 73.010000000000005 110.954 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.31 99.25 6.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 110.877 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 17.2 t80 -114.3 127.33 55.82 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.912 -0.585 . . . . 71.450000000000003 111.108 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.673 ' HB2' HG22 ' B' ' 84' ' ' THR . 31.0 ttt180 -63.22 120.14 59.05 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.583 -0.281 . . . . 70.319999999999993 110.415 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.438 ' CG ' ' HB2' ' B' ' 133' ' ' ASP . 58.3 Cg_endo -72.6 9.58 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.065 2.51 . . . . 70.019999999999996 113.995 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.71 22.6 0.79 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.497 0.189 . . . . 64.409999999999997 111.178 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.545 ' HB2' ' HB3' ' B' ' 109' ' ' ARG . 0.1 OUTLIER -73.34 -29.02 62.39 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.581 0.229 . . . . 64.230000000000004 111.215 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.98 -39.6 2.49 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.943 -0.646 . . . . 23.420000000000002 112.617 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -88.13 -173.32 4.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.29 163.25 2.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.227 -0.897 . . . . 74.230000000000004 111.192 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 88' ' ' LEU . 1.3 mm? -75.99 -101.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.327 -0.397 . . . . 70.319999999999993 110.513 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 170.53 168.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.521 0.328 . . . . 62.25 110.525 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.97 -31.84 71.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.379 -0.373 . . . . 63.409999999999997 111.273 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -47.74 68.82 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.559 -0.291 . . . . 70.310000000000002 110.799 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.36 -47.08 88.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 72.010000000000005 110.745 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -60.47 -39.9 89.3 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.513 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.15 98.44 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.195 -0.526 . . . . 61.100000000000001 112.287 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.79 -40.65 80.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.624 0.249 . . . . 74.25 110.913 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.26 85.09 3.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 111.315 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.11 -19.26 34.56 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.945 -0.57 . . . . 74.0 111.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.99 -10.7 44.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.129 -0.558 . . . . 55.350000000000001 113.701 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -73.61 0.15 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.189 0.495 . . . . 71.099999999999994 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 8.2 mpt_? -114.84 -13.93 11.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.443 -0.799 . . . . 62.420000000000002 111.913 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.62 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 2.6 t80 -105.04 122.37 45.72 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 110.922 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -128.81 126.83 40.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.167 -0.47 . . . . 52.520000000000003 111.106 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' B' ' 106' ' ' CYS . 44.0 t -108.97 94.99 3.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.89 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.3 m0 -86.95 147.78 25.61 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.067 -0.515 . . . . 73.209999999999994 111.141 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 5.6 p-10 -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 63.219999999999999 111.257 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.1 p90 -109.8 122.24 47.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 64.019999999999996 111.058 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -98.82 94.36 6.56 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.531 . . . . 61.409999999999997 111.548 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 50.98 -102.64 0.12 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.972 0.73 . . . . 74.25 112.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.97 -2.58 1.3 Allowed Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.352 -0.84 . . . . 71.299999999999997 113.128 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -95.73 3.76 53.57 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.261 0.531 . . . . 72.420000000000002 111.528 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 12.7 p -67.24 -37.12 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 120.74 0.305 . . . . 42.130000000000003 111.184 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.71 -38.36 70.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 73.209999999999994 110.491 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 14.5 m -66.28 -41.02 90.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.248 -0.433 . . . . 73.329999999999998 110.562 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.534 ' HB3' HD21 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -71.48 -36.76 71.27 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.017 -0.538 . . . . 75.519999999999996 111.124 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.88 -39.1 76.48 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.381 -0.372 . . . . 72.140000000000001 110.864 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.85 -37.95 73.16 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.627 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -68.91 -34.13 74.89 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.202 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 28.0 t80 -68.21 -40.97 81.97 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.624 -0.262 . . . . 71.209999999999994 110.928 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 35' ' ' LEU . 0.7 OUTLIER -76.26 -34.56 59.14 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.367 -0.379 . . . . 75.310000000000002 110.702 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -73.15 -38.11 66.35 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 54.039999999999999 110.765 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -72.4 -26.93 62.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.398 -0.364 . . . . 74.420000000000002 111.171 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -75.73 -39.3 57.5 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.387 -0.369 . . . . 71.530000000000001 110.794 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.09 -36.2 69.42 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.102 -0.499 . . . . 71.099999999999994 111.205 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.9 p -72.34 -33.06 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.495 -0.321 . . . . 72.319999999999993 111.65 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.32 -32.59 29.33 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.536 0.207 . . . . 75.129999999999995 110.902 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 60.17 27.12 16.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 111.252 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -71.24 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.473 -0.331 . . . . 75.230000000000004 111.104 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -174.26 130.82 0.38 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.431 -0.349 . . . . 74.200000000000003 110.858 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.81 148.83 45.86 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.259 -0.428 . . . . 72.010000000000005 110.889 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.91 162.74 13.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.161 -0.472 . . . . 73.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.087 -0.959 . . . . 73.510000000000005 111.185 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.619 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.623 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.548 0.213 . . . . 75.109999999999999 111.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.33 128.44 25.7 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.439 -0.346 . . . . 64.010000000000005 111.137 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.24 124.28 41.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.08 -0.509 . . . . 71.150000000000006 110.46 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.995 ' HB3' HD21 ' A' ' 42' ' ' LEU . 34.2 m -134.89 115.72 13.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.244 -0.435 . . . . 64.340000000000003 111.172 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 HG12 ' A' ' 78' ' ' VAL . 34.2 t -111.87 118.1 56.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.275 -0.42 . . . . 71.439999999999998 110.976 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.7 t80 -98.55 119.79 37.86 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.33 -0.395 . . . . 65.019999999999996 110.834 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.546 ' CG ' HD13 ' A' ' 31' ' ' ILE . 47.8 t80 -103.09 116.51 32.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.302 -0.408 . . . . 71.329999999999998 110.928 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.17 111.13 16.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.21 -0.45 . . . . 62.549999999999997 110.817 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.25 8.22 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.925 -0.655 . . . . 54.43 113.662 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 3.0 t 67.33 102.63 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.065 0.432 . . . . 65.340000000000003 110.999 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.783 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -95.43 -40.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 110.461 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.559 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER 48.95 40.38 16.72 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.564 -0.744 . . . . 74.25 110.452 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.6 27.26 70.68 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.246 -0.888 . . . . 71.140000000000001 112.608 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.26 155.91 21.54 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 113.3 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -98.17 8.53 44.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.732 -0.234 . . . . 75.340000000000003 111.294 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.8 -11.66 26.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.681 0.276 . . . . 75.319999999999993 111.018 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.4 -30.34 14.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.119 -0.491 . . . . 75.010000000000005 110.83 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.17 -42.21 72.86 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.687 -0.233 . . . . 75.420000000000002 111.22 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.35 88.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.626 -0.261 . . . . 55.43 111.106 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' OE2' ' A' ' 82' ' ' GLU . 13.6 tp -73.7 -36.53 65.26 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 71.400000000000006 110.324 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 46' ' ' VAL . 5.2 m-85 -69.9 -33.23 71.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.751 -0.659 . . . . 70.329999999999998 111.258 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -67.13 -39.06 86.55 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.62 -0.264 . . . . 73.439999999999998 111.204 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -34.14 58.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.496 -0.32 . . . . 64.319999999999993 111.473 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' A' ' 28' ' ' TYR . 2.7 pp -78.56 -31.77 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.253 -0.179 . . . . 71.120000000000005 111.118 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 41' ' ' VAL . 5.3 p -67.34 -33.22 61.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.717 -0.22 . . . . 71.439999999999998 111.201 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.3 -40.92 73.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.663 0.268 . . . . 41.030000000000001 110.465 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -36.48 67.5 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.217 -0.447 . . . . 72.129999999999995 110.792 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 31' ' ' ILE . 5.6 mp -67.28 -40.44 86.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 111.007 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.38 -31.54 65.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.489 -0.323 . . . . 75.299999999999997 110.908 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -34.68 73.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.332 -0.395 . . . . 72.340000000000003 111.355 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.74 -50.68 8.98 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.732 0.301 . . . . 74.349999999999994 110.611 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.33 -91.9 0.1 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.074 -0.584 . . . . 75.209999999999994 112.23 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.93 133.68 16.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 72.140000000000001 111.061 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 32' ' ' VAL . 8.7 p -84.99 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 62.130000000000003 110.583 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.2 mm? -114.95 8.06 15.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.26 0.466 . . . . 72.099999999999994 112.26 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.26 57.82 1.69 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.37 0.605 . . . . 72.450000000000003 110.775 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.83 -29.67 18.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.65 -0.704 . . . . 73.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.467 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 57.0 p-80 -49.7 -41.96 44.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.594 0.358 . . . . 74.239999999999995 111.751 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.783 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.61 -25.36 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.383 -0.371 . . . . 71.140000000000001 111.236 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.68 52.3 2.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.804 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.61 147.57 23.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.983 0.42 . . . . 71.219999999999999 111.369 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.02 54.22 1.35 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.646 0.736 . . . . 51.420000000000002 110.263 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER 174.19 67.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.318 -1.31 . . . . 71.299999999999997 109.858 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.36 105.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.035 -0.53 . . . . 64.209999999999994 111.263 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -114.72 81.73 7.46 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 73.329999999999998 111.5 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.69 81.67 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.951 2.434 . . . . 64.439999999999998 112.326 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -99.0 130.0 45.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.321 -0.4 . . . . 70.319999999999993 111.022 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.65 -160.14 25.25 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.063 -0.589 . . . . 70.340000000000003 112.748 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.78 118.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.577 0.351 . . . . 64.540000000000006 111.29 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 53.66 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 110.905 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.49 145.18 6.63 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.937 -0.574 . . . . 65.140000000000001 111.17 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.42 8.74 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 111.041 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.94 142.44 3.46 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.066 -0.588 . . . . 74.310000000000002 112.655 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' ILE . . . -89.09 -14.65 60.25 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.155 -0.545 . . . . 64.319999999999993 113.435 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' B' ' 122' ' ' GLY . 7.6 p-10 -60.66 -48.39 81.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.026 0.413 . . . . 75.420000000000002 111.361 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.39 -29.41 64.05 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.696 0.284 . . . . 65.109999999999999 110.766 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.01 -34.22 68.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 110.344 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.87 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 24.9 mt -60.31 -45.94 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 110.942 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 29.5 t-80 -67.82 -37.81 82.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.723 -0.671 . . . . 75.010000000000005 111.269 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -35.98 67.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.491 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 72' ' ' TRP . 2.4 mm100 -69.92 -38.14 76.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.464 -0.334 . . . . 74.150000000000006 111.373 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.81 87.32 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.822 0.305 . . . . 55.130000000000003 111.822 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -72.49 -35.79 68.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.686 -0.234 . . . . 70.519999999999996 111.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -70.64 -37.21 73.73 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.894 0.331 . . . . 73.430000000000007 111.894 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 12.8 m0 -74.54 -34.08 62.89 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 111.743 0.275 . . . . 74.109999999999999 111.743 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -76.03 -19.12 58.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.607 -0.27 . . . . 64.420000000000002 111.558 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.31 -33.34 65.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.458 0.17 . . . . 72.030000000000001 110.985 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -117.09 4.72 12.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.449 -0.341 . . . . 74.040000000000006 111.771 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.47 107.37 1.66 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.848 0.356 . . . . 60.240000000000002 111.398 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -24.86 64.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 64.120000000000005 110.902 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -158.43 135.34 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.835 0.35 . . . . 72.019999999999996 111.024 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' A' ' 104' ' ' ILE . 36.6 t -112.49 126.43 69.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.141 -0.481 . . . . 72.030000000000001 110.431 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.18 141.82 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 73.030000000000001 110.341 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 94' ' ' LEU . . . -131.4 148.62 52.67 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.023 0.379 . . . . 71.230000000000004 112.023 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' OE2' HG21 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.65 3.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 110.554 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 87' ' ' SER . 1.8 t -142.82 134.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.287 -0.415 . . . . 62.229999999999997 111.354 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 109' ' ' ARG . 62.7 p -99.33 28.39 4.57 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.331 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.72 155.13 1.28 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-O 120.528 0.204 . . . . 74.340000000000003 110.956 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 88' ' ' LEU . 12.2 Cg_endo -54.71 98.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.884 2.389 . . . . 71.219999999999999 112.114 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.5 ' HB2' HG11 ' A' ' 83' ' ' VAL . 18.1 t -97.55 128.35 44.22 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.993 -0.549 . . . . 65.25 111.159 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.741 HD22 HD11 ' B' ' 120' ' ' ILE . 0.7 OUTLIER -75.28 -44.51 45.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 72.239999999999995 111.162 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.62 -43.83 93.74 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.054 -0.593 . . . . 72.540000000000006 112.54 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 61.6 t -71.8 -38.4 65.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.316 0.103 . . . . 62.219999999999999 110.929 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.26 -34.57 89.62 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.685 -0.769 . . . . 64.129999999999995 111.305 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.72 86.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.548 0.339 . . . . 75.140000000000001 110.328 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.93 -38.12 87.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.048 -0.524 . . . . 75.25 110.7 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 81' ' ' ALA . 1.5 mp -64.73 -40.77 95.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 111.0 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.77 -41.95 99.76 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.737 -0.744 . . . . 73.319999999999993 111.821 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.18 -29.61 64.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.677 0.275 . . . . 74.400000000000006 110.293 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.57 ' HB2' HD11 ' A' ' 73' ' ' LEU . . . -66.33 -39.04 89.0 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 111.476 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.69 -35.89 51.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.532 0.206 . . . . 74.430000000000007 110.772 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.5 -37.03 68.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.401 -0.363 . . . . 64.239999999999995 111.497 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.78 -55.49 3.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.36 . . . . 72.430000000000007 111.29 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.46 -126.58 5.43 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.022 -0.609 . . . . 72.200000000000003 112.511 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.6 -59.27 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.367 0.136 . . . . 71.549999999999997 111.367 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.709 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.2 Cg_endo -69.48 96.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.576 2.184 . . . . 74.400000000000006 112.687 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 79' ' ' VAL . 33.5 mm -110.58 148.77 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.051 -0.522 . . . . 63.350000000000001 111.583 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.782 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 tm? -130.63 138.95 50.35 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.853 -0.612 . . . . 55.240000000000002 110.202 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.03 133.86 44.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.404 -0.362 . . . . 73.420000000000002 111.152 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 11.9 mt -118.41 93.34 4.09 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.915 0.388 . . . . 72.140000000000001 111.02 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 24.8 t80 -104.53 122.29 45.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.935 -0.575 . . . . 73.510000000000005 110.922 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.795 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.1 OUTLIER -67.83 121.48 79.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 72.310000000000002 110.724 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.553 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 69.2 Cg_endo -76.36 9.16 2.61 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.727 2.285 . . . . 75.349999999999994 113.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.91 12.76 3.38 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.275 0.23 . . . . 72.25 111.158 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 83.3 p -71.93 -31.18 66.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.612 0.244 . . . . 63.119999999999997 111.251 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.75 -37.43 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.023 -0.608 . . . . 70.239999999999995 112.189 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -172.08 3.89 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.271 0.558 . . . . 62.240000000000002 110.574 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.01 154.19 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.368 -0.833 . . . . 51.539999999999999 111.36 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 120' ' ' ILE . 16.1 mt -78.92 135.56 37.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.197 -0.456 . . . . 63.340000000000003 110.658 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 p -66.37 172.04 4.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.975 0.417 . . . . 62.530000000000001 111.581 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' B' ' 65' ' ' ILE . . . -66.31 -30.86 71.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.85 -0.613 . . . . 63.340000000000003 111.687 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.422 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 0.0 OUTLIER -63.73 -45.94 87.62 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.613 0.244 . . . . 65.239999999999995 110.576 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.764 HD11 HD22 ' B' ' 88' ' ' LEU . 32.9 mm -64.76 -46.44 92.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.559 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.13 -42.49 90.74 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 110.131 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -62.3 -40.29 98.84 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.89 -0.595 . . . . 64.109999999999999 112.307 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -59.44 -40.18 85.98 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.538 0.208 . . . . 75.329999999999998 110.734 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.78 78.67 2.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.18 -0.463 . . . . 45.119999999999997 110.688 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.59 -15.45 54.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 43.43 111.677 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.54 -11.7 46.78 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.924 -0.655 . . . . 63.32 113.564 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.46 -76.99 0.09 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.215 0.507 . . . . 60.329999999999998 111.406 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 4.9 mpt_? -118.25 -0.56 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 75.109999999999999 112.295 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 104' ' ' ILE . 2.3 t80 -111.65 123.06 49.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.713 0.292 . . . . 75.25 111.288 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.43 137.91 52.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.012 -0.54 . . . . 74.400000000000006 110.657 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 106' ' ' CYS . 40.8 t -122.51 96.34 4.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.446 -0.343 . . . . 75.329999999999998 110.932 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 36.1 m0 -86.54 147.23 26.04 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.49 . . . . 71.439999999999998 111.586 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -104.07 114.01 27.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.559 -0.746 . . . . 73.540000000000006 109.862 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 13.9 p90 -110.6 142.5 42.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.022 -0.535 . . . . 64.400000000000006 111.87 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.91 164.88 12.02 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.678 -0.692 . . . . 74.030000000000001 110.016 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.08 102.53 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.788 -0.642 . . . . 53.32 110.62 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.31 19.32 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.695 -0.684 . . . . 65.549999999999997 112.461 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.91 -17.1 25.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.431 0.292 . . . . 53.43 111.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.608 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.5 p -52.47 -36.1 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.682 0.277 . . . . 63.119999999999997 111.681 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.7 -41.85 82.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 70.140000000000001 110.004 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 145' ' ' ARG . 2.5 m -66.14 -38.87 89.18 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.936 -0.574 . . . . 64.140000000000001 110.521 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 142' ' ' MET . 0.9 OUTLIER -67.62 -39.17 84.7 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.015 -0.539 . . . . 73.230000000000004 111.01 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.543 ' CD2' HG22 ' A' ' 31' ' ' ILE . 4.4 mp -65.36 -40.5 93.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 72.120000000000005 111.155 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.29 -35.27 66.12 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.327 -0.397 . . . . 70.340000000000003 111.145 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 141' ' ' THR . 18.6 mtt-85 -74.43 -35.77 63.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.402 -0.363 . . . . 60.329999999999998 111.069 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 11.5 t80 -71.08 -37.63 72.45 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.454 -0.339 . . . . 74.219999999999999 111.303 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -33.76 47.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.564 0.221 . . . . 74.129999999999995 111.181 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' VAL . 1.2 tt0 -78.9 -33.91 45.17 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.451 -0.341 . . . . 70.140000000000001 111.524 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.44 -25.43 50.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.564 0.221 . . . . 71.040000000000006 111.194 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.629 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.16 -40.97 64.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.309 -0.405 . . . . 45.549999999999997 110.855 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.02 -35.82 72.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 110.99 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 148' ' ' GLU . 62.2 t -68.2 -39.48 81.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.327 -0.397 . . . . 31.530000000000001 111.186 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -76.61 -33.23 58.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.551 -0.295 . . . . 65.439999999999998 110.995 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.09 17.43 10.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.367 -0.378 . . . . 73.040000000000006 111.444 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.29 175.36 1.49 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.727 0.299 . . . . 74.200000000000003 111.139 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.97 108.48 6.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.274 -0.421 . . . . 74.340000000000003 110.786 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -160.77 145.83 14.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.134 -0.485 . . . . 73.239999999999995 111.094 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.91 153.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.085 -0.507 . . . . 64.239999999999995 111.381 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.138 -0.934 . . . . 71.319999999999993 111.204 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 8.0 tpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.565 0.221 . . . . 72.030000000000001 111.407 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -138.31 128.46 25.76 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.423 -0.353 . . . . 74.049999999999997 111.161 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -97.25 124.34 41.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.095 -0.502 . . . . 60.32 110.419 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.061 ' HB3' HD21 ' B' ' 42' ' ' LEU . 34.0 m -134.9 115.69 13.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 111.216 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.691 HG22 HG12 ' B' ' 78' ' ' VAL . 33.6 t -111.89 118.04 56.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.34 -0.391 . . . . 74.219999999999999 110.971 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.507 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 1.7 t80 -98.52 119.78 37.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.298 -0.41 . . . . 74.299999999999997 110.768 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.541 ' CG ' HD13 ' B' ' 31' ' ' ILE . 47.4 t80 -103.08 116.5 32.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.262 -0.426 . . . . 74.230000000000004 110.944 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -122.09 111.04 16.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.216 -0.447 . . . . 61.32 110.894 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.21 15.35 8.22 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.94 -0.647 . . . . 71.430000000000007 113.655 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.537 ' HB2' HG21 ' B' ' 90' ' ' VAL . 3.0 t 67.26 102.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.083 0.441 . . . . 71.109999999999999 111.094 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.8 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -95.34 -40.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-O 120.939 0.4 . . . . 73.109999999999999 110.587 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.569 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER 48.94 40.23 16.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.47 -0.786 . . . . 63.219999999999999 110.547 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.468 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.7 27.21 70.7 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 112.589 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.22 155.89 21.55 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.778 -0.725 . . . . 54.399999999999999 113.347 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -98.21 8.52 44.68 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.212 0.205 . . . . 73.219999999999999 111.321 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -95.88 -11.67 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.659 0.266 . . . . 70.420000000000002 110.945 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.38 -30.35 14.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.153 -0.476 . . . . 53.219999999999999 110.883 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -55.18 -42.18 72.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.632 -0.258 . . . . 71.349999999999994 111.207 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.4 88.18 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.629 -0.26 . . . . 43.509999999999998 111.12 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.442 HD21 ' OE2' ' B' ' 82' ' ' GLU . 13.6 tp -73.7 -36.51 65.27 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.455 -0.339 . . . . 74.400000000000006 110.328 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.668 ' CD2' HG21 ' B' ' 46' ' ' VAL . 5.3 m-85 -69.9 -33.18 71.85 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.805 -0.634 . . . . 75.120000000000005 111.274 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.552 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -67.17 -39.07 86.38 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.603 0.24 . . . . 52.450000000000003 111.13 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -34.2 58.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 111.532 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' B' ' 28' ' ' TYR . 2.7 pp -78.49 -31.75 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 121.211 -0.195 . . . . 64.040000000000006 111.265 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.979 HG23 HG21 ' B' ' 41' ' ' VAL . 5.3 p -67.39 -33.14 60.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.627 -0.26 . . . . 75.450000000000003 111.201 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.0 t -70.37 -40.95 73.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.685 0.278 . . . . 74.319999999999993 110.413 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -36.39 67.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.767 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.458 HD13 ' O ' ' B' ' 31' ' ' ILE . 5.6 mp -67.37 -40.36 85.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.206 -0.452 . . . . 43.350000000000001 111.003 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -72.32 -31.71 65.92 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.442 -0.345 . . . . 54.32 110.869 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -34.73 72.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.244 -0.435 . . . . 73.239999999999995 111.377 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.77 -50.77 8.86 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.592 -0.276 . . . . 74.120000000000005 110.553 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.28 -91.93 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.006 -0.616 . . . . 65.019999999999996 112.199 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -149.9 133.7 16.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 72.519999999999996 111.14 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.979 HG21 HG23 ' B' ' 32' ' ' VAL . 8.7 p -84.96 148.57 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.315 -0.402 . . . . 63.32 110.605 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 1.061 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.2 mm? -114.92 8.04 15.8 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.611 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -130.23 57.88 1.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.27 0.557 . . . . 70.099999999999994 110.746 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -29.65 18.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 75.109999999999999 111.256 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' B' ' 43' ' ' THR . 57.0 p-80 -49.67 -42.07 44.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.633 0.373 . . . . 61.450000000000003 111.699 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -52.42 -25.46 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.444 -0.344 . . . . 62.229999999999997 111.34 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.69 52.35 2.09 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.449 -0.342 . . . . 70.109999999999999 110.768 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -95.63 147.59 23.43 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.948 0.404 . . . . 61.310000000000002 111.439 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.04 54.23 1.35 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.629 0.728 . . . . 72.200000000000003 110.222 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 0.9 OUTLIER 174.11 67.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.354 -1.294 . . . . 73.400000000000006 109.927 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 15.1 mt -46.24 105.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.937 -0.574 . . . . 74.109999999999999 111.308 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -114.68 81.73 7.41 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.019 -0.537 . . . . 74.310000000000002 111.499 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -86.77 81.66 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.943 2.429 . . . . 63.149999999999999 112.3 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 tp -98.98 130.04 45.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.269 -0.423 . . . . 53.219999999999999 111.039 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.62 -160.13 25.28 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.129 -0.557 . . . . 62.210000000000001 112.664 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 70.8 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.836 0.35 . . . . 53.140000000000001 111.336 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.93 53.76 0.92 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 75.019999999999996 110.85 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -165.55 145.09 6.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.906 -0.588 . . . . 74.140000000000001 111.129 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.45 102.56 8.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.151 -0.477 . . . . 75.349999999999994 110.959 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.89 142.48 3.47 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 52.539999999999999 112.622 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.426 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -89.08 -14.85 59.98 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.242 -0.504 . . . . 64.439999999999998 113.454 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . 7.6 p-10 -60.54 -48.42 81.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.94 0.37 . . . . 73.140000000000001 111.395 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -57.42 -29.34 64.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 110.813 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.17 -34.09 68.21 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.331 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.879 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 24.8 mt -60.39 -45.85 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.139 -0.482 . . . . 73.329999999999998 110.975 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.495 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 29.9 t-80 -67.89 -37.82 82.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.689 -0.687 . . . . 63.219999999999999 111.219 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.55 -36.07 68.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 73.150000000000006 111.518 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 72' ' ' TRP . 2.4 mm100 -69.87 -38.13 76.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.466 -0.334 . . . . 62.310000000000002 111.412 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.75 87.05 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 111.789 0.292 . . . . 55.549999999999997 111.789 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -35.72 68.03 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.721 -0.218 . . . . 73.430000000000007 111.24 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' OE1' ' B' ' 74' ' ' GLN . 5.5 m-80 -70.55 -37.33 74.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.927 0.343 . . . . 63.130000000000003 111.927 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 12.9 m0 -74.42 -34.16 63.16 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.734 0.272 . . . . 63.409999999999997 111.734 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.628 -0.26 . . . . 65.230000000000004 111.538 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' B' ' 71' ' ' ASN . 45.2 mt-30 -56.31 -33.37 65.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.463 0.173 . . . . 70.420000000000002 110.988 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -116.99 4.64 12.8 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.507 -0.315 . . . . 74.239999999999995 111.846 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.49 107.39 1.67 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.944 0.402 . . . . 75.439999999999998 111.339 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -24.9 64.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.719 -0.673 . . . . 75.450000000000003 110.996 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.695 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -158.38 135.28 2.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 111.105 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.43 ' HB ' HD12 ' B' ' 104' ' ' ILE . 36.9 t -112.49 126.4 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 63.219999999999999 110.417 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.779 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.8 OUTLIER -118.03 141.77 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 45.229999999999997 110.453 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 94' ' ' LEU . . . -131.46 148.6 52.66 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.943 0.401 . . . . 74.219999999999999 112.037 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.588 ' OE2' HG21 ' B' ' 139' ' ' VAL . 0.0 OUTLIER -140.14 100.58 3.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.773 -0.649 . . . . 74.049999999999997 110.561 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 87' ' ' SER . 1.8 t -142.8 134.18 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.369 -0.378 . . . . 63.219999999999999 111.31 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.797 HG22 ' HB2' ' B' ' 109' ' ' ARG . 62.9 p -99.4 28.43 4.57 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.25 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -176.76 155.22 1.27 Allowed Pre-proline 0 N--CA 1.463 0.211 0 CA-C-O 120.545 0.212 . . . . 72.430000000000007 110.917 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.442 ' HA ' HD12 ' A' ' 88' ' ' LEU . 12.2 Cg_endo -54.73 98.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.884 2.389 . . . . 71.329999999999998 112.1 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . 0.489 ' HB2' HG11 ' B' ' 83' ' ' VAL . 18.0 t -97.5 128.36 44.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 73.349999999999994 111.112 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -75.29 -44.6 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.128 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.6 -43.81 93.81 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' B' ' 17' ' ' SER . 61.3 t -71.85 -38.3 64.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.344 0.072 . . . . 75.099999999999994 110.985 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.6 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.25 -34.62 89.75 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.688 -0.768 . . . . 71.120000000000005 111.295 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.619 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 6.1 t80 -66.14 -43.69 86.32 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.547 0.339 . . . . 75.420000000000002 110.35 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.97 -38.09 87.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.069 -0.514 . . . . 61.5 110.662 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' B' ' 81' ' ' ALA . 1.5 mp -64.71 -40.7 95.81 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.19 -0.459 . . . . 61.43 111.024 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.95 -41.98 99.77 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.687 -0.768 . . . . 71.219999999999999 111.768 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -72.04 -29.59 64.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 62.039999999999999 110.417 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' B' ' 73' ' ' LEU . . . -66.33 -38.97 88.87 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 116.18 -0.464 . . . . 70.430000000000007 111.601 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.71 -36.01 51.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.477 0.179 . . . . 65.019999999999996 110.68 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.0 68.82 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.391 -0.368 . . . . 71.540000000000006 111.605 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.53 3.93 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 64.209999999999994 111.252 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.38 -126.54 5.4 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.061 -0.59 . . . . 64.030000000000001 112.536 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -170.61 -59.32 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.357 0.132 . . . . 74.340000000000003 111.357 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.695 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.2 Cg_endo -69.58 96.38 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.512 2.141 . . . . 52.509999999999998 112.706 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' B' ' 79' ' ' VAL . 33.5 mm -110.5 148.82 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 111.619 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.779 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.4 tm? -130.68 139.04 50.31 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.856 -0.611 . . . . 60.329999999999998 110.216 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.756 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.13 133.8 44.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.433 -0.349 . . . . 70.120000000000005 111.112 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.0 mt -118.4 93.3 4.07 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.347 -0.388 . . . . 64.239999999999995 111.043 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 25.0 t80 -104.48 122.19 45.01 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.906 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.797 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.1 OUTLIER -67.72 121.49 79.58 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.409 -0.359 . . . . 72.040000000000006 110.799 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.557 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 69.1 Cg_endo -76.37 9.14 2.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.746 2.297 . . . . 73.099999999999994 113.283 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -135.88 12.85 3.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.238 0.215 . . . . 74.409999999999997 111.18 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 83.4 p -71.99 -31.07 65.89 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.683 0.278 . . . . 75.510000000000005 111.313 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.6 -37.34 3.41 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.968 -0.634 . . . . 45.100000000000001 112.231 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -172.15 3.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 110.635 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.97 154.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.329 -0.85 . . . . 64.450000000000003 111.297 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.654 HD22 HG21 ' B' ' 120' ' ' ILE . 16.1 mt -78.96 135.58 36.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.146 -0.479 . . . . 62.020000000000003 110.657 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 24.5 p -66.37 171.99 4.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.959 0.409 . . . . 63.43 111.578 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 65' ' ' ILE . . . -66.39 -30.73 71.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.827 -0.624 . . . . 71.549999999999997 111.674 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.41 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -63.74 -45.87 87.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.564 0.221 . . . . 53.5 110.638 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.741 HD11 HD22 ' A' ' 88' ' ' LEU . 32.8 mm -64.86 -46.31 92.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.548 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -59.22 -42.56 91.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 71.349999999999994 110.092 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -62.24 -40.29 98.8 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.615 . . . . 63.509999999999998 112.306 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -59.46 -40.11 85.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.58 0.228 . . . . 71.329999999999998 110.786 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.79 78.68 2.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.048 0.452 . . . . 53.039999999999999 110.673 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.57 -15.52 54.51 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.745 -0.661 . . . . 65.540000000000006 111.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.62 46.51 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.913 -0.66 . . . . 62.310000000000002 113.476 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -69.53 -76.96 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.203 0.502 . . . . 64.340000000000003 111.4 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 4.9 mpt_? -118.26 -0.59 11.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 112.264 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.6 123.02 49.36 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.805 0.336 . . . . 74.230000000000004 111.334 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.44 137.94 52.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.014 -0.539 . . . . 74.019999999999996 110.638 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' B' ' 106' ' ' CYS . 40.8 t -122.59 96.47 4.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.405 -0.361 . . . . 75.230000000000004 110.914 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 35.9 m0 -86.6 147.24 26.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.06 -0.518 . . . . 70.129999999999995 111.476 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -104.03 113.98 27.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.573 -0.74 . . . . 74.200000000000003 109.929 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.59 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 13.8 p90 -110.62 142.42 42.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.918 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.79 164.9 12.03 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.679 -0.691 . . . . 34.130000000000003 110.107 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.17 102.49 0.09 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.895 -0.593 . . . . 74.129999999999995 110.59 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 114.52 -16.14 19.46 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.721 -0.672 . . . . 73.430000000000007 112.454 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.04 -17.08 25.56 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.386 0.274 . . . . 71.219999999999999 111.592 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.7 p -52.42 -36.22 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.682 0.277 . . . . 73.109999999999999 111.633 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.55 -41.99 83.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.25 109.978 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -66.1 -38.77 89.07 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.928 -0.578 . . . . 70.019999999999996 110.635 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' B' ' 142' ' ' MET . 0.9 OUTLIER -67.74 -39.22 84.25 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.943 -0.571 . . . . 75.349999999999994 110.956 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.55 ' CD2' HG22 ' B' ' 31' ' ' ILE . 4.4 mp -65.25 -40.5 94.09 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.352 -0.386 . . . . 62.119999999999997 111.179 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.3 -35.27 66.07 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 111.15 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -74.36 -35.85 63.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.076 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.555 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 11.5 t80 -71.05 -37.61 72.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.405 -0.361 . . . . 71.430000000000007 111.248 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -33.72 46.75 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.574 0.226 . . . . 74.549999999999997 111.162 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.501 ' O ' HG23 ' B' ' 152' ' ' VAL . 1.2 tt0 -79.07 -33.74 44.31 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.359 -0.382 . . . . 75.040000000000006 111.497 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.53 -25.34 50.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.619 0.247 . . . . 43.049999999999997 111.236 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.631 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.1 -41.0 64.52 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.311 -0.404 . . . . 72.530000000000001 110.861 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.12 -35.76 71.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.462 -0.336 . . . . 72.450000000000003 110.881 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 148' ' ' GLU . 61.2 t -68.29 -39.47 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.298 -0.41 . . . . 71.239999999999995 111.091 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.67 -33.29 58.28 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.543 -0.299 . . . . 70.209999999999994 110.953 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.18 17.4 10.66 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.306 -0.406 . . . . 74.319999999999993 111.377 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.3 175.36 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.788 0.327 . . . . 72.319999999999993 111.044 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -137.99 108.49 6.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.231 -0.44 . . . . 70.409999999999997 110.84 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -160.74 145.96 14.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 72.299999999999997 111.039 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 69.8 153.48 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.049 -0.523 . . . . 72.230000000000004 111.383 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.13 -0.938 . . . . 75.530000000000001 111.215 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.87 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.879 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.545 0.212 . . . . 64.409999999999997 111.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.07 116.67 27.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.498 -0.319 . . . . 75.109999999999999 110.897 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.73 129.01 38.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.122 -0.49 . . . . 71.0 110.605 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.753 ' HB3' HD21 ' A' ' 42' ' ' LEU . 24.2 m -136.07 135.02 39.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.326 -0.397 . . . . 54.310000000000002 111.383 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 78' ' ' VAL . 21.7 t -118.77 125.21 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.074 -0.512 . . . . 62.130000000000003 110.787 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.9 t80 -100.74 122.49 43.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.495 -0.32 . . . . 53.009999999999998 110.861 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 31' ' ' ILE . 42.5 t80 -106.57 119.93 40.6 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.807 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 9.4 p -127.95 126.07 40.74 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.352 -0.386 . . . . 71.430000000000007 111.352 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.3 25.6 2.48 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.914 -0.66 . . . . 71.420000000000002 113.248 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 63.67 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.399 0.28 . . . . 62.409999999999997 111.171 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.535 HG12 ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -99.41 -42.03 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 121.093 0.473 . . . . 55.140000000000001 109.884 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 18' ' ' ILE . 41.7 mtm180 50.85 44.14 28.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.077 -0.965 . . . . 73.25 110.391 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 59.46 28.95 65.63 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.32 -0.855 . . . . 74.140000000000001 112.42 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.51 156.3 22.03 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 120.823 -0.704 . . . . 51.140000000000001 113.223 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.88 7.8 45.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.796 -0.202 . . . . 73.340000000000003 111.3 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -96.74 -10.92 25.8 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.597 0.237 . . . . 74.530000000000001 111.062 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.72 -31.16 13.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.364 -0.38 . . . . 71.439999999999998 110.994 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.89 74.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.75 -0.205 . . . . 73.299999999999997 111.106 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -38.55 85.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.521 -0.309 . . . . 74.420000000000002 111.386 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.492 HD21 ' OE2' ' A' ' 82' ' ' GLU . 9.2 tp -74.87 -35.62 62.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.467 -0.333 . . . . 41.119999999999997 110.737 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 46' ' ' VAL . 7.1 m-85 -70.77 -33.85 71.21 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.051 -0.522 . . . . 72.219999999999999 111.184 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.2 85.95 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.713 -0.221 . . . . 61.539999999999999 111.138 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.52 -37.49 74.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 111.331 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.8 pp -76.71 -29.59 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.0 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.944 HG22 HG11 ' A' ' 41' ' ' VAL . 3.0 t -68.31 -37.63 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.513 -0.312 . . . . 72.219999999999999 110.584 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.45 -42.25 96.08 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.714 0.292 . . . . 72.329999999999998 110.579 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.24 -35.82 68.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 111.083 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.835 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.6 mp -72.69 -36.9 67.97 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.308 -0.406 . . . . 74.030000000000001 111.224 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 41' ' ' VAL . 1.8 mtp180 -67.55 -32.36 73.08 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.45 -0.341 . . . . 75.329999999999998 110.871 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -30.05 66.94 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 111.458 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.67 -50.51 6.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 110.54 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 -94.19 0.11 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.051 -0.595 . . . . 64.129999999999995 112.288 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -152.32 132.44 13.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.682 0.277 . . . . 72.450000000000003 111.265 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 32' ' ' VAL . 3.2 t -85.69 140.21 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 71.319999999999993 110.613 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 11' ' ' SER . 1.3 mm? -99.39 8.6 44.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.924 0.342 . . . . 73.239999999999995 111.924 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.587 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -127.72 58.77 1.48 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.644 0.735 . . . . 74.150000000000006 110.156 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.5 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.884 -1.053 . . . . 74.439999999999998 111.006 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.1 p-80 -57.99 -32.8 68.24 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.361 -0.382 . . . . 73.400000000000006 111.057 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -62.35 -24.45 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.91 -0.587 . . . . 42.130000000000003 111.231 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.08 60.34 1.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.946 0.403 . . . . 53.100000000000001 110.76 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -108.67 131.66 54.68 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.116 -0.493 . . . . 70.219999999999999 111.757 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.89 58.33 0.85 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.366 0.603 . . . . 72.439999999999998 110.321 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.28 68.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.747 -1.115 . . . . 72.430000000000007 110.146 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.33 107.39 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.917 -0.583 . . . . 62.32 111.28 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 84.29 14.55 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.511 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.06 81.86 2.28 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.87 2.38 . . . . 73.430000000000007 112.275 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.88 140.84 39.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.138 -0.483 . . . . 64.150000000000006 111.067 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.15 -169.07 47.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.054 -0.593 . . . . 61.25 112.644 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.07 129.06 38.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.667 0.27 . . . . 75.310000000000002 111.012 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 139.57 52.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 63.329999999999998 110.965 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.14 171.04 12.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.073 -0.512 . . . . 74.540000000000006 111.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.95 94.74 2.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.186 -0.461 . . . . 64.120000000000005 111.117 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.42 -158.96 10.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.139 -0.553 . . . . 62.210000000000001 112.646 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.45 -106.34 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.907 -0.663 . . . . 74.310000000000002 112.557 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.18 -43.31 99.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.403 0.144 . . . . 53.420000000000002 111.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.29 -39.15 72.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.723 0.297 . . . . 71.530000000000001 110.788 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -65.52 -34.94 79.43 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.082 -0.508 . . . . 72.019999999999996 110.919 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 33.0 mt -62.22 -41.48 91.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.431 -0.349 . . . . 74.420000000000002 110.792 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 30.0 t-80 -71.07 -36.99 72.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.884 -0.598 . . . . 74.349999999999994 111.302 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.62 -36.25 65.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 111.445 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.49 -37.16 68.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.644 -0.253 . . . . 70.430000000000007 111.25 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.78 -37.03 70.5 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.592 -0.276 . . . . 41.43 111.187 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.5 HD11 ' NE ' ' A' ' 96' ' ' ARG . 2.4 mm? -70.41 -38.38 74.61 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 73.439999999999998 111.117 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -69.14 -38.87 79.04 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 111.054 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.69 76.11 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.297 -0.411 . . . . 70.209999999999994 111.098 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 97' ' ' ALA . 0.3 OUTLIER -62.22 -34.77 77.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.315 -0.402 . . . . 62.420000000000002 110.964 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.19 81.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.453 -0.34 . . . . 60.130000000000003 111.033 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.55 -27.55 20.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.304 -0.407 . . . . 75.010000000000005 111.421 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -62.49 108.91 1.22 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 111.475 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.33 -20.25 62.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.72 -0.673 . . . . 72.040000000000006 111.189 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 12' ' ' VAL . 2.2 p -150.49 135.69 10.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.892 0.377 . . . . 71.230000000000004 110.87 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 97' ' ' ALA . 39.9 t -110.13 135.59 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 73.349999999999994 110.577 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -129.63 135.39 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 70.450000000000003 110.362 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' CYS . . . -126.48 146.08 50.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 73.450000000000003 111.551 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' OE2' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.32 98.32 3.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.947 -0.57 . . . . 75.120000000000005 110.71 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.22 138.65 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.341 -0.39 . . . . 53.539999999999999 111.359 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' ARG . 37.8 p -97.45 25.19 5.86 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.396 -0.365 . . . . 62.549999999999997 111.525 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.19 152.91 1.24 Allowed Pre-proline 0 C--O 1.233 0.203 0 CA-C-O 120.469 0.176 . . . . 73.540000000000006 110.911 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.792 ' HA ' HD12 ' B' ' 88' ' ' LEU . 13.1 Cg_endo -55.63 102.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.884 2.389 . . . . 73.340000000000003 112.21 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -100.0 127.97 46.15 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.01 -0.541 . . . . 55.119999999999997 110.932 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.906 HD22 HD11 ' B' ' 120' ' ' ILE . 0.4 OUTLIER -69.6 -51.86 31.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 75.120000000000005 111.239 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.96 -43.39 99.24 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 50.439999999999998 112.634 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 17' ' ' SER . 38.6 t -68.91 -38.67 78.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.407 0.146 . . . . 54.520000000000003 110.86 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' B' ' 88' ' ' LEU . . . -64.47 -34.68 90.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.221 -0.751 . . . . 71.120000000000005 111.221 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 18.8 t80 -63.99 -45.94 86.76 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.161 -0.311 . . . . 71.530000000000001 110.161 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -39.07 93.37 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 64.450000000000003 110.405 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.574 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -64.36 -41.24 96.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 44.25 110.612 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -60.53 -42.66 99.2 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.877 -0.678 . . . . 30.41 111.775 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' CD ' ' HB2' ' B' ' 99' ' ' ALA . 2.3 mmm-85 -68.62 -33.82 74.69 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.67 0.271 . . . . 73.219999999999999 110.48 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -63.41 -34.68 78.27 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.652 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.477 HG21 ' OH ' ' B' ' 92' ' ' TYR . 58.0 t -75.41 -35.89 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.734 -0.212 . . . . 74.239999999999995 111.048 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' B' ' 96' ' ' ARG . . . -76.23 -35.77 58.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.417 -0.356 . . . . 64.209999999999994 111.371 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 70' ' ' LEU . 19.2 mt -87.19 -53.15 5.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.377 -0.374 . . . . 65.010000000000005 111.466 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.41 -129.32 6.4 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.977 -0.63 . . . . 61.100000000000001 112.76 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -61.01 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 111.407 0.151 . . . . 73.040000000000006 111.407 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' HG23 ' A' ' 78' ' ' VAL . 57.3 Cg_endo -70.63 96.89 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.489 2.126 . . . . 65.409999999999997 112.764 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 79' ' ' VAL . 27.1 mm -110.71 150.58 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.063 -0.517 . . . . 70.219999999999999 111.706 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.686 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -131.55 138.66 48.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 110.033 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.751 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -132.31 134.91 45.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.455 -0.339 . . . . 70.129999999999995 111.075 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 142' ' ' MET . 1.0 OUTLIER -118.94 97.54 5.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 110.525 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 21.9 t80 -106.88 135.31 48.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.056 -0.52 . . . . 71.150000000000006 111.051 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HB2' HG22 ' A' ' 84' ' ' THR . 30.8 ttm180 -78.39 117.41 66.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.616 -0.266 . . . . 75.310000000000002 110.38 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.602 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 59.6 Cg_endo -75.62 3.65 5.74 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.668 2.245 . . . . 74.25 113.183 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -124.51 0.83 8.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.239 0.215 . . . . 75.310000000000002 111.431 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 1.3 p -63.59 -34.98 79.01 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 120.534 0.207 . . . . 71.450000000000003 110.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.4 -38.56 2.93 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.014 -0.613 . . . . 52.140000000000001 112.896 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 78.8 mtt85 -82.69 -174.07 5.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.306 0.574 . . . . 71.540000000000006 110.901 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.04 163.88 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 111.773 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 120' ' ' ILE . 1.0 OUTLIER -87.06 145.16 26.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 64.219999999999999 110.121 178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.7 p -75.67 -177.18 3.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.94 0.4 . . . . 70.310000000000002 111.692 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.84 74.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.886 -0.597 . . . . 74.349999999999994 112.352 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.469 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 3.4 tpt -63.13 -41.53 99.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.619 0.247 . . . . 74.040000000000006 110.942 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.877 HD11 HD22 ' B' ' 88' ' ' LEU . 42.0 mm -69.77 -46.0 75.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.339 -0.392 . . . . 73.040000000000006 110.918 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -59.77 -42.22 92.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.327 -0.397 . . . . 64.319999999999993 110.527 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.92 -37.6 94.87 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.009 -0.541 . . . . 64.349999999999994 112.513 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -59.72 -37.92 80.25 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.542 0.211 . . . . 62.140000000000001 111.046 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.11 92.27 3.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.868 0.366 . . . . 64.25 111.418 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -16.94 29.62 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.983 -0.553 . . . . 73.239999999999995 111.036 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.7 72.51 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.234 -0.508 . . . . 73.040000000000006 113.044 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 74.209999999999994 110.933 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 9.0 mpt_? -119.0 -17.29 9.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.427 -0.806 . . . . 74.129999999999995 112.108 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.574 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.0 t80 -102.52 121.02 41.53 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.692 0.282 . . . . 53.240000000000002 110.915 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.26 126.94 43.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.751 HG13 ' HB3' ' A' ' 106' ' ' CYS . 21.9 t -108.77 95.42 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 111.019 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 44.1 m0 -87.73 141.92 28.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.086 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 2.7 m-20 -96.53 119.19 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 70.25 110.003 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -114.73 147.77 39.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.096 0.475 . . . . 73.049999999999997 111.723 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.47 159.14 16.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.485 -0.78 . . . . 70.239999999999995 109.886 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -57.44 103.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 64.150000000000006 110.549 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.21 -19.62 10.81 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.628 -0.715 . . . . 71.349999999999994 111.908 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.33 -8.14 30.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.413 0.285 . . . . 75.140000000000001 111.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.604 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 10.9 p -58.86 -35.68 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-O 120.693 0.282 . . . . 34.539999999999999 110.832 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.78 -43.1 84.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 109.724 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.7 m -66.4 -38.99 88.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.98 -0.554 . . . . 63.509999999999998 110.564 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.578 ' HG2' HD11 ' A' ' 107' ' ' LEU . 1.2 ttm -66.33 -40.25 89.75 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.969 -0.559 . . . . 74.030000000000001 111.227 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 31' ' ' ILE . 3.5 mp -66.97 -39.51 87.24 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.37 -0.377 . . . . 63.130000000000003 110.947 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.79 -37.03 70.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.323 -0.399 . . . . 54.109999999999999 110.721 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.71 -36.47 70.54 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.173 -0.467 . . . . 74.25 111.039 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' ' HG ' ' A' ' 105' ' ' LEU . 12.5 t80 -67.84 -39.69 83.79 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.361 -0.381 . . . . 75.540000000000006 110.946 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -34.94 60.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.456 -0.338 . . . . 73.219999999999999 111.288 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.53 51.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.457 -0.338 . . . . 64.129999999999995 111.296 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 157' ' ' HIS . . . -73.77 -30.31 62.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 111.232 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.54 -41.02 76.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.316 -0.402 . . . . 73.450000000000003 110.656 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 tp -67.57 -38.19 83.73 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.232 -0.44 . . . . 65.549999999999997 110.891 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 148' ' ' GLU . 72.7 t -68.79 -37.49 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 111.567 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -84.52 -21.5 30.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.687 -0.233 . . . . 72.099999999999994 111.477 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.13 33.22 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.883 0.473 . . . . 63.210000000000001 111.669 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.41 -67.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.264 -0.425 . . . . 72.510000000000005 111.212 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -175.08 110.57 0.12 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.296 -0.411 . . . . 72.310000000000002 110.674 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.487 ' CG ' ' HB1' ' A' ' 149' ' ' ALA . 3.6 t-80 -72.2 144.56 48.46 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 111.258 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.15 150.09 29.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.032 -0.531 . . . . 73.200000000000003 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -0.769 . . . . 75.310000000000002 111.005 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.482 0.182 . . . . 64.409999999999997 111.41 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -117.06 116.68 27.81 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.449 -0.341 . . . . 62.030000000000001 110.871 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.76 129.04 38.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.657 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.772 ' HB3' HD21 ' B' ' 42' ' ' LEU . 24.3 m -136.11 135.07 38.99 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.276 -0.42 . . . . 71.230000000000004 111.318 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 78' ' ' VAL . 21.7 t -118.85 125.3 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.001 -0.545 . . . . 70.310000000000002 110.75 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.524 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.9 t80 -100.8 122.4 43.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.441 -0.345 . . . . 70.140000000000001 110.844 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.534 ' CB ' HD13 ' B' ' 31' ' ' ILE . 42.2 t80 -106.57 119.97 40.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.173 -0.467 . . . . 71.299999999999997 110.791 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 9.1 p -128.08 126.16 40.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.292 -0.413 . . . . 72.349999999999994 111.292 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.35 25.7 2.47 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.936 -0.65 . . . . 62.25 113.172 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.597 ' HB2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER 63.56 105.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.778 0.289 . . . . 63.420000000000002 111.261 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.542 HG12 ' N ' ' B' ' 19' ' ' ARG . 0.1 OUTLIER -99.39 -42.05 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.013 0.435 . . . . 72.150000000000006 109.882 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' N ' HG12 ' B' ' 18' ' ' ILE . 41.7 mtm180 50.94 44.01 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.061 -0.972 . . . . 65.329999999999998 110.392 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.42 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 59.44 28.97 65.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.313 -0.858 . . . . 24.140000000000001 112.45 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.49 156.31 22.04 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.842 -0.694 . . . . 51.210000000000001 113.298 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -96.9 7.77 45.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.792 -0.204 . . . . 74.329999999999998 111.338 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -96.66 -10.88 26.04 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.585 0.231 . . . . 61.539999999999999 111.097 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.71 -31.16 13.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.375 -0.375 . . . . 73.319999999999993 111.007 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -55.34 -42.93 74.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.715 -0.22 . . . . 74.230000000000004 111.166 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.49 85.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.523 -0.308 . . . . 75.239999999999995 111.434 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.495 HD21 ' OE2' ' B' ' 82' ' ' GLU . 9.3 tp -75.02 -35.53 61.96 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.55 -0.295 . . . . 74.0 110.792 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.723 ' CE2' HG21 ' B' ' 46' ' ' VAL . 7.1 m-85 -70.69 -33.95 71.45 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 116.047 -0.524 . . . . 72.219999999999999 111.187 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.638 -0.256 . . . . 55.109999999999999 111.217 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -70.41 -37.5 74.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.302 -0.408 . . . . 74.310000000000002 111.346 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.8 pp -76.83 -29.49 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 120.507 0.194 . . . . 44.329999999999998 110.966 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.923 HG22 HG11 ' B' ' 41' ' ' VAL . 3.0 t -68.35 -37.59 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 116.497 -0.319 . . . . 73.430000000000007 110.575 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 -42.3 95.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.705 0.288 . . . . 52.549999999999997 110.628 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -72.16 -35.82 69.15 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 74.510000000000005 111.106 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.6 mp -72.7 -36.96 67.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.313 -0.403 . . . . 71.209999999999994 111.252 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.561 ' HG2' HG23 ' B' ' 41' ' ' VAL . 1.8 mtp180 -67.4 -32.42 73.31 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.439 -0.346 . . . . 72.25 110.886 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -30.0 67.01 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.47 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -86.72 -50.54 6.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.601 0.239 . . . . 75.299999999999997 110.492 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.22 -94.24 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.076 -0.583 . . . . 44.219999999999999 112.326 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -152.3 132.49 13.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.657 0.265 . . . . 74.319999999999993 111.29 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.923 HG11 HG22 ' B' ' 32' ' ' VAL . 3.2 t -85.74 140.3 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.394 -0.366 . . . . 53.240000000000002 110.56 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' B' ' 11' ' ' SER . 1.3 mm? -99.38 8.48 44.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.886 0.328 . . . . 74.450000000000003 111.886 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -127.74 58.76 1.48 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.616 0.722 . . . . 75.230000000000004 110.093 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -89.49 -29.54 18.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.933 -1.03 . . . . 62.130000000000003 110.963 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.434 ' NE2' HG22 ' B' ' 46' ' ' VAL . 50.1 p-80 -57.97 -32.82 68.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.877 0.37 . . . . 74.439999999999998 111.07 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' B' ' 28' ' ' TYR . 0.2 OUTLIER -62.32 -24.44 34.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.886 -0.597 . . . . 73.409999999999997 111.309 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.99 60.22 1.31 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.878 0.371 . . . . 55.399999999999999 110.771 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -108.62 131.61 54.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.796 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.8 58.36 0.85 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.409 0.624 . . . . 64.5 110.395 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.23 68.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.8 -1.091 . . . . 72.420000000000002 110.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.25 107.31 0.11 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.904 -0.589 . . . . 74.519999999999996 111.287 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.45 84.37 14.61 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.433 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.08 81.97 2.25 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.909 2.406 . . . . 74.430000000000007 112.301 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.89 140.73 39.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.097 -0.501 . . . . 75.239999999999995 111.139 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.18 -169.07 47.48 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.961 -0.638 . . . . 62.32 112.692 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.03 128.98 38.52 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.688 0.28 . . . . 74.230000000000004 111.041 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.34 139.57 52.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.033 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.19 171.13 12.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.13 -0.486 . . . . 34.549999999999997 111.279 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.08 94.78 2.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.129 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.4 -158.94 10.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.1 -0.571 . . . . 75.099999999999994 112.621 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.408 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -177.47 -106.39 0.2 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.992 -0.623 . . . . 73.510000000000005 112.553 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.06 -43.4 98.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.5 0.191 . . . . 73.329999999999998 111.262 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -56.33 -39.09 72.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 75.530000000000001 110.787 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -65.47 -35.05 79.73 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.86 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.837 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 32.7 mt -62.12 -41.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.838 0.351 . . . . 74.099999999999994 110.825 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 29.9 t-80 -71.1 -36.97 72.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.325 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -73.6 -36.27 65.48 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.448 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -72.61 -37.04 68.2 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 111.251 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.71 -37.08 70.71 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.625 -0.261 . . . . 61.43 111.218 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.503 HD11 ' NE ' ' B' ' 96' ' ' ARG . 2.4 mm? -70.42 -38.4 74.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.372 -0.377 . . . . 62.009999999999998 111.13 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -69.14 -38.88 79.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.37 . . . . 73.140000000000001 110.975 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 3.2 m0 -69.89 -37.8 76.13 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.285 -0.416 . . . . 75.25 111.067 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 97' ' ' ALA . 0.3 OUTLIER -62.25 -34.66 76.96 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.318 -0.401 . . . . 74.400000000000006 111.037 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -37.14 81.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.452 -0.34 . . . . 63.219999999999999 111.003 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -89.72 -27.48 20.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -62.4 108.83 1.19 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.911 0.386 . . . . 61.310000000000002 111.541 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.34 -20.21 62.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.744 -0.662 . . . . 74.400000000000006 111.222 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.695 HG13 HG13 ' B' ' 12' ' ' VAL . 2.2 p -150.45 135.66 10.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 110.922 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.595 HG21 ' HB1' ' B' ' 97' ' ' ALA . 39.9 t -110.12 135.52 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 110.564 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.719 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -129.68 135.37 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 55.310000000000002 110.27 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' B' ' 15' ' ' CYS . . . -126.47 146.09 50.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 111.587 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.495 ' OE2' HD21 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -140.34 98.35 3.41 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.69 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.23 138.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.283 -0.417 . . . . 60.229999999999997 111.3 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.877 HG22 ' HB2' ' B' ' 109' ' ' ARG . 37.7 p -97.47 25.13 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.384 -0.371 . . . . 53.32 111.575 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -176.18 152.9 1.25 Allowed Pre-proline 0 N--CA 1.464 0.249 0 CA-C-O 120.587 0.232 . . . . 73.030000000000001 110.835 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.761 ' HA ' HD12 ' A' ' 88' ' ' LEU . 13.2 Cg_endo -55.62 102.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.784 2.323 . . . . 74.209999999999994 112.313 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -99.96 128.02 46.1 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.002 -0.544 . . . . 63.229999999999997 110.942 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.877 HD22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -69.54 -52.01 30.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 74.340000000000003 111.221 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.9 -43.38 99.27 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.076 -0.583 . . . . 64.010000000000005 112.603 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' B' ' 17' ' ' SER . 38.9 t -68.99 -38.64 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.415 0.15 . . . . 61.25 110.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 88' ' ' LEU . . . -64.46 -34.64 90.45 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.228 -0.749 . . . . 72.5 111.228 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.543 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 19.0 t80 -64.05 -45.97 86.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.107 -0.331 . . . . 64.409999999999997 110.107 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -39.12 93.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.977 -0.556 . . . . 72.409999999999997 110.449 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 0.5 OUTLIER -64.38 -41.17 96.84 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.083 -0.508 . . . . 62.450000000000003 110.646 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.544 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -60.6 -42.65 99.3 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.917 -0.658 . . . . 75.120000000000005 111.758 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.562 ' NE ' ' HB2' ' A' ' 99' ' ' ALA . 2.3 mmm-85 -68.6 -33.81 74.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.628 0.251 . . . . 71.329999999999998 110.444 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.595 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -63.57 -34.54 78.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.588 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.485 HG21 ' OH ' ' A' ' 92' ' ' TYR . 57.8 t -75.56 -35.65 32.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.529 0.204 . . . . 71.239999999999995 111.157 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' CD ' ' A' ' 96' ' ' ARG . . . -76.32 -35.84 58.58 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.416 -0.357 . . . . 65.200000000000003 111.329 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' B' ' 70' ' ' LEU . 19.1 mt -87.09 -53.16 5.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.338 -0.392 . . . . 64.239999999999995 111.547 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.34 -129.32 6.39 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.987 -0.625 . . . . 64.150000000000006 112.855 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.47 -61.02 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.469 0.174 . . . . 61.420000000000002 111.469 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' B' ' 78' ' ' VAL . 57.4 Cg_endo -70.52 96.83 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.518 2.145 . . . . 70.540000000000006 112.807 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.421 HD12 ' HB ' ' B' ' 79' ' ' VAL . 27.3 mm -110.73 150.56 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.116 -0.493 . . . . 73.049999999999997 111.672 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.719 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.4 OUTLIER -131.57 138.64 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.624 . . . . 62.119999999999997 110.115 179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.763 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.1 OUTLIER -132.3 134.97 45.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 61.420000000000002 111.08 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' B' ' 142' ' ' MET . 1.0 OUTLIER -118.99 97.53 5.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.488 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 22.0 t80 -106.91 135.34 48.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.049 -0.523 . . . . 74.340000000000003 110.934 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.877 ' HB2' HG22 ' B' ' 84' ' ' THR . 30.8 ttm180 -78.42 117.43 66.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.557 -0.292 . . . . 72.239999999999995 110.424 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 59.4 Cg_endo -75.6 3.61 5.77 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 113.215 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -124.55 0.96 8.25 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.78 -0.191 . . . . 70.140000000000001 111.506 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 1.3 p -63.53 -35.14 79.5 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 120.486 0.184 . . . . 62.310000000000002 110.928 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.51 -38.62 2.9 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.0 -0.619 . . . . 73.0 112.883 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HD2' ' HD2' ' B' ' 86' ' ' PRO . 78.8 mtt85 -82.67 -174.14 5.05 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.265 0.555 . . . . 73.319999999999993 110.952 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.92 163.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 73.109999999999999 111.844 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -87.05 145.13 26.59 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.969 -0.56 . . . . 74.129999999999995 110.167 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 54.1 p -75.67 -177.15 3.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.039 0.447 . . . . 75.219999999999999 111.632 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.65 -32.96 74.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.818 -0.628 . . . . 71.420000000000002 112.358 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.49 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 3.4 tpt -63.02 -41.52 99.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.532 0.206 . . . . 65.109999999999999 111.003 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.906 HD11 HD22 ' A' ' 88' ' ' LEU . 41.9 mm -69.8 -46.06 75.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.379 -0.373 . . . . 72.409999999999997 110.851 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 21.7 mtm-85 -59.68 -42.26 92.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 110.591 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.8 95.23 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.991 -0.55 . . . . 32.509999999999998 112.43 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -59.67 -37.96 80.18 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.591 0.234 . . . . 72.230000000000004 111.043 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.13 92.33 3.22 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.952 0.406 . . . . 44.100000000000001 111.386 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -16.93 29.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 71.129999999999995 111.006 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.98 -9.77 72.57 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.271 -0.49 . . . . 40.329999999999998 113.1 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -67.07 0.57 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.004 0.43 . . . . 74.099999999999994 110.933 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 9.0 mpt_? -118.96 -17.31 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 72.409999999999997 112.129 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.1 t80 -102.55 121.0 41.51 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.788 0.328 . . . . 73.230000000000004 110.878 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.29 127.04 43.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.08 -0.509 . . . . 70.209999999999994 110.877 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.763 HG13 ' HB3' ' B' ' 106' ' ' CYS . 21.9 t -108.8 95.34 3.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.194 -0.457 . . . . 70.219999999999999 111.08 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 44.1 m0 -87.65 141.91 28.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 111.003 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 2.7 m-20 -96.5 119.19 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.566 . . . . 65.030000000000001 110.07 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.61 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.0 p90 -114.74 147.82 39.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.103 0.478 . . . . 73.349999999999994 111.687 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.51 159.12 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.487 -0.778 . . . . 62.009999999999998 109.923 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.41 103.73 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 64.209999999999994 110.528 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.19 -19.76 10.78 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.635 -0.711 . . . . 62.32 111.962 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -97.19 -8.23 30.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.48 0.312 . . . . 74.400000000000006 111.233 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 10.9 p -58.91 -35.61 57.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 CA-C-O 120.709 0.29 . . . . 71.239999999999995 110.851 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.83 -43.05 84.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 109.722 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -66.47 -38.89 88.31 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 115.962 -0.563 . . . . 73.030000000000001 110.55 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.591 ' HG2' HD11 ' B' ' 107' ' ' LEU . 1.2 ttm -66.38 -40.24 89.57 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.983 -0.553 . . . . 41.219999999999999 111.19 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' B' ' 31' ' ' ILE . 3.5 mp -66.92 -39.55 87.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.295 -0.411 . . . . 75.310000000000002 111.028 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.83 -36.94 70.37 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.196 -0.456 . . . . 75.200000000000003 110.781 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -71.75 -36.56 70.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.007 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.497 ' CD1' ' HG ' ' B' ' 105' ' ' LEU . 12.6 t80 -67.74 -39.69 84.22 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.437 -0.347 . . . . 72.420000000000002 110.956 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -35.01 60.67 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.464 -0.335 . . . . 71.120000000000005 111.282 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.473 ' O ' HG23 ' B' ' 152' ' ' VAL . 2.2 tp10 -77.79 -35.52 51.39 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 65.349999999999994 111.271 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' B' ' 157' ' ' HIS . . . -73.77 -30.25 62.67 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.466 -0.333 . . . . 70.439999999999998 111.236 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.477 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.05 76.51 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.327 -0.397 . . . . 65.219999999999999 110.73 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.5 -38.13 83.86 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.136 -0.484 . . . . 75.040000000000006 111.009 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 148' ' ' GLU . 72.5 t -68.91 -37.4 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 111.527 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.59 -21.53 30.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.725 -0.216 . . . . 71.120000000000005 111.367 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.4 p80 44.17 33.24 0.78 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.88 0.472 . . . . 63.200000000000003 111.67 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.44 -67.6 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 111.143 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.1 110.54 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.39 . . . . 54.409999999999997 110.713 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . 0.494 ' CG ' ' HB1' ' B' ' 149' ' ' ALA . 3.7 t-80 -72.18 144.64 48.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.172 -0.467 . . . . 75.219999999999999 111.234 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -110.19 150.15 29.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.99 -0.55 . . . . 70.549999999999997 111.146 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.401 -0.809 . . . . 45.210000000000001 111.018 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.84 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.837 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.776 0.322 . . . . 54.310000000000002 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.62 133.16 22.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.403 -0.362 . . . . 70.540000000000006 111.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.87 118.74 35.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 42' ' ' LEU . 36.1 m -134.42 116.84 15.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.472 . . . . 62.229999999999997 111.153 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 78' ' ' VAL . 32.0 t -111.2 115.14 49.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 53.399999999999999 111.233 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.574 ' HB2' HD12 ' A' ' 42' ' ' LEU . 1.4 t80 -94.66 122.19 37.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.417 -0.356 . . . . 73.010000000000005 110.503 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.517 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 38.5 t80 -96.11 110.4 22.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.142 -0.481 . . . . 65.209999999999994 110.084 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -95.93 96.77 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.941 -0.572 . . . . 72.0 111.521 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -133.67 131.83 6.2 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.781 -0.645 . . . . 75.209999999999994 112.191 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 40.2 t -62.18 122.77 16.42 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.699 0.285 . . . . 73.299999999999997 110.469 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.795 HG21 HG11 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -97.78 -34.68 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.614 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.76 49.85 9.53 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.816 -0.629 . . . . 71.129999999999995 110.971 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.54 -17.38 54.73 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.846 -0.692 . . . . 60.409999999999997 113.558 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 108.95 -172.52 16.49 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.602 -0.809 . . . . 14.41 114.323 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER 86.7 -34.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.24 -0.98 . . . . 74.120000000000005 110.151 -178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.04 9.17 24.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.041 -0.527 . . . . 75.209999999999994 110.168 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -111.1 -37.66 5.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.842 -0.617 . . . . 61.229999999999997 110.322 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -43.58 79.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.68 -0.236 . . . . 55.439999999999998 111.449 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.26 -32.32 62.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.237 0.458 . . . . 60.020000000000003 112.237 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.6 tp -83.95 -32.43 25.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.44 0.163 . . . . 75.200000000000003 111.44 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 13.2 m-85 -78.02 -27.54 48.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.66 -0.246 . . . . 65.099999999999994 110.911 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.55 76.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 121.18 -0.208 . . . . 75.450000000000003 110.932 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -76.15 -33.19 59.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.505 -0.316 . . . . 62.399999999999999 111.7 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 2.3 pp -78.85 -30.87 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 121.113 -0.235 . . . . 75.019999999999996 111.139 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 3.6 t -68.11 -37.11 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 116.834 -0.166 . . . . 54.450000000000003 111.122 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.6 t -66.54 -40.69 89.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.589 0.233 . . . . 73.230000000000004 111.045 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.99 -34.5 61.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.372 -0.376 . . . . 74.150000000000006 111.067 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.771 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -73.22 -36.66 66.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.371 . . . . 65.209999999999994 111.474 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -75.01 -30.22 61.07 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.755 -0.202 . . . . 63.32 111.066 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -29.72 67.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 74.319999999999993 111.407 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.01 -51.59 5.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.52 0.2 . . . . 71.439999999999998 110.762 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.8 -96.85 0.21 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.792 -0.718 . . . . 74.030000000000001 112.321 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -150.77 132.3 14.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.42 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.8 t -79.49 139.69 17.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.429 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 11' ' ' SER . 68.7 mt -106.33 21.78 16.84 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.963 0.357 . . . . 75.120000000000005 111.963 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -138.52 62.53 1.55 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.259 0.552 . . . . 54.509999999999998 110.574 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.614 -0.721 . . . . 64.420000000000002 112.243 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 46' ' ' VAL . 49.0 p-80 -50.9 -42.67 59.41 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.918 0.389 . . . . 61.420000000000002 111.31 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -64.92 -44.03 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.725 -0.67 . . . . 65.030000000000001 111.152 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 60.03 1.54 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.955 0.407 . . . . 74.329999999999998 110.427 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.44 131.68 34.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.013 -0.54 . . . . 51.229999999999997 111.688 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.86 62.53 0.63 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.838 -0.619 . . . . 61.109999999999999 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.98 53.51 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.94 -1.027 . . . . 62.340000000000003 110.97 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -164.9 91.13 0.54 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.914 -0.585 . . . . 73.530000000000001 110.736 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.81 70.05 50.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 111.041 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 51' ' ' LEU . 91.5 Cg_endo -76.34 -166.45 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.937 2.424 . . . . 74.340000000000003 112.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.35 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.362 -0.835 . . . . 72.400000000000006 111.686 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.68 140.6 8.84 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.92 -0.582 . . . . 54.109999999999999 112.54 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.03 157.46 11.52 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 111.267 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.16 163.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.914 -0.585 . . . . 72.439999999999998 111.606 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.52 98.08 2.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.984 -0.553 . . . . 74.230000000000004 111.025 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.92 166.07 28.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.996 -0.547 . . . . 72.219999999999999 110.991 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.81 12.43 65.88 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.629 -0.796 . . . . 71.519999999999996 113.879 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 -8.89 12.22 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.733 -0.733 . . . . 62.32 114.252 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 7.7 p-10 -59.05 -47.3 85.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.553 0.677 . . . . 75.099999999999994 111.298 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -58.07 -43.21 86.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.511 -0.313 . . . . 55.119999999999997 110.693 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.69 -39.43 93.65 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.639 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.817 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 15.9 mt -58.64 -43.53 87.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.825 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 16.5 t-80 -68.65 -37.75 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 71.25 111.772 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.21 -33.12 61.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.753 0.279 . . . . 74.200000000000003 111.753 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.538 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.773 0.286 . . . . 73.109999999999999 111.773 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.24 64.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.883 0.327 . . . . 71.319999999999993 111.883 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.575 HD22 ' HG2' ' A' ' 96' ' ' ARG . 1.2 mt -72.54 -35.16 67.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.52 0.2 . . . . 75.510000000000005 111.209 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -39.82 87.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.401 -0.363 . . . . 71.299999999999997 111.836 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.3 -37.79 80.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.443 0.164 . . . . 73.519999999999996 111.443 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.58 -22.7 63.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.648 -0.251 . . . . 73.409999999999997 111.58 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -57.79 -35.15 70.41 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.649 -0.25 . . . . 50.149999999999999 110.908 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -120.25 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.473 -0.33 . . . . 61.329999999999998 111.089 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.9 111.2 23.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 34.200000000000003 111.255 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -21.99 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 72.400000000000006 110.953 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -162.51 136.16 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.794 0.331 . . . . 73.340000000000003 110.625 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 104' ' ' ILE . 12.8 t -118.57 111.09 32.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.88 0.371 . . . . 64.010000000000005 111.081 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.944 HG23 ' HB3' ' A' ' 105' ' ' LEU . 2.0 p -105.29 131.18 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.806 -0.633 . . . . 72.150000000000006 110.702 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.23 152.68 35.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.76 0.314 . . . . 73.209999999999994 111.585 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.22 5.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.056 -0.52 . . . . 75.409999999999997 111.008 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 90' ' ' VAL . 2.0 t -146.16 136.11 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.349 -0.387 . . . . 75.549999999999997 111.35 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 109' ' ' ARG . 46.1 p -102.18 25.81 8.41 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.413 -0.358 . . . . 63.25 111.627 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.25 0.99 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-O 120.524 0.202 . . . . 74.349999999999994 111.349 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 85' ' ' GLN . 18.1 Cg_endo -59.26 93.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.774 2.316 . . . . 55.119999999999997 112.346 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.1 m -95.35 125.03 39.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.842 -0.617 . . . . 72.439999999999998 110.541 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HD11 ' B' ' 120' ' ' ILE . 1.0 OUTLIER -71.44 -43.78 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 72.540000000000006 111.767 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA3' ' O2P' ' A' ' 187' ' ' 5GP . . . -70.1 -43.86 62.81 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.625 -0.798 . . . . 74.409999999999997 112.247 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 83' ' ' VAL . 44.9 t -71.53 -34.37 52.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.468 -0.197 . . . . 62.43 110.468 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -62.1 -35.45 91.51 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.454 -0.659 . . . . 61.409999999999997 111.454 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.6 t80 -65.36 -44.14 88.6 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.174 -0.306 . . . . 75.409999999999997 110.174 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' B' ' 119' ' ' MET . 11.7 mt-10 -59.8 -41.53 91.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.994 -0.548 . . . . 62.340000000000003 110.574 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 6.6 tp -59.42 -42.55 92.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.086 -0.506 . . . . 60.310000000000002 110.765 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -63.85 -40.2 98.14 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.9 -0.667 . . . . 53.25 112.146 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' HG2' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -64.51 -37.78 88.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.522 0.201 . . . . 75.530000000000001 111.004 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -68.27 -34.98 77.17 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.012 0.375 . . . . 73.030000000000001 112.012 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 t -70.7 -37.79 70.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 111.818 0.303 . . . . 73.430000000000007 111.818 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 -26.94 23.42 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.224 0.453 . . . . 60.049999999999997 112.224 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.6 tp -87.09 -42.38 13.09 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.711 -0.222 . . . . 74.540000000000006 111.466 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 -119.56 3.68 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.955 -0.64 . . . . 64.400000000000006 112.428 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.03 -61.64 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.05 0.14 . . . . 52.539999999999999 111.026 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.779 ' HB2' HG23 ' A' ' 78' ' ' VAL . 56.3 Cg_endo -70.04 92.93 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.09 . . . . 71.420000000000002 112.17 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB ' ' A' ' 79' ' ' VAL . 14.7 mm -110.65 149.88 13.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.016 -0.538 . . . . 75.25 111.673 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.944 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.3 tm? -131.22 140.82 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.684 -0.689 . . . . 64.430000000000007 110.018 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.75 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.5 t -130.49 126.77 37.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.455 -0.339 . . . . 45.5 110.913 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 14.4 mt -109.84 96.14 6.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 54.140000000000001 110.609 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 18.5 t80 -104.21 147.51 27.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.896 -0.593 . . . . 65.340000000000003 111.243 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -88.15 117.02 67.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 72.540000000000006 110.963 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 56.1 Cg_endo -74.29 4.99 3.9 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.615 2.21 . . . . 63.140000000000001 113.258 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.3 11.3 3.27 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.446 0.165 . . . . 62.399999999999999 111.446 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.59 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 61.2 p -69.12 -31.13 69.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.532 0.206 . . . . 75.329999999999998 111.329 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.44 -35.65 4.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.789 -0.719 . . . . 13.52 112.2 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 39.2 mmt180 -80.67 -172.24 3.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.302 0.572 . . . . 74.129999999999995 110.612 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.04 163.26 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.418 -0.81 . . . . 75.209999999999994 111.904 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 108' ' ' PHE . 1.6 mm? -86.01 131.25 34.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.577 . . . . 65.099999999999994 110.24 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.458 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 0.0 OUTLIER -72.33 179.04 3.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.8 0.334 . . . . 44.310000000000002 111.446 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.24 89.21 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.147 -0.479 . . . . 73.5 112.285 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' B' ' 93' ' ' GLU . 0.0 OUTLIER -65.33 -46.12 81.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.789 -0.187 . . . . 74.420000000000002 111.081 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.55 HD11 HD22 ' B' ' 88' ' ' LEU . 21.2 mm -64.63 -46.9 91.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.467 -0.333 . . . . 74.019999999999996 111.074 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.96 -39.75 95.61 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.504 -0.316 . . . . 73.430000000000007 110.535 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.28 -39.5 97.92 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.059 -0.518 . . . . 62.299999999999997 112.163 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.53 72.91 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.668 0.27 . . . . 64.310000000000002 110.761 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.47 87.54 5.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.111 -0.495 . . . . 52.509999999999998 110.948 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.4 -16.31 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.918 -0.583 . . . . 72.030000000000001 111.171 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.43 61.47 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.121 -0.561 . . . . 71.319999999999993 112.997 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.2 m -68.62 -78.66 0.06 Allowed 'General case' 0 C--O 1.23 0.041 0 CA-C-N 116.888 0.344 . . . . 72.439999999999998 110.82 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.94 -8.01 13.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.993 -0.548 . . . . 74.439999999999998 112.089 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.612 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 5.6 t80 -111.02 123.81 50.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.722 0.296 . . . . 54.409999999999997 110.655 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -127.17 135.85 51.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.103 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 106' ' ' CYS . 41.6 t -116.93 96.76 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.264 -0.425 . . . . 44.32 110.975 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 42.3 m0 -90.58 142.36 27.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.316 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 3.7 m-20 -93.77 118.61 31.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.888 -0.596 . . . . 52.109999999999999 109.798 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.613 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 8.9 p90 -115.02 150.01 36.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.903 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.03 159.18 16.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.332 -0.849 . . . . 75.140000000000001 110.04 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.64 104.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.393 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.45 -19.24 14.78 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.64 -0.709 . . . . 54.219999999999999 112.126 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.64 -13.12 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.548 0.339 . . . . 75.239999999999995 111.297 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.613 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 7.8 p -59.21 -36.42 63.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.658 0.266 . . . . 62.109999999999999 111.275 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -41.34 79.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 64.120000000000005 109.995 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -68.96 -38.37 79.35 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.452 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.68 -36.65 78.8 Favored 'General case' 0 C--N 1.336 0.017 0 CA-C-N 115.929 -0.578 . . . . 62.43 110.947 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 31' ' ' ILE . 1.3 mp -63.45 -42.37 98.65 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.447 -0.342 . . . . 72.439999999999998 110.894 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 4.6 t70 -69.57 -37.42 76.97 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.409 -0.359 . . . . 74.340000000000003 110.867 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -73.95 -35.85 64.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 110.807 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.469 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 7.5 t80 -68.37 -39.07 81.91 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.984 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -75.14 -35.78 61.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.586 -0.279 . . . . 71.230000000000004 111.018 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.65 -36.53 62.86 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.334 -0.394 . . . . 75.530000000000001 111.264 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -76.3 -21.93 55.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.359 -0.382 . . . . 73.420000000000002 111.656 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -79.39 -39.53 32.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.751 0.31 . . . . 75.099999999999994 110.334 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.19 -36.28 69.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.962 -0.563 . . . . 63.149999999999999 111.092 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 149' ' ' ALA . 9.2 p -72.03 -35.47 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.462 -0.336 . . . . 52.119999999999997 111.552 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.07 -33.23 44.75 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.719 -0.219 . . . . 75.400000000000006 110.981 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.93 18.41 11.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.242 -0.436 . . . . 71.400000000000006 111.539 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.92 0.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.629 -0.26 . . . . 71.420000000000002 110.814 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.86 113.27 9.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.397 -0.365 . . . . 72.299999999999997 110.728 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -168.68 61.78 0.06 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.976 -0.557 . . . . 75.140000000000001 110.621 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -159.19 159.47 34.34 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.985 -0.552 . . . . 74.340000000000003 111.359 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.592 -0.718 . . . . 72.329999999999998 111.4 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.768 0.318 . . . . 64.409999999999997 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -144.65 133.21 22.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 70.129999999999995 111.3 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -97.91 118.64 34.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.2 -0.454 . . . . 74.340000000000003 110.559 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.64 ' HB3' HD11 ' B' ' 42' ' ' LEU . 35.6 m -134.38 116.84 15.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.174 -0.466 . . . . 71.439999999999998 111.17 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.77 HG22 HG12 ' B' ' 78' ' ' VAL . 32.0 t -111.18 115.2 49.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.285 -0.416 . . . . 71.430000000000007 111.166 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.57 ' HB2' HD12 ' B' ' 42' ' ' LEU . 1.4 t80 -94.73 122.19 37.08 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.423 -0.353 . . . . 74.5 110.511 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.537 ' HD2' ' CE1' ' B' ' 28' ' ' TYR . 38.3 t80 -96.15 110.38 22.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.134 -0.484 . . . . 70.120000000000005 110.076 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.9 m -95.83 96.81 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.94 -0.573 . . . . 75.430000000000007 111.523 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.457 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -133.72 131.82 6.19 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.794 -0.639 . . . . 50.219999999999999 112.207 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.567 ' HB2' ' CG2' ' B' ' 90' ' ' VAL . 40.2 t -62.1 122.77 16.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.611 0.243 . . . . 54.299999999999997 110.426 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.794 HG21 HG11 ' B' ' 46' ' ' VAL . 0.8 OUTLIER -97.86 -34.75 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 111.57 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 58.75 49.91 9.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.819 -0.628 . . . . 74.209999999999994 110.94 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.46 -17.33 54.78 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.856 -0.687 . . . . 54.210000000000001 113.582 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 22' ' ' ARG . . . 108.9 -172.45 16.47 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.632 -0.794 . . . . 50.420000000000002 114.343 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER 86.64 -34.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.273 -0.963 . . . . 72.519999999999996 110.222 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -110.17 9.1 23.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.096 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -111.03 -37.68 5.3 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.888 -0.596 . . . . 64.510000000000005 110.351 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -43.61 79.4 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.643 -0.253 . . . . 73.310000000000002 111.46 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.32 62.84 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.199 0.444 . . . . 15.210000000000001 112.199 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.576 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.7 tp -84.0 -32.43 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.416 0.154 . . . . 75.549999999999997 111.416 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.558 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 13.2 m-85 -77.96 -27.54 49.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.699 -0.228 . . . . 64.450000000000003 110.967 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.29 -41.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.168 -0.213 . . . . 74.329999999999998 111.023 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -76.21 -33.25 59.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 73.109999999999999 111.671 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.576 HG23 ' O ' ' B' ' 27' ' ' LEU . 2.3 pp -78.8 -30.86 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 121.123 -0.231 . . . . 73.329999999999998 111.152 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.817 HG22 HG11 ' B' ' 41' ' ' VAL . 3.6 t -68.16 -37.09 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 116.826 -0.17 . . . . 63.140000000000001 111.129 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.7 t -66.6 -40.73 89.0 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 121.131 -0.228 . . . . 54.439999999999998 110.981 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -74.95 -34.46 62.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.372 -0.376 . . . . 72.209999999999994 111.115 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.767 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -73.22 -36.68 66.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.38 -0.373 . . . . 64.319999999999993 111.437 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.551 ' HG3' HG23 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -74.99 -30.26 61.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.785 -0.189 . . . . 75.0 111.043 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -29.69 67.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.395 -0.366 . . . . 74.040000000000006 111.46 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.03 -51.58 5.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.725 -0.216 . . . . 61.009999999999998 110.776 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.79 -96.74 0.21 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.806 -0.712 . . . . 74.530000000000001 112.391 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -150.8 132.26 14.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 74.239999999999995 111.478 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.817 HG11 HG22 ' B' ' 32' ' ' VAL . 3.8 t -79.5 139.63 18.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.206 -0.452 . . . . 61.109999999999999 110.42 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' B' ' 11' ' ' SER . 69.5 mt -106.3 21.68 16.99 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.91 0.337 . . . . 74.120000000000005 111.91 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.484 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -138.43 62.55 1.55 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.27 0.557 . . . . 63.549999999999997 110.593 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.83 -29.31 18.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.555 -0.748 . . . . 73.340000000000003 112.336 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' B' ' 46' ' ' VAL . 49.1 p-80 -50.97 -42.67 60.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.854 0.359 . . . . 62.149999999999999 111.239 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.794 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -64.89 -43.98 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 111.178 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.65 60.09 1.54 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.955 0.407 . . . . 72.519999999999996 110.425 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -87.5 131.72 34.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.981 -0.554 . . . . 71.099999999999994 111.615 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.85 62.51 0.63 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.791 -0.64 . . . . 75.120000000000005 110.203 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 75.93 53.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.974 -1.012 . . . . 73.209999999999994 110.971 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.538 HD13 ' HD3' ' B' ' 53' ' ' PRO . 0.1 OUTLIER -164.89 91.14 0.54 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.944 -0.571 . . . . 54.240000000000002 110.75 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -137.83 70.11 50.83 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 116.117 -0.492 . . . . 72.409999999999997 111.014 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.538 ' HD3' HD13 ' B' ' 51' ' ' LEU . 91.9 Cg_endo -76.38 -166.51 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.956 2.438 . . . . 65.430000000000007 112.538 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.44 164.12 0.27 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.364 -0.835 . . . . 55.43 111.604 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.7 140.62 8.85 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.852 -0.613 . . . . 62.43 112.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -167.08 157.39 11.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.725 0.298 . . . . 72.530000000000001 111.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.27 163.04 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.901 -0.59 . . . . 72.25 111.582 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.43 98.07 2.67 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.97 -0.559 . . . . 74.239999999999995 111.04 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.04 28.88 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.055 -0.521 . . . . 44.340000000000003 111.016 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.78 12.4 65.94 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.617 -0.801 . . . . 40.020000000000003 113.913 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.69 -8.82 12.73 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.718 -0.741 . . . . 70.519999999999996 114.256 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.635 ' HA ' HD12 ' B' ' 65' ' ' ILE . 7.7 p-10 -59.16 -47.36 85.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.552 0.676 . . . . 73.129999999999995 111.241 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -57.98 -43.23 86.42 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.547 -0.297 . . . . 73.510000000000005 110.695 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -64.78 -39.33 93.44 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.097 -0.501 . . . . 74.129999999999995 110.657 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.828 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 15.9 mt -58.67 -43.46 87.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.839 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.48 ' O ' ' HG ' ' B' ' 70' ' ' LEU . 16.6 t-80 -68.68 -37.79 79.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.752 -0.658 . . . . 64.310000000000002 111.759 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -33.15 61.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.784 0.29 . . . . 72.209999999999994 111.784 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.535 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 68.1 mt-30 -73.84 -35.84 64.85 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.764 0.283 . . . . 72.109999999999999 111.764 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.07 -34.26 63.95 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 111.836 0.31 . . . . 63.340000000000003 111.836 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' B' ' 96' ' ' ARG . 1.2 mt -72.55 -35.18 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.496 0.189 . . . . 75.340000000000003 111.164 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.95 -39.86 87.4 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.87 0.322 . . . . 73.219999999999999 111.87 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -68.31 -37.8 80.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.461 0.171 . . . . 73.349999999999994 111.461 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 73' ' ' LEU . 6.2 mt -69.57 -22.61 63.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.628 -0.26 . . . . 74.310000000000002 111.543 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.88 -35.1 70.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.718 -0.219 . . . . 62.299999999999997 110.849 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -120.26 40.01 3.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.472 -0.331 . . . . 73.299999999999997 111.106 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.96 111.26 23.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.27 -0.423 . . . . 73.510000000000005 111.213 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -22.01 66.72 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.951 -0.568 . . . . 74.319999999999993 110.957 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.77 HG12 HG22 ' B' ' 12' ' ' VAL . 0.6 OUTLIER -162.48 136.09 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.722 0.296 . . . . 75.030000000000001 110.653 179.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' HD12 ' B' ' 104' ' ' ILE . 12.8 t -118.48 111.13 32.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.355 . . . . 70.129999999999995 111.103 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.916 HG23 ' HB3' ' B' ' 105' ' ' LEU . 1.9 p -105.35 131.13 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.864 -0.607 . . . . 74.400000000000006 110.763 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.12 152.63 35.23 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.733 0.302 . . . . 72.200000000000003 111.642 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 11.3 tt0 -140.41 108.27 5.68 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.061 -0.518 . . . . 74.340000000000003 110.963 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' B' ' 90' ' ' VAL . 2.0 t -146.22 136.09 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.331 -0.395 . . . . 55.039999999999999 111.408 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.631 HG22 ' HB2' ' B' ' 109' ' ' ARG . 45.7 p -102.19 25.83 8.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.373 -0.376 . . . . 75.430000000000007 111.596 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 0.0 OUTLIER -179.1 160.31 0.99 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-O 120.518 0.199 . . . . 71.299999999999997 111.321 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HG3' ' B' ' 114' ' ' ARG . 18.1 Cg_endo -59.28 93.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.712 2.274 . . . . 64.030000000000001 112.306 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . 0.429 ' HB2' HG11 ' B' ' 83' ' ' VAL . 3.1 m -95.31 125.04 39.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.848 -0.614 . . . . 72.239999999999995 110.611 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -71.46 -43.81 65.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 63.299999999999997 111.758 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA3' ' O2P' ' B' ' 187' ' ' 5GP . . . -70.08 -43.88 62.93 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.638 -0.792 . . . . 74.209999999999994 112.268 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' B' ' 83' ' ' VAL . 44.8 t -71.44 -34.47 53.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 110.453 -0.203 . . . . 65.329999999999998 110.453 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -62.1 -35.43 91.47 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.44 -0.664 . . . . 64.209999999999994 111.44 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.6 t80 -65.33 -44.2 88.56 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 110.137 -0.32 . . . . 74.349999999999994 110.137 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.44 ' OE2' " H4'" ' B' ' 187' ' ' 5GP . 11.8 mt-10 -59.73 -41.56 91.18 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.998 -0.546 . . . . 73.040000000000006 110.59 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.607 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 6.6 tp -59.39 -42.64 92.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.111 -0.495 . . . . 65.409999999999997 110.749 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -63.84 -40.11 98.06 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.856 -0.688 . . . . 75.200000000000003 112.164 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.573 ' HG2' HD22 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -64.58 -37.69 88.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.218 . . . . 75.420000000000002 111.02 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -68.35 -34.92 76.96 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.404 -0.362 . . . . 62.439999999999998 111.949 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 94' ' ' LEU . 91.0 t -70.71 -37.85 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 111.781 0.289 . . . . 73.129999999999995 111.781 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.15 -26.89 23.37 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.189 0.44 . . . . 62.240000000000002 112.189 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.09 -42.27 13.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.765 -0.198 . . . . 54.310000000000002 111.466 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.66 -119.61 3.68 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.02 -0.61 . . . . 73.230000000000004 112.458 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.94 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.196 0 C-N-CA 122.033 0.133 . . . . 61.409999999999997 111.017 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.766 ' HB2' HG23 ' B' ' 78' ' ' VAL . 56.4 Cg_endo -69.99 92.86 0.54 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.484 2.123 . . . . 43.32 112.224 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.601 HD12 ' HB ' ' B' ' 79' ' ' VAL . 14.5 mm -110.62 149.9 13.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.045 -0.525 . . . . 63.420000000000002 111.718 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.916 ' HB3' HG23 ' B' ' 80' ' ' VAL . 1.3 tm? -131.19 140.88 49.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.688 -0.687 . . . . 61.039999999999999 109.916 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.765 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.5 t -130.57 126.75 37.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 64.019999999999996 110.945 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 14.4 mt -109.85 96.16 6.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.664 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 18.4 t80 -104.24 147.52 27.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.862 -0.608 . . . . 75.439999999999998 111.207 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.631 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.0 OUTLIER -88.14 117.08 68.0 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 63.420000000000002 111.023 179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 56.0 Cg_endo -74.33 4.99 3.92 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.617 2.211 . . . . 75.150000000000006 113.263 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.22 11.24 3.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.118 0.167 . . . . 74.439999999999998 111.443 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 61.1 p -69.08 -31.13 69.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 71.540000000000006 111.395 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.38 -35.55 4.39 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.844 -0.693 . . . . 74.019999999999996 112.144 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' B' ' 86' ' ' PRO . 39.2 mmt180 -80.64 -172.23 3.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 110.68 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.08 163.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.447 -0.797 . . . . 61.229999999999997 111.887 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.02 131.22 34.32 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.94 -0.573 . . . . 62.350000000000001 110.228 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.462 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 0.0 OUTLIER -72.26 179.0 3.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.829 0.347 . . . . 55.210000000000001 111.449 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.31 89.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 112.215 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -65.25 -46.12 81.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.454 0.169 . . . . 73.200000000000003 111.126 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.558 HD11 HD22 ' A' ' 88' ' ' LEU . 21.0 mm -64.66 -46.91 90.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.44 -0.345 . . . . 74.310000000000002 111.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.9 -39.81 95.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.438 -0.346 . . . . 73.409999999999997 110.511 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.27 -39.51 97.94 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 116.065 -0.516 . . . . 34.420000000000002 112.129 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.5 72.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.605 0.24 . . . . 43.329999999999998 110.719 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.53 87.61 5.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.156 -0.475 . . . . 65.340000000000003 110.891 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.39 -16.27 35.43 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.866 -0.606 . . . . 71.439999999999998 111.216 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.26 -10.46 61.56 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.17 -0.538 . . . . 75.530000000000001 112.989 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 -78.69 0.06 Allowed 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.875 0.338 . . . . 70.540000000000006 110.797 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -112.9 -7.99 13.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.034 -0.53 . . . . 64.409999999999997 112.073 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 5.6 t80 -111.04 123.78 50.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.671 0.272 . . . . 65.299999999999997 110.623 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -127.18 135.81 51.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 71.239999999999995 111.082 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' B' ' 106' ' ' CYS . 41.6 t -116.86 96.71 4.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.003 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.459 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 42.4 m0 -90.49 142.34 27.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.35 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 3.8 m-20 -93.78 118.64 31.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.928 -0.578 . . . . 63.509999999999998 109.81 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 8.9 p90 -115.06 150.13 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 72.140000000000001 111.85 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.1 159.1 16.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.263 -0.88 . . . . 62.539999999999999 110.098 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -57.56 104.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 75.099999999999994 110.428 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.4 -19.27 14.86 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.653 -0.703 . . . . 53.340000000000003 112.168 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -91.63 -13.04 32.54 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.509 0.324 . . . . 63.299999999999997 111.352 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.616 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 7.8 p -59.26 -36.43 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 120.713 0.292 . . . . 71.209999999999994 111.294 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -41.39 79.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.420000000000002 110.077 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -68.91 -38.44 79.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.902 -0.59 . . . . 51.210000000000001 110.41 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 47.9 tpp -68.62 -36.64 78.91 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 115.968 -0.56 . . . . 73.209999999999994 110.931 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.47 HD21 HG22 ' B' ' 31' ' ' ILE . 1.3 mp -63.5 -42.42 98.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 4.6 t70 -69.52 -37.42 77.14 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.37 -0.377 . . . . 62.219999999999999 110.872 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -73.97 -35.89 64.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.284 -0.416 . . . . 44.200000000000003 110.744 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.464 ' CE1' ' HG ' ' B' ' 105' ' ' LEU . 7.5 t80 -68.34 -39.09 82.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.227 -0.442 . . . . 44.450000000000003 110.951 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.7 OUTLIER -75.16 -35.74 61.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.571 -0.286 . . . . 64.109999999999999 110.998 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASP . 0.3 OUTLIER -74.73 -36.53 62.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.354 -0.385 . . . . 71.030000000000001 111.215 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -76.35 -21.85 55.62 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.347 -0.388 . . . . 60.130000000000003 111.64 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -79.41 -39.6 32.02 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.729 0.3 . . . . 71.219999999999999 110.293 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.15 -36.34 69.3 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.929 -0.578 . . . . 73.239999999999995 111.057 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 149' ' ' ALA . 9.3 p -71.94 -35.55 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.47 -0.332 . . . . 73.420000000000002 111.588 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.06 -33.21 44.85 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.703 -0.226 . . . . 72.340000000000003 110.958 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 6.8 m80 63.88 18.42 11.16 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.307 -0.406 . . . . 75.230000000000004 111.594 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -178.92 -173.9 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.592 -0.276 . . . . 64.140000000000001 110.809 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.83 113.19 9.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.433 -0.348 . . . . 71.219999999999999 110.75 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -168.65 61.89 0.06 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.052 -0.522 . . . . 55.340000000000003 110.565 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -159.23 159.47 34.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.979 -0.555 . . . . 75.120000000000005 111.335 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.636 -0.697 . . . . 73.109999999999999 111.392 179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.817 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.828 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 53.200000000000003 111.164 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.0 147.69 28.15 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 111.248 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.07 130.5 51.77 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.977 -0.556 . . . . 73.200000000000003 110.791 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.448 ' HB3' HD11 ' A' ' 42' ' ' LEU . 73.5 m -132.2 113.61 13.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.732 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 HG12 ' A' ' 78' ' ' VAL . 21.9 t -104.76 128.14 58.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 62.039999999999999 110.75 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.6 t80 -109.25 123.25 48.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.414 -0.357 . . . . 75.329999999999998 110.953 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' HD2' ' CE1' ' A' ' 28' ' ' TYR . 34.3 t80 -89.97 133.21 34.92 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 110.414 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 88.6 m -113.26 100.13 8.33 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.077 0.465 . . . . 72.219999999999999 111.562 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.593 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -140.12 121.27 1.96 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.535 -0.757 . . . . 52.100000000000001 111.426 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.535 ' HA ' " O5'" ' A' ' 187' ' ' 5GP . 6.1 t -54.5 125.47 19.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.954 0.377 . . . . 72.120000000000005 110.891 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -104.29 -45.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.976 -0.29 . . . . 73.219999999999999 110.527 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 18' ' ' ILE . 4.5 ttm180 48.56 36.23 7.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.057 -0.519 . . . . 65.5 110.565 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.539 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 62.5 26.8 68.62 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.523 -0.762 . . . . 72.040000000000006 112.047 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.95 166.45 35.51 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 120.882 -0.675 . . . . 52.420000000000002 113.296 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.66 14.78 24.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.793 -0.204 . . . . 72.239999999999995 111.097 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.69 -11.52 16.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.643 0.259 . . . . 74.219999999999999 111.65 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.07 -32.04 13.3 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.445 -0.343 . . . . 65.129999999999995 110.792 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -43.43 72.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.395 -0.366 . . . . 63.229999999999997 110.957 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.09 -40.63 98.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.405 -0.362 . . . . 75.439999999999998 110.9 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 31' ' ' ILE . 25.6 tp -72.52 -36.13 68.27 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.428 -0.351 . . . . 73.530000000000001 110.644 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 46' ' ' VAL . 4.8 m-85 -69.06 -35.92 77.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.177 -0.465 . . . . 41.329999999999998 111.554 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.35 86.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.647 0.26 . . . . 54.100000000000001 110.9 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.09 -35.86 66.68 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.266 -0.425 . . . . 63.039999999999999 111.619 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 143' ' ' LEU . 2.6 pp -76.58 -33.94 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 121.307 -0.157 . . . . 75.439999999999998 111.047 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 41' ' ' VAL . 4.9 t -66.03 -36.28 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.72 -0.218 . . . . 75.209999999999994 110.628 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.12 -41.34 90.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.697 0.284 . . . . 74.400000000000006 110.681 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -36.85 68.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.91 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.753 ' HB3' HG22 ' A' ' 41' ' ' VAL . 7.0 mp -70.26 -38.42 75.11 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.195 -0.457 . . . . 32.409999999999997 111.033 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.31 71.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.309 -0.405 . . . . 71.219999999999999 110.711 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.455 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.32 -52.13 5.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.592 0.234 . . . . 70.540000000000006 111.117 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.67 -92.03 0.1 OUTLIER Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.792 -0.718 . . . . 72.109999999999999 112.619 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.79 133.29 17.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.737 0.303 . . . . 72.439999999999998 111.453 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.909 HG11 HG22 ' A' ' 32' ' ' VAL . 2.8 t -87.83 148.94 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 110.254 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 76' ' ' ALA . 11.7 mt -112.96 1.32 15.38 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.33 0.492 . . . . 73.310000000000002 112.33 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -123.64 54.85 1.27 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.262 0.553 . . . . 65.439999999999998 110.211 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.8 -24.13 21.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.601 -0.727 . . . . 73.120000000000005 111.759 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.409 ' CE1' " O2'" ' A' ' 187' ' ' 5GP . 54.2 p-80 -52.82 -43.89 66.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.406 0.282 . . . . 74.319999999999993 111.56 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -51.47 -33.55 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 41.439999999999998 111.174 -179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.9 49.37 2.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.962 0.411 . . . . 53.109999999999999 110.348 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.42 125.97 30.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.005 -0.543 . . . . 71.329999999999998 111.634 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.0 64.66 4.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.909 -0.587 . . . . 71.030000000000001 109.498 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.58 55.9 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.96 -1.018 . . . . 64.430000000000007 110.106 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.36 159.56 30.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.666 -0.697 . . . . 74.299999999999997 111.044 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.21 129.02 0.13 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.813 -0.631 . . . . 72.109999999999999 110.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.62 -166.82 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.092 2.528 . . . . 73.439999999999998 112.636 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.97 163.9 7.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 74.510000000000005 111.212 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.03 11.29 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.252 -0.499 . . . . 30.199999999999999 113.114 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 155.82 36.42 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.301 . . . . 73.200000000000003 111.255 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 57.9 51.91 8.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.54 . . . . 64.129999999999995 110.898 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 64' ' ' PHE . . . -163.17 73.48 0.33 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.656 -0.702 . . . . 63.25 110.829 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.21 171.09 20.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.989 -0.55 . . . . 64.019999999999996 111.345 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.64 172.5 20.61 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.053 -0.594 . . . . 74.129999999999995 112.648 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.84 -98.08 0.17 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.076 -0.583 . . . . 74.239999999999995 112.621 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.2 p30 -69.7 -37.17 76.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.358 0.123 . . . . 75.430000000000007 111.099 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 122' ' ' GLY . 50.7 tp60 -54.99 -38.2 67.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.52 -0.309 . . . . 70.299999999999997 111.115 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 58' ' ' ALA . 2.0 t80 -70.2 -34.1 72.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.303 -0.408 . . . . 74.420000000000002 110.659 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.735 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 83.1 mt -62.55 -44.9 99.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.079 -0.509 . . . . 75.040000000000006 111.117 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t60 -70.76 -36.37 73.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.846 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.87 -40.59 87.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.087 -0.245 . . . . 74.099999999999994 111.107 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -68.31 -38.33 81.5 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.514 0.197 . . . . 71.299999999999997 111.263 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' B' ' 119' ' ' MET . . . -68.08 -38.66 82.62 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.406 -0.361 . . . . 64.120000000000005 111.215 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 96' ' ' ARG . 2.5 mm? -60.81 -42.28 97.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.416 -0.356 . . . . 73.409999999999997 110.864 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.83 -38.54 86.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.316 -0.402 . . . . 75.519999999999996 110.922 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 15.6 m0 -68.19 -38.61 82.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.492 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 97' ' ' ALA . 2.2 mm? -66.26 -35.1 79.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 73.219999999999999 111.435 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HA ' HD21 ' A' ' 100' ' ' LEU . 46.4 mt-30 -57.99 -41.31 82.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.612 -0.267 . . . . 62.420000000000002 111.177 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.8 -16.63 29.78 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.416 -0.357 . . . . 71.319999999999993 111.651 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -59.96 113.81 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.942 0.401 . . . . 75.430000000000007 111.524 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.12 -17.25 53.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.766 -0.652 . . . . 65.239999999999995 111.123 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' PRO . 3.8 p -161.93 136.29 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.795 0.331 . . . . 70.400000000000006 110.762 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' A' ' 97' ' ' ALA . 93.5 t -110.96 143.9 19.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.229 -0.442 . . . . 54.329999999999998 111.199 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -140.11 124.01 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.886 -0.597 . . . . 62.149999999999999 110.186 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.631 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . . . -117.38 148.41 41.78 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.983 0.364 . . . . 65.430000000000007 111.983 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -140.09 96.32 3.03 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.815 -0.63 . . . . 72.409999999999997 110.509 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 HG11 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -141.91 140.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.33 -0.395 . . . . 63.310000000000002 111.196 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 109' ' ' ARG . 24.5 p -102.26 16.93 24.7 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.477 -0.329 . . . . 42.32 111.662 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.56 154.37 25.09 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.565 0.221 . . . . 61.009999999999998 110.958 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 114' ' ' ARG . 22.7 Cg_endo -60.76 96.26 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.806 2.338 . . . . 73.430000000000007 112.25 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -96.31 127.21 42.1 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 110.694 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.679 ' CD2' HD23 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -71.2 -56.01 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.629 . . . . 62.409999999999997 111.269 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -60.91 -44.38 98.19 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.789 -0.72 . . . . 73.219999999999999 112.202 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 17' ' ' SER . 21.7 t -68.37 -39.36 80.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.593 0.235 . . . . 64.439999999999998 110.9 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' HD23 ' A' ' 94' ' ' LEU . . . -63.55 -29.76 75.61 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.969 -0.634 . . . . 64.019999999999996 111.713 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' CE1' ' HA3' ' B' ' 95' ' ' GLY . 2.9 t80 -71.63 -38.87 70.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.515 0.197 . . . . 70.299999999999997 110.717 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.59 99.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.528 -0.306 . . . . 65.019999999999996 111.08 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.594 HD23 ' HA2' ' A' ' 91' ' ' GLY . 1.2 pp -72.37 -36.14 68.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.553 -0.294 . . . . 74.049999999999997 110.419 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' B' ' 92' ' ' TYR . . . -68.06 -40.62 88.41 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.067 -0.587 . . . . 54.25 111.719 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD2' HD11 ' A' ' 70' ' ' LEU . 2.7 ttp-105 -67.16 -33.47 75.48 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.061 -0.348 . . . . 72.0 110.061 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' A' ' 79' ' ' VAL . . . -70.1 -29.85 66.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 115.837 -0.62 . . . . 75.129999999999995 111.359 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 94' ' ' LEU . 70.7 t -71.19 -40.54 74.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.557 0.218 . . . . 51.109999999999999 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.58 33.21 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.286 -0.415 . . . . 75.049999999999997 111.666 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' GLN . 28.8 tp -87.34 -48.39 8.03 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.492 -0.322 . . . . 62.219999999999999 111.862 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.83 -121.18 4.88 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.936 -0.649 . . . . 62.439999999999998 112.609 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.41 -60.8 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 111.565 0.209 . . . . 72.030000000000001 111.565 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 78' ' ' VAL . 61.6 Cg_endo -74.26 93.22 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.44 2.093 . . . . 53.219999999999999 112.542 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CD1' ' HB1' ' A' ' 97' ' ' ALA . 24.0 mm -110.31 144.26 18.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.892 -0.594 . . . . 75.329999999999998 111.516 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.697 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -125.58 139.84 53.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 74.340000000000003 109.995 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.561 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.3 m -138.08 133.79 33.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.822 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -120.8 103.71 9.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 52.43 110.872 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 11.1 t80 -114.13 126.49 55.14 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.988 -0.551 . . . . 74.109999999999999 110.481 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 84' ' ' THR . 43.7 ttt180 -61.74 122.04 68.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 111.447 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.533 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 34.5 Cg_endo -69.42 118.17 5.51 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.528 2.152 . . . . 75.030000000000001 111.289 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.46 31.29 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.0 -0.545 . . . . 65.400000000000006 110.619 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 14.1 p -65.5 -25.2 67.36 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.057 -0.52 . . . . 72.319999999999993 111.24 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.47 -39.11 2.45 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.192 -0.528 . . . . 74.019999999999996 112.135 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' A' ' 86' ' ' PRO . 1.7 mpt_? -100.37 -175.71 3.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.201 0.524 . . . . 75.409999999999997 110.714 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.4 t -149.44 144.77 17.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.244 -0.889 . . . . 64.219999999999999 110.68 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.666 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.1 mp -70.44 -84.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.492 -0.322 . . . . 75.400000000000006 111.091 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.44 -175.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.974 0.416 . . . . 65.340000000000003 110.776 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.22 -21.41 25.87 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.946 -0.57 . . . . 63.350000000000001 111.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -73.58 -48.63 31.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.722 0.267 . . . . 64.510000000000005 111.722 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' B' ' 92' ' ' TYR . 30.1 mm -69.99 -44.78 78.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.565 -0.289 . . . . 64.530000000000001 110.965 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.52 -37.38 83.5 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.537 -0.301 . . . . 72.209999999999994 110.352 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 63' ' ' GLN . . . -65.33 -38.83 95.46 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.222 -0.513 . . . . 74.099999999999994 112.408 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.11 -37.74 67.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.569 0.223 . . . . 71.299999999999997 111.016 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 101.31 1.02 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.985 0.422 . . . . 75.530000000000001 111.466 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.34 -21.14 18.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.725 -0.671 . . . . 72.519999999999996 111.178 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.79 -10.08 62.28 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.11 -0.567 . . . . 30.43 112.7 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -71.93 -61.76 1.67 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.099 0.476 . . . . 63.340000000000003 110.362 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HB3' ' HA ' ' A' ' 103' ' ' PRO . 2.0 mpt_? -125.9 -20.06 4.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.268 -0.878 . . . . 72.530000000000001 111.932 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' ILE . 4.4 t80 -107.69 121.41 44.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.696 0.284 . . . . 72.150000000000006 110.699 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 151.61 51.45 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 111.311 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 106' ' ' CYS . 22.3 t -125.27 94.84 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.01 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 37.3 m0 -82.24 150.44 27.32 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 111.371 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.533 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 3.8 m-20 -103.09 116.82 33.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.532 -0.758 . . . . 71.230000000000004 110.517 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.657 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 14.2 p90 -115.93 142.43 46.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.078 0.466 . . . . 63.229999999999997 111.665 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.62 161.08 13.83 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.797 -0.638 . . . . 72.340000000000003 109.815 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 104.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.115 -0.493 . . . . 54.020000000000003 110.043 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 117.98 -19.42 11.1 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.642 -0.708 . . . . 53.229999999999997 112.015 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.71 -9.57 34.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.591 0.357 . . . . 71.120000000000005 111.491 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.2 p -60.47 -33.24 53.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-O 120.66 0.267 . . . . 72.549999999999997 111.234 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -40.8 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 74.030000000000001 109.999 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.24 -37.41 74.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.903 -0.59 . . . . 64.420000000000002 110.846 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' CE3' ' A' ' 132' ' ' TRP . 42.6 tpp -69.81 -38.78 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.954 -0.566 . . . . 75.200000000000003 111.374 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 31' ' ' ILE . 24.5 tp -67.57 -39.86 84.9 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.454 -0.339 . . . . 73.299999999999997 110.792 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.22 -38.07 72.02 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.631 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.26 -38.2 78.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 111.204 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 3.4 t80 -66.83 -39.29 87.62 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.381 -0.372 . . . . 73.049999999999997 110.956 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -36.55 63.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.544 -0.298 . . . . 75.239999999999995 111.185 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 152' ' ' VAL . 59.3 mt-10 -73.25 -37.46 66.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.485 -0.325 . . . . 71.010000000000005 111.198 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.23 63.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.475 -0.329 . . . . 71.209999999999994 111.113 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -69.45 -41.41 76.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.695 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.19 -38.24 85.04 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.125 -0.489 . . . . 75.049999999999997 111.087 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 148' ' ' GLU . 78.7 t -69.58 -37.57 74.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.358 -0.383 . . . . 74.0 111.531 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.32 -33.12 43.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.597 -0.274 . . . . 72.319999999999993 111.106 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.8 m80 61.16 19.24 9.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 111.347 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.52 176.49 1.02 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.848 0.356 . . . . 75.150000000000006 111.311 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -153.09 111.66 3.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.09 -0.504 . . . . 70.319999999999993 110.854 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.34 154.15 22.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 111.328 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 127' ' ' SER . 59.3 t-80 -143.1 -63.25 0.41 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.173 -0.467 . . . . 62.340000000000003 110.918 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.1 -0.953 . . . . 70.209999999999994 110.988 179.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 27.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.725 0.297 . . . . 70.510000000000005 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.64 28.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.203 -0.453 . . . . 65.409999999999997 111.327 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.98 130.52 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.094 -0.503 . . . . 72.530000000000001 110.799 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.447 ' HB3' HD11 ' B' ' 42' ' ' LEU . 73.7 m -132.27 113.64 13.48 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.23 -0.441 . . . . 65.040000000000006 110.676 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.616 HG22 HG12 ' B' ' 78' ' ' VAL . 21.9 t -104.83 128.17 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 74.230000000000004 110.759 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.6 t80 -109.22 123.25 48.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.304 -0.407 . . . . 72.129999999999995 110.927 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.496 ' HD2' ' CE2' ' B' ' 28' ' ' TYR . 34.5 t80 -89.91 133.3 34.84 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.173 -0.467 . . . . 75.510000000000005 110.467 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 88.6 m -113.38 100.22 8.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.096 0.474 . . . . 71.439999999999998 111.528 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.598 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -140.21 121.29 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.518 -0.765 . . . . 44.210000000000001 111.44 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.549 ' HA ' " O5'" ' B' ' 187' ' ' 5GP . 6.1 t -54.65 125.46 19.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.921 0.36 . . . . 64.310000000000002 110.818 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.528 HG13 ' H ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -104.26 -45.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 120.977 -0.289 . . . . 40.219999999999999 110.544 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.426 ' N ' HG12 ' B' ' 18' ' ' ILE . 4.5 ttm180 48.48 36.32 7.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.091 -0.504 . . . . 73.120000000000005 110.59 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.528 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.51 26.72 68.56 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.504 -0.771 . . . . 40.119999999999997 112.025 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.93 166.39 35.5 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.855 -0.688 . . . . 43.329999999999998 113.29 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -108.55 14.72 24.38 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.726 -0.237 . . . . 70.239999999999995 111.162 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.72 -11.49 16.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.594 -0.276 . . . . 73.200000000000003 111.596 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.06 -32.01 13.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.449 -0.341 . . . . 72.310000000000002 110.841 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.57 72.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.45 -0.341 . . . . 73.540000000000006 110.868 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.63 98.26 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.472 -0.331 . . . . 54.240000000000002 110.952 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 31' ' ' ILE . 25.6 tp -72.52 -36.19 68.26 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 64.120000000000005 110.645 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' B' ' 46' ' ' VAL . 4.9 m-85 -68.96 -35.91 77.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.6 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.46 86.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.678 0.275 . . . . 53.140000000000001 110.818 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -73.17 -35.82 66.48 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.294 -0.412 . . . . 74.409999999999997 111.568 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' B' ' 143' ' ' LEU . 2.6 pp -76.59 -33.93 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 121.232 -0.187 . . . . 64.530000000000001 111.047 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.938 HG22 HG11 ' B' ' 41' ' ' VAL . 5.0 t -65.82 -36.34 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.521 0.201 . . . . 74.409999999999997 110.758 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.25 -41.24 90.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.639 0.257 . . . . 74.239999999999995 110.677 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -36.72 68.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.154 -0.475 . . . . 62.5 110.899 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' B' ' 41' ' ' VAL . 7.0 mp -70.39 -38.35 74.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.083 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -33.45 72.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 110.794 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -29.38 68.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 111.57 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -88.29 -52.16 5.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.716 -0.22 . . . . 74.150000000000006 111.063 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.62 -91.94 0.09 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.699 -0.762 . . . . 43.219999999999999 112.592 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.8 133.27 17.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.712 0.291 . . . . 74.439999999999998 111.474 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.938 HG11 HG22 ' B' ' 32' ' ' VAL . 2.8 t -87.9 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.327 -0.397 . . . . 62.299999999999997 110.326 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' B' ' 76' ' ' ALA . 11.7 mt -112.82 1.17 15.46 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.351 0.5 . . . . 74.239999999999995 112.351 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.57 ' H ' HG12 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -123.59 54.87 1.27 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.379 0.609 . . . . 71.319999999999993 110.258 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -89.87 -24.04 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.608 -0.723 . . . . 63.340000000000003 111.683 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.403 ' CE1' " O2'" ' B' ' 187' ' ' 5GP . 54.3 p-80 -52.9 -43.88 66.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.459 0.304 . . . . 61.130000000000003 111.538 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -51.44 -33.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.043 -0.526 . . . . 74.120000000000005 111.191 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.88 49.42 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.939 0.399 . . . . 72.450000000000003 110.344 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.5 125.91 29.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.047 -0.524 . . . . 73.319999999999993 111.598 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 64.58 4.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.895 -0.593 . . . . 72.439999999999998 109.472 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 81.57 55.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.944 -1.026 . . . . 41.350000000000001 110.081 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tp -124.29 159.64 29.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.633 -0.712 . . . . 72.109999999999999 111.085 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.19 129.03 0.13 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 115.9 -0.591 . . . . 75.129999999999995 110.953 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.67 -166.78 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.035 2.49 . . . . 75.329999999999998 112.572 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.98 163.85 7.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.278 -0.874 . . . . 72.439999999999998 111.309 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.21 162.0 11.28 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.247 -0.502 . . . . 52.210000000000001 113.086 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.26 155.77 36.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.75 0.31 . . . . 74.120000000000005 111.323 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 57.93 51.83 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.085 -0.507 . . . . 63.450000000000003 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' B' ' 64' ' ' PHE . . . -163.05 73.44 0.34 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.636 -0.711 . . . . 63.149999999999999 110.872 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.17 171.12 20.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.028 -0.533 . . . . 74.310000000000002 111.411 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.59 172.52 20.65 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.084 -0.579 . . . . 73.099999999999994 112.635 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.87 -98.14 0.17 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.077 -0.583 . . . . 72.129999999999995 112.64 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' B' ' 65' ' ' ILE . 1.2 p30 -69.56 -37.13 76.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.389 0.138 . . . . 64.439999999999998 111.144 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 50.6 tp60 -55.03 -38.28 67.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 65.319999999999993 111.048 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.411 ' CE1' ' HB1' ' B' ' 58' ' ' ALA . 2.0 t80 -70.15 -34.1 72.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.308 -0.405 . . . . 71.329999999999998 110.659 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.72 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 82.8 mt -62.52 -44.88 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 111.1 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.549 ' CD2' ' C ' ' B' ' 66' ' ' HIS . 1.7 t60 -70.92 -36.3 72.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 74.299999999999997 110.831 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.7 -40.8 88.64 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.157 -0.217 . . . . 45.310000000000002 111.11 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -68.19 -38.36 81.92 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.665 -0.243 . . . . 63.130000000000003 111.213 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 119' ' ' MET . . . -68.12 -38.73 82.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.376 -0.374 . . . . 72.239999999999995 111.189 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' B' ' 96' ' ' ARG . 2.5 mm? -60.7 -42.3 96.92 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.374 -0.375 . . . . 75.209999999999994 110.942 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -66.88 -38.47 86.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.999 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 15.6 m0 -68.23 -38.68 82.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 111.486 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' B' ' 97' ' ' ALA . 2.2 mm? -66.09 -35.09 79.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.509 -0.314 . . . . 75.420000000000002 111.496 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . 0.431 ' HA ' HD21 ' B' ' 100' ' ' LEU . 46.4 mt-30 -58.04 -41.37 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.663 -0.244 . . . . 71.150000000000006 111.132 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.66 -16.75 29.76 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.382 -0.372 . . . . 73.109999999999999 111.706 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' B' ' 42' ' ' LEU . . . -59.84 113.8 2.47 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.956 0.407 . . . . 44.119999999999997 111.629 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.13 -17.27 52.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.704 -0.68 . . . . 74.120000000000005 111.155 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.675 HG23 ' HB2' ' B' ' 103' ' ' PRO . 3.8 p -161.88 136.15 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.77 0.319 . . . . 52.329999999999998 110.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.65 HG21 ' CB ' ' B' ' 97' ' ' ALA . 94.0 t -110.94 143.91 19.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.209 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -140.01 124.02 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 110.222 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' B' ' 15' ' ' CYS . . . -117.44 148.4 41.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.892 0.377 . . . . 73.310000000000002 111.951 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' B' ' 107' ' ' LEU . 0.3 OUTLIER -140.04 96.44 3.06 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.8 -0.636 . . . . 43.240000000000002 110.55 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.416 HG21 HG11 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -141.98 140.75 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 73.540000000000006 111.173 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.918 HG22 ' HB2' ' B' ' 109' ' ' ARG . 24.6 p -102.24 16.9 24.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.44 -0.345 . . . . 64.329999999999998 111.606 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.63 154.38 24.98 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.454 0.169 . . . . 54.229999999999997 110.954 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' B' ' 114' ' ' ARG . 22.9 Cg_endo -60.73 96.2 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.804 2.336 . . . . 70.329999999999998 112.241 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -96.23 127.11 41.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.967 -0.56 . . . . 64.230000000000004 110.773 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.666 ' CD2' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -71.11 -56.03 6.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.63 . . . . 63.409999999999997 111.256 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -60.97 -44.29 98.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 112.194 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 17' ' ' SER . 21.8 t -68.4 -39.39 80.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.546 0.212 . . . . 64.209999999999994 110.808 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.576 ' HA2' HD23 ' B' ' 94' ' ' LEU . . . -63.67 -29.64 75.31 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.961 -0.638 . . . . 13.41 111.721 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 95' ' ' GLY . 3.0 t80 -71.69 -38.81 70.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.49 0.186 . . . . 75.420000000000002 110.716 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 5.5 mt-10 -63.28 -42.6 99.12 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.552 -0.295 . . . . 73.239999999999995 111.086 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.576 HD23 ' HA2' ' B' ' 91' ' ' GLY . 1.2 pp -72.44 -36.21 68.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.362 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 92' ' ' TYR . . . -67.95 -40.66 88.89 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.104 -0.57 . . . . 72.299999999999997 111.761 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' B' ' 70' ' ' LEU . 2.7 ttp-105 -67.08 -33.5 75.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.882 0.373 . . . . 73.299999999999997 110.152 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.65 ' CB ' HG21 ' B' ' 79' ' ' VAL . . . -70.07 -29.86 66.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.774 -0.648 . . . . 63.219999999999999 111.398 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 94' ' ' LEU . 69.9 t -71.13 -40.44 75.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.673 0.273 . . . . 62.200000000000003 110.839 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.64 -30.56 32.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.203 -0.453 . . . . 61.520000000000003 111.619 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 74' ' ' GLN . 28.7 tp -87.26 -48.39 8.06 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.896 0.332 . . . . 73.219999999999999 111.896 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.89 -121.2 4.89 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.971 -0.633 . . . . 74.0 112.561 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -170.37 -60.89 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.48 0.178 . . . . 55.310000000000002 111.48 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' B' ' 78' ' ' VAL . 61.6 Cg_endo -74.21 93.15 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.345 2.03 . . . . 74.400000000000006 112.621 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HB1' ' B' ' 97' ' ' ALA . 23.9 mm -110.19 144.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.866 -0.606 . . . . 72.120000000000005 111.516 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.699 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.3 OUTLIER -125.59 139.83 53.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.662 -0.699 . . . . 63.25 110.04 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.559 ' N ' HD13 ' B' ' 105' ' ' LEU . 1.3 m -138.08 133.8 33.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 110.864 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.508 ' HB2' ' HG3' ' B' ' 82' ' ' GLU . 0.8 OUTLIER -120.81 103.72 9.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 73.420000000000002 110.911 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 11.0 t80 -114.11 126.5 55.16 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.99 -0.55 . . . . 74.150000000000006 110.496 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.918 ' HB2' HG22 ' B' ' 84' ' ' THR . 43.8 ttt180 -61.81 121.99 68.6 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.498 -0.319 . . . . 74.140000000000001 111.457 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 34.3 Cg_endo -69.39 118.08 5.46 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.375 2.05 . . . . 54.25 111.398 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.58 31.25 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.012 -0.54 . . . . 74.25 110.605 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 14.1 p -65.52 -25.15 67.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.089 -0.505 . . . . 64.310000000000002 111.262 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.5 -39.2 2.42 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.205 -0.522 . . . . 73.420000000000002 112.163 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.527 ' HB3' ' HD3' ' B' ' 86' ' ' PRO . 1.7 mpt_? -100.32 -175.65 2.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.26 0.552 . . . . 73.329999999999998 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 93.8 t -149.52 144.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.33 -0.85 . . . . 74.329999999999998 110.643 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.679 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.1 mp -70.47 -84.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.432 -0.349 . . . . 53.450000000000003 111.123 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.45 -175.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.915 0.388 . . . . 62.030000000000001 110.833 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.28 25.78 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.006 -0.543 . . . . 71.409999999999997 111.794 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.572 ' CE ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -73.67 -48.61 31.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.736 0.272 . . . . 74.120000000000005 111.736 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 92' ' ' TYR . 30.2 mm -69.91 -44.89 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.583 -0.28 . . . . 63.140000000000001 110.971 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -61.43 -37.36 83.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.407 -0.361 . . . . 55.140000000000001 110.381 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' GLN . . . -65.39 -38.85 95.38 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 116.071 -0.513 . . . . 63.43 112.319 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.22 -37.65 67.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.536 0.208 . . . . 53.310000000000002 110.974 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.7 101.29 1.02 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.905 0.383 . . . . 63.130000000000003 111.357 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -95.42 -20.93 18.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.836 -0.62 . . . . 62.32 111.223 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.68 -10.17 62.53 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.135 -0.555 . . . . 41.229999999999997 112.767 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' B' ' 158' ' ' HIS . 0.1 OUTLIER -71.9 -61.68 1.7 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.118 0.485 . . . . 70.030000000000001 110.425 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' B' ' 103' ' ' PRO . 2.0 mpt_? -125.93 -19.97 4.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.26 -0.882 . . . . 71.340000000000003 111.933 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.421 ' CD1' ' HB ' ' B' ' 104' ' ' ILE . 4.3 t80 -107.75 121.37 44.59 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.624 0.25 . . . . 72.109999999999999 110.725 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.57 151.64 51.43 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' B' ' 106' ' ' CYS . 22.4 t -125.27 94.9 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 110.944 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 37.7 m0 -82.16 150.47 27.41 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.051 -0.522 . . . . 75.200000000000003 111.386 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 3.8 m-20 -103.28 116.84 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.575 -0.739 . . . . 74.310000000000002 110.444 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.652 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 14.3 p90 -115.9 142.48 46.72 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.075 -0.512 . . . . 75.040000000000006 111.694 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.55 161.09 13.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.741 -0.663 . . . . 55.340000000000003 109.82 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.57 103.92 0.15 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.099 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.46 10.95 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.661 -0.7 . . . . 51.130000000000003 112.009 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.66 -9.62 34.38 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.616 0.367 . . . . 70.099999999999994 111.466 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.652 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.1 p -60.34 -33.45 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -40.82 70.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 73.310000000000002 109.982 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -70.26 -37.47 74.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.884 -0.598 . . . . 75.109999999999999 110.742 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.468 ' SD ' ' CE3' ' B' ' 132' ' ' TRP . 42.2 tpp -69.7 -38.79 77.09 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.041 -0.527 . . . . 73.230000000000004 111.411 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' B' ' 31' ' ' ILE . 24.6 tp -67.6 -39.89 84.78 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.451 -0.341 . . . . 74.0 110.765 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -71.23 -38.08 71.99 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.638 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -69.17 -38.26 78.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.208 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' B' ' 80' ' ' VAL . 3.4 t80 -66.78 -39.27 87.75 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.389 -0.368 . . . . 72.540000000000006 110.992 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -36.66 63.08 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.548 -0.296 . . . . 62.530000000000001 111.091 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.458 ' O ' HG23 ' B' ' 152' ' ' VAL . 59.3 mt-10 -73.19 -37.48 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.494 -0.321 . . . . 62.399999999999999 111.244 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.18 63.41 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.367 -0.379 . . . . 74.239999999999995 111.106 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.574 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -69.52 -41.26 76.25 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 116.242 -0.435 . . . . 74.329999999999998 110.731 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.35 -38.11 84.3 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.064 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 148' ' ' GLU . 78.2 t -69.65 -37.59 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.314 -0.403 . . . . 73.540000000000006 111.503 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.31 -33.14 43.46 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.604 -0.271 . . . . 74.040000000000006 111.084 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.9 m80 61.2 19.08 9.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 53.409999999999997 111.421 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -178.41 176.51 1.04 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.813 0.339 . . . . 75.430000000000007 111.361 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -153.1 111.68 3.7 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 75.329999999999998 110.807 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -160.32 154.1 22.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.309 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.576 ' HB3' ' HA ' ' B' ' 127' ' ' SER . 59.3 t-80 -142.99 -63.35 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.13 -0.487 . . . . 73.409999999999997 110.929 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.09 -0.957 . . . . 73.239999999999995 110.98 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.735 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.72 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.659 0.266 . . . . 75.340000000000003 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 147.53 27.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.266 -0.424 . . . . 62.140000000000001 111.287 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.11 125.97 43.35 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.068 -0.515 . . . . 74.519999999999996 110.75 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.983 ' HB3' HD21 ' A' ' 42' ' ' LEU . 69.6 m -138.51 120.02 14.99 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.298 -0.41 . . . . 73.310000000000002 111.05 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG12 ' A' ' 78' ' ' VAL . 30.4 t -118.3 119.23 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.337 -0.392 . . . . 63.119999999999997 111.334 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.1 t80 -97.2 123.6 41.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 74.430000000000007 110.656 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 31' ' ' ILE . 33.5 t80 -95.63 118.07 31.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.583 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.47 114.3 28.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.95 0.405 . . . . 71.219999999999999 111.434 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' H5'1 ' A' ' 187' ' ' 5GP . . . -149.99 122.3 1.39 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.784 -0.644 . . . . 74.409999999999997 111.952 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.5 ' HB2' HG21 ' A' ' 90' ' ' VAL . 1.3 t -58.52 112.32 1.55 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.789 0.294 . . . . 72.329999999999998 110.73 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.612 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -98.02 -43.09 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 120.747 0.308 . . . . 72.200000000000003 110.41 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.497 ' N ' HG12 ' A' ' 18' ' ' ILE . 88.7 mtm180 49.99 41.26 22.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.617 -0.72 . . . . 65.5 110.4 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.496 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.89 27.65 68.94 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.316 -0.857 . . . . 72.450000000000003 112.359 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.0 158.98 25.23 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.931 -0.652 . . . . 33.229999999999997 113.423 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.11 8.55 44.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.13 0.172 . . . . 73.140000000000001 111.418 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.3 -5.41 29.8 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.513 0.19 . . . . 64.420000000000002 111.513 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.12 -33.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.555 -0.293 . . . . 64.019999999999996 111.001 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.77 -40.1 75.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.556 -0.293 . . . . 70.040000000000006 111.145 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.86 86.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.636 0.255 . . . . 74.349999999999994 110.975 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 tp -73.42 -36.25 65.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.308 -0.405 . . . . 63.32 110.33 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 46' ' ' VAL . 3.3 m-85 -69.07 -35.44 76.54 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.381 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.84 90.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.608 0.242 . . . . 73.099999999999994 111.052 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -74.05 -35.54 64.31 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.316 -0.402 . . . . 72.049999999999997 111.488 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.632 HG22 HD22 ' A' ' 143' ' ' LEU . 2.7 pp -77.64 -33.09 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 121.14 -0.224 . . . . 72.349999999999994 111.011 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 41' ' ' VAL . 3.3 t -65.04 -37.14 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.642 -0.254 . . . . 73.239999999999995 110.659 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -66.39 -41.03 89.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.689 -0.232 . . . . 72.430000000000007 110.625 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -36.32 66.47 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.359 -0.382 . . . . 72.420000000000002 110.822 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.809 ' HB3' HG22 ' A' ' 41' ' ' VAL . 6.5 mp -69.01 -39.35 79.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.176 -0.466 . . . . 74.150000000000006 111.016 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 2.3 tpt180 -72.76 -31.65 65.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.388 -0.369 . . . . 75.200000000000003 110.759 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.16 -31.23 67.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.355 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.4 -48.92 6.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.67 -0.241 . . . . 74.129999999999995 110.81 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.44 -95.78 0.16 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.817 -0.706 . . . . 54.530000000000001 112.585 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 36' ' ' ARG . 3.1 ttpm? -150.01 132.23 15.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.803 0.335 . . . . 74.340000000000003 111.466 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 32' ' ' VAL . 3.6 t -81.51 140.1 17.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.665 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.983 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.9 mm? -97.55 -17.09 19.77 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.505 -0.316 . . . . 65.430000000000007 111.712 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' HE1' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -101.75 44.87 0.99 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.208 0.527 . . . . 73.439999999999998 110.945 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 13.9 mt-10 -89.03 88.23 7.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.637 -0.71 . . . . 55.509999999999998 109.658 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.527 ' HE1' HG22 ' A' ' 43' ' ' THR . 46.3 p-80 -175.91 -39.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.291 -0.868 . . . . 75.510000000000005 110.827 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -52.46 -22.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.88 -0.6 . . . . 55.25 111.644 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.64 44.17 2.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.864 0.32 . . . . 44.149999999999999 111.864 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 p30 -103.85 151.16 23.42 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.02 0.438 . . . . 72.409999999999997 111.142 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.0 52.78 1.92 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.601 0.715 . . . . 51.100000000000001 110.206 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.92 70.04 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.282 -1.326 . . . . 73.400000000000006 110.099 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.34 99.49 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.227 -0.442 . . . . 61.140000000000001 110.923 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.89 107.77 0.86 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.718 -0.673 . . . . 64.030000000000001 111.984 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.32 -165.9 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.303 2.668 . . . . 55.32 112.504 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.74 163.3 0.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.339 -0.846 . . . . 71.329999999999998 111.59 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.24 -156.99 16.59 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.972 -0.633 . . . . 60.229999999999997 112.656 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.78 157.53 14.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.771 0.319 . . . . 72.510000000000005 111.115 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.63 52.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.168 -0.469 . . . . 55.210000000000001 110.969 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.11 152.26 48.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.151 -0.477 . . . . 52.229999999999997 111.233 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.63 101.97 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 110.817 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 142.44 6.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.968 -0.634 . . . . 51.030000000000001 112.359 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' ILE . . . -68.38 -21.8 74.42 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.062 -0.59 . . . . 54.240000000000002 113.329 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 p-10 -58.42 -48.07 81.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.705 0.253 . . . . 71.420000000000002 111.365 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -38.87 85.45 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.628 -0.26 . . . . 55.210000000000001 110.97 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -37.44 87.53 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.272 -0.422 . . . . 71.439999999999998 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.608 HG12 ' C6 ' ' A' ' 187' ' ' 5GP . 66.2 mt -62.75 -42.75 97.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.277 -0.42 . . . . 63.549999999999997 110.887 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' B' ' 123' ' ' ALA . 14.9 t-80 -64.73 -39.81 94.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.983 -0.553 . . . . 74.510000000000005 111.439 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.0 -38.67 86.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.363 -0.38 . . . . 74.430000000000007 111.242 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.89 -41.9 97.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.495 -0.32 . . . . 71.239999999999995 110.963 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB1' ' NH2' ' A' ' 96' ' ' ARG . . . -67.05 -37.73 84.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.328 -0.396 . . . . 74.519999999999996 111.319 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.587 HD22 ' CD ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -64.62 -41.81 95.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.304 -0.407 . . . . 72.319999999999993 110.915 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.02 -33.71 68.26 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.325 -0.398 . . . . 64.25 111.192 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 14.1 m0 -68.68 -39.18 80.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 71.030000000000001 111.636 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD12 ' NE ' ' A' ' 96' ' ' ARG . 6.1 mt -79.09 -17.36 55.29 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.737 0.273 . . . . 75.349999999999994 111.737 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.82 -34.16 72.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.585 0.231 . . . . 71.420000000000002 110.906 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.61 26.89 9.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.377 -0.374 . . . . 72.209999999999994 111.472 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.84 108.34 19.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.899 0.38 . . . . 71.219999999999999 111.411 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.01 -24.05 65.98 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.864 -0.607 . . . . 75.450000000000003 110.953 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.719 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -158.1 139.47 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.538 -0.301 . . . . 63.439999999999998 110.439 179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HB ' HD12 ' A' ' 104' ' ' ILE . 22.1 t -121.68 116.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 70.420000000000002 111.199 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.12 151.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.592 . . . . 73.25 110.224 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' CYS . . . -135.96 142.47 44.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.86 0.362 . . . . 60.009999999999998 111.804 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.9 mt-10 -139.76 96.84 3.14 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.82 -0.627 . . . . 74.219999999999999 110.511 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 90' ' ' VAL . 1.3 t -143.16 139.81 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.356 -0.384 . . . . 73.510000000000005 111.144 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.9 p -105.51 18.79 21.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 111.539 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.23 148.82 10.88 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-O 120.592 0.234 . . . . 63.149999999999999 111.181 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' B' ' 88' ' ' LEU . 33.2 Cg_endo -63.47 96.55 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.833 2.356 . . . . 71.329999999999998 112.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.3 m -100.08 126.49 46.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.737 HD23 HG13 ' B' ' 120' ' ' ILE . 4.6 tp -64.77 -44.63 89.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 60.340000000000003 111.639 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' B' ' 120' ' ' ILE . . . -62.68 -45.36 95.94 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.962 -0.637 . . . . 62.350000000000001 112.337 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 83' ' ' VAL . 39.0 t -68.86 -35.64 70.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.519 0.199 . . . . 75.019999999999996 110.478 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.01 99.09 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 121.125 -0.559 . . . . 54.109999999999999 111.761 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.63 ' CE2' ' HA2' ' B' ' 95' ' ' GLY . 4.4 t80 -61.29 -44.85 96.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 110.036 -0.357 . . . . 73.230000000000004 110.036 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' OE1' " H4'" ' A' ' 187' ' ' 5GP . 47.9 mt-10 -57.72 -39.31 76.98 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.975 -0.557 . . . . 72.5 110.614 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.515 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 4.9 tp -62.76 -42.24 99.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.293 -0.412 . . . . 61.520000000000003 110.44 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' B' ' 92' ' ' TYR . . . -62.78 -40.49 99.29 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.972 -0.632 . . . . 71.219999999999999 112.025 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' CD ' HD22 ' A' ' 70' ' ' LEU . 17.8 ttp-105 -69.52 -38.88 77.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.573 0.225 . . . . 65.329999999999998 110.466 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -64.73 -39.36 93.5 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.377 -0.374 . . . . 51.229999999999997 111.86 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 104' ' ' ILE . 89.9 t -76.54 -33.83 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.555 0.217 . . . . 70.230000000000004 111.083 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.74 58.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.356 -0.384 . . . . 44.32 111.547 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.31 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.589 -0.278 . . . . 64.349999999999994 111.259 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.88 -126.38 4.42 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.106 -0.569 . . . . 61.439999999999998 112.632 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.53 -60.05 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 111.381 0.141 . . . . 74.340000000000003 111.381 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.717 ' HB2' HG23 ' A' ' 78' ' ' VAL . 58.3 Cg_endo -71.83 95.04 0.71 Allowed 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.377 2.051 . . . . 61.409999999999997 112.284 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 98' ' ' VAL . 32.7 mm -110.71 152.07 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.933 -0.576 . . . . 64.530000000000001 111.617 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 106' ' ' CYS . 1.2 tm? -133.62 137.72 45.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.776 -0.647 . . . . 73.230000000000004 109.969 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.675 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.46 133.83 44.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 72.329999999999998 110.936 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 134' ' ' TYR . 6.8 mt -122.33 102.64 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.539999999999999 111.009 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.7 t80 -111.36 122.58 48.23 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.431 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.829 ' HB2' HG22 ' A' ' 84' ' ' THR . 1.3 ttt180 -61.0 120.75 56.89 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.496 -0.32 . . . . 65.140000000000001 111.23 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.458 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 29.3 Cg_endo -67.64 123.62 10.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.356 2.038 . . . . 63.509999999999998 111.598 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.29 28.44 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.962 -0.563 . . . . 51.020000000000003 111.089 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 21.1 p -65.99 -24.71 66.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.336 -0.393 . . . . 71.329999999999998 111.576 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.83 -37.07 2.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.266 -0.493 . . . . 53.329999999999998 111.926 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -100.02 -173.18 2.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.172 0.51 . . . . 75.420000000000002 110.568 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -144.36 149.4 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.346 -0.843 . . . . 72.299999999999997 110.746 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.671 HD23 ' CD2' ' B' ' 88' ' ' LEU . 1.8 mp -72.13 -87.93 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.379 -0.373 . . . . 72.040000000000006 110.725 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.88 179.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.943 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.5 -35.76 34.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.203 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.6 mmm -65.3 -47.84 75.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.681 -0.236 . . . . 74.519999999999996 110.713 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.728 HG13 HD23 ' B' ' 88' ' ' LEU . 29.8 mm -62.14 -47.45 93.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.537 -0.301 . . . . 74.349999999999994 110.516 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -60.05 -41.77 93.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.061 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.18 -37.69 94.9 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.805 -0.634 . . . . 23.140000000000001 112.113 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -57.11 -39.32 74.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.634 0.254 . . . . 54.240000000000002 110.795 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.91 86.15 2.26 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.114 -0.493 . . . . 54.5 111.023 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.88 -20.3 49.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.793 -0.64 . . . . 71.120000000000005 111.231 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.18 -12.96 60.4 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.157 -0.544 . . . . 54.310000000000002 113.224 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -63.9 1.01 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.036 0.418 . . . . 72.439999999999998 110.854 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -120.94 -19.26 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 73.409999999999997 111.981 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.5 t80 -106.38 117.85 35.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.715 0.293 . . . . 62.509999999999998 110.73 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.71 153.95 37.52 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.02 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 106' ' ' CYS . 33.4 t -133.72 102.99 4.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 111.173 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 39.0 m0 -95.75 150.6 20.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' ' CG ' ' A' ' 110' ' ' PRO . 1.1 m-20 -106.58 117.82 35.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.659 . . . . 51.409999999999997 110.413 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 22.3 p90 -113.15 125.61 54.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.057 -0.52 . . . . 65.230000000000004 111.545 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -93.1 124.48 37.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.098 -0.501 . . . . 73.25 110.144 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 1.4 pm0 -17.38 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.087 0.867 . . . . 70.109999999999999 112.543 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.67 -13.63 5.33 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.711 -1.131 . . . . 73.400000000000006 111.784 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.63 -8.23 23.15 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.61 0.226 . . . . 63.299999999999997 111.61 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.635 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 6.2 p -57.43 -35.62 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 43.200000000000003 111.635 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.02 -38.86 69.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.895 -0.593 . . . . 72.040000000000006 110.567 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -70.26 -38.01 75.01 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.972 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 132' ' ' TRP . 2.5 mmt -71.19 -37.17 72.13 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.223 -0.444 . . . . 60.32 111.272 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 31' ' ' ILE . 19.3 tp -70.9 -38.43 73.0 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.57 -0.286 . . . . 74.420000000000002 111.11 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -37.27 64.52 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.293 -0.412 . . . . 63.130000000000003 110.878 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -73.4 -33.62 65.09 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.366 -0.379 . . . . 65.109999999999999 110.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 14.5 t80 -67.81 -41.08 83.67 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.338 -0.392 . . . . 74.019999999999996 110.818 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -74.96 -35.09 62.11 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.523 -0.308 . . . . 73.310000000000002 111.088 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -74.57 -37.01 63.07 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.497 -0.32 . . . . 74.540000000000006 111.059 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.68 -30.15 62.72 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.454 -0.339 . . . . 52.130000000000003 111.163 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -70.16 -41.41 73.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.464 -0.335 . . . . 72.219999999999999 110.503 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.11 97.52 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.503 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' A' ' 159' ' ' HIS . 89.2 t -69.3 -37.76 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.102 -0.499 . . . . 53.549999999999997 110.834 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.98 -36.93 85.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.142 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -34.81 74.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.367 -0.379 . . . . 74.530000000000001 111.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.29 -66.4 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.664 -0.244 . . . . 61.109999999999999 111.322 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.92 165.73 11.19 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.339 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -113.04 160.18 18.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.039 -0.528 . . . . 74.030000000000001 110.965 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.04 -75.71 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.088 -0.505 . . . . 71.420000000000002 111.314 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.49 ' CG ' HG11 ' A' ' 152' ' ' VAL . 16.6 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.039 -0.981 . . . . 72.099999999999994 111.298 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.664 0.269 . . . . 62.219999999999999 111.148 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.16 147.55 27.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.242 -0.435 . . . . 74.519999999999996 111.229 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -98.07 125.86 43.24 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.062 -0.517 . . . . 71.540000000000006 110.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.014 ' HB3' HD21 ' B' ' 42' ' ' LEU . 69.4 m -138.5 120.06 15.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.332 -0.395 . . . . 62.219999999999999 110.992 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.718 HG22 HG12 ' B' ' 78' ' ' VAL . 29.5 t -118.21 119.2 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.421 . . . . 75.310000000000002 111.382 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.52 ' HA ' ' HB2' ' B' ' 42' ' ' LEU . 1.1 t80 -97.21 123.61 41.04 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.376 -0.375 . . . . 72.420000000000002 110.655 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.543 ' CG ' HD13 ' B' ' 31' ' ' ILE . 33.9 t80 -95.68 118.04 31.61 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.19 -0.459 . . . . 74.450000000000003 110.614 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 114.43 28.42 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.957 0.408 . . . . 72.040000000000006 111.454 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.557 ' O ' H5'1 ' B' ' 187' ' ' 5GP . . . -150.07 122.39 1.4 Allowed Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.777 -0.647 . . . . 51.340000000000003 111.861 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.497 ' HB2' HG21 ' B' ' 90' ' ' VAL . 1.3 t -58.6 112.46 1.61 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.716 0.258 . . . . 74.230000000000004 110.744 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 46' ' ' VAL . 0.3 OUTLIER -98.16 -43.04 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 120.758 0.313 . . . . 72.019999999999996 110.406 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.503 ' N ' HG12 ' B' ' 18' ' ' ILE . 88.7 mtm180 49.98 41.18 22.69 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.665 -0.698 . . . . 71.450000000000003 110.435 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.514 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 62.08 27.59 69.15 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.307 -0.861 . . . . 35.539999999999999 112.32 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.1 159.05 25.17 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 120.93 -0.653 . . . . 43.219999999999999 113.388 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -97.12 8.47 44.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.115 0.166 . . . . 74.140000000000001 111.378 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.16 -5.58 29.82 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.547 0.213 . . . . 64.230000000000004 111.557 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.04 -33.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.493 -0.321 . . . . 71.420000000000002 111.065 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -56.66 -40.1 74.89 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.537 -0.301 . . . . 63.509999999999998 111.307 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.96 86.35 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.541 -0.299 . . . . 70.319999999999993 110.917 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 25.6 tp -73.29 -36.33 66.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.371 -0.377 . . . . 71.120000000000005 110.347 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.584 ' CD1' HG21 ' B' ' 46' ' ' VAL . 3.2 m-85 -69.12 -35.4 76.38 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.881 -0.6 . . . . 72.319999999999993 111.357 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.76 90.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.609 0.242 . . . . 71.019999999999996 111.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -73.99 -35.53 64.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.525 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.634 HG22 HD22 ' B' ' 143' ' ' LEU . 2.7 pp -77.66 -33.13 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 121.19 -0.204 . . . . 72.099999999999994 110.961 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 41' ' ' VAL . 3.4 t -65.08 -37.14 79.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.633 -0.258 . . . . 61.020000000000003 110.617 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -66.32 -41.01 90.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.576 0.227 . . . . 72.329999999999998 110.689 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.29 -36.26 66.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.277 -0.419 . . . . 74.5 110.897 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.802 ' HB3' HG22 ' B' ' 41' ' ' VAL . 6.5 mp -69.06 -39.36 79.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.122 -0.49 . . . . 63.340000000000003 111.05 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' B' ' 40' ' ' LYS . 2.3 tpt180 -72.77 -31.56 64.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.401 -0.363 . . . . 71.319999999999993 110.817 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -58.2 -31.27 67.16 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.229 -0.441 . . . . 72.010000000000005 111.377 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -90.29 -48.87 6.87 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.543 0.211 . . . . 75.239999999999995 110.888 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.49 -95.75 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.779 -0.724 . . . . 64.219999999999999 112.585 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' B' ' 36' ' ' ARG . 3.1 ttpm? -150.05 132.29 15.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.702 0.287 . . . . 73.549999999999997 111.43 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 32' ' ' VAL . 3.6 t -81.61 140.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.642 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.9 mm? -97.51 -17.23 19.72 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.46 -0.336 . . . . 53.25 111.666 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.531 HG22 ' HE1' ' B' ' 45' ' ' HIS . 0.0 OUTLIER -101.67 44.76 1.0 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.165 0.507 . . . . 75.219999999999999 110.921 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' B' ' 41' ' ' VAL . 13.9 mt-10 -88.93 88.27 7.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.687 -0.688 . . . . 74.329999999999998 109.611 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.531 ' HE1' HG22 ' B' ' 43' ' ' THR . 46.1 p-80 -175.91 -39.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.296 -0.865 . . . . 72.439999999999998 110.809 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -52.44 -22.52 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.962 -0.563 . . . . 75.329999999999998 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 44.21 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.865 0.32 . . . . 65.299999999999997 111.865 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -103.81 151.15 23.41 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.979 0.418 . . . . 73.329999999999998 111.169 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.02 52.83 1.92 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.514 0.673 . . . . 62.329999999999998 110.193 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 163.87 70.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.261 -1.336 . . . . 63.549999999999997 110.105 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.32 99.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.149 -0.478 . . . . 64.230000000000004 110.933 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -49.89 107.82 0.87 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.744 -0.662 . . . . 74.319999999999993 112.015 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.45 -165.94 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.253 2.635 . . . . 54.32 112.43 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.78 163.23 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.304 -0.862 . . . . 75.230000000000004 111.584 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.29 -156.94 16.58 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.041 -0.6 . . . . 71.219999999999999 112.745 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.81 157.5 14.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.777 0.323 . . . . 73.219999999999999 111.136 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 136.74 52.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.18 -0.464 . . . . 72.25 110.92 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.17 152.19 48.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.066 -0.516 . . . . 73.219999999999999 111.261 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.62 101.96 1.1 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 75.349999999999994 110.829 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 142.4 6.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.984 -0.627 . . . . 63.130000000000003 112.308 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.415 ' O ' HG13 ' B' ' 65' ' ' ILE . . . -68.31 -21.87 74.32 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.117 -0.564 . . . . 65.349999999999994 113.3 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.553 ' HA ' HD12 ' B' ' 65' ' ' ILE . 8.9 p-10 -58.37 -48.14 81.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.721 0.26 . . . . 74.140000000000001 111.376 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.99 85.4 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.937 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -37.49 87.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.313 -0.403 . . . . 73.319999999999993 110.862 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.616 HG12 ' C6 ' ' B' ' 187' ' ' 5GP . 66.0 mt -62.73 -42.74 97.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 110.894 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 123' ' ' ALA . 14.9 t-80 -64.67 -39.87 94.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.982 -0.554 . . . . 73.519999999999996 111.421 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.91 -38.65 86.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.397 -0.365 . . . . 70.209999999999994 111.355 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.99 -41.73 97.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.348 -0.387 . . . . 73.230000000000004 110.998 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.528 ' HB1' ' NH2' ' B' ' 96' ' ' ARG . . . -67.27 -37.62 83.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.313 -0.403 . . . . 63.299999999999997 111.259 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.58 HD22 ' CD ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -64.6 -41.87 95.93 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.279 -0.419 . . . . 75.109999999999999 110.963 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.92 -33.72 68.51 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.308 -0.405 . . . . 64.530000000000001 111.262 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 14.0 m0 -68.79 -39.22 80.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.553 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.492 HD12 ' NE ' ' B' ' 96' ' ' ARG . 6.1 mt -78.92 -17.45 55.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.829 0.307 . . . . 75.430000000000007 111.829 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -59.81 -34.16 72.68 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.508 0.194 . . . . 70.209999999999994 110.891 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.55 26.89 9.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.464 -0.335 . . . . 74.040000000000006 111.492 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.93 108.34 19.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.963 0.411 . . . . 72.219999999999999 111.418 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -66.92 -24.12 66.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.84 -0.618 . . . . 64.099999999999994 110.945 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.718 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -158.09 139.37 4.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.523 -0.308 . . . . 74.25 110.522 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' B' ' 104' ' ' ILE . 22.1 t -121.52 116.54 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.524 -0.307 . . . . 73.319999999999993 111.273 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -103.13 152.01 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.965 -0.561 . . . . 74.340000000000003 110.171 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' B' ' 106' ' ' CYS . . . -135.97 142.49 44.56 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.771 0.319 . . . . 74.030000000000001 111.831 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.466 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 1.9 mt-10 -139.82 96.86 3.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.928 -0.578 . . . . 63.229999999999997 110.529 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.577 HG21 HG11 ' B' ' 90' ' ' VAL . 1.3 t -143.22 139.72 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.339 -0.391 . . . . 75.209999999999994 111.094 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.82 HG22 ' HB2' ' B' ' 109' ' ' ARG . 34.1 p -105.34 18.64 21.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.344 -0.389 . . . . 72.340000000000003 111.642 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -162.18 148.83 10.96 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.601 0.238 . . . . 73.140000000000001 111.116 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 88' ' ' LEU . 33.1 Cg_endo -63.53 96.5 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.904 2.403 . . . . 63.409999999999997 112.384 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 60.8 m -100.05 126.42 46.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.121 -0.491 . . . . 71.430000000000007 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.728 HD23 HG13 ' A' ' 120' ' ' ILE . 4.6 tp -64.75 -44.69 89.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 62.43 111.686 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.539 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . -62.59 -45.37 95.97 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.993 -0.622 . . . . 33.420000000000002 112.357 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.577 HG11 HG21 ' B' ' 83' ' ' VAL . 39.0 t -68.85 -35.66 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 75.329999999999998 110.433 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.86 -41.0 99.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.129 -0.557 . . . . 73.5 111.765 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.632 ' CE2' ' HA2' ' A' ' 95' ' ' GLY . 4.4 t80 -61.39 -44.86 96.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.949 -0.389 . . . . 64.299999999999997 109.949 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.487 ' OE1' " H4'" ' B' ' 187' ' ' 5GP . 48.0 mt-10 -57.66 -39.35 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.012 -0.54 . . . . 64.5 110.633 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.514 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 4.9 tp -62.68 -42.33 99.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 110.448 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.63 ' HA2' ' CE2' ' A' ' 92' ' ' TYR . . . -62.82 -40.4 99.19 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.953 -0.642 . . . . 63.350000000000001 112.046 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.58 ' CD ' HD22 ' B' ' 70' ' ' LEU . 17.8 ttp-105 -69.58 -38.88 77.55 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.537 0.208 . . . . 73.239999999999995 110.479 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.451 ' HB1' HD12 ' B' ' 104' ' ' ILE . . . -64.69 -39.44 93.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.375 -0.375 . . . . 52.140000000000001 111.833 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.601 HG22 HG13 ' B' ' 104' ' ' ILE . 89.5 t -76.57 -33.73 22.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.558 0.218 . . . . 72.019999999999996 111.115 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.34 -36.77 58.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.399 -0.364 . . . . 64.25 111.53 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' B' ' 96' ' ' ARG . 0.2 OUTLIER -87.54 -52.2 5.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.637 -0.256 . . . . 75.25 111.314 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.87 -126.55 4.47 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.199 -0.524 . . . . 65.319999999999993 112.581 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -60.01 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 111.378 0.14 . . . . 72.349999999999994 111.378 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' B' ' 78' ' ' VAL . 58.3 Cg_endo -71.93 94.88 0.72 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.437 2.091 . . . . 74.230000000000004 112.331 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.601 HG13 HG22 ' B' ' 98' ' ' VAL . 32.8 mm -110.57 152.08 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.918 -0.583 . . . . 72.099999999999994 111.638 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.681 HD13 ' N ' ' B' ' 106' ' ' CYS . 1.2 tm? -133.56 137.63 45.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.654 . . . . 74.129999999999995 109.965 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.681 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.1 OUTLIER -132.49 133.98 44.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.794 0.331 . . . . 60.509999999999998 110.944 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' B' ' 134' ' ' TYR . 6.9 mt -122.41 102.61 8.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.237 -0.438 . . . . 73.329999999999998 110.943 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.8 t80 -111.37 122.67 48.45 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.404 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.82 ' HB2' HG22 ' B' ' 84' ' ' THR . 1.4 ttt180 -61.17 120.77 57.62 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.451 -0.34 . . . . 65.150000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.468 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 29.4 Cg_endo -67.57 123.64 11.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.375 2.05 . . . . 73.099999999999994 111.548 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 73.35 28.43 1.78 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.025 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.488 ' HA ' ' CZ ' ' B' ' 109' ' ' ARG . 21.3 p -66.09 -24.63 66.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.394 -0.366 . . . . 62.130000000000003 111.587 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.82 -37.2 2.76 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.24 -0.505 . . . . 72.120000000000005 111.879 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -99.97 -173.24 2.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.208 0.528 . . . . 70.230000000000004 110.562 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.23 149.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.343 -0.844 . . . . 73.140000000000001 110.751 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.678 HD23 ' CD2' ' A' ' 88' ' ' LEU . 1.8 mp -72.23 -88.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.388 -0.369 . . . . 75.239999999999995 110.616 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 2.4 p 163.91 179.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.83 0.348 . . . . 75.109999999999999 110.879 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.47 -35.81 34.31 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.067 -0.515 . . . . 74.099999999999994 111.137 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 23.5 mmm -65.27 -47.72 75.69 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.724 -0.216 . . . . 73.329999999999998 110.738 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.737 HG13 HD23 ' A' ' 88' ' ' LEU . 29.8 mm -62.27 -47.42 93.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 75.340000000000003 110.467 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -60.04 -41.73 92.92 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 74.209999999999994 110.055 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.07 -37.93 95.28 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.819 -0.628 . . . . 51.229999999999997 112.066 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -57.03 -39.42 74.77 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.604 0.24 . . . . 74.239999999999995 110.753 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.82 86.14 2.21 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.177 -0.465 . . . . 61.350000000000001 111.133 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.89 -20.36 49.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 54.219999999999999 111.202 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.26 -13.08 60.24 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.071 -0.585 . . . . 62.350000000000001 113.214 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.0 -63.99 0.99 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.004 0.402 . . . . 62.229999999999997 110.816 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.79 -19.3 7.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.504 -0.771 . . . . 71.409999999999997 112.1 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.5 t80 -106.33 117.85 35.11 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.731 0.3 . . . . 74.450000000000003 110.732 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -121.65 153.97 37.43 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.022 -0.535 . . . . 72.310000000000002 111.044 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' B' ' 106' ' ' CYS . 33.2 t -133.7 102.93 4.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.265 -0.425 . . . . 72.25 111.24 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 39.0 m0 -95.68 150.67 20.11 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.154 -0.476 . . . . 74.120000000000005 111.127 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' CG ' ' B' ' 110' ' ' PRO . 1.1 m-20 -106.52 117.69 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.513 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.623 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 22.4 p90 -113.15 125.6 54.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.09 -0.504 . . . . 72.239999999999995 111.548 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' B' ' 136' ' ' GLU . . . -93.02 124.52 37.05 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.979 -0.555 . . . . 74.209999999999994 110.084 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' B' ' 135' ' ' ALA . 1.4 pm0 -17.46 89.44 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.112 0.882 . . . . 72.5 112.577 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.69 -13.62 5.32 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.661 -1.154 . . . . 71.439999999999998 111.691 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -100.65 -8.21 23.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.285 0.234 . . . . 64.329999999999998 111.583 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 6.3 p -57.5 -35.67 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.783 0.325 . . . . 73.400000000000006 111.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.07 -38.75 69.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 110.559 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -70.35 -38.02 74.76 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.14 -0.482 . . . . 62.039999999999999 110.843 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' B' ' 132' ' ' TRP . 2.4 mmt -71.12 -37.27 72.32 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 116.2 -0.455 . . . . 63.299999999999997 111.304 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.634 HD22 HG22 ' B' ' 31' ' ' ILE . 19.3 tp -70.86 -38.43 73.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.494 -0.321 . . . . 64.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -37.21 64.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.895 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -73.43 -33.56 64.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.316 -0.402 . . . . 74.299999999999997 110.86 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.528 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 14.7 t80 -67.77 -41.15 83.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.401 -0.363 . . . . 75.099999999999994 110.824 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' B' ' 35' ' ' LEU . 0.8 OUTLIER -74.99 -35.14 62.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.519 -0.309 . . . . 73.310000000000002 111.053 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.44 -37.1 63.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.47 -0.332 . . . . 74.200000000000003 111.022 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.18 62.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.486 -0.324 . . . . 60.109999999999999 111.113 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -70.13 -41.39 73.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.438 -0.346 . . . . 72.450000000000003 110.589 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -64.03 -41.15 97.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.483 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' B' ' 159' ' ' HIS . 88.7 t -69.36 -37.73 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.098 -0.501 . . . . 55.219999999999999 110.789 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.96 -36.89 85.83 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.277 -0.42 . . . . 71.25 111.166 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -34.78 74.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 74.310000000000002 111.528 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.27 -66.42 0.91 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.692 -0.231 . . . . 62.25 111.362 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -100.83 165.73 11.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.862 0.363 . . . . 72.129999999999995 111.431 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -113.06 160.26 18.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.091 -0.504 . . . . 44.329999999999998 110.98 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 70.01 -75.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.998 -0.546 . . . . 72.230000000000004 111.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . 0.49 ' CG ' HG11 ' B' ' 152' ' ' VAL . 16.7 t-160 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.997 -1.002 . . . . 74.230000000000004 111.248 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.608 ' C6 ' HG12 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.616 ' C6 ' HG12 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.031 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.87 125.2 18.94 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.998 -0.546 . . . . 55.450000000000003 111.011 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.56 133.87 42.31 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.094 -0.503 . . . . 63.219999999999999 110.549 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' HD21 ' A' ' 42' ' ' LEU . 17.3 m -140.75 120.85 13.75 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.941 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 78' ' ' VAL . 14.1 t -116.76 121.69 68.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.526 -0.307 . . . . 65.400000000000006 110.995 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -101.02 116.22 32.33 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.416 -0.356 . . . . 75.209999999999994 110.757 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CG ' HD13 ' A' ' 31' ' ' ILE . 60.9 t80 -92.13 126.22 37.12 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.586 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.93 103.99 12.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.987 0.423 . . . . 73.540000000000006 111.241 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -135.18 94.77 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.712 -0.676 . . . . 51.409999999999997 111.74 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 1.5 p -26.15 113.23 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.176 0.59 . . . . 74.530000000000001 112.129 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.839 HG21 HG11 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -95.47 -42.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 116.385 -0.37 . . . . 64.340000000000003 110.572 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 49.43 37.63 12.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.935 -0.575 . . . . 63.5 110.387 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.13 28.53 69.15 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.495 -0.775 . . . . 73.120000000000005 111.901 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.64 156.03 24.43 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.684 -0.769 . . . . 52.509999999999998 113.249 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.95 25.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.601 -0.299 . . . . 74.120000000000005 110.954 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -105.17 -31.09 9.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.834 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 -25.3 31.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.93 -0.577 . . . . 65.430000000000007 110.871 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -55.5 -38.33 69.02 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.52 -0.309 . . . . 74.420000000000002 110.733 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.61 91.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.29 -0.413 . . . . 75.450000000000003 110.356 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 31' ' ' ILE . 6.8 tp -67.24 -36.88 82.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 110.079 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.756 ' HE1' HG21 ' A' ' 43' ' ' THR . 4.6 m-85 -64.64 -39.87 94.46 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 115.988 -0.551 . . . . 74.25 111.427 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.46 90.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.639 0.257 . . . . 74.0 111.096 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.83 -35.99 64.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.233 -0.439 . . . . 73.209999999999994 111.699 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 HD21 ' A' ' 143' ' ' LEU . 2.7 pp -76.85 -32.55 20.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.524 0.202 . . . . 71.409999999999997 110.984 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 41' ' ' VAL . 4.3 t -65.34 -40.03 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.488 -0.324 . . . . 74.340000000000003 110.543 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.56 -40.25 95.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.731 -0.213 . . . . 65.549999999999997 111.0 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.83 -37.07 70.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.321 -0.399 . . . . 74.140000000000001 111.065 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' HG22 ' A' ' 41' ' ' VAL . 5.6 mp -68.33 -39.26 81.99 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.259 -0.428 . . . . 71.439999999999998 111.255 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -69.82 -31.96 70.13 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.533 -0.303 . . . . 65.329999999999998 110.898 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -30.19 68.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.62 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.8 -54.95 4.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.786 -0.188 . . . . 72.329999999999998 111.074 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.64 -90.99 0.12 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.693 -0.765 . . . . 53.409999999999997 112.553 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.97 133.73 20.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.723 0.297 . . . . 72.409999999999997 111.033 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG22 ' A' ' 32' ' ' VAL . 3.4 t -84.01 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 53.030000000000001 110.384 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.45 0.47 26.8 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.223 0.453 . . . . 70.450000000000003 112.223 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.756 HG21 ' HE1' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -110.91 46.03 1.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.099 0.476 . . . . 74.049999999999997 110.728 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.74 90.78 8.37 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.65 . . . . 60.030000000000001 110.359 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.511 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 54.4 p-80 178.77 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 52.539999999999999 110.763 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.839 HG11 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -53.56 -28.47 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.929 -0.578 . . . . 74.030000000000001 111.09 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.36 1.23 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.764 0.316 . . . . 55.109999999999999 110.865 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.47 132.59 35.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.944 0.402 . . . . 74.430000000000007 111.347 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -124.34 58.43 1.2 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.378 0.609 . . . . 54.119999999999997 110.548 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 35.5 tt0 172.7 68.29 0.0 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.683 -1.144 . . . . 71.239999999999995 109.918 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 102.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.925 -0.58 . . . . 64.310000000000002 111.49 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.79 108.36 1.13 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.77 -0.65 . . . . 75.120000000000005 111.746 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.96 -166.17 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.332 2.688 . . . . 74.409999999999997 112.651 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.28 150.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.241 -0.89 . . . . 64.329999999999998 111.595 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.27 143.79 9.11 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.164 -0.541 . . . . 51.109999999999999 112.749 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.45 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.691 0.281 . . . . 63.32 111.145 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.03 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.071 -0.513 . . . . 72.319999999999993 111.192 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 63.07 87.69 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 74.219999999999999 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.12 133.05 36.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.332 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.44 140.67 5.56 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.099 -0.572 . . . . 65.109999999999999 112.649 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.53 -8.62 3.49 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.278 -0.487 . . . . 64.430000000000007 113.805 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.4 p-10 -58.25 -48.32 80.78 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.417 0.608 . . . . 71.049999999999997 111.141 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -35.82 69.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.549 -0.296 . . . . 75.329999999999998 110.978 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -68.92 -37.74 79.12 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.385 -0.37 . . . . 74.109999999999999 110.499 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.735 HG23 ' C4 ' ' A' ' 187' ' ' 5GP . 94.4 mt -58.61 -45.27 90.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.09 -0.504 . . . . 73.150000000000006 110.716 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.472 ' HA ' ' HE3' ' B' ' 119' ' ' MET . 15.1 t-80 -65.69 -38.97 90.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.771 -0.65 . . . . 65.120000000000005 111.38 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.54 85.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.93 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.3 -43.53 96.23 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.256 -0.429 . . . . 70.420000000000002 110.694 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.03 82.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 73.150000000000006 111.23 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 96' ' ' ARG . 2.4 mm? -66.13 -40.59 90.76 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 111.203 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -70.44 -37.05 74.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.385 -0.37 . . . . 61.539999999999999 111.215 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.423 ' HZ3' HN22 ' A' ' 187' ' ' 5GP . 11.4 m0 -69.66 -38.79 77.23 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.206 -0.452 . . . . 75.439999999999998 111.252 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.64 -27.22 63.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.569 -0.287 . . . . 74.219999999999999 111.471 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.49 -43.66 79.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.795 0.331 . . . . 54.539999999999999 110.421 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -91.11 -17.27 26.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.95 -0.568 . . . . 71.099999999999994 111.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.792 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.01 113.61 1.29 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.352 0.501 . . . . 73.200000000000003 112.352 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.73 -26.36 54.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.648 -0.705 . . . . 64.530000000000001 109.853 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.677 HG13 HG13 ' A' ' 12' ' ' VAL . 9.3 p -156.83 139.95 6.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 110.763 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HB ' HD12 ' A' ' 104' ' ' ILE . 78.4 t -115.16 126.65 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.438 . . . . 61.109999999999999 110.767 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.674 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.59 136.99 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.043 -0.526 . . . . 65.150000000000006 110.307 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.61 145.16 49.78 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.858 0.361 . . . . 44.5 111.68 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tt0 -140.3 101.76 4.2 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.905 -0.589 . . . . 64.299999999999997 110.741 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 90' ' ' VAL . 1.5 t -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.293 -0.412 . . . . 74.010000000000005 111.264 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.846 HG22 ' HB2' ' A' ' 109' ' ' ARG . 32.8 p -106.45 24.05 13.19 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 64.109999999999999 111.557 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.55 3.4 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-O 120.637 0.256 . . . . 73.530000000000001 111.049 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.8 ' HA ' HD12 ' B' ' 88' ' ' LEU . 20.8 Cg_endo -59.88 99.89 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.809 2.34 . . . . 74.329999999999998 112.341 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.21 129.11 46.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.98 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' B' ' 86' ' ' PRO . 1.1 tt -71.51 -51.95 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.975 -0.557 . . . . 73.109999999999999 111.223 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -61.74 -42.09 99.7 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.189 -0.529 . . . . 51.140000000000001 112.532 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 21.0 t -70.94 -40.63 76.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.393 0.139 . . . . 73.400000000000006 110.747 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.43 94.55 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.324 -0.71 . . . . 74.299999999999997 111.324 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.67 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 7.8 t80 -65.15 -46.09 82.34 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.481 0.312 . . . . 75.140000000000001 110.176 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.78 -37.98 86.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.59 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 129' ' ' PHE . 5.2 tp -64.32 -41.96 96.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.343 -0.389 . . . . 65.519999999999996 110.274 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.666 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -62.89 -40.63 99.5 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 121.048 -0.596 . . . . 72.409999999999997 111.937 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 13.6 mtm105 -68.01 -35.0 77.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.646 0.26 . . . . 73.129999999999995 110.761 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.603 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -67.18 -38.03 84.71 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.208 -0.451 . . . . 44.119999999999997 111.886 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' A' ' 104' ' ' ILE . 72.7 t -75.05 -35.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.52 0.2 . . . . 74.0 111.196 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' B' ' 96' ' ' ARG . . . -76.24 -35.69 58.87 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.398 -0.365 . . . . 74.129999999999995 111.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.3 -53.59 4.76 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.337 -0.392 . . . . 71.420000000000002 111.328 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.58 -131.15 5.52 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.066 -0.588 . . . . 60.399999999999999 112.577 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.55 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 111.609 0.226 . . . . 55.009999999999998 111.609 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 78' ' ' VAL . 73.1 Cg_endo -75.09 97.24 1.07 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.349 2.033 . . . . 72.040000000000006 112.599 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 79' ' ' VAL . 29.7 mm -110.71 148.68 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.85 -0.614 . . . . 64.310000000000002 111.38 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.9 OUTLIER -127.62 141.33 51.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.878 -0.601 . . . . 73.409999999999997 110.057 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.678 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -132.86 133.07 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 55.310000000000002 110.744 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 13.5 mt -121.59 103.09 8.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 63.039999999999999 111.407 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.4 t80 -111.8 129.05 56.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.095 -0.502 . . . . 74.519999999999996 110.921 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.846 ' HB2' HG22 ' A' ' 84' ' ' THR . 33.8 ttm180 -69.13 117.85 56.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.435 -0.348 . . . . 75.409999999999997 111.202 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 95.2 Cg_endo -78.76 67.81 8.35 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.861 2.374 . . . . 70.209999999999994 111.612 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' PRO . 3.2 mm-40 160.96 -11.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 112.538 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 109' ' ' ARG . 88.2 p -48.61 -31.51 6.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.864 0.302 . . . . 55.020000000000003 111.808 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.31 -37.01 3.71 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.859 -0.686 . . . . 32.340000000000003 112.266 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -83.35 -175.05 5.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.288 0.566 . . . . 73.420000000000002 110.44 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.04 163.88 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.239 -0.891 . . . . 70.209999999999994 111.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 120' ' ' ILE . 1.4 mp -85.42 -114.85 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.091 -0.504 . . . . 55.229999999999997 110.398 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.54 ' HB2' ' O3P' ' B' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.52 2.31 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.958 0.344 . . . . 72.540000000000006 111.456 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.82 92.36 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.968 -0.56 . . . . 61.140000000000001 111.437 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' B' ' 66' ' ' HIS . 6.8 tpt -60.19 -45.52 92.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.563 -0.29 . . . . 64.25 110.797 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -67.48 -44.04 86.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.355 -0.384 . . . . 41.340000000000003 110.959 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -59.4 -43.4 93.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.492 -0.322 . . . . 64.329999999999998 110.135 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -63.69 -38.92 96.95 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.844 -0.616 . . . . 62.299999999999997 111.918 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' B' ' 66' ' ' HIS . . . -56.47 -41.23 76.19 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.718 0.294 . . . . 71.450000000000003 110.67 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.33 76.62 7.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.829 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -82.0 -16.89 48.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 73.25 111.253 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.33 -8.9 45.1 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.985 -0.626 . . . . 72.519999999999996 113.529 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.94 -77.33 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 117.324 0.562 . . . . 63.5 111.177 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.92 -6.47 11.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.847 -0.615 . . . . 63.329999999999998 111.938 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 94' ' ' LEU . 3.8 t80 -107.1 121.45 44.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.754 0.311 . . . . 63.149999999999999 111.101 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -119.78 139.49 52.23 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.39 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 106' ' ' CYS . 46.8 t -124.75 91.73 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 111.244 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.48 ' HB3' ' SD ' ' A' ' 142' ' ' MET . 40.2 m0 -87.21 151.91 22.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.23 0.538 . . . . 73.439999999999998 111.346 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.388 -0.824 . . . . 75.010000000000005 111.054 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' ' HG3' ' A' ' 142' ' ' MET . 14.7 p90 -118.99 116.42 26.39 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 73.319999999999993 111.021 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -93.19 92.3 7.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.975 -0.557 . . . . 73.519999999999996 111.236 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.48 -93.94 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 113.122 0.786 . . . . 74.409999999999997 113.122 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.95 -2.9 2.16 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 115.064 -0.971 . . . . 33.32 113.001 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 1.1 mp0 -98.85 3.7 47.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.262 0.531 . . . . 73.109999999999999 111.676 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 9.3 p -68.35 -35.79 72.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.766 0.317 . . . . 71.5 111.097 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.79 -38.24 64.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 73.400000000000006 110.342 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -39.36 80.12 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 116.071 -0.513 . . . . 64.230000000000004 110.607 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.58 ' HG3' ' HB3' ' A' ' 134' ' ' TYR . 14.7 mmt -68.63 -38.32 80.44 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 111.224 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.616 HD21 HG22 ' A' ' 31' ' ' ILE . 1.9 mp -70.58 -38.15 74.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.426 -0.352 . . . . 64.209999999999994 111.034 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.9 t70 -74.34 -36.93 63.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.388 -0.369 . . . . 70.519999999999996 110.884 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -71.3 -35.31 71.23 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.383 -0.371 . . . . 75.329999999999998 111.327 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 24.8 t80 -69.23 -39.66 78.41 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.464 -0.334 . . . . 74.530000000000001 110.976 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.74 -34.62 52.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.639 -0.255 . . . . 72.400000000000006 110.629 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -71.9 -39.25 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.443 -0.344 . . . . 54.530000000000001 110.832 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.95 68.42 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.428 -0.351 . . . . 71.299999999999997 110.938 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.14 -42.2 84.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.633 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.06 -37.76 81.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.101 -0.5 . . . . 54.409999999999997 110.983 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 148' ' ' GLU . 71.2 t -66.95 -40.08 84.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.366 -0.379 . . . . 75.439999999999998 111.014 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -33.52 60.5 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 111.084 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.6 17.83 11.04 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.321 -0.399 . . . . 70.230000000000004 111.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.92 177.9 0.47 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.552 -0.294 . . . . 75.340000000000003 110.804 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.84 110.65 15.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.362 -0.381 . . . . 72.109999999999999 110.689 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.09 60.97 0.58 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 75.230000000000004 110.972 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -80.55 167.12 20.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.094 -0.503 . . . . 74.310000000000002 110.885 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.204 -0.903 . . . . 75.409999999999997 111.06 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -139.86 125.18 18.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.067 -0.515 . . . . 72.129999999999995 111.011 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.55 133.92 42.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.115 -0.493 . . . . 72.530000000000001 110.506 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.456 ' HB3' HD21 ' B' ' 42' ' ' LEU . 17.3 m -140.82 120.79 13.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.265 -0.425 . . . . 62.219999999999999 110.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 78' ' ' VAL . 14.2 t -116.82 121.67 68.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.484 -0.325 . . . . 75.439999999999998 111.007 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -100.95 116.32 32.54 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.356 -0.384 . . . . 74.219999999999999 110.627 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' B' ' 31' ' ' ILE . 60.5 t80 -92.32 126.2 37.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.569 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 97.4 m -111.9 103.96 12.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 111.309 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' B' ' 17' ' ' SER . . . -135.13 94.78 0.25 Allowed Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.681 -0.69 . . . . 45.240000000000002 111.683 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 1.5 p -26.1 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.195 0.598 . . . . 71.25 112.141 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.814 HG21 HG11 ' B' ' 46' ' ' VAL . 0.5 OUTLIER -95.43 -41.94 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 116.459 -0.337 . . . . 73.439999999999998 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.44 ' N ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER 49.39 37.67 12.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.948 -0.569 . . . . 73.430000000000007 110.41 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.508 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.03 28.63 69.16 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.516 -0.765 . . . . 73.109999999999999 111.89 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.59 156.02 24.46 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.731 -0.747 . . . . 74.120000000000005 113.308 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -104.48 16.79 25.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.279 . . . . 75.530000000000001 110.961 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -104.97 -31.13 9.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.878 0.371 . . . . 70.299999999999997 110.893 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 -25.44 31.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 110.825 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.51 -38.35 69.07 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.506 -0.316 . . . . 74.010000000000005 110.627 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.78 -41.54 91.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.297 -0.41 . . . . 51.409999999999997 110.379 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 31' ' ' ILE . 6.8 tp -67.33 -36.8 82.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.031 -0.531 . . . . 71.239999999999995 110.05 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.78 ' HE1' HG21 ' B' ' 43' ' ' THR . 4.6 m-85 -64.71 -39.94 94.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.039 -0.528 . . . . 72.219999999999999 111.368 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.35 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.648 -0.251 . . . . 63.399999999999999 111.105 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -73.79 -36.1 65.0 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.26 -0.427 . . . . 75.030000000000001 111.658 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.62 HG22 HD21 ' B' ' 143' ' ' LEU . 2.7 pp -76.87 -32.52 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 121.227 -0.189 . . . . 74.010000000000005 110.999 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.789 HG22 HG11 ' B' ' 41' ' ' VAL . 4.4 t -65.29 -40.0 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.395 -0.366 . . . . 51.240000000000002 110.644 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -64.69 -40.11 94.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.672 -0.24 . . . . 41.340000000000003 111.047 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.85 -37.08 70.32 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.39 -0.368 . . . . 75.310000000000002 111.029 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' B' ' 41' ' ' VAL . 5.6 mp -68.45 -39.18 81.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.218 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.83 -31.84 69.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.547 -0.297 . . . . 75.420000000000002 110.934 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -30.2 68.8 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.241 -0.436 . . . . 75.450000000000003 111.584 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.77 -55.08 4.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.745 -0.207 . . . . 75.439999999999998 111.034 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.51 -91.06 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.751 -0.737 . . . . 53.420000000000002 112.541 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -146.99 133.76 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.627 0.251 . . . . 63.340000000000003 111.084 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.789 HG11 HG22 ' B' ' 32' ' ' VAL . 3.4 t -84.05 137.78 20.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 65.120000000000005 110.394 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' B' ' 76' ' ' ALA . 0.2 OUTLIER -105.42 0.36 26.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.231 0.456 . . . . 53.439999999999998 112.231 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.78 HG21 ' HE1' ' B' ' 28' ' ' TYR . 0.3 OUTLIER -110.87 45.98 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.159 0.504 . . . . 24.34 110.784 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.69 90.81 8.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.752 -0.658 . . . . 70.450000000000003 110.326 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.509 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 54.4 p-80 178.81 -43.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.811 -0.631 . . . . 61.039999999999999 110.76 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.814 HG11 HG21 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -53.51 -28.46 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.894 -0.594 . . . . 71.439999999999998 111.109 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.65 51.43 1.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.808 0.337 . . . . 52.329999999999998 110.791 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.55 132.69 35.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.932 0.396 . . . . 63.539999999999999 111.367 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -124.37 58.42 1.21 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.353 0.597 . . . . 71.340000000000003 110.473 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 35.6 tt0 172.73 68.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.671 -1.149 . . . . 61.200000000000003 109.871 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.17 101.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.901 -0.591 . . . . 60.409999999999997 111.432 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.74 108.36 1.13 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.908 -0.587 . . . . 65.200000000000003 111.698 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.96 -166.19 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.338 2.692 . . . . 64.340000000000003 112.667 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.31 150.44 0.08 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.198 -0.91 . . . . 73.319999999999993 111.542 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.25 143.8 9.12 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.119 -0.563 . . . . 71.140000000000001 112.705 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 163.52 39.75 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.713 0.292 . . . . 70.200000000000003 111.113 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 73.01 160.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.021 -0.536 . . . . 73.030000000000001 111.26 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . 62.98 87.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.088 -0.505 . . . . 64.310000000000002 111.213 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.05 133.04 36.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.98 -0.555 . . . . 54.539999999999999 111.408 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.37 140.65 5.57 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.206 -0.521 . . . . 71.430000000000007 112.698 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -129.43 -8.64 3.51 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.324 -0.465 . . . . 41.310000000000002 113.907 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.532 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.5 p-10 -58.25 -48.39 80.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.371 0.585 . . . . 73.299999999999997 111.112 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -35.78 69.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.492 -0.322 . . . . 74.340000000000003 110.954 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -68.98 -37.72 78.93 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.395 -0.366 . . . . 75.430000000000007 110.422 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.732 HG23 ' C4 ' ' B' ' 187' ' ' 5GP . 94.4 mt -58.58 -45.32 90.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.131 -0.486 . . . . 62.240000000000002 110.649 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 119' ' ' MET . 15.3 t-80 -65.73 -38.94 90.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 75.25 111.319 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -39.6 85.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.29 -0.414 . . . . 74.120000000000005 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.27 -43.5 96.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.3 -37.11 82.86 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.254 -0.43 . . . . 51.520000000000003 111.216 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' B' ' 96' ' ' ARG . 2.4 mm? -66.08 -40.62 90.97 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.385 -0.37 . . . . 55.32 111.172 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -70.38 -37.17 74.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.46 -0.336 . . . . 73.200000000000003 111.093 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.41 ' HZ3' HN22 ' B' ' 187' ' ' 5GP . 11.5 m0 -69.57 -38.89 77.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 111.222 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -70.65 -27.23 63.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.578 -0.283 . . . . 72.109999999999999 111.421 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -56.55 -43.66 80.12 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.77 0.319 . . . . 72.430000000000007 110.397 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -91.16 -17.15 26.58 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.93 -0.577 . . . . 72.030000000000001 111.439 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.797 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -54.08 113.56 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.372 0.508 . . . . 42.450000000000003 112.372 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.69 -26.33 54.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 109.924 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.685 HG13 HG13 ' B' ' 12' ' ' VAL . 9.1 p -156.83 140.01 6.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.085 -0.507 . . . . 72.209999999999994 110.706 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.566 ' HB ' HD12 ' B' ' 104' ' ' ILE . 79.4 t -115.17 126.69 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.423 . . . . 52.210000000000001 110.765 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -115.66 136.93 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 75.510000000000005 110.271 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.59 145.14 49.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.779 0.323 . . . . 73.219999999999999 111.697 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 6.3 tt0 -140.27 101.63 4.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.906 -0.588 . . . . 70.340000000000003 110.786 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.461 HG21 HG11 ' B' ' 90' ' ' VAL . 1.5 t -141.45 142.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.279 -0.418 . . . . 64.010000000000005 111.279 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.84 HG22 ' HB2' ' B' ' 109' ' ' ARG . 32.6 p -106.48 24.16 13.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.307 -0.406 . . . . 73.120000000000005 111.485 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -172.64 156.56 3.4 Favored Pre-proline 0 C--O 1.232 0.164 0 CA-C-O 120.6 0.238 . . . . 63.210000000000001 111.018 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.785 ' HA ' HD12 ' A' ' 88' ' ' LEU . 20.7 Cg_endo -59.91 99.85 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.856 2.371 . . . . 63.229999999999997 112.329 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 3.5 m -100.17 129.13 46.16 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.049 -0.523 . . . . 70.129999999999995 110.945 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 86' ' ' PRO . 1.1 tt -71.56 -51.94 20.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.945 -0.57 . . . . 74.209999999999994 111.208 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -61.71 -42.11 99.7 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.114 -0.565 . . . . 63.240000000000002 112.509 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 21.0 t -70.94 -40.61 76.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.439 0.162 . . . . 73.209999999999994 110.729 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.32 -38.41 94.6 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.267 -0.733 . . . . 51.049999999999997 111.267 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.666 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 7.9 t80 -65.1 -46.08 82.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.51 0.324 . . . . 75.150000000000006 110.229 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -37.94 86.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.196 -0.457 . . . . 74.430000000000007 110.569 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' B' ' 129' ' ' PHE . 5.2 tp -64.44 -41.81 96.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.333 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.67 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -62.97 -40.61 99.51 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.092 -0.575 . . . . 71.439999999999998 111.927 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.497 ' CZ ' HD22 ' B' ' 70' ' ' LEU . 13.6 mtm105 -68.02 -34.96 77.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.611 0.243 . . . . 71.540000000000006 110.726 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.596 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -67.13 -38.16 85.08 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.289 -0.414 . . . . 65.310000000000002 111.884 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' B' ' 104' ' ' ILE . 71.9 t -75.04 -35.47 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.633 0.254 . . . . 71.120000000000005 111.16 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . . . -76.12 -35.78 59.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.408 -0.36 . . . . 60.409999999999997 111.358 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 100' ' ' LEU . 2.2 tm? -87.24 -53.52 4.8 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.355 -0.384 . . . . 75.430000000000007 111.359 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.66 -131.1 5.53 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.999 -0.62 . . . . 63.109999999999999 112.554 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -162.2 -63.73 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 111.527 0.195 . . . . 74.049999999999997 111.527 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' B' ' 78' ' ' VAL . 72.8 Cg_endo -74.86 97.11 1.04 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.371 2.048 . . . . 65.200000000000003 112.74 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.566 HD12 ' HB ' ' B' ' 79' ' ' VAL . 29.7 mm -110.66 148.69 13.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.835 -0.62 . . . . 75.450000000000003 111.415 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.691 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.9 OUTLIER -127.54 141.28 51.69 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 110.082 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.691 ' N ' HD13 ' B' ' 105' ' ' LEU . 0.5 OUTLIER -132.84 133.04 42.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 75.120000000000005 110.772 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 13.5 mt -121.51 103.1 8.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.437 -0.347 . . . . 63.450000000000003 111.449 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.81 129.05 56.26 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.84 ' HB2' HG22 ' B' ' 84' ' ' THR . 33.9 ttm180 -69.21 117.78 55.5 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.391 -0.368 . . . . 72.340000000000003 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.467 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 94.9 Cg_endo -78.63 67.88 8.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.899 2.399 . . . . 75.209999999999994 111.6 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' B' ' 110' ' ' PRO . 3.2 mm-40 160.84 -11.41 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 112.584 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' B' ' 109' ' ' ARG . 87.4 p -48.6 -31.47 6.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.807 0.299 . . . . 74.430000000000007 111.807 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.25 -36.95 3.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.931 -0.652 . . . . 65.430000000000007 112.276 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.44 ' HB3' ' CD ' ' B' ' 86' ' ' PRO . 0.7 OUTLIER -83.42 -175.17 5.69 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.281 0.562 . . . . 72.140000000000001 110.515 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.86 164.0 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.292 -0.867 . . . . 65.010000000000005 111.218 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.592 HD22 HG21 ' B' ' 120' ' ' ILE . 1.4 mp -85.52 -114.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.471 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.538 ' HB2' ' O3P' ' A' ' 187' ' ' 5GP . 0.2 OUTLIER -174.56 176.45 2.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.926 0.393 . . . . 70.25 111.421 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.889 -0.596 . . . . 64.329999999999998 111.421 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 66' ' ' HIS . 6.8 tpt -60.13 -45.67 92.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.568 -0.287 . . . . 70.209999999999994 110.699 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.592 HG21 HD22 ' B' ' 116' ' ' LEU . 0.4 OUTLIER -67.51 -43.95 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.363 -0.38 . . . . 72.319999999999993 110.935 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -59.54 -43.31 93.53 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.485 -0.325 . . . . 73.219999999999999 110.128 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -63.67 -38.89 96.9 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.899 -0.591 . . . . 52.530000000000001 111.961 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 66' ' ' HIS . . . -56.51 -41.3 76.48 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.669 0.271 . . . . 72.239999999999995 110.634 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.23 76.55 7.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.09 -0.505 . . . . 72.340000000000003 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -82.02 -16.73 49.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.808 -0.633 . . . . 70.099999999999994 111.343 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.23 -8.94 45.46 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.003 -0.618 . . . . 62.32 113.626 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 1.6 m -67.96 -77.31 0.08 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.275 0.537 . . . . 73.019999999999996 111.214 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -116.88 -6.45 11.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.819 -0.628 . . . . 73.239999999999995 111.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' B' ' 94' ' ' LEU . 3.8 t80 -107.1 121.51 44.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.837 0.351 . . . . 74.129999999999995 111.056 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -119.87 139.55 52.2 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.922 -0.581 . . . . 63.130000000000003 110.287 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' B' ' 106' ' ' CYS . 46.9 t -124.77 91.74 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 111.213 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.487 ' HB3' ' SD ' ' B' ' 142' ' ' MET . 40.3 m0 -87.24 151.89 22.77 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.411 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 14.1 m-20 -106.32 123.87 48.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.346 -0.843 . . . . 71.319999999999993 111.053 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.572 ' HB3' ' HG3' ' B' ' 142' ' ' MET . 14.6 p90 -118.92 116.4 26.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.024 0.44 . . . . 71.099999999999994 110.973 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -93.19 92.22 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.239999999999995 111.291 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 47.69 -93.97 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 113.05 0.759 . . . . 74.129999999999995 113.05 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -2.9 2.22 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.938 -1.028 . . . . 63.329999999999998 113.07 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 1.1 mp0 -98.76 3.62 47.57 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.24 0.52 . . . . 72.420000000000002 111.693 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 9.5 p -68.32 -35.83 72.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 111.072 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.75 -38.34 64.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.821 -0.627 . . . . 74.109999999999999 110.288 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 13.0 m -68.83 -39.44 80.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.497 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.572 ' HG3' ' HB3' ' B' ' 134' ' ' TYR . 14.7 mmt -68.56 -38.35 80.67 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 111.207 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.62 HD21 HG22 ' B' ' 31' ' ' ILE . 1.9 mp -70.47 -38.17 74.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.416 -0.356 . . . . 53.420000000000002 111.051 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 16.0 t70 -74.42 -36.96 63.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.299 -0.409 . . . . 53.310000000000002 110.814 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -71.24 -35.33 71.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.425 -0.352 . . . . 75.010000000000005 111.322 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 24.5 t80 -69.24 -39.69 78.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.535 -0.302 . . . . 75.310000000000002 110.937 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.7 -34.63 52.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.641 -0.254 . . . . 71.25 110.669 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 152' ' ' VAL . 0.6 OUTLIER -71.93 -39.22 69.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.394 -0.366 . . . . 53.509999999999998 110.809 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.55 -32.98 68.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.447 -0.342 . . . . 43.310000000000002 111.088 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -67.25 -42.12 84.46 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.138 -0.483 . . . . 65.209999999999994 110.567 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.14 -37.69 81.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.02 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 148' ' ' GLU . 70.5 t -67.04 -40.03 84.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.304 -0.407 . . . . 71.109999999999999 110.93 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.42 60.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.278 -0.419 . . . . 64.209999999999994 111.054 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 65.51 17.87 11.08 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.363 -0.38 . . . . 71.150000000000006 111.217 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 178.9 177.86 0.47 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.492 -0.322 . . . . 75.349999999999994 110.823 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -123.9 110.79 15.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.681 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -156.12 60.95 0.58 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 110.946 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -80.65 167.18 20.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.084 -0.507 . . . . 75.409999999999997 110.915 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 m170 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.169 -0.919 . . . . 71.239999999999995 111.04 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.735 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.732 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.62 0.247 . . . . 61.219999999999999 111.192 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 143.13 35.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.286 -0.416 . . . . 74.150000000000006 111.276 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 8.3 ptp85 -108.57 134.21 51.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 110.804 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.749 ' HB3' HD21 ' A' ' 42' ' ' LEU . 50.3 m -128.65 123.57 33.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.264 -0.426 . . . . 72.409999999999997 110.953 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HG12 ' A' ' 78' ' ' VAL . 39.8 t -109.61 114.22 46.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 111.319 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HE2' ' HB2' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -93.48 122.66 36.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.072 -0.513 . . . . 53.119999999999997 110.218 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 28' ' ' TYR . 7.1 t80 -94.67 139.85 30.67 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.522 -0.308 . . . . 73.239999999999995 110.431 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.9 m -126.78 116.58 21.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.9 0.381 . . . . 71.120000000000005 111.737 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' " H3'" ' A' ' 187' ' ' 5GP . . . -144.35 130.96 4.16 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.947 -0.57 . . . . 61.32 112.241 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.495 ' N ' HG21 ' A' ' 90' ' ' VAL . 66.6 p -63.27 120.14 10.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.734 0.267 . . . . 61.130000000000003 110.437 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.682 HG21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -41.97 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.519 -0.309 . . . . 73.219999999999999 111.443 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.1 mtm105 52.79 40.78 31.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 75.0 110.501 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 63.94 26.16 69.93 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.753 -0.658 . . . . 74.209999999999994 112.54 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.83 157.93 23.83 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.935 -0.65 . . . . 41.450000000000003 113.207 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -101.1 14.26 32.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.853 -0.173 . . . . 73.239999999999995 111.345 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -97.53 -15.95 20.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.536 0.208 . . . . 75.25 111.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.44 17.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.532 -0.304 . . . . 72.430000000000007 110.861 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -45.29 84.09 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.638 -0.255 . . . . 74.530000000000001 110.863 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.27 96.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.384 -0.371 . . . . 61.530000000000001 110.746 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.416 HD21 ' OE1' ' A' ' 82' ' ' GLU . 25.2 tp -70.04 -37.83 75.67 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.45 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 43' ' ' THR . 2.0 m-85 -67.25 -36.42 81.59 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 111.829 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.77 86.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.587 0.232 . . . . 71.420000000000002 111.324 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.78 -35.56 62.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.415 -0.357 . . . . 63.229999999999997 111.608 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' O ' HD22 ' A' ' 35' ' ' LEU . 2.2 pp -77.02 -32.85 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 121.043 -0.263 . . . . 75.400000000000006 110.848 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 HG11 ' A' ' 41' ' ' VAL . 2.8 t -62.12 -38.93 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.501 -0.318 . . . . 72.129999999999995 110.643 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -38.4 80.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.637 0.256 . . . . 74.019999999999996 110.823 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -71.06 -37.88 72.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.28 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.67 78.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 110.897 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -70.18 -33.37 71.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.318 -0.401 . . . . 72.510000000000005 111.027 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -41.19 75.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.298 -0.41 . . . . 70.310000000000002 111.355 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -57.87 3.89 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.6 -0.273 . . . . 75.239999999999995 110.508 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' A' ' 10' ' ' ARG . . . -147.97 -82.84 0.04 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.093 -0.575 . . . . 71.400000000000006 112.061 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.93 137.51 24.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 62.509999999999998 111.04 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 32' ' ' VAL . 13.1 p -107.26 141.69 21.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.314 -0.403 . . . . 71.150000000000006 110.662 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 11' ' ' SER . 3.3 mm? -98.99 -122.06 0.14 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.738 -0.467 . . . . 71.329999999999998 109.738 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.613 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.2 OUTLIER 26.04 47.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.94 0.896 . . . . 70.329999999999998 112.583 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.67 87.35 6.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.207 -0.906 . . . . 71.340000000000003 110.767 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 46' ' ' VAL . 51.3 p-80 -179.58 -37.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.784 -0.644 . . . . 72.019999999999996 111.116 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.682 ' CG1' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.28 -12.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.086 -0.506 . . . . 71.329999999999998 112.17 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.5 46.59 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.386 0.513 . . . . 71.120000000000005 112.386 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -113.78 142.34 46.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.895 0.379 . . . . 62.520000000000003 110.956 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -123.2 53.94 1.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.46 0.648 . . . . 62.210000000000001 110.446 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 37.2 tt0 167.23 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.37 -1.286 . . . . 75.239999999999995 109.834 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 104.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.455 . . . . 71.310000000000002 110.669 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.92 83.08 14.05 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 74.150000000000006 111.831 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.17 -167.72 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.931 2.42 . . . . 62.399999999999999 112.251 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.05 149.79 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.533 -0.758 . . . . 51.130000000000003 111.417 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.77 148.54 19.54 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.006 -0.616 . . . . 74.019999999999996 112.944 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.74 115.91 14.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.637 0.256 . . . . 73.439999999999998 110.676 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.2 7.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 64.340000000000003 111.257 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . . . -64.56 160.45 19.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 70.519999999999996 111.414 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 120.91 9.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 64.340000000000003 111.448 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.79 141.75 12.24 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.151 -0.547 . . . . 73.409999999999997 112.743 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.96 -7.48 84.07 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.38 -0.438 . . . . 65.120000000000005 113.414 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 65' ' ' ILE . 6.9 p-10 -55.97 -45.98 78.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.934 0.367 . . . . 65.25 111.057 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -59.92 -37.87 80.7 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 110.705 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.42 80.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.229 -0.441 . . . . 61.140000000000001 110.404 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.906 HG23 ' C5 ' ' A' ' 187' ' ' 5GP . 4.2 mt -59.8 -42.91 90.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.06 -0.518 . . . . 74.409999999999997 110.648 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' B' ' 123' ' ' ALA . 17.9 t-80 -69.06 -38.33 79.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.961 -0.563 . . . . 41.149999999999999 111.284 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.87 -37.98 82.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.31 -0.405 . . . . 74.109999999999999 111.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HB3' HN21 ' A' ' 187' ' ' 5GP . 1.4 mp0 -67.61 -38.14 83.52 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.547 0.203 . . . . 62.140000000000001 111.547 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 79.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.71 -0.223 . . . . 74.109999999999999 111.528 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 96' ' ' ARG . 3.0 mm? -66.55 -40.09 88.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.484 -0.325 . . . . 74.519999999999996 111.475 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.54 -37.09 76.93 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.367 -0.379 . . . . 74.120000000000005 111.794 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.52 ' CZ3' ' N2 ' ' A' ' 187' ' ' 5GP . 53.2 m0 -74.3 -35.44 63.7 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.655 -0.248 . . . . 73.200000000000003 111.445 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -70.07 -30.79 68.12 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.591 -0.277 . . . . 64.129999999999995 111.114 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.7 -41.47 81.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.57 -0.287 . . . . 75.099999999999994 110.861 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.77 -25.65 21.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.211 -0.45 . . . . 64.430000000000007 111.65 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 11' ' ' SER . . . -60.75 108.11 0.8 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.921 0.391 . . . . 30.34 111.561 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.25 -23.49 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 111.011 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -145.01 139.95 22.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.909 0.385 . . . . 71.239999999999995 110.909 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HB ' HD12 ' A' ' 104' ' ' ILE . 56.7 t -115.93 134.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 73.099999999999994 110.678 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -127.74 131.34 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.136 -0.484 . . . . 52.450000000000003 110.242 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.86 146.66 45.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 61.210000000000001 111.705 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 107' ' ' LEU . 4.6 tt0 -140.31 103.18 4.52 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.956 -0.566 . . . . 55.299999999999997 110.901 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.91 141.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.397 -0.365 . . . . 55.43 111.302 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 109' ' ' ARG . 33.1 p -105.55 26.23 9.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.288 -0.414 . . . . 61.310000000000002 111.574 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 9.5 pt20 -171.77 158.14 4.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 120.545 0.212 . . . . 63.310000000000002 111.234 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.816 ' HA ' HD12 ' B' ' 88' ' ' LEU . 19.9 Cg_endo -59.67 98.47 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.865 2.377 . . . . 44.409999999999997 112.172 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 90' ' ' VAL . 2.5 p -98.91 123.83 43.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.886 -0.597 . . . . 73.030000000000001 110.873 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' B' ' 86' ' ' PRO . 0.4 OUTLIER -71.45 -52.3 19.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.966 -0.561 . . . . 73.329999999999998 111.288 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA3' ' O1P' ' A' ' 187' ' ' 5GP . . . -61.72 -43.51 99.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.008 -0.615 . . . . 60.329999999999998 112.639 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 17' ' ' SER . 23.4 t -67.24 -40.1 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 110.332 -0.247 . . . . 45.450000000000003 110.332 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' B' ' 88' ' ' LEU . . . -59.55 -35.26 84.96 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.081 -0.808 . . . . 62.009999999999998 111.081 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.663 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 12.7 t80 -64.22 -43.54 94.67 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.039 -0.356 . . . . 72.420000000000002 110.039 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.11 -39.74 94.69 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.92 -0.582 . . . . 74.230000000000004 110.565 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.06 -40.37 90.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.639 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.671 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -66.45 -39.14 94.01 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.95 -0.643 . . . . 44.420000000000002 111.814 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' A' ' 70' ' ' LEU . 13.2 ttp-105 -72.04 -30.53 65.28 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.567 0.222 . . . . 74.140000000000001 110.595 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -68.74 -37.26 79.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.598 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 92' ' ' TYR . 15.9 t -73.27 -36.52 49.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.55 0.214 . . . . 61.229999999999997 110.803 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.08 63.42 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.365 -0.38 . . . . 75.450000000000003 111.173 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 100' ' ' LEU . 3.2 tm? -84.94 -55.81 3.88 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.402 -0.363 . . . . 71.420000000000002 111.266 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.14 -127.52 5.41 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.128 -0.558 . . . . 42.32 112.793 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.93 -61.52 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.59 0.219 . . . . 75.019999999999996 111.59 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HB2' HG23 ' A' ' 78' ' ' VAL . 60.7 Cg_endo -72.84 94.08 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.47 2.113 . . . . 74.420000000000002 112.541 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.48 HD12 ' HB1' ' A' ' 97' ' ' ALA . 28.2 mm -110.62 149.16 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.014 -0.539 . . . . 64.319999999999993 111.536 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 106' ' ' CYS . 0.8 OUTLIER -129.7 140.4 51.12 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.736 -0.665 . . . . 72.340000000000003 110.616 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.714 ' HB3' HG13 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -130.48 132.83 45.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 72.530000000000001 110.593 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 12.6 mt -120.29 103.67 9.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.499 -0.319 . . . . 75.420000000000002 111.255 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 16.5 t80 -111.97 143.43 42.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.097 -0.501 . . . . 64.310000000000002 110.79 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' THR . 16.2 ttm180 -87.28 115.48 62.88 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.553 -0.294 . . . . 75.140000000000001 111.201 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 133' ' ' ASP . 92.1 Cg_endo -77.87 67.52 7.98 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.89 2.393 . . . . 65.540000000000006 111.719 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.2 -15.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.624 -0.717 . . . . 64.540000000000006 112.335 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -47.79 -32.4 5.97 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.663 0.246 . . . . 72.5 111.663 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.31 -35.96 4.01 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.015 -0.612 . . . . 33.229999999999997 112.156 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -86.0 -174.55 5.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.269 0.557 . . . . 70.219999999999999 110.418 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.25 161.32 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.338 -0.846 . . . . 74.319999999999993 111.352 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 120' ' ' ILE . 2.9 mt -78.51 -94.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.306 -0.407 . . . . 74.510000000000005 110.576 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HB2' ' O1P' ' B' ' 187' ' ' 5GP . 2.3 p 168.74 176.3 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.809 0.338 . . . . 55.310000000000002 111.304 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.63 -35.74 77.7 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.019 -0.537 . . . . 61.149999999999999 111.322 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.445 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 10.0 tpt -66.57 -41.22 88.93 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 110.644 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD11 HD22 ' B' ' 88' ' ' LEU . 31.8 mm -66.63 -47.61 82.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.342 -0.39 . . . . 74.200000000000003 110.569 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.59 -41.39 97.37 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.996 -0.372 . . . . 73.540000000000006 109.996 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.89 -36.33 92.97 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.828 -0.623 . . . . 62.25 112.075 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' B' ' 66' ' ' HIS . . . -57.07 -37.11 71.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.476 0.179 . . . . 70.310000000000002 110.826 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.0 75.91 2.21 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.101 0.477 . . . . 73.319999999999993 110.573 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -15.93 58.98 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.721 -0.672 . . . . 70.200000000000003 111.652 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.81 -9.72 66.14 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.892 -0.671 . . . . 63.32 112.362 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -71.08 0.21 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.339 . . . . 45.240000000000002 110.867 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' A' ' 156' ' ' HIS . 7.7 mmt85 -133.61 10.48 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.832 -0.622 . . . . 64.310000000000002 112.237 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.81 122.78 41.05 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.646 0.26 . . . . 73.219999999999999 110.73 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.01 140.87 52.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.246 -0.433 . . . . 62.539999999999999 110.88 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.714 HG13 ' HB3' ' A' ' 106' ' ' CYS . 53.3 t -124.67 91.77 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.303 -0.408 . . . . 72.120000000000005 111.119 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 33.3 m0 -83.26 145.58 29.04 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 111.159 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.663 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 1.8 m-20 -97.7 120.05 37.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.724 -0.671 . . . . 72.200000000000003 109.988 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.579 ' CD2' ' HB ' ' A' ' 139' ' ' VAL . 12.0 p90 -116.29 143.15 45.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 111.86 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.59 160.54 14.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.721 -0.672 . . . . 54.009999999999998 109.626 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.97 103.99 0.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 61.149999999999999 110.014 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.13 -19.1 13.69 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.756 -0.656 . . . . 33.119999999999997 111.959 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.16 -16.4 26.33 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.716 0.406 . . . . 74.340000000000003 111.308 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 11.5 p -50.3 -41.04 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 111.886 0.328 . . . . 72.430000000000007 111.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.283 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.12 -37.32 78.27 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.952 -0.567 . . . . 63.140000000000001 110.759 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' A' ' 142' ' ' MET . 4.2 mmm -69.51 -38.5 77.62 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.263 -0.426 . . . . 74.420000000000002 110.995 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.17 -40.39 90.47 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.344 -0.389 . . . . 62.350000000000001 111.223 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.315 -0.402 . . . . 70.219999999999999 110.931 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -74.32 -34.49 63.48 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.357 -0.383 . . . . 72.340000000000003 110.812 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 8.2 t80 -68.71 -39.92 80.23 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.411 -0.358 . . . . 72.450000000000003 110.973 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.66 ' HZ ' HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -75.18 -34.69 61.58 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.572 -0.285 . . . . 74.439999999999998 111.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 152' ' ' VAL . 27.7 tt0 -77.88 -35.81 50.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.441 -0.345 . . . . 72.010000000000005 111.174 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.32 -30.01 61.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.395 -0.366 . . . . 71.209999999999994 111.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -70.05 -40.54 75.04 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.412 -0.358 . . . . 75.510000000000005 110.752 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.58 -36.22 70.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.416 -0.357 . . . . 71.239999999999995 111.126 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 148' ' ' GLU . 75.8 t -71.85 -38.16 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.412 -0.358 . . . . 64.420000000000002 111.172 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.27 -30.98 38.42 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.231 -0.441 . . . . 60.210000000000001 111.537 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.5 m80 63.94 20.16 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.541 -0.3 . . . . 75.329999999999998 111.363 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.86 -178.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.391 -0.368 . . . . 55.25 110.434 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -118.0 138.87 51.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.721 0.296 . . . . 73.019999999999996 110.804 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 168.78 19.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.124 -0.489 . . . . 70.450000000000003 111.112 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.13 148.09 37.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 73.329999999999998 111.386 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.156 -0.926 . . . . 64.109999999999999 111.049 179.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.689 0.281 . . . . 71.209999999999994 111.223 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 143.18 35.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.256 -0.429 . . . . 72.510000000000005 111.229 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 8.4 ptp85 -108.55 134.2 51.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.133 -0.485 . . . . 62.509999999999998 110.846 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.725 ' HB3' HD21 ' B' ' 42' ' ' LEU . 50.7 m -128.69 123.56 33.42 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.294 -0.412 . . . . 44.240000000000002 110.875 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.702 HG22 HG12 ' B' ' 78' ' ' VAL . 39.7 t -109.58 114.27 46.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.26 -0.427 . . . . 74.120000000000005 111.342 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.434 ' HE2' ' HB2' ' B' ' 72' ' ' TRP . 0.3 OUTLIER -93.57 122.72 36.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 110.17 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' B' ' 28' ' ' TYR . 7.1 t80 -94.74 139.9 30.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.458 -0.337 . . . . 62.119999999999997 110.447 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 84.3 m -126.75 116.51 21.04 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.873 0.368 . . . . 73.010000000000005 111.742 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.473 ' O ' " H3'" ' B' ' 187' ' ' 5GP . . . -144.33 131.01 4.18 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.954 -0.566 . . . . 54.420000000000002 112.235 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.496 ' N ' HG21 ' B' ' 90' ' ' VAL . 66.6 p -63.28 120.16 11.02 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.673 0.236 . . . . 44.130000000000003 110.423 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.686 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.5 OUTLIER -106.33 -42.07 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.503 -0.317 . . . . 75.200000000000003 111.402 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.448 ' N ' HG12 ' B' ' 18' ' ' ILE . 2.1 mtm105 52.78 40.84 31.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.15 0.5 . . . . 74.319999999999993 110.53 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.475 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 63.86 26.16 69.82 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 112.621 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.79 157.95 23.88 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.881 -0.676 . . . . 45.100000000000001 113.237 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -101.1 14.32 32.36 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.437 0.16 . . . . 73.540000000000006 111.37 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.59 -15.9 20.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.572 0.225 . . . . 74.239999999999995 111.483 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.68 -26.49 17.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.571 -0.286 . . . . 72.25 110.807 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.39 -45.18 84.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.637 -0.256 . . . . 75.310000000000002 110.793 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.3 96.75 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.45 -0.341 . . . . 64.129999999999995 110.76 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.419 HD21 ' OE1' ' B' ' 82' ' ' GLU . 25.2 tp -69.94 -37.84 75.99 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.174 -0.466 . . . . 71.230000000000004 110.463 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.614 ' CE1' HG21 ' B' ' 43' ' ' THR . 2.0 m-85 -67.29 -36.41 81.48 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 115.924 -0.58 . . . . 75.019999999999996 111.837 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.68 86.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.602 0.239 . . . . 72.340000000000003 111.275 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -74.79 -35.62 62.51 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.456 -0.338 . . . . 74.319999999999993 111.586 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.547 ' O ' HD22 ' B' ' 35' ' ' LEU . 2.2 pp -77.04 -32.88 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 121.07 -0.252 . . . . 73.030000000000001 110.833 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.78 HG13 HG11 ' B' ' 41' ' ' VAL . 2.8 t -62.12 -38.92 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.496 -0.32 . . . . 73.099999999999994 110.633 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 3.5 t -68.76 -38.35 80.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.67 -0.241 . . . . 75.510000000000005 110.81 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.05 -37.93 72.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.547 HD22 ' O ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -69.37 -38.62 78.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.344 -0.389 . . . . 71.239999999999995 110.907 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -70.22 -33.35 71.56 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.332 -0.394 . . . . 72.439999999999998 110.972 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -41.16 75.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.358 -0.383 . . . . 63.310000000000002 111.325 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -57.83 3.91 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.642 -0.254 . . . . 72.329999999999998 110.561 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' B' ' 10' ' ' ARG . . . -147.98 -82.91 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 73.329999999999998 112.034 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -145.87 137.48 25.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.709 0.29 . . . . 74.450000000000003 111.009 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.78 HG11 HG13 ' B' ' 32' ' ' VAL . 13.0 p -107.25 141.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.644 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' B' ' 11' ' ' SER . 3.3 mm? -99.02 -122.11 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.683 -0.488 . . . . 71.319999999999993 109.683 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.614 HG21 ' CE1' ' B' ' 28' ' ' TYR . 0.2 OUTLIER 26.06 47.06 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.919 0.888 . . . . 72.420000000000002 112.609 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.74 87.4 6.98 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.266 -0.879 . . . . 51.340000000000003 110.749 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' B' ' 46' ' ' VAL . 51.2 p-80 -179.58 -37.83 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.74 -0.664 . . . . 64.409999999999997 111.084 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -61.29 -12.9 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.127 -0.488 . . . . 43.299999999999997 112.207 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.41 46.58 2.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.406 0.521 . . . . 54.140000000000001 112.406 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.79 142.34 46.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.882 0.372 . . . . 73.099999999999994 110.909 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -123.19 53.93 1.28 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 61.350000000000001 110.461 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 37.2 tt0 167.25 69.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.404 -1.271 . . . . 73.439999999999998 109.738 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.5 104.11 0.09 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.699 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.84 83.09 13.86 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.048 -0.524 . . . . 73.120000000000005 111.8 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.12 -167.74 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.97 2.447 . . . . 73.5 112.279 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.08 149.73 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 70.420000000000002 111.384 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.74 148.53 19.45 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.122 -0.561 . . . . 62.340000000000003 112.967 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.7 115.91 14.81 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.664 0.268 . . . . 52.520000000000003 110.635 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -130.9 177.23 7.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 75.25 111.216 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.572 ' HB3' ' HG2' ' B' ' 63' ' ' GLN . . . -64.63 160.41 19.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.985 -0.552 . . . . 74.329999999999998 111.414 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.83 120.9 9.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.113 -0.494 . . . . 63.140000000000001 111.482 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.84 141.74 12.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.124 -0.56 . . . . 75.150000000000006 112.771 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.01 -7.46 84.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.339 -0.458 . . . . 65.109999999999999 113.358 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.653 ' HA ' HD12 ' B' ' 65' ' ' ILE . 6.9 p-10 -55.95 -46.01 78.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.958 0.379 . . . . 55.530000000000001 111.077 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.572 ' HG2' ' HB3' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -59.87 -37.91 80.68 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 110.674 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -65.5 -35.43 80.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.348 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.922 HG23 ' C5 ' ' B' ' 187' ' ' 5GP . 4.1 mt -59.84 -42.86 90.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.049 -0.523 . . . . 74.099999999999994 110.645 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 123' ' ' ALA . 17.9 t-80 -69.02 -38.43 79.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.903 -0.59 . . . . 73.219999999999999 111.238 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -37.94 82.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.725 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.46 ' HB3' HN21 ' B' ' 187' ' ' 5GP . 1.4 mp0 -67.64 -38.12 83.39 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.598 0.221 . . . . 75.049999999999997 111.598 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.84 80.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.686 -0.234 . . . . 61.119999999999997 111.524 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' B' ' 96' ' ' ARG . 3.0 mm? -66.51 -40.15 89.05 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 111.456 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.5 -37.11 77.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.372 -0.376 . . . . 73.030000000000001 111.772 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.526 ' CZ3' ' N2 ' ' B' ' 187' ' ' 5GP . 53.2 m0 -74.33 -35.43 63.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.568 -0.287 . . . . 72.109999999999999 111.386 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' B' ' 97' ' ' ALA . 0.2 OUTLIER -69.98 -30.81 68.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.612 -0.267 . . . . 63.039999999999999 111.186 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.71 -41.43 81.71 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.507 -0.315 . . . . 74.040000000000006 110.91 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -89.84 -25.62 20.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 111.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' B' ' 11' ' ' SER . . . -60.65 108.0 0.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.877 0.37 . . . . 72.349999999999994 111.564 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.26 -23.41 61.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.803 -0.635 . . . . 72.450000000000003 111.053 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.702 HG12 HG22 ' B' ' 12' ' ' VAL . 0.3 OUTLIER -145.11 139.85 22.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 73.5 110.923 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' B' ' 104' ' ' ILE . 56.8 t -115.9 134.36 59.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.023 -0.535 . . . . 75.25 110.666 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -127.76 131.32 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 110.244 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.77 146.63 45.49 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.753 0.311 . . . . 55.299999999999997 111.744 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 4.6 tt0 -140.24 103.19 4.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.045 -0.525 . . . . 62.229999999999997 110.904 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.94 141.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.434 -0.348 . . . . 72.530000000000001 111.327 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.888 HG22 ' HB2' ' B' ' 109' ' ' ARG . 33.3 p -105.51 26.23 9.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.304 -0.407 . . . . 74.120000000000005 111.612 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' B' ' 86' ' ' PRO . 9.5 pt20 -171.74 158.16 4.5 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.619 0.247 . . . . 64.310000000000002 111.185 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.799 ' HA ' HD12 ' A' ' 88' ' ' LEU . 19.8 Cg_endo -59.65 98.41 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 75.549999999999997 112.166 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . 0.407 ' OG ' ' HB ' ' B' ' 90' ' ' VAL . 2.6 p -98.87 123.76 43.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.915 -0.584 . . . . 54.32 110.904 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -71.33 -52.37 19.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.003 -0.544 . . . . 73.549999999999997 111.358 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.518 ' HA3' ' O1P' ' B' ' 187' ' ' 5GP . . . -61.76 -43.41 99.27 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.913 -0.66 . . . . 71.010000000000005 112.617 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.496 HG21 ' N ' ' B' ' 17' ' ' SER . 23.6 t -67.28 -40.14 84.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 110.306 -0.257 . . . . 53.350000000000001 110.306 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 88' ' ' LEU . . . -59.49 -35.22 84.58 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.124 -0.791 . . . . 55.25 111.124 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.671 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 12.7 t80 -64.3 -43.55 94.38 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.98 -0.378 . . . . 73.420000000000002 109.98 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.16 -39.59 94.32 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 71.409999999999997 110.525 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.17 -40.41 90.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 60.219999999999999 110.627 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.663 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -66.38 -39.2 94.13 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.952 -0.642 . . . . 73.019999999999996 111.856 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.513 ' HD2' HD11 ' B' ' 70' ' ' LEU . 13.1 ttp-105 -71.98 -30.56 65.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.6 0.238 . . . . 70.25 110.628 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.549 ' HA ' HD21 ' B' ' 73' ' ' LEU . . . -68.71 -37.28 79.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.253 -0.431 . . . . 53.409999999999997 111.605 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.493 HG21 ' OH ' ' A' ' 92' ' ' TYR . 15.8 t -73.31 -36.43 49.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.6 0.238 . . . . 74.109999999999999 110.86 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.14 63.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.38 -0.373 . . . . 71.010000000000005 111.158 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.432 HD13 ' C ' ' B' ' 100' ' ' LEU . 3.2 tm? -84.92 -55.84 3.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.348 -0.387 . . . . 60.439999999999998 111.277 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -96.09 -127.59 5.42 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.13 -0.557 . . . . 64.530000000000001 112.758 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 -61.49 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.577 0.214 . . . . 65.230000000000004 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.648 ' HB2' HG23 ' B' ' 78' ' ' VAL . 60.6 Cg_endo -72.89 94.16 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.369 2.046 . . . . 74.109999999999999 112.535 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB1' ' B' ' 97' ' ' ALA . 28.1 mm -110.53 149.2 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.03 -0.532 . . . . 65.310000000000002 111.642 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.699 HD13 ' N ' ' B' ' 106' ' ' CYS . 0.8 OUTLIER -129.73 140.36 51.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 70.430000000000007 110.652 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.721 ' HB3' HG13 ' B' ' 131' ' ' VAL . 0.0 OUTLIER -130.43 132.94 45.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.286 -0.415 . . . . 51.119999999999997 110.587 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' B' ' 82' ' ' GLU . 12.6 mt -120.41 103.73 9.43 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.477 -0.329 . . . . 73.150000000000006 111.217 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 16.3 t80 -111.89 143.42 42.88 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.069 -0.514 . . . . 64.200000000000003 110.899 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.888 ' HB2' HG22 ' B' ' 84' ' ' THR . 16.2 ttm180 -87.31 115.45 62.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.613 -0.267 . . . . 65.230000000000004 111.229 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.653 ' HG3' ' HB3' ' B' ' 133' ' ' ASP . 90.2 Cg_endo -77.91 67.56 7.99 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.829 2.352 . . . . 64.5 111.752 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 165.21 -15.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.602 -0.726 . . . . 70.400000000000006 112.392 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' B' ' 109' ' ' ARG . 90.3 p -47.81 -32.28 5.89 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.695 0.258 . . . . 72.200000000000003 111.695 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.25 -36.06 3.97 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.909 -0.663 . . . . 63.539999999999999 112.177 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -85.92 -174.54 5.16 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.296 0.569 . . . . 74.129999999999995 110.426 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.21 161.35 3.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.341 -0.845 . . . . 73.239999999999995 111.35 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.719 HD22 HG21 ' B' ' 120' ' ' ILE . 2.9 mt -78.49 -94.4 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 110.564 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.549 ' HB2' ' O1P' ' A' ' 187' ' ' 5GP . 2.3 p 168.78 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.825 0.345 . . . . 74.540000000000006 111.283 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.68 77.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.98 -0.555 . . . . 62.210000000000001 111.321 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.44 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 10.0 tpt -66.75 -41.15 88.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.516 -0.311 . . . . 73.349999999999994 110.535 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.721 HD11 HD22 ' A' ' 88' ' ' LEU . 31.9 mm -66.55 -47.64 82.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.408 -0.36 . . . . 41.210000000000001 110.594 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -61.62 -41.34 97.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 74.019999999999996 110.058 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.88 -36.31 92.94 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.886 -0.597 . . . . 71.319999999999993 112.105 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . . . -57.07 -37.13 71.4 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.481 0.182 . . . . 64.5 110.814 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.02 75.89 2.22 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.127 0.489 . . . . 63.049999999999997 110.549 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -15.9 58.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.684 -0.689 . . . . 73.140000000000001 111.626 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.78 -9.67 66.21 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.951 -0.642 . . . . 74.319999999999993 112.408 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -71.09 0.21 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.825 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' B' ' 156' ' ' HIS . 7.8 mmt85 -133.65 10.53 4.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.783 -0.644 . . . . 75.0 112.26 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -120.93 122.83 41.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.696 0.284 . . . . 71.310000000000002 110.708 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.03 140.86 52.26 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.217 -0.447 . . . . 75.349999999999994 110.88 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' B' ' 106' ' ' CYS . 52.5 t -124.65 91.69 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.281 -0.418 . . . . 74.430000000000007 111.172 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 33.4 m0 -83.18 145.63 29.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.246 -0.434 . . . . 73.209999999999994 111.162 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' B' ' 110' ' ' PRO . 1.8 m-20 -97.74 120.05 37.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 72.040000000000006 109.948 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.572 ' CD2' ' HB ' ' B' ' 139' ' ' VAL . 12.1 p90 -116.33 143.13 45.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.076 0.465 . . . . 64.129999999999995 111.868 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.53 160.52 14.28 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.666 -0.697 . . . . 74.430000000000007 109.645 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 104.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 109.996 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.13 13.74 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.784 -0.644 . . . . 63.240000000000002 111.947 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.08 -16.43 26.41 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 122.72 0.408 . . . . 71.420000000000002 111.295 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 11.5 p -50.29 -41.03 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.889 0.329 . . . . 72.409999999999997 111.889 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -38.1 88.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 45.310000000000002 110.284 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 4.6 m -69.14 -37.34 78.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.005 -0.543 . . . . 71.430000000000007 110.72 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' B' ' 142' ' ' MET . 4.2 mmm -69.39 -38.69 78.11 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 110.962 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.08 -40.45 90.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.37 -0.377 . . . . 73.140000000000001 111.154 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.41 -36.63 68.68 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.337 -0.392 . . . . 75.239999999999995 110.95 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -74.35 -34.45 63.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.341 -0.391 . . . . 72.299999999999997 110.804 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.472 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 8.2 t80 -68.72 -39.9 80.21 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.34 -0.391 . . . . 73.0 110.983 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' B' ' 12' ' ' VAL . 0.2 OUTLIER -75.15 -34.67 61.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.536 -0.302 . . . . 70.340000000000003 111.314 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.476 ' O ' HG23 ' B' ' 152' ' ' VAL . 27.7 tt0 -77.98 -35.76 49.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.378 -0.373 . . . . 73.120000000000005 111.123 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.07 61.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.473 -0.33 . . . . 53.020000000000003 111.257 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' B' ' 146' ' ' TYR . 0.1 OUTLIER -70.02 -40.56 75.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.422 -0.354 . . . . 71.319999999999993 110.787 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tp -71.5 -36.25 71.04 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 70.040000000000006 111.19 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 148' ' ' GLU . 75.4 t -71.85 -38.15 64.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.366 -0.379 . . . . 71.129999999999995 111.19 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.28 -30.97 38.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.269 -0.423 . . . . 73.25 111.49 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m80 63.85 20.28 12.14 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.618 -0.264 . . . . 71.439999999999998 111.367 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 177.79 -178.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.411 -0.359 . . . . 75.329999999999998 110.429 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . 0.537 ' HB3' ' HA ' ' B' ' 128' ' ' ARG . 0.2 OUTLIER -118.07 138.9 51.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 110.774 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 168.71 19.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 111.091 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -60.1 148.04 37.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 111.375 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.155 -0.926 . . . . 74.209999999999994 111.144 179.833 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.906 ' C5 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.922 ' C5 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.529 0.204 . . . . 64.340000000000003 111.423 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -129.35 134.57 47.96 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.399 -0.364 . . . . 74.450000000000003 111.037 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.48 127.46 43.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.076 -0.511 . . . . 64.219999999999999 110.738 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 m -113.71 123.3 49.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.253 -0.43 . . . . 34.210000000000001 111.342 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG13 ' A' ' 78' ' ' VAL . 32.7 t -102.82 121.5 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.025 -0.534 . . . . 62.399999999999999 110.877 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 43' ' ' THR . 1.4 t80 -101.0 117.36 34.88 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.751 0.31 . . . . 61.100000000000001 110.488 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.52 ' CG ' HD13 ' A' ' 31' ' ' ILE . 15.3 t80 -100.41 136.45 40.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.7 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.77 135.74 49.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 110.827 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.28 24.83 1.24 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.561 -0.828 . . . . 64.150000000000006 114.066 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.615 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 84.0 p 52.1 103.24 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.84 0.456 . . . . 72.109999999999999 111.707 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.666 HG21 HG11 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.69 -40.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 120.716 0.294 . . . . 73.299999999999997 111.02 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.4 mpp_? 50.28 41.5 24.41 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.303 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 61.52 26.97 67.22 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.258 -0.883 . . . . 63.539999999999999 112.565 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.2 155.01 21.7 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.794 -0.717 . . . . 54.109999999999999 113.253 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 11.83 37.61 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.565 -0.317 . . . . 60.130000000000003 111.274 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.97 -9.74 20.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.174 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -27.97 14.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 110.685 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.57 -44.43 80.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.388 -0.369 . . . . 53.25 110.899 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.63 94.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.494 -0.321 . . . . 63.200000000000003 110.82 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.39 -35.96 68.57 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.389 -0.368 . . . . 64.400000000000006 110.465 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.697 ' CD1' HG21 ' A' ' 46' ' ' VAL . 2.6 m-85 -67.79 -35.97 79.62 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 115.982 -0.553 . . . . 72.140000000000001 111.482 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.16 -40.17 82.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.246 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.14 73.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.289 -0.414 . . . . 73.420000000000002 111.263 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD13 ' CG ' ' A' ' 14' ' ' PHE . 2.7 pp -76.12 -30.33 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.55 0.214 . . . . 63.210000000000001 110.873 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.88 HG22 HG21 ' A' ' 41' ' ' VAL . 2.5 t -66.65 -38.7 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.44 -0.345 . . . . 62.109999999999999 110.779 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 t -65.69 -40.65 92.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.553 -0.294 . . . . 62.240000000000002 110.834 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -72.12 -37.04 69.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.292 -0.413 . . . . 74.200000000000003 110.967 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 31' ' ' ILE . 6.3 mp -69.6 -39.02 77.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.266 -0.425 . . . . 70.439999999999998 110.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 1.6 mmm180 -70.25 -34.01 72.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.286 -0.415 . . . . 72.349999999999994 110.857 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -35.35 73.96 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.348 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.69 -55.98 4.62 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 110.535 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.69 -89.09 0.1 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.917 -0.659 . . . . 60.109999999999999 112.29 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 129.84 12.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.548 0.213 . . . . 73.439999999999998 111.321 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.88 HG21 HG22 ' A' ' 32' ' ' VAL . 5.9 p -85.13 144.04 10.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.674 -0.239 . . . . 75.219999999999999 110.54 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 72' ' ' TRP . 31.1 mt -111.1 11.69 21.97 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.895 0.332 . . . . 73.319999999999993 111.895 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.57 ' H ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -134.22 58.89 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.224 0.535 . . . . 74.230000000000004 110.776 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 41' ' ' VAL . 2.1 mt-10 -89.84 -31.86 17.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.849 -0.614 . . . . 60.539999999999999 110.801 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.5 ' CD2' ' C2 ' ' A' ' 187' ' ' 5GP . 48.8 p-80 -50.97 -37.22 43.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 50.439999999999998 112.147 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG21 ' CD1' ' A' ' 28' ' ' TYR . 0.1 OUTLIER -58.55 -15.94 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.222 -0.445 . . . . 71.530000000000001 112.118 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.21 70.34 1.47 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.692 0.256 . . . . 61.039999999999999 111.692 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.91 120.21 17.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.162 0.506 . . . . 72.530000000000001 111.194 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . -101.68 58.76 0.85 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.344 0.592 . . . . 72.129999999999995 110.471 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 32.3 tt0 171.13 68.3 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.842 -1.072 . . . . 74.230000000000004 110.114 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.42 110.18 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 70.420000000000002 110.971 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.87 78.44 65.16 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.438 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.04 -166.61 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.952 2.435 . . . . 33.119999999999997 112.427 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.77 149.81 22.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.541 -0.754 . . . . 65.340000000000003 111.331 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.68 -172.52 27.39 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.182 -0.533 . . . . 42.520000000000003 112.747 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 118.19 6.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.822 0.344 . . . . 72.230000000000004 110.995 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.69 165.38 26.03 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.021 -0.536 . . . . 73.329999999999998 110.768 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -78.13 79.8 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.138 -0.483 . . . . 62.25 111.06 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 58' ' ' ALA . . . 71.1 116.19 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.82 -0.627 . . . . 72.400000000000006 111.772 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.14 147.79 18.88 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.865 -0.607 . . . . 73.319999999999993 112.301 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.1 -96.54 0.1 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.853 -0.689 . . . . 73.420000000000002 112.774 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.791 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.8 p-10 -58.98 -46.93 86.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.396 0.141 . . . . 65.219999999999999 111.192 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.33 -42.14 86.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.632 -0.258 . . . . 75.540000000000006 110.781 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.78 -36.89 80.13 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.487 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 62' ' ' ASP . 62.6 mt -60.63 -41.4 87.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.185 -0.461 . . . . 51.310000000000002 110.533 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -67.74 -38.8 83.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.785 -0.643 . . . . 60.030000000000001 111.001 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -66.15 -39.47 89.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.222 -0.445 . . . . 72.519999999999996 111.387 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -66.53 -39.9 88.86 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.337 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.165 -0.47 . . . . 44.520000000000003 112.021 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.673 HD21 ' CZ ' ' A' ' 96' ' ' ARG . 3.9 mm? -68.12 -38.65 82.47 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.702 -0.226 . . . . 51.409999999999997 111.27 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.89 -37.78 79.21 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.398 -0.364 . . . . 55.450000000000003 111.509 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 13.1 m0 -68.95 -38.39 79.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.481 -0.327 . . . . 71.019999999999996 111.479 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.66 -17.4 53.8 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.57 -0.287 . . . . 51.32 111.718 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.532 ' HA ' HD21 ' A' ' 100' ' ' LEU . 5.6 mt-30 -57.78 -33.98 69.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.452 0.168 . . . . 73.120000000000005 111.069 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.29 6.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.741 0.305 . . . . 75.340000000000003 111.303 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 111.63 22.05 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.931 0.396 . . . . 64.209999999999994 111.403 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.91 -22.4 65.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.731 -0.668 . . . . 74.25 110.885 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 150' ' ' TYR . 13.2 p -169.94 141.22 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.939 0.399 . . . . 64.439999999999998 111.435 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 104' ' ' ILE . 26.5 t -114.93 133.81 59.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 110.56 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -124.06 130.38 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.424 -0.353 . . . . 51.340000000000003 110.08 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -117.84 153.29 33.75 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.265 0.469 . . . . 60.109999999999999 112.265 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' HG3' ' CB ' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -140.01 92.44 2.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.415 -0.811 . . . . 74.409999999999997 110.18 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 90' ' ' VAL . 2.2 t -141.54 129.46 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.118 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 109' ' ' ARG . 27.2 p -95.58 24.04 5.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.314 -0.403 . . . . 70.120000000000005 111.734 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.59 157.62 6.69 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.533 0.206 . . . . 61.5 111.069 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.02 95.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.767 2.311 . . . . 65.120000000000005 112.062 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.84 123.57 37.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.799 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.842 ' HG ' HD23 ' B' ' 116' ' ' LEU . 1.0 OUTLIER -66.37 -49.03 68.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 74.219999999999999 111.512 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' B' ' 119' ' ' MET . . . -65.83 -41.91 95.34 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.028 -0.606 . . . . 71.439999999999998 112.832 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 59.9 t -72.36 -36.33 54.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.539 0.169 . . . . 73.109999999999999 110.83 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.52 77.97 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.088 -0.805 . . . . 33.229999999999997 111.088 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.664 ' CZ ' ' HA2' ' B' ' 95' ' ' GLY . 8.3 t80 -67.22 -44.68 78.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.787 0.435 . . . . 74.239999999999995 110.202 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.1 -35.8 74.42 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.818 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 81' ' ' ALA . 20.5 mt -69.07 -38.51 79.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.325 -0.398 . . . . 64.030000000000001 111.111 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.652 ' HA2' ' CZ ' ' B' ' 92' ' ' TYR . . . -65.52 -40.3 96.07 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.621 -0.8 . . . . 53.210000000000001 112.259 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.673 ' CZ ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -74.74 -25.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.499 0.19 . . . . 72.510000000000005 110.617 178.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 79' ' ' VAL . . . -68.26 -36.38 79.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.08 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.677 HG23 HG13 ' A' ' 104' ' ' ILE . 4.4 t -73.19 -37.73 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.639 0.256 . . . . 75.030000000000001 110.7 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.68 66.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.27 -0.423 . . . . 44.32 111.269 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' GLN . 13.9 tp -81.4 -57.59 3.41 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.287 -0.415 . . . . 62.130000000000003 110.74 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.21 -117.15 2.82 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.213 -0.518 . . . . 71.319999999999993 112.275 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.79 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 N-CA-C 111.469 0.174 . . . . 71.140000000000001 111.469 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 Cg_endo -71.16 96.04 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.538 2.159 . . . . 60.43 112.752 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.677 HG13 HG23 ' A' ' 98' ' ' VAL . 35.0 mm -111.09 149.21 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.873 -0.603 . . . . 73.109999999999999 111.58 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.726 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.12 141.79 51.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.008 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.534 ' H ' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -135.29 126.88 28.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.472 -0.331 . . . . 73.310000000000002 111.274 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 134' ' ' TYR . 1.6 mm? -110.25 100.38 9.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.343 -0.39 . . . . 74.010000000000005 110.717 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 9.1 t80 -107.8 115.16 29.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 110.509 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 84' ' ' THR . 0.8 OUTLIER -58.81 121.85 57.42 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 61.009999999999998 111.543 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' CG ' ' HB3' ' A' ' 133' ' ' ASP . 21.0 Cg_endo -66.71 129.41 20.97 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.341 2.027 . . . . 43.5 111.245 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.22 25.71 2.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.972 -0.558 . . . . 73.129999999999995 111.056 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.31 -30.12 71.31 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.347 . . . . 53.130000000000003 111.261 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.61 -37.41 3.23 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.141 -0.552 . . . . 74.510000000000005 112.075 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.26 -177.44 3.52 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 110.849 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.1 t -149.46 151.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 74.439999999999998 110.705 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' B' ' 88' ' ' LEU . 1.4 mp -75.94 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.473 -0.331 . . . . 73.109999999999999 110.875 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' HB2' ' O2P' ' B' ' 187' ' ' 5GP . 4.4 p 171.81 -176.17 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.867 0.365 . . . . 70.120000000000005 111.165 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.11 65.32 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 111.532 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.594 ' HB3' ' HA2' ' B' ' 89' ' ' GLY . 7.9 tpt -59.51 -44.91 93.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.919 -0.128 . . . . 60.229999999999997 110.926 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 116' ' ' LEU . 5.2 tp -69.96 -36.57 69.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.61 -0.268 . . . . 74.530000000000001 111.212 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.54 -45.17 88.29 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.73 -0.47 . . . . 65.099999999999994 109.73 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' B' ' 62' ' ' ASP . . . -66.87 -37.09 91.99 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.676 -0.693 . . . . 52.420000000000002 111.97 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.56 -44.18 91.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.584 0.23 . . . . 72.530000000000001 110.601 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 129' ' ' PHE . . . -78.6 81.54 4.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.977 0.418 . . . . 54.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -78.48 -17.34 56.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.829 -0.623 . . . . 62.43 111.362 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.25 44.58 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.976 -0.631 . . . . 72.209999999999994 113.489 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 158' ' ' HIS . 1.9 m -68.41 -77.34 0.08 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.264 0.532 . . . . 41.149999999999999 111.05 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.662 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -107.49 -12.28 15.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.91 -0.586 . . . . 75.340000000000003 111.738 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.4 t80 -106.82 118.67 37.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.701 0.286 . . . . 72.299999999999997 110.858 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.81 146.23 49.88 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.914 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 106' ' ' CYS . 21.2 t -130.65 102.22 6.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.279 -0.419 . . . . 60.310000000000002 111.184 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 146' ' ' TYR . 46.8 m0 -96.0 153.2 17.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 74.150000000000006 111.582 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.1 m-20 -103.11 121.1 41.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.58 ' HB3' HD12 ' A' ' 107' ' ' LEU . 14.9 p90 -119.75 122.29 41.09 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.054 0.454 . . . . 73.420000000000002 111.611 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' H ' ' HB2' ' A' ' 138' ' ' GLU . . . -95.4 93.27 7.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.069 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 48.01 -95.97 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 113.252 0.834 . . . . 72.239999999999995 113.252 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.82 -2.37 1.81 Allowed Glycine 0 C--N 1.305 -1.19 0 CA-C-N 114.927 -1.033 . . . . 70.219999999999999 113.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 135' ' ' ALA . 0.6 OUTLIER -93.53 -10.86 33.41 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.205 0.503 . . . . 73.109999999999999 112.042 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.574 ' HB ' ' CD2' ' A' ' 134' ' ' TYR . 5.3 p -58.99 -32.69 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.747 0.308 . . . . 62.43 111.468 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -39.24 62.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.561 . . . . 73.239999999999995 110.366 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.7 -37.39 73.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.012 -0.54 . . . . 70.25 110.909 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -69.33 -39.08 78.4 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.231 -0.44 . . . . 64.400000000000006 110.866 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 143' ' ' LEU . 2.8 tp -71.25 -37.43 71.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.218 -0.446 . . . . 75.340000000000003 110.964 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.52 -40.14 80.9 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.378 -0.374 . . . . 73.519999999999996 110.601 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -72.0 -35.09 69.35 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.035 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 132' ' ' TRP . 13.9 t80 -69.65 -39.08 77.32 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.395 -0.366 . . . . 62.229999999999997 110.953 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.43 -33.69 48.36 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.581 -0.282 . . . . 75.540000000000006 110.757 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.28 -38.06 66.05 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 152' ' ' VAL . . . -74.73 -25.3 59.03 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.416 -0.357 . . . . 72.230000000000004 111.045 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -73.54 -41.04 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.369 -0.378 . . . . 73.549999999999997 110.848 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.49 -36.51 76.58 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.964 -0.562 . . . . 73.329999999999998 111.466 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 149' ' ' ALA . 8.0 p -74.98 -34.05 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.817 0.303 . . . . 73.510000000000005 111.817 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -80.07 -34.12 38.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.712 -0.222 . . . . 75.340000000000003 110.938 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.97 16.98 10.29 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.56 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 179.61 175.08 0.77 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.742 0.306 . . . . 61.549999999999997 111.088 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.02 109.77 11.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.803 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.46 -178.59 4.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 111.078 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 127' ' ' SER . 56.1 m80 -44.41 115.58 0.88 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.153 -0.476 . . . . 65.030000000000001 111.336 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.146 -0.931 . . . . 74.340000000000003 111.165 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.571 0.224 . . . . 74.319999999999993 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -129.35 134.59 47.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.456 -0.338 . . . . 74.239999999999995 111.041 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -97.49 127.46 43.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 71.120000000000005 110.757 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.1 m -113.69 123.28 49.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.254 -0.43 . . . . 72.510000000000005 111.286 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.531 HG13 HG13 ' B' ' 78' ' ' VAL . 32.7 t -102.78 121.54 54.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.073 -0.512 . . . . 74.530000000000001 110.853 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.496 ' CE1' HG23 ' B' ' 43' ' ' THR . 1.4 t80 -101.02 117.36 34.87 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.776 0.322 . . . . 54.350000000000001 110.49 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.515 ' CG ' HD13 ' B' ' 31' ' ' ILE . 15.5 t80 -100.4 136.51 40.17 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.698 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 94.4 m -128.81 135.75 49.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.849 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.41 24.95 1.23 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.478 -0.867 . . . . 52.130000000000003 113.967 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.609 ' HB3' ' CG2' ' B' ' 90' ' ' VAL . 84.1 p 51.96 103.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.986 0.514 . . . . 72.349999999999994 111.683 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.661 HG21 ' CG1' ' B' ' 46' ' ' VAL . 0.3 OUTLIER -96.82 -40.72 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.593 -0.276 . . . . 53.530000000000001 111.015 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.517 ' N ' HG12 ' B' ' 18' ' ' ILE . 3.4 mpp_? 50.34 41.45 24.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.755 -0.657 . . . . 75.540000000000006 110.248 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.473 ' H ' HG13 ' B' ' 18' ' ' ILE . . . 61.57 26.99 67.33 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.358 -0.837 . . . . 64.409999999999997 112.466 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.18 154.98 21.69 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 120.855 -0.688 . . . . 42.420000000000002 113.307 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 11.67 37.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.664 -0.268 . . . . 73.299999999999997 111.287 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -101.88 -9.7 20.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.607 0.241 . . . . 75.120000000000005 111.192 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.38 -28.02 14.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.291 -0.413 . . . . 65.019999999999996 110.69 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.6 -44.34 81.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.314 -0.403 . . . . 73.200000000000003 110.909 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.61 94.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 62.329999999999998 110.904 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.37 -35.97 68.63 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.325 -0.398 . . . . 72.099999999999994 110.509 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.696 ' CD1' HG21 ' B' ' 46' ' ' VAL . 2.6 m-85 -67.9 -35.85 79.2 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.979 -0.555 . . . . 60.409999999999997 111.422 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.12 82.55 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.607 0.242 . . . . 51.310000000000002 111.308 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -38.19 73.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.296 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' B' ' 14' ' ' PHE . 2.7 pp -76.1 -30.34 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.696 -0.229 . . . . 74.510000000000005 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.884 HG22 HG21 ' B' ' 41' ' ' VAL . 2.5 t -66.63 -38.8 82.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.412 -0.358 . . . . 71.340000000000003 110.77 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.4 t -65.62 -40.57 92.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.561 -0.29 . . . . 75.420000000000002 110.864 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -72.18 -37.01 69.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.295 -0.412 . . . . 74.310000000000002 110.959 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 31' ' ' ILE . 6.3 mp -69.55 -39.11 77.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.245 -0.434 . . . . 65.239999999999995 110.993 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' HB ' ' B' ' 41' ' ' VAL . 1.6 mmm180 -70.22 -33.93 72.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 110.874 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.35 74.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.248 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.65 -55.96 4.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.579 -0.282 . . . . 75.400000000000006 110.589 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -143.77 -89.01 0.1 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.93 -0.653 . . . . 72.5 112.312 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 129.65 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.496 0.189 . . . . 74.140000000000001 111.343 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.884 HG21 HG22 ' B' ' 32' ' ' VAL . 5.9 p -84.98 144.03 10.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.707 -0.224 . . . . 73.329999999999998 110.575 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 72' ' ' TRP . 31.6 mt -111.12 11.7 21.94 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.886 0.328 . . . . 73.340000000000003 111.886 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.573 ' H ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -134.16 58.85 1.75 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.229 0.538 . . . . 71.510000000000005 110.839 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.46 ' HG3' HG11 ' B' ' 41' ' ' VAL . 2.1 mt-10 -89.86 -31.76 17.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.806 -0.634 . . . . 74.040000000000006 110.802 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' HIS . . . . . 0.503 ' CD2' ' C2 ' ' B' ' 187' ' ' 5GP . 48.8 p-80 -50.93 -37.35 43.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 64.109999999999999 112.149 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.696 HG21 ' CD1' ' B' ' 28' ' ' TYR . 0.1 OUTLIER -58.56 -15.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.147 -0.478 . . . . 74.5 112.104 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.22 70.44 1.47 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.638 0.256 . . . . 73.519999999999996 111.688 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -135.94 120.21 17.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.095 0.474 . . . . 61.310000000000002 111.214 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 50' ' ' GLU . . . -101.7 58.81 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.254 0.549 . . . . 72.430000000000007 110.495 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 32.3 tt0 171.03 68.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.789 -1.096 . . . . 60.130000000000003 110.067 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.51 110.24 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.925 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.88 78.36 65.27 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.139 -0.482 . . . . 75.409999999999997 111.478 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.11 -166.63 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.952 2.435 . . . . 54.5 112.411 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.65 149.81 22.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.596 -0.729 . . . . 70.25 111.393 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.64 -172.48 27.38 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.221 -0.514 . . . . 73.329999999999998 112.754 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.61 118.14 6.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.851 0.358 . . . . 71.319999999999993 110.972 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.68 165.4 25.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.541 . . . . 64.400000000000006 110.747 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' B' ' 59' ' ' ALA . . . -78.15 79.8 4.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.018 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 58' ' ' ALA . . . 71.13 116.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.855 -0.611 . . . . 73.349999999999994 111.762 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.09 147.84 18.88 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.965 -0.561 . . . . 71.010000000000005 112.286 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.13 -96.52 0.1 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.774 -0.727 . . . . 54.439999999999998 112.726 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.806 ' HA ' HD12 ' B' ' 65' ' ' ILE . 5.8 p-10 -58.94 -46.98 86.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.487 0.184 . . . . 64.239999999999995 111.188 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -58.27 -42.24 86.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.58 -0.282 . . . . 75.239999999999995 110.68 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -60.78 -36.93 80.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.246 -0.434 . . . . 72.040000000000006 110.477 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' B' ' 62' ' ' ASP . 62.4 mt -60.65 -41.31 87.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.558 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -67.8 -38.73 83.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.81 -0.632 . . . . 73.120000000000005 111.013 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -66.2 -39.45 89.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.227 -0.442 . . . . 61.229999999999997 111.43 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -66.54 -39.89 88.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.5 -0.318 . . . . 72.420000000000002 111.228 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.58 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.282 -0.417 . . . . 32.439999999999998 112.104 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.679 HD21 ' CZ ' ' B' ' 96' ' ' ARG . 3.9 mm? -68.14 -38.77 82.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.661 -0.245 . . . . 74.109999999999999 111.246 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -68.87 -37.74 79.26 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.392 -0.367 . . . . 64.409999999999997 111.492 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 42' ' ' LEU . 13.1 m0 -68.96 -38.43 79.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.469 -0.332 . . . . 73.040000000000006 111.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 73' ' ' LEU . 12.3 mt -79.63 -17.36 53.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.463 -0.335 . . . . 73.140000000000001 111.754 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLN . . . . . 0.53 ' HA ' HD21 ' B' ' 100' ' ' LEU . 5.5 mt-30 -57.86 -33.89 69.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.51 0.195 . . . . 74.340000000000003 111.117 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -121.09 32.21 6.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.512 -0.313 . . . . 74.150000000000006 111.277 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.52 111.57 21.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 111.436 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.86 -22.39 65.99 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.644 -0.707 . . . . 71.219999999999999 110.946 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' B' ' 150' ' ' TYR . 12.9 p -169.9 141.26 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.936 0.398 . . . . 75.530000000000001 111.338 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' B' ' 104' ' ' ILE . 26.2 t -114.91 133.78 60.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.547 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' B' ' 105' ' ' LEU . 0.5 OUTLIER -124.02 130.39 73.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 110.045 -0.354 . . . . 74.109999999999999 110.045 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 94' ' ' LEU . . . -117.87 153.21 33.93 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 112.327 0.491 . . . . 51.299999999999997 112.327 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' B' ' 107' ' ' LEU . 0.1 OUTLIER -140.02 92.49 2.55 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.487 -0.778 . . . . 71.040000000000006 110.104 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' VAL . . . . . 0.565 HG21 HG11 ' B' ' 90' ' ' VAL . 2.2 t -141.56 129.56 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.136 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.667 HG22 ' HB2' ' B' ' 109' ' ' ARG . 27.1 p -95.61 24.02 5.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.309 -0.405 . . . . 62.130000000000003 111.726 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.52 157.61 6.76 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.497 0.189 . . . . 75.439999999999998 111.112 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.02 95.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.78 2.32 . . . . 63.350000000000001 112.059 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 123.51 37.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 110.804 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -66.34 -48.98 68.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 65.409999999999997 111.566 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 119' ' ' MET . . . -65.84 -41.84 95.36 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.997 -0.621 . . . . 22.23 112.882 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.609 ' CG2' ' HB3' ' B' ' 17' ' ' SER . 60.3 t -72.49 -36.21 53.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.459 0.13 . . . . 74.040000000000006 110.733 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.24 -31.48 77.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.063 -0.815 . . . . 72.329999999999998 111.063 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.652 ' CZ ' ' HA2' ' A' ' 95' ' ' GLY . 8.3 t80 -67.25 -44.65 78.89 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.811 0.444 . . . . 74.519999999999996 110.171 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -70.15 -35.87 74.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.851 -0.613 . . . . 75.129999999999995 110.793 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 81' ' ' ALA . 20.4 mt -69.12 -38.41 78.85 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.315 -0.402 . . . . 74.329999999999998 111.089 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . 0.664 ' HA2' ' CZ ' ' A' ' 92' ' ' TYR . . . -65.48 -40.34 96.17 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.673 -0.775 . . . . 74.25 112.255 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.679 ' CZ ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -74.85 -25.31 58.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.518 0.199 . . . . 73.340000000000003 110.623 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . 0.47 ' HB1' HG21 ' B' ' 79' ' ' VAL . . . -68.38 -36.3 78.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.415 -0.357 . . . . 62.439999999999998 111.107 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 104' ' ' ILE . 4.4 t -73.2 -37.79 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.642 0.258 . . . . 74.019999999999996 110.657 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.74 67.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.247 -0.433 . . . . 43.299999999999997 111.294 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 74' ' ' GLN . 13.9 tp -81.36 -57.49 3.46 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.316 -0.402 . . . . 61.240000000000002 110.813 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -94.26 -117.15 2.83 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 74.340000000000003 112.29 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -177.76 -61.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.476 0.176 . . . . 65.329999999999998 111.476 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.659 ' HA ' ' HB2' ' B' ' 128' ' ' ARG . 55.8 Cg_endo -71.22 96.04 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.456 2.104 . . . . 75.140000000000001 112.779 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.69 HG13 HG23 ' B' ' 98' ' ' VAL . 35.0 mm -111.05 149.2 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.961 -0.563 . . . . 54.130000000000003 111.562 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.721 ' HB3' HG23 ' B' ' 80' ' ' VAL . 0.2 OUTLIER -129.13 141.8 51.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.884 -0.598 . . . . 64.349999999999994 110.014 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' CYS . . . . . 0.545 ' H ' HD13 ' B' ' 105' ' ' LEU . 0.8 OUTLIER -135.32 126.9 28.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.416 -0.356 . . . . 30.199999999999999 111.155 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' B' ' 134' ' ' TYR . 1.6 mm? -110.3 100.47 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 72.140000000000001 110.739 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 133' ' ' ASP . 9.1 t80 -107.91 115.18 29.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.171 -0.468 . . . . 71.140000000000001 110.476 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ARG . . . . . 0.667 ' HB2' HG22 ' B' ' 84' ' ' THR . 0.8 OUTLIER -58.78 121.93 57.9 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.356 -0.384 . . . . 72.5 111.492 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' B' ' 133' ' ' ASP . 21.1 Cg_endo -66.77 129.38 20.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.467 2.111 . . . . 73.209999999999994 111.227 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 110' ' ' PRO . 6.1 mt-30 72.2 25.7 2.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 111.043 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 87.2 p -63.29 -30.2 71.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.47 -0.332 . . . . 52.219999999999999 111.255 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.65 -37.4 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.161 -0.542 . . . . 74.430000000000007 112.05 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.18 -177.55 3.56 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.273 0.559 . . . . 65.099999999999994 110.863 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 83.6 t -149.39 151.74 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.26 -0.882 . . . . 73.409999999999997 110.708 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.842 HD23 ' HG ' ' A' ' 88' ' ' LEU . 1.4 mp -75.99 -95.62 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.399 -0.364 . . . . 62.240000000000002 110.857 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.455 ' HB2' ' O2P' ' A' ' 187' ' ' 5GP . 4.4 p 171.78 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.894 0.378 . . . . 63.130000000000003 111.127 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.63 -30.14 65.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.136 -0.483 . . . . 73.409999999999997 111.531 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.593 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 7.9 tpt -59.57 -44.86 93.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.849 -0.159 . . . . 71.200000000000003 110.952 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.532 HG12 HD22 ' B' ' 116' ' ' LEU . 5.2 tp -69.97 -36.5 69.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.621 -0.263 . . . . 74.129999999999995 111.242 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -64.51 -45.36 87.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.705 -0.48 . . . . 72.209999999999994 109.705 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 62' ' ' ASP . . . -66.74 -37.18 92.19 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.623 -0.717 . . . . 51.439999999999998 111.999 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.12 92.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.544 0.212 . . . . 70.319999999999993 110.678 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 129' ' ' PHE . . . -78.6 81.49 4.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.309 -0.405 . . . . 74.519999999999996 110.788 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -78.47 -17.3 56.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.866 -0.606 . . . . 73.420000000000002 111.377 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.56 -16.32 44.56 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.036 -0.602 . . . . 74.420000000000002 113.548 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 158' ' ' HIS . 1.9 m -68.28 -77.4 0.08 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.161 0.481 . . . . 55.229999999999997 111.1 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -107.46 -12.24 15.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.931 -0.577 . . . . 71.409999999999997 111.819 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 124' ' ' ALA . 1.4 t80 -106.84 118.69 37.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.644 0.259 . . . . 73.019999999999996 110.832 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.84 146.2 49.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.987 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 106' ' ' CYS . 21.2 t -130.59 102.22 6.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 73.209999999999994 111.125 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.572 ' CZ3' ' HB2' ' B' ' 146' ' ' TYR . 46.7 m0 -96.01 153.3 17.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.217 0.532 . . . . 75.109999999999999 111.524 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 108' ' ' PHE . 1.1 m-20 -103.19 121.09 41.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.282 -0.872 . . . . 51.420000000000002 110.569 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . 0.584 ' HB3' HD12 ' B' ' 107' ' ' LEU . 15.3 p90 -119.73 122.34 41.22 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.993 0.425 . . . . 74.319999999999993 111.615 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' B' ' 138' ' ' GLU . . . -95.45 93.35 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 73.310000000000002 110.951 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 47.96 -95.96 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.312 0.856 . . . . 75.0 113.312 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.87 -2.31 1.82 Allowed Glycine 0 C--N 1.306 -1.137 0 CA-C-N 114.873 -1.058 . . . . 62.049999999999997 113.167 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' B' ' 135' ' ' ALA . 0.6 OUTLIER -93.59 -10.81 33.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.287 0.543 . . . . 74.239999999999995 111.999 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' B' ' 134' ' ' TYR . 5.2 p -58.92 -32.75 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.721 0.295 . . . . 64.430000000000007 111.515 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -39.33 63.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 72.230000000000004 110.372 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 5.0 m -70.61 -37.47 73.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.994 -0.548 . . . . 73.239999999999995 110.913 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 142' ' ' MET . 0.0 OUTLIER -69.29 -39.04 78.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.152 -0.476 . . . . 71.310000000000002 110.825 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 143' ' ' LEU . 2.8 tp -71.41 -37.4 71.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.312 -0.404 . . . . 72.439999999999998 110.847 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -68.51 -40.17 80.96 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.442 -0.345 . . . . 64.319999999999993 110.635 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -71.92 -35.05 69.55 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.251 -0.431 . . . . 74.049999999999997 111.047 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' TYR . . . . . 0.572 ' HB2' ' CZ3' ' B' ' 132' ' ' TRP . 13.4 t80 -69.72 -39.12 77.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.88 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.42 -33.7 48.46 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.56 -0.291 . . . . 73.349999999999994 110.699 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.12 -38.23 66.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.352 -0.385 . . . . 64.430000000000007 110.87 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' B' ' 152' ' ' VAL . . . -74.64 -25.34 59.15 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.376 -0.374 . . . . 60.439999999999998 111.1 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' TYR . . . . . 0.6 ' CE2' HG21 ' B' ' 78' ' ' VAL . 0.1 OUTLIER -73.44 -41.11 63.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.295 -0.411 . . . . 75.540000000000006 110.804 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.5 -36.51 76.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.078 -0.51 . . . . 71.310000000000002 111.414 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' B' ' 149' ' ' ALA . 8.0 p -74.96 -34.15 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.574 -0.284 . . . . 60.32 111.763 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.91 -34.28 39.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.548 0.213 . . . . 74.310000000000002 110.866 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.92 17.07 10.32 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.198 -0.455 . . . . 74.019999999999996 111.623 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 179.55 175.06 0.76 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.817 0.341 . . . . 74.409999999999997 111.088 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.92 109.75 11.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.737 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -178.55 4.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 73.209999999999994 111.174 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 127' ' ' SER . 56.3 m80 -44.43 115.61 0.88 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.465 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.167 -0.92 . . . . 70.010000000000005 111.083 -179.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' 5GP . . . . . 0.698 ' C4 ' HG23 ' A' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' 5GP . . . . . 0.686 ' C4 ' HG23 ' B' ' 65' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_